patients

Transcription

patients

Final Program
ASTRO 55TH ANNUAL MEETING
Meeting Dates: September 22-25, 2013 • Exhibit Dates: September 22-24, 2013 • Georgia World Congress Center • Atlanta
PATIENTS
Hope • Guide • Heal
Download
ASTROmobile The official
meeting app.
See 17 page for details.
ANNUAL MEE TING
S C I E N C E B A S E D, PAT I E N T D R I V E N
www.astro.org/annualmeeting
#ASTRO13
ROOM SERVICE NOW AVAILABLE
Medical centers that never considered proton therapy accessible
are now installing single-room conﬁgurations of the MEVION S250™
system. Thanks to a radically smaller footprint, lower capital outlay,
reduced operating costs, and complete system integration, advanced
proton therapy is now available at the press of a button.
Welcome to the world of High Energy Cancer Care™... for everyone.
Visit us at ASTRO 2013
Booth #1253
mevion.com
LAD130401
Final Program
Meeting Dates: September 22-25, 2013 • Exhibit Dates: September 22-24, 2013 • Georgia World Congress Center • Atlanta
PATIENTS
Hope • Guide • Heal
Download
ASTROmobile The official
meeting app.
See 17 page for details.
HELD IN CONJUNCTION WITH:
AMERICAN SOCIETY OF RADIOLOGIC TECHNOLOGISTS (ASRT)
ANNUAL MEE TING
ASSOCIATION OF RESIDENTS IN RADIATION ONCOLOGY (ARRO)
SOCIETY FOR RADIATION ONCOLOGY ADMINISTRATORS (SROA)
#ASTRO13
Welcome
TO THE 55TH ANNUAL MEETING OF
THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY
“Patients: Hope, Guide, Heal”
Dear Colleagues,
On behalf of the American Society for Radiation Oncology, I would like to welcome you to
ASTRO’s 55th Annual Meeting. We have developed an exciting program that will provide
many opportunities for exchanging scientific information as well as professional networking.
The theme this year is “Patients: Hope, Guide, Heal.” Given all of the changes we are facing
in health care, I feel that it is extremely important to keep our focus on our patients and the
best care we can provide them. With this in mind, the Annual Meeting will provide an array
of education on safety, multidisciplinary care, reimbursement, technology assessments and
the importance of registries.
The Annual Meeting program begins with the Presidential Symposium, “Prostate Cancer:
Patient Focused Advances,” on Sunday. Moderated by Deborah A. Kuban, MD, FASTRO, and
Anthony L. Zietman, MD, FASTRO, the symposium will focus on controversial and
cutting-edge issues with a patient-centered view. On Sunday afternoon, guest lecturer
Jeff A. Sloan, PhD, of the Mayo Clinic in Rochester, Minn., will help us better comprehend the
impact of patient-reported outcomes on our ability to improve patient care.
Our keynote speakers, Darrell G. Kirch, MD, Otis W. Brawley, MD, and Peter Friedl, MD, PhD, will
continue the focus on patients and help push us to better patient care (see page 45 for more
details).
The Annual Meeting Scientific Committee chairman and vice-chairman Lynn D. Wilson,
MD, MPH, FASTRO, and Benjamin Movsas, MD, FASTRO, and the Annual Meeting Education
Committee chairman and vice-chairman Andrea Ng, MD, and Catherine Park, MD, have put
together a fabulous program with 19 panel discussions, 50 educational sessions, 363 oral
presentations, 1,460 poster presentations and 144 digital posters in 19 disease site tracks.
I invite you to join me in congratulating the 2013 Gold Medalists, Honorary Member and
ASTRO Fellows during the Awards Ceremony on Tuesday at 10:15 a.m. in the Thomas Murphy
Ballroom. These colleagues have impacted us all through their work, and it is a pleasure to
recognize their achievements.
Be sure to take advantage of the opportunity to interact with our industry colleagues, who
will display the latest developments and technology in cancer treatment in the Exhibit Hall.
I hope the Annual Meeting serves as a positive professional and educational experience, and
that you are able to enjoy all of the amenities Atlanta has to offer.
Sincerely,
Colleen A. F. Lawton, MD, FASTRO
President, ASTRO
Chairman, Annual Meeting Steering Committee
2
ASTRO 2013 / 55TH ANNUAL MEE TING
Table of Contents
WELCOME TO THE 55TH ANNUAL MEETING
2
Board of Directors
Continuing Medical Education
Annual Meeting Committee Members
Abstract Reviewers
Gold Medal and Honorary Member Recipients
Fellow Recipients
Awards
4
5
7
8
9
11
12
GENERAL INFORMATION
ASTROmobile
Industry-Expert Theater
Industry Satellite Symposia
Shuttle Service
Georgia World Congress Center Floor Plans
15
17
21
22
26
29
SCHEDULE OF EVENTS
eContouring Learning Lab
Live Self-Assessment Module (SAM) Sessions
Presidential Symposium
Meeting Highlights
ARRO Program
Young Physicians’ Workshop
Nurses’ Program
International Program
ASTRO Accreditation Program for Excellence (APEx)
Schedule by Day
Saturday
Sunday
Monday
Tuesday
Wednesday
55
57
68
84
105
POSTER PRESENTATIONS
127
INDEXES
By Author
By Topic
181
190
EXHIBITOR LISTINGS
Exhibitor List
Exhibitor List by Product/Service Category
Exhibit Hall Floor Plan
203
212
216
41
42
44
45
48
50
51
52
54
Board of Directors
2013 Officers and Board of Directors
Michael L. Steinberg, MD, FASTRO
Chairman
Colleen A. F. Lawton, MD, FASTRO
President
Bruce G. Haffty, MD, FASTRO
President-elect
Phillip M. Devlin, MD
Secretary/Treasurer
Leonard L. Gunderson, MD, MS, FASTRO
Immediate Past Chairman
Council Chairmen and Vice-chairmen
Carol H. Hahn, MD
Clinical Affairs and Quality Council Chairman
Lawrence B. Marks, MD, FASTRO
Clinical Affairs and Quality Council
Vice-chairman
Laura A. Dawson, MD
Education Council Chairman
Paul M. Harari, MD, FASTRO
Education Council Vice-chairman
Bharat B. Mittal, MD, FASTRO
Government Relations Council Chairman
Geraldine M. Jacobson, MD, MBA, MPA
Government Relations Council Vice-chairman
Najeeb Mohideen, MD
Health Policy Council Chairman
Brian Kavanagh, MD, MPH
Health Policy Council Vice-chairman
Jacqueline Patricia Williams, PhD, FASTRO
Science Council Chairman
Mary K. Martel, PhD, FASTRO
Science Council Vice-chairman
Laura I. Thevenot
Chief Executive Officer
4
Continuing Medical Education
NEEDS STATEMENT
Cancer is a leading cause of death worldwide.
According to the World Health Organization (WHO),
cancer deaths worldwide are projected to continue
to rise to more than 11 million in 2030. Nearly
two-thirds of these patients will receive radiation
therapy during their illness – most with the intent to
cure the cancer. Advances in the applications,
technologies and methodologies of radiation
oncology continue to evolve rapidly and the delivery
of radiation therapy has become more complex,
making it imperative that the radiation oncology
professional remain current in state-of-the-art
techniques. The American Society for Radiation
Oncology is committed to providing educational
programming that creates a forum for global
collaboration on issues in radiation oncology to
improve professional practice by increasing their level
of knowledge, as required to improve competency in
the field of oncology.
PROGRAM DESCRIPTION AND OBJECTIVES
The scientific program will continue to be the ideal
platform to bring together clinicians, scientists and
researchers from all of the oncologic disciplines to
exchange ideas, promote multidisciplinary care
and address the educational and professional
development interests of our attendees. Scientific
and educational sessions will cover specific clinical
areas including breast, central nervous system,
gastrointestinal, genitourinary, gynecological, head
and neck, lymphoma, musculoskeletal, pediatric,
sarcoma and thoracic cancers. Radiation biology and
radiation physics concepts will also be explored.
The 2013 Annual Meeting will focus on patientreported outcomes and patient-centered care.
Patient-reported outcomes have become a clear
need in terms of understanding exactly what patients
experience both during treatment as well as in follow
up and in their survivorship. Physicians are well aware
that the traditional clinician-reported outcomes of the
past underestimate the challenges that patients
experience during their treatment and beyond.
Therefore, obtaining the “real results” via patientreported outcomes becomes paramount if we want to
provide the best care possible. The focus on patientcentered care is just as important as doctor-patient
communication and paramount in helping patients
make the best decisions for their care.
We will continue to emphasize quality and safety
issues in the delivery of radiation therapy in the areas
of treatment techniques, equipment, terminology and
professional responsibilities.
At the conclusion of this activity, the learner will be able
to:
1.
2.
3.
Evaluate methods to provide multidisciplinary
care with a focus on improving patient
outcomes.
Employ quality and safety measures in the
delivery of radiation therapy.
Summarize the importance of patient-reported
outcomes in improving patient care, and apply
lessons learned in his/her own practice.
ELEMENTS OF COMPETENCE
The Annual Meeting program has been designed
to narrow the competency gaps of patient care,
professionalism, systems-based practice,
patient-centered care, medical knowledge,
evidence-based practice, evaluation of performance
in practice, interpersonal skills and communication,
practice-based learning and improvement, utilization
of informatics, work in interdisciplinary teams, quality
improvement, professional standing and commitment
to lifelong learning, 14 of the 15 core competencies
embraced by the American Board of Medical
Specialties, the Accreditation Council for Graduate
Medical Education and the Institute of Medicine.
TARGET AUDIENCE
The Annual Meeting program is intended for all
health professionals in the field of oncology, with
particular emphasis on radiation oncologists,
radiation oncology residents, radiation biologists,
radiation physicists, oncological surgeons, medical
dosimetrists, radiation therapists, pathologists and
radiation oncology nurses.
CONTINUING MEDICAL EDUCATION
PHYSICIANS
The American Society for Radiation Oncology is
accredited by the Accreditation Council for
Continuing Medical Education to provide
continuing medical education for physicians.
CREDIT DESIGNATION
ASTRO designates this live activity for a maximum
of 35 AMA PRA Category 1 Credits™. Physicians should
claim only the credit commensurate with the extent
of their participation in the activity.
PHYSICISTS
This activity has been approved for a maximum of 35
credits by the Commission on Accreditation of
Medical Physics Education Program.
5
DOSIMETRISTS
This activity has been approved for 31.5 continuing
education credits by the Medical Dosimetrist
Certification Board.
NURSES
This activity has been submitted to the Oncology
Nursing Society (ONS) for approval to award
contact hours. ONS is accredited as an approver of
continuing nursing education by the American
Nurses Credentialing Center’s Commission on
Accreditation.
PROGRAM EVALUATION PROCESS AND
CONTINUING EDUCATION CREDITS
You must be a full-conference or one-day only
registrant to receive continuing education credits.
To receive continuing education credits, you must
submit an evaluation indicating the sessions that you
attended. All attendees will be able to complete this
evaluation online during the meeting or after the
conclusion of the meeting.
Keep track of the sessions you attended throughout
the meeting to save time in the evaluation process.
For questions regarding continuing education credits,
please visit the CE Central Booth located off the main
lobby, Level B, at the Georgia World Congress Center.
Visit the CE Central Booth or Cyber Café to complete
your online evaluation form and obtain your
certificate. The CE Central Booth is located off the
main lobby B, and the Cyber Café is located in the
Exhibit Hall. You will need your badge number to
complete the evaluation form. Please write your
badge number here for future reference:
Badge #: _________________________________
Any conflicts of interest are resolved prior to
participation. In addition to written disclosure,
presenters will disclose any vested interest
or their intention to discuss off‐label use of
pharmaceuticals or devices, if applicable, to the
audience at the beginning of their presentation and
in accordance with the ACCME standards and the
Food and Drug Administration requirements.
In an effort to increase transparency and easy access
to all disclosures, ASTRO’s Faculty, Committee and
Planner disclosure information will be available
online for the 2013 Annual Meeting. Go to the
ASTRO Annual Meeting Program Web page
www.astro.org/soe13. In addition, disclosure slides
will be shown at the beginning of each session and
every presenter is also asked to display their
disclosure. Disclosure information will not be
printed in paper versions of the meeting materials.
DISCLAIMER
ASTRO is committed to the free exchange of
medical education. Inclusion of any presentation in
this program, including presentations of off-label
uses, does not imply an endorsement by ASTRO of
the uses, products or techniques presented.
The information contained in this program is
current as of August 26, 2013, and is subject to
change. Program changes will be provided in an
addendum and posted online.
Ann Smith, MD
ASTRO
Fairfax, VA
123456
Your badge number
6
DISCLOSURE OF VESTED INTEREST
ASTRO is an accredited provider of continuing
medical education. Since our accreditation is
important to us, we plan activities that are
compliant with the Accreditation Council for
Continuing Medical Education (ACCME) and the
content or format of CME activities and related
materials will promote improvements or quality in
health care and not a specific proprietary business
interest or commercial bias. Planning Committee
members and speakers are required to disclose the
existence of any financial or other relationship with
the manufacturer(s) of any commercial product(s) or
provider(s) of any commercial services discussed in
an educational presentation.
2013 Committee Members
2012-2013 Annual Meeting Steering Committee
Colleen A. F. Lawton, MD, FASTRO, Chairman
Bruce G. Haffty, MD, FASTRO, Vice-chairman
Lynn D. Wilson, MD, MPH, FASTRO, Chairman, Scientific Committee
Benjamin Movsas, MD, FASTRO, Vice-chairman, Scientific Committee
Andrea K. Ng, MD, MPH, Chairman, Education Committee
Catherine C. Park, MD, Vice-chairman, Education Committee
Laura A. Dawson, MD, Chairman, Education Council
Lynn D. Wilson, MD, MPH, FASTRO
Theodore L. DeWeese, MD, Chairman, Best of ASTRO
Chairman, Scientific Committee
2012-2013 Annual Meeting Scientific Committee
Lynn D. Wilson, MD, MPH, FASTRO,
Chairman
Benjamin Movsas, MD, FASTRO
Vice-chairman *
May Abdel-Wahab, MD, PhD
Ross A. Abrams, MD, FASTRO *
Sanjeev Aggarwal, MD
Kaled Alektiar, MD *
Elizabeth Baldini, MD, MPH
Beth Beadle, MD, PhD
Ramesh Bilimagga, MD
Kevin A. Camphausen, MD
Allen Chen, MD
Ronald Chen, MD *
Julia Compton, MD
Louis S. Constine, MD, FASTRO *
Shari Damast, MD *
Indra Das, PhD, FASTRO
Prajnan Das, MD, MS
Roy Decker, MD, PhD
Jun Deng, PhD
Theodore DeWeese, MD
Adam Dicker, MD, PhD *
Gary Freedman, MD *
Laurie Gaspar, MD, MBA, FASTRO *
James Hayman, MD *
Susan Higgins, MD, MS
Salma Jabbour, MD
Rojymon Jacob, MD
David Jaffray, PhD *
Lisa Kachnic, MD
Patrick Kupelian, MD *
Alexander Lin, MD *
Bo Lu, MD, PhD
Stephen Thomas Lutz, MD *
Anita Mahajan, MD
Nina Mayr, MD, FASTRO
Robert Miller, MD, MS
Rolf-Peter Mueller, MD, PhD
Arnold C. Paulino, MD *
Kenneth Rosenzweig, MD *
Lakshmi Santanam, PhD
Ben Slotman, MD, PhD
Benjamin Smith, MD *
Timothy D. Solberg, PhD
Mohan Suntharalingam, MD, MBA
Katherine S. Tzou, MD
Akila N. Viswanathan, MD, MPH*
Stephanie E. Weiss, MD
Theodore E. Yaeger, MD
Gary Yang, MD
* = Track Chairman
2012-2013 Annual Meeting Education Committee
Andrea K. Ng, MD, MPH, Chairman
Catherine C. Park, MD,
Vice-chairman
James Balter, PhD
Changhu Chen, MD
Brian Czito, MD
Robert Den, MD
B. Ashleigh Guadagnolo, MD, MPH
Daniel Hamstra, MD, PhD
Kun (Kim) Huang, MD
Jordan Kharofa, MD
Krystyna Kiel, MD
Patrick Kupelian, MD
Joshua D. Lawson, MD
Harvey Mamon, MD, PhD
Brian Marples, PhD
Loren K. Mell, MD
Joanne M. Moar, RN, OCN
Arno J. Mundt III, MD, FASTRO
Christopher F. Njeh, PhD
Baldev Patyal, PhD
Narayan Sahoo, PhD
Roy B. Tishler, MD, PhD
Akila N. Viswanathan, MD, MPH
George D. Wilson, PhD
Suzanne L. Wolden, MD
Min Yao, MD, PhD
James Yu, MD
7
2013 Abstract Reviewers
May Abdel-Wahab
Ross Abrams **
Peter Ahn
Kevin Albuquerque *
Kaled Alektiar **
Berthe Aleman
Brian Alexander
Ozer Algan
Jonathan Ashman
Elizabeth Baldini
Voichita BarAd
Chris Barker
Glenn Stuart Bauman
Beth Beadle
Clair Beard
Justin Bekelman *
Jennifer Bellon *
Stanley Benedict
Sushil Beriwal
Lawrence Berk
Matt Biagioli
Ranjit Bindra
Sławomir Blamek
Jeffrey Bogart
James Bonner
Kristy Brock
Stephen Brown
Kevin Camphausen
David Carlson
Jimmy Caudell
A. Bapsi Chakravarthy*
Arnab Chakravarti
Annie Chan
Daniel Chang
Eric Chang
Ronald Chen **
Aileen Chen
Peter Chen
Allen Chen
Bhisham Chera
Indrin Chetty *
Steven Chmura
Seungtaek Choi
Jay Ciezki
Deborah Citrin
C. Norman Coleman
Louis Constine **
Joseph S. Contessa
Chris Crane
Bouthaina Dabaja *
Megan Daly
Shari Damast **
Parima Daroui
Indra Das
Laura Dawson
Joseph Deasy
Roy Decker
Andre Dekker
Thomas Delaney
John DeMarco
Robert Den
Jun Deng
Adam Dicker **
Thomas Dilling
Thomas DiPetrillo
Lei Dong
Jadranka Dragovic
Jason Efstathiou *
Hans Eich
John Einck
Issam El Naqa
Rodney Ellis
8
Thank You
Mohamed Elshaikh
Beth Erickson
Suzanne Evans *
Liu Fei-Fei
Steven Feigenberg
Felix Feng *
Robert Foote
Eric Ford
Benedick Fraass
Gary Freedman **
Martin Fuss
Thomas Galloway
Yolanda Garces
Adam Garden
Laurie Gaspar **
Hiram Gay
Daniel Gomez
James Gordon
Elizabeth Gore
Alexander Gottschalk
Daila Gridley
Katherine Griem
Inga Grills
Ashleigh Guadagnolo
Vishal Gupta
Daphne Haas-Kogen
Karl Haglund
Russell Hales
Michele Halyard
Daniel Hamstra
James Hansen
Paul Harari
James Hayman **
Mark Henderson
Joseph Herman
Susan Higgins
Ariel Hirsch
Sarah Hoffe
Brad Hoppe
Peter Hoskin
David Howell
Dimitre Hristov
I-Chow Hsu
Geoff Hugo
Arthur Hung
Mark Hurwitz
Zain Husain
Geoffrey Ibbott
Timothy Illidge
David Jaffray **
Nora Janjan
Ryan Jensen
Steve Jiang
Candice Johnstone
William Jones III
Lisa Kachnic
Mitchell Kamrava
Atif Khan
Krystyna Kiel
Catherine Kim
Christopher King
Youlia Kirova
Eric Klein
Marisa Kollmeier
Kevin Kozak
David Kozono
Daniel Krauss
Jon Kruse
Greg Kubicek
Charles Kunos
Patrick Kupelian **
Nadia Laack
Joshua Lawson
Colleen Lawton
Quynh Le
Larissa Lee
Andrew Lee
Percy Lee
Stanley Liauw
Steven Lin
Lillie Lin
Alexander Lin **
Arthur Liu
Daniel Low
Andrew Lowy
Join Luh
Stephen Thomas Lutz **
C. M. Charlie Ma
Shannon MacDonald
Mitchell Machtay
Gig Mageras
Anand Mahadevan *
Anita Mahajan
Raymond Mak
Sheida Mani
Danielle Margalit
Rufus Mark
Mary Martel
Neil Martin
Vivek Mehta
Loren Mell
Joshua Meyer
Michael Milano
Robert Miller
Drew Moghanaki *
Radhe Mohan
Jean Moran
Sabin Motwani
Benjamin Movsas **
Sasa Mutic
Ashwatha Narayana
Andrea Ng
Jatinder Palta
Catherine Park
Abhijit Patel
Shilpen Patel
Arnold Paulino **
Todd Pawlicki
Christopher Pelloski
Mark Phillips
Jean-Philippe Pignol
Alan Pollack
Louis Potters
Jean Pouliot
Deepak Pradhan
Robert Prosnitz
Rinaa Punglia
Rachel Rabinovitch
Abram Recht
Andreas Rimner
Mark Rivard
Mack Roach
Kenneth Roberts
Cliff Robinson
Ken Rosenzweig **
Mihaela Rosu
Christian Rube
Samel Ryu
Lakshmi Santanam
Amit Sawant
Julie Schwarz
David Sebag-Montefiore
Suresh Senan
Jan Seuntjens
to the 2013
Abstract Reviewers
Simona Shaitelman
Michael Sharpe
Xinglei Shen
Ke Sheng
David Sher
Wenyin Shi
Timothy Showalter
Farzan Siddiqui *
Nicole Simone
Charles Simone
Heath Skinner
Ben Slotman
BenjaminSmith **
Danny Song
William Song
Jan-Jakob Sonke
Baldassarre Stea
Kevin Stephans
Jonathan Strauss
Erik Sulman
Alphonse Taghian
Michael Tee
Rahul Tendulkar
Welela Tereffe
Stephanie Terezakis
Juliette Thariat
Charles Thomas
Wade Thorstad
Robert Timmerman
Roy Tishler
Michael Tomblyn
Wolfgang Tome
Javier Torres-Roca
Phuoc Tran
Minh-Tam Truong
Katherine Tzou
Neha Vapiwala
Greg Videtic
Akila Viswanathan **
Sujay Vora
Eleanor Walker
Andrew Wang
Stephanie Weiss *
Maria Werner-Wasik *
Julia White
Henning Willers
Lynn Wilson
Karen Winkfield
Julia Wong
Rebecca Wong
John W. Wong
Wendy Woodward
Ping Xia
Ying Xiao
Lei Xing
Ted Yaeger
Di Yan
Gary Yang
Johnny Yap
Catheryn Yashar
Fang-Fang Yin
Torunn Yock
Sue Yom
James Yu
Jennifer Yu
Richard Zellars
(Weining) Ken Zhen
Key
** Track chairman
* Track co-chairman/vice-chairman
Gold Medal Recipients
The Gold Medal is ASTRO’s highest honor bestowed
on revered members who have made outstanding
contributions to the field of radiation oncology.
2013 GOLD MEDALISTS
AMATO J. GIACCIA, PHD
Dr. Giaccia is the Jack, Lulu and Sam Willson
Professor of Cancer Biology, associate chairman of the
department of radiation oncology and director of the Division of
Radiation and Cancer Biology at Stanford University School of
Medicine in Stanford, Calif. He has made considerable contributions
to radiation oncology research on the role of tumor
microenvironment in tumor progression and metastasis, specifically
tumor hypoxia.
RADHE MOHAN, PHD, FASTRO
Dr. Mohan is a professor and the Larry and Pat McNeil Chairman in
Cancer Research in the department of radiation physics at The
University of Texas MD Anderson Cancer Center. As a medical
physicist for 42 years, he has had a major influence on several areas
of radiation oncology, including radiation dosimetry, 3-D conformal
radiation therapy, intensity modulated radiation therapy and
ongoing research in proton therapy.
PRABHAKAR TRIPURANENI, MD, FASTRO
Dr. Tripuraneni serves as the head of the division of radiation oncology
at Scripps Clinic in La Jolla, Calif., and the chief medical officer of Viewray
Inc., in Cleveland. He has impacted the clinical aspect of radiation
oncology with his insights in vascular brachytherapy and influenced
enhancements to ASTRO, through leadership roles on ASTRO’s Board of
Directors and his volunteer work on behalf of ASTRO in areas including
practice accreditation, website development and e-learning initiatives.
9
Honorary Member Recipient
Honorary Membership is awarded annually to a distinguished cancer researcher
or leader in a discipline other than radiation oncology, radiation physics or
radiobiology.
2013 HONORARY MEMBER
JEAN OWEN, PHD
Dr. Owen is an accomplished researcher with more than 20 years
of experience with the American College of Radiology Clinical
Research Center, where she served as project director of the ACR
Quality Research in Radiation Oncology (QRRO) project, formerly the
Patterns of Care Study (PCS). In that role, she was involved in
developing detailed clinical performance measures and survey
processes to measure quality of care benchmarks in radiation
oncology nationwide. Dr. Owen is currently working as an
independent health care consultant and is pursuing a graduate
certificate in research ethics from the Medical College of Wisconsin’s
Graduate School of Biomedical Sciences.
2012 Honorary Member Mark P. Carol, MD
10
Fellow Recipients
The ASTRO Fellows designation honors those who have been an Active or Emeritus Member of
ASTRO for at least 15 years, have given the equivalent of 10 years of service to ASTRO and have
made significant contributions to the field of radiation oncology.
ASTRO PROUDLY RECOGNIZES THE 2013 CLASS OF FELLOWS
•
Jonathan J. Beitler, MD, MBA, Winship Cancer Institute of Emory University, Atlanta
•
Phillip M. Devlin, MD, Harvard Medical School, Boston
•
Thomas J. Eichler, MD, Thomas Johns Cancer Hospital, Richmond, Va.
•
Silvia C. Formenti, MD, New York University School of Medicine, New York
•
Stephen M. Hahn, MD, Perelman School of Medicine at the University of Pennsylvania, Philadelphia
•
Geraldine M. Jacobson, MD, MPH, MBA, West Virginia University, Morgantown, W.Va.
•
Tariq Altaf Mian, PhD, Medical Radiation Physics Inc., Scottsdale, Ariz.
•
Bhudatt R. Paliwal, PhD, University of Wisconsin, Madison, Wis.
•
Seth A. Rosenthal, MD, Radiation Oncology Center and Sutter Cancer Center, Roseville, Calif.
•
Peter B. Schiff, MD, PhD, New York University School of Medicine, New York
Fellows Class of 2012
11
Annual Meeting Abstract Awards
2013 ASTRO ANNUAL MEETING AWARD RECIPIENTS
RESIDENT CLINICAL/BASIC SCIENCE RESEARCH AWARD
Timothy J. Harris, MD, PhD (Radiation and Cancer Biology)
Michael R. Folkert, MD, PhD (Radiation Physics)
Alireza Fotouhi Ghiam, MD, MSc (Clinical)
RESIDENT DIGITAL POSTER RECOGNITION AWARD
Daniel Bracey, MD (Radiation and Cancer Biology)
Mu-Han Lin, PhD (Radiation Physics)
Ann Raldow, MD (Clinical)
RESIDENT POSTER VIEWING RECOGNITION AWARD – CLINICAL
Emma Holliday, MD (1st place)
Naamit Gerber, MD (2nd place)
Christine Min, MD (3rd place)
RESIDENT POSTER VIEWING RECOGNITION AWARD – RADIATION AND CANCER BIOLOGY
Carmen Perez, MD, PhD (1st place)
Anthony Apicelli, MD, PhD (2nd place)
Youssef Zeidan, MD, PhD (3rd place)
RESIDENT POSTER VIEWING RECOGNITION AWARD – RADIATION PHYSICS
Junaid Pasha, MD (1st place)
Shikui Tang, PhD (2nd place)
Charles Wooten, MD (3rd place)
BASIC SCIENCE ABSTRACT AWARD – RADIATION PHYSICS
Bin Han, PhD
Teo Stanescu, PhD
Seishin Takao, PhD
Eric Williams, PhD
Yun Yang, PhD
BASIC SCIENCE ABSTRACT AWARD – RADIATION AND CANCER BIOLOGY
Anita Aiyer, MS
Mekhail Anwar, MD, PhD
Michael Spiotto, MD, PhD
Gregory Vlacich, MD, PhD
Ting Xu, MD
ANNUAL MEETING SCIENTIFIC ABSTRACT (TRAVEL) AWARD
Scott Bratman, MD, PhD
Christopher Chapman, MS
Avani Dholakia, BS
Aaron Falchook, MD
Annemarie Fernandes, MD
Victor Mangona, MD
Ankit Modh, BS
David Palma, MD, PhD
Anupam Rishi, MD
Roshan Sethi, BS
Anand Shah, MD
Arshin Sheybani, MD
Terence Sio, MD, MS
Christopher Tinkle, MD, PhD
Ralph Vatner, MD, PhD
INTERNATIONAL – U.S. ANNUAL MEETING SCIENTIFIC ABSTRACT AWARD
Antonio Zuliani, MD, PhD, MBA, MS
ANNUAL MEETING NURSE ABSTRACT AWARD
Jean Hamker, RN
12
General Information
ASTROmobile – Official Meeting App
Shuttle Bus Schedule
Georgia World Congress Center Floor Plans
General Information
INSIDE:
General Information
2013 Ambassador Recognition
(AS OF AUGUST 26, 2013)
ASTRO proudly recognizes our
2013 Corporate Ambassadors for their outstanding
year-round leadership and support of radiation oncology.
General Information
GEORGIA WORLD CONGRESS CENTER
285 Andrew Young International Blvd. NW
Atlanta, GA 30313
www.gwcc.com
All activities take place in Buildings A and B at the
Georgia World Congress Center unless stated
otherwise. All information is current as of
August 26, 2013, and is subject to change.
ATTENDEE REGISTRATION
Registration Hall, Building B
Attendee registration counters will be located in
Registration Hall in Building B of the Georgia World
Congress Center.
ATTENDEE REGISTRATION HOURS
Saturday, September 21
Sunday, September 22
Monday, September 23
Tuesday, September 24
Wednesday, September 25
7:00 a.m. - 5:00 p.m.
6:30 a.m. - 5:00 p.m.
7:00 a.m. - 6:00 p.m.
7:00 a.m. - 5:00 p.m.
7:00 a.m. - 2:00 p.m.
EXHIBITOR REGISTRATION
Exhibitor registration counters will be located in the
Registration Hall in Building B of the Georgia World
Congress Center.
EXHIBITOR REGISTRATION HOURS
Thursday, September 19
Friday, September 20
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
7:00 a.m. - 5:00 p.m.
7:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
AFFILIATED MEETINGS
37th ASRT RADIATION THERAPY
CONFERENCE
September 22-24, 2013
Hyatt Regency Atlanta
The 37th Annual ASRT Radiation Therapy
Conference will take place at the Hyatt Regency
Atlanta. ASTRO registered attendees may attend
ASRT sessions by paying a reduced registration
fee of $195. Proof of registration (registration
confirmation or badge) is required to receive
this reduced rate. If you have not registered to
attend the ASRT conference but would like to do
so, please register on-site at the Hyatt Regency
Atlanta.
30TH SROA ANNUAL MEETING
InterContinental Buckhead Atlanta
The 30th SROA Annual Meeting will take
place at the InterContinental Buckhead Atlanta.
ASTRO registered attendees may attend the
SROA general sessions by paying a reduced
registration fee of $210. Proof of registration
(registration confirmation or badge) is required
to receive this reduced rate. If you have not
registered to attend the SROA conference but
would like to do so, please register on-site at the
InterContinental Buckhead Atlanta.
C NNNECT
Stop by ASTRO Connect - the new Annual Meeting networking lounge.
Main Lobby of Building B, Georgia World Congress Center
New in 2013, we are introducing ASTRO Connect, a
networking lounge that not only offers charging stations but
also is the perfect place to meet up with colleagues, have
informal meetings, make new connections within the
radiation oncology community and check in on social media
sites.
Connect with attendees.
Tweet
#ASTRO13
15
ASTRO CAREER FAIR
Room B207, Building B
Take advantage of the ASTRO Career Fair to connect
with candidates for employment. Equipped with
computers and printers for your convenience, the
Career Fair is available for employers to conduct
interviews with job applicants. Employers and
applicants must register through the online ASTRO
Career Center in order to schedule interviews at the
on-site Career Fair.
Hours of Operation:
Saturday, September 21 1:00 p.m. - 6:00 p.m.
8:00 a.m. - 6:00 p.m.
Monday, September 23 8:00 a.m. - 6:00 p.m.
Tuesday, September 24 8:00 a.m. - 6:00 p.m.
Private interview rooms are also available. These
rooms are ideal if you have multiple interviews to
conduct or just need more privacy. A limited
number of meeting rooms will be available to
rent for three-hour periods Sunday, September 22
through Wednesday, September 25. For more
information, contact Todd Karstaedt at toddk@
astro.org.
ASTRO PAC LOUNGE
ASTRO’s political action committee (PAC) is
offering access to an exclusive lounge for all ASTRO
members who have donated to the ASTRO PAC in
2013. The PAC lounge will feature Internet access,
coffee and beverages, food and a place to rest
between sessions. Members who have not made
their contribution yet will be able to donate on-site.
ASTRO PAC provides ASTRO with the opportunity
to more fully participate in government and ensure
your voice is heard by key policy makers on Capitol
Hill. Be sure to stop by the lounge to get the most
recent legislative and election updates. For more
information, please email
shandih@astro.org or visit www.astro.org/
ASTROPAC.
Hours of Operation:
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 5:30 p.m.
Happy Hour and Legislative Issue Forum
5:00 p.m. - 6:00 p.m.
10:00 a.m. - 3:00 p.m.
16
ASTRO RESOURCE CENTER
Booth 543, Exhibit Hall, Building B
Visit the ASTRO Resource Center in the Exhibit
Hall to find out about ASTRO’s products and services.
The Resource Center is your one-stop-shop to learn
about ASTRO member benefits, including the
Radiation Oncology-Incident Learning System
(RO-ILS) – the new medical error reporting system,
APEX – our new practice accreditation program,
educational meetings and webinars, advocacy and
much more. ASTRO’s knowledgeable staff will be on
hand to answer questions about your membership.
Be sure to stop by to have your picture taken and
uploaded to ASTRO’s online membership directory
on ROhub. The Survivor Circle is also located in the
Resource Center.
Hours of Operation:
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 5:00 p.m.
Interesting Speaker?
Tweet
#ASTRO13
ASTROmobile – Your Annual Meeting Guide
ASTROmobile gives you access to the meeting
program and the ability to customize your meeting
experience with personalized maps and planners.
 Search








sessions by day, track or speaker.
Search exhibitors by name, booth number
or product/service category.
Session and exhibitor details with location maps.
Search and view abstracts.
Preview general meeting information.
Access your “MyPlan” – your personal Annual Meeting
schedule.
View convention center maps.
Take notes on a session or exhibitor and access your
notes from your mobile device.
Search and exchange messages with colleagues
attending the meeting using Find a Friend. Find a Friend
is integrated with your “My Plan” on the Online
Conference Planner and ASTROmobile.
Funded in part by
ASTROmobile Login Instructions
An account has been created for all registered attendees. Please log in as follows:
iPhone Users
SmartPhone Users
1. Simply download “ASTROmobile13”
from the iTunes store.
1. Go to www.astro.org/ASTROmobile in
your mobile web browser.
2. Log in with the following credentials:
2. Log in with the following credentials:
Registration ID: Badge No.
Password: Last Name
Email ID: Email Address
Registration ID: Badge No.
Password: Last Name
Smartphone users can also access
ASTROmobile using a QR Code reader
and the QR Code to the right.
Login Tips
Your badge number is located on the front of your badge. Your email address is the email that you
provided at the time of registration. Your last name must exactly match the spelling on your badge.
17
ATLANTA TOURISM AND CONCIERGE DESK
CE CENTRAL
Main Lobby, Building B
Attendees can stop by the Atlanta tourism and
concierge desk located in the Main Lobby of Building
B at the Georgia World Congress Center to receive
restaurant recommendations, make reservations
and receive Atlanta visitor guides, maps, destination
information and local directions.
Located off Main Lobby, Building B
Do you have questions about continuing
education or the 2013 changes to the American
Board of Radiology (ABR) Maintenance of
Certification (MOC) program? Staff from ASTRO
and the ABR will be on hand during the meeting
to answer your individual questions about
continuing education and MOC requirements.
Hours of Operation:
9:00 a.m. - 5:00 p.m.
9:00 a.m. - 5:30 p.m.
9:00 a.m. - 5:30 p.m.
9:00 a.m. - 5:30 p.m.
9:00 a.m. - 2:00 p.m.
BUSINESS CENTER
Located off of the Main Lobby, Building B
A business center is conveniently located off of the
Main Lobby of Building B of the Georgia World
Congress Center. The business center offers a variety
of services including packing and shipping, sign
production, copying and office supplies.
Hours of Operation:
8:30 a.m. - 5:00 p.m.
8:30 a.m. - 5:00 p.m.
8:30 a.m. - 5:00 p.m.
8:30 a.m. - 5:00 p.m.
8:30 a.m. - 5:00 p.m.
Great Session?
Tweet
#ASTRO13
18
CE Central computer stations provide access
for you to:
• Complete your continuing education and
meeting evaluation.
• View/print a session tracking form.
• Search abstracts.
• Search exhibitors.
• Access your Online Conference Planner.
Hours of Operation:
1:00 p.m. - 5:00 p.m.
8:00 a.m. - 6:00 p.m.
8:00 a.m. - 6:00 p.m.
8:00 a.m. - 6:00 p.m.
8:00 a.m. - 4:30 p.m.
BUSINESS MEETING
11:30 a.m. - 1:00 p.m.
Room B302–B305, Building B
ASTRO voting members (Active, Affiliate, Allied and
International members) are invited to attend the
Business Meeting on Tuesday, September 24, from
11:30 a.m. - 1:00 p.m. Leaders of the Society will
discuss important topics of interest to ASTRO
members. You should not miss this important
meeting. Lunch will be served.
SEARCHING FOR QUALIFIED RADIATION
ONCOLOGY PROFESSIONALS?
Find them online on the ASTRO Career Center
and in Atlanta at the ASTRO Career Fair
It’s easy to find the right talent for your
practice when you use the ASTRO Career
Center. Advanced features allow you to
search our resume database by various
criteria including education, title, location
and more.
Planning to attend the ASTRO Annual
Meeting? The ASTRO Career Fair is a
perfect opportunity to interview qualified
candidates. Employer interview space at
the Career Fair is free for ASTRO members
with your purchase of an online career
center posting. For more information or to
purchase a posting, go to
www.astro.org/careercenter.
R A D I AT I O N O N C O L O G Y
C A R E E R C E N T E R
JOB SEEKERS
Be sure to indicate your availability for an
interview at the ASTRO Annual Meeting by selecting the
Career Fair option on “MyAccount” in the Career Center.
Career Center jobs can also be found on the
ASTRO Facebook page and on Twitter.
19
CYBER CAFÉ
FACULTY/VIP OFFICE
Booth 126, Exhibit Hall, Building B
ASTRO attendees can browse the Internet and
check, retrieve and send email messages at the
Cyber Café in the Exhibit Hall.
Faculty members and VIPs should check in at the
Faculty/VIP Office, Room B401, to pick up
registration materials and receive last-minute
updates and program changes. The Faculty/VIP
Office is conveniently located next to the Speaker
Ready Room. Faculty and VIPs are welcome in the
Faculty/VIP Office throughout the meeting.
Hours of Operation:
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 5:00 p.m.
ELECTRONIC BUSINESS CARD
Included with your badge, you will receive an
electronic business card equipped with a magnetic
strip containing your contact information and other
demographic data. This card can be scanned in card
readers located in exhibitor booths throughout the
Exhibit Hall. Simply give your electronic business
card to the exhibitor and your contact information
will be recorded for follow-up by the exhibitor.
Note: Attendee email addresses will be included in
the contact information given to exhibitors unless
you indicated to exclude your email at the time of
registration.
EXHIBIT HALL
Halls B1-B3, Building B
Learn about the latest products in cancer treatment
in the Exhibit Hall.
Hours of Operation:
Note: Presenters of abstracts are not classified as
faculty and should follow attendee registration
instructions.
Hours of Operation:
6:30 a.m. - 6:00 p.m.
6:30 a.m. - 6:00 p.m.
6:30 a.m. - 6:00 p.m.
6:30 a.m. - 6:00 p.m.
6:30 a.m. - 4:30 p.m.
FIRST AID
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 5:00 p.m.
Tweet
#ASTRO13
20
Faculty members include:
• Educational session lecturers.
• Panel moderators and presenters.
• Scientific session moderators and discussants.
• eContouring Learning Lab presenters.
• Presidential Symposium lecturers.
• Keynote speakers and introducers.
• Nursing program speakers.
• International Symposium presenters.
First Aid Office outside Hall B1, Building B
First Aid is located outside of Hall B1 between the
entrance of Halls B1 and B2 at the Georgia World
Congress Center. The first aid phone number is
404-223-4041, or dial ext. 4041 from a house
phone. In an emergency, please contact first aid or
go to ASTRO Registration and have a staff person
contact security.
Hours of Operation:
Friday, September 20
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
7:00 a.m. - 6:00 p.m.
6:30 a.m. - 6:30 p.m.
7:00 a.m. - 7:00 p.m.
7:00 a.m. - 10:00 p.m.
7:00 a.m. - 8:00 p.m.
8:00 a.m. - 5:00 p.m.
GEORGIA WORLD CONGRESS CENTER
INFORMATION
Main Lobby, Building B
The Georgia World Congress Center’s friendly staff
can help with convention center brochures and
maps.
Hours of Operation:
Great Session?
7:00 a.m. - 5:00 p.m.
6:30 a.m. - 5:00 p.m.
7:00 a.m. - 6:00 p.m.
7:00 a.m. - 5:00 p.m.
7:00 a.m. - 4:30 p.m.
Tweet
#ASTRO13
INDUSTRY-EXPERT THEATER*
Rear of 100 Aisle, Exhibit Hall B1
This activity allows companies to present their noteworthy products and services through a live
presentation in the Industry-Expert Theater located in the Exhibit Hall. Seating is available on a first-come,
first-served basis. The Industry-Expert Theater content and views expressed therein are those of the
exhibitor and not of ASTRO.
*Industry-Expert Theaters are not accredited for continuing medical education credits.
Time: 12:45 p.m. – 1:45 p.m.
Accuray: Dynamic Technology in Motion
Supported by Accuray
Contact: Jim Bilich
Phone: 925-348-2082
Box lunch provided
Time: 12:15 p.m. – 1:15 p.m.
An In-depth Look at Xofigo® (radium Ra 223
dichloride)
Supported by Bayer HealthCare and Algeta
Contact: The Lockwood Group
Phone: 203-817-0951
Box lunch provided
Time: 10:15 a.m. – 10:45 a.m.
Electronic Brachytherapy Utilizing the
Xoft® System for the Treatment of
Non-Melanoma Skin Cancer
Supported by Xoft, A subsidiary of iCAD Inc.
Contact: Donna Breault
Phone: 978-337-2786
Refreshments provided
11:45 a.m. – 12:45 p.m.
Increasing Quality in Radiation Therapy
Supported by ScandiDos
Contact: Marni Brown
Phone: 608-630-9415
Box lunch provided
21
INDUSTRY SATELLITE SYMPOSIA
ASTRO has reviewed and approved these symposia as appropriate for presentation. These symposia represent
the content and views of the sponsors and are not part of the official ASTRO Annual Meeting.
Sunday, September 22, 2013
Monday, September 23, 2013
6:30 p.m. – 8:30 p.m.
6:00 p.m. – 7:45 p.m.
(Registration and dinner begin at 6:00 p.m.)
(Registration 5:00 p.m. – 6:00 p.m.; Reception to follow
symposium.)
Bone-Seeking Radiopharmaceuticals for
Treatment of Prostate Cancer with Bone
Metastases: Implications of Emerging Data
Showing Survival Improvements
Omni Hotel at CNN Center, Grand Ballroom E
Accreditation: This activity has been planned
and implemented in accordance with the Essential Areas
and Policies of the Accreditation Council for Continuing
Medical Education (ACCME) through the joint sponsorship
of Medical Education Resources (MER) and PleXus
Communications. MER is accredited by the ACCME to
provide continuing medical education for physicians.
Hope, Guidance and Healing: Necessary
Components of Effective Proton Therapy and
Clinical Research
Piedmont Driving Club
1215 Piedmont Avenue NE
Atlanta, GA 30309
Accreditation: The University of Florida College of Medicine
is accredited by the Accreditation Council for Continuing
Medical Education to provide continuing medical education
for physicians.
CME Credits: Medical Education Resources designates this
live activity for a maximum of 2.0 AMA PRA Category 1
Credits™. Physicians should claim only the credit
commensurate with the extent of their participation in the
activity.
CME Credits: The University of Florida College of Medicine
designates this live activity for a maximum of 2.0 AMA PRA
Category 1 Credits™. Physicians should claim only the credit
activity.
Target Audience: This activity is intended for radiation
oncologists, nuclear medicine physicians, radiation
biologists and physicists caring for patients with prostate
cancer.
This activity is hosted by the University of Florida and is
supported by an educational grant from IBA.
This activity is hosted by Medical Education Resources and
PleXus Communications and is supported by an educational
grant from Bayer HealthCare Pharmaceuticals Inc/Algeta
U.S. LLC.
7:00 p.m. – 9:30 p.m.
(Registration begins at 6:00 p.m. in the Juniper Room.)
Radiotherapy Approaches: Is Genomic
Profiling the Answer?
Omni Hotel at CNN Center, International
Ballroom D
Accreditation: EXCEL Continuing Education is
accredited by the Accreditation Council for Continuing
Medical Education to provide continuing medical education
for physicians.
CME Credits: EXCEL Continuing Education designates this
live activity for a maximum of 1.5 AMA PRA Category 1
Credits™. Physicians should claim only the credit
activity.
This activity is hosted by EXCEL Continuing Education and is
supported by an educational grant from Genomic Health.
22
INFORMATION DESKS
PARKING
Outside of Registration Hall and located off Main
Lobby, Building B
Have a question? Stop by the Information Desk to
get your questions answered.
There is self parking available at the Georgia World
Congress Center. ASTRO does not validate
parking.
Hours of Operation:
7:00 a.m. - 5:00 p.m.
6:30 a.m. - 5:00 p.m.
7:00 a.m. - 6:00 p.m.
7:00 a.m. - 5:00 p.m.
7:00 a.m. - 4:30 p.m.
LOST AND FOUND
Outside of Registration Hall and located off Main
Lobby, Building B
To report a missing item, to check to see if an item
has been turned into security or to turn in a lost
item, please stop by one of the Information Desks.
Hours of Operation:
7:00 a.m. - 5:00 p.m.
6:30 a.m. - 5:00 p.m.
7:00 a.m. - 6:00 p.m.
7:00 a.m. - 5:00 p.m.
7:00 a.m. - 4:30 p.m.
LUNCH VOUCHER
Attendees will receive a lunch voucher valued at
$10 that can be used at food outlets in the Exhibit
Hall only. This voucher is provided to all attendees
and exhibitors with their registration materials. Lost
vouchers will not be replaced.
Self-Parking
If you plan on driving to the Georgia World Congress
Center, there is self-parking provided in the Red
(International) Deck. This parking lot is closest to
Buildings A and B where the ASTRO Annual Meeting
will be held. This lot is gated with an attendant on
duty during all show/event hours. The standard rate
for parking is $10, which is subject to change at any
time.
POSTER VIEWING
Hall B4, Building B
Poster Set-up:
12:00 p.m. - 5:00 p.m.
7:30 a.m. - 10:00 a.m.
Poster Viewing Hours:
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 6:30 p.m.
Poster Viewing Session and Reception
5:30 p.m. - 6:30 p.m.
(Authors will be available for Q and A.)
10:00 a.m. - 5:00 p.m.
Poster Removal:
5:00 p.m. - 7:00 p. m.
Important: Posters not removed during this time
will be thrown away.
LUGGAGE/COAT CHECK
Luggage and coat check will be available at the
Georgia World Congress Center for $3 per item.
Hours of Operation:
6:30 a.m. - 6:00 p.m.
6:00 a.m. - 6:30 p.m.
7:00 a.m. - 7:00 p.m.
7:00 a.m. - 6:30 p.m.
7:00 a.m. - 5:00 p.m.
Posters from the following categories will be
displayed:
Biology
Breast
CNS
Gastrointestinal
Genitourinary
Gynecologic
Head and Neck
Health Services Research
History
Informatics/Bioinformatics
Lung
Lymphoma
Non-malignant
Palliative Care
Patient Reported
Outcomes
Patient Safety
Pediatric
Physics
Sarcoma
23
PASSPORT PROGRAM
A special thank you to our Survivor Circle Passport Program Participants. Through their generous donations,
the Cancer Foundation of Northeast Georgia and the South Georgia Medical Center, Pearlman Cancer Center
received grants to help support their initiatives helping Georgia cancer survivors.
(As of August 28, 2013)
24
POSTER PICK-UP OFFICE:
REGISTRANT LOCATOR – FIND-A-FRIEND
Room: B215
For those who chose to use the poster printing
service, there is a special pickup room located just
outside of the poster hall. Please go to Room B215
to pick-up your poster during regular poster set-up
hours and poster viewing hours as listed above.
Looking to connect with an attendee at the Annual
Meeting? You can now use the Find-a-Friend feature
with ASTROmobile, the official Annual Meeting app.
Find-a-Friend allows you to search for an attendee
and send messages while at the Annual Meeting.
See page 17 for details.
POSTER VIEWING SESSION
AND RECEPTION
Hall B4, Building B
5:30 p.m. - 6:30 p.m.
RADIATION ONCOLOGY INSTITUTE (ROI)
BOOTH
Located on Level 4, Building B
During this reception, poster presenters will be
available at their poster to answer questions and
explain their research. New this year, there will be a
presentation area where poster award winners will
provide highlights of their research and be available
for questions. The presentation schedule will be
available in the poster viewing area.
Each full conference attendee, exhibitor and Monday
one-day conference attendee will receive one drink
ticket that can be used for complimentary
beverage at the Poster Viewing Session and
Reception on Monday, September 23. After your
ticket has been redeemed, drinks are available for
purchase. You must be 21 years of age to consume
alcoholic beverages. Your drink ticket is included
with your badge in your registration materials.
*This session is not accredited for continuing
medical education credits.
Attendees are invited to visit the Radiation
Oncology Institute booth, located on Level 4 in
Building B of the Georgia World Congress Center.
Learn about ROI’s research initiatives and current
projects, including the National Radiation Oncology
Registry (NROR), Safety and Quality in IMRT Delivery
Accuracy and Best Practices in Toxicity
Management.
Our mascot, “ROI” the gorilla, will also be on hand
for those wishing to accept our Gorilla Challenge.
Don’t miss out on this great opportunity to show
your support of the Institute!
Hours of Operation:
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.
8:00 a.m. - 12:00 p.m.
PRESS ROOM
Room B403 and B404, Building B
Abstract presenters are encouraged to bring press
releases promoting their presentation in Atlanta to
the Press Room. For more information about ASTRO’s
Press Program and Policies, please contact ASTRO’s
Press Office at 703-286-1600 or press@astro.org.
Hours of Operation:
Interesting Speaker?
Tweet
#ASTRO13
7:00 a.m. - 4:00 p.m.
7:00 a.m. - 4:00 p.m.
7:00 a.m. - 4:00 p.m.
7:00 a.m. - 12:00 p.m.
For Press Room Information and Policies, visit
www.astro.org/ampress.
25
Shuttle Service
Shuttle Service to the Georgia World Congress Center – Building B (GWCC)
Complimentary shuttle service will be provided between the Georgia World Congress Center and official
ASTRO hotels. The shuttle drop-off and pick-up locations are located along Andrew Young International
Blvd., just outside the Registration Hall at the Georgia World Congress Center. The shuttle schedule is subject
to change at any time. Please refer to signs at the convention center, the on-site shuttle flyer and your hotel
lobby for the most current information.
Hours of Operation:
7:00 a.m. - 6:00 p.m.*
6:30 a.m. - 7:00 p.m.*
6:30 a.m. - 7:30 p.m.*
6:30 a.m. - 7:00 p.m.*
6:30 a.m. - 5:00 p.m.*
* Indicates last time buses depart the convention center returning to ASTRO official hotels. Last shuttle
departs hotels approximately 60 minutes prior to this last time.
HOTELS AND BOARDING LOCATIONS
All travel times are approximate depending time of day, day of week and traffic conditions.
Route
Hotel
Boarding Location at Hotel
DoubleTree by Hilton Atlanta Downtown
At Westin Peachtree Plaza.
Hampton Inn and Suites
1
2
3
4
Holiday Inn Atlanta Downtown
Westin Peachtree Plaza
Curbside on Spring.
Hyatt Regency Atlanta
On Baker at Peachtree Street.
Courtyard Atlanta Downtown
On Ellis at Peachtree Street.
Ellis
Ritz-Carlton Atlanta
Twelve Hotel Centennial Park
Curbside on Spring Street.
W Atlanta Downtown
Curbside on Spring Street.
Sheraton Atlanta Hotel
On International at Courtland.
Atlanta Marriott Marquis
Curbside on Peachtree Center.
5
Approximate
one-way
travel time
Frequency
in minutes
7-12 minutes
Peak 10-15
Nonpeak 15-20
10-15 minutes
13-17 minutes
10-15 minutes
10-15 minutes
Hilton Atlanta
Peak 10-15
Nonpeak 15-20
Peak 10-15
Nonpeak 15-20
Peak 10-15
Nonpeak 15-20
Peak 10-15
Nonpeak 15-20
At Atlanta Marriott Marquis.
Embassy Suites Atlanta
Walk
Hotels
Glenn Hotel, The
No Shuttle Service
Hilton Garden Inn
Omni Hotel at CNN Center
Funded in part by
26
SMOKING
TECHNOLOGY HELP DESK
Georgia World Congress Center is a nonsmoking
facility.
Located off Main Lobby, Building B
Need help using ASTROmobile, the official app for
the Annual Meeting? Have questions about the
touch screen interactive wayfinder stations that
will help you navigate the convention center? Stop
by the Technology Help Desk located off the Main
Lobby in Building B at the Georgia World Congress
Center to get your technology-related questions
answered.
SPEAKER READY ROOM
Faculty members and abstract presenters should
upload their PowerPoint presentation in advance
of their session in order to have it pre-loaded
onto the ASTRO conference network. To ensure
presentations have been properly uploaded, faculty
members and abstract presenters are asked to check
in at the Speaker Ready Room to review the
information and make any last-minute edits.
Speakers should plan to save their presentation on
a portable device and bring it to the Speaker
Ready Room at least 24 hours in advance of their
presentation or upon arrival at the Georgia World
Congress Center.
Hours of Operation:
6:30 a.m. - 6:00 p.m.
6:30 a.m. - 6:00 p.m.
6:30 a.m. - 6:00 p.m.
6:30 a.m. - 6:00 p.m.
6:30 a.m. - 4:30 p.m.
Hours of Operation:
7:00 a.m. - 5:00 p.m.
6:30 a.m. - 5:00 p.m.
7:00 a.m. - 6:00 p.m.
7:00 a.m. - 5:00 p.m.
7:00 a.m. - 4:30 p.m.
TRANSPORTATION
Atlanta offers a number of convenient transportation
options to help attendees easily get around the city.
Airport
The Hartsfield-Jackson Atlanta International Airport
is 11 miles from downtown Atlanta. Board outbound
scheduled buses, shared ride and long distance vans,
taxis, and hotel and rental car courtesy vans located
in the arrival area of each terminal.
SURVIVOR CIRCLE
ASTRO Resource Center, Booth 543, Exhibit Hall,
Building B
In 2003, ASTRO created the Survivor Circle as a way
to honor cancer survivors. Each year, ASTRO partners
with two local patient support organizations and
features them at the Survivor Circle at the Annual
Meeting. It was our hope that by partnering with
local organizations in the cities that host our
meeting, we would be able to not only give back to
the cities we visit, but also help raise awareness of
these important organizations among our members.
Through generous donations from exhibitors and
attendees, ASTRO raises funds for the two
organizations featured in the Survivor Circle. Since
its inception, the Survivor Circle has raised more
than $250,000 for our partner organizations. Stop
by the Survivor Circle, located in Booth 543, to learn
more about this year’s Survivor Circle Grant
recipients: The Cancer Foundation of Northeast
Georgia and the South Georgia Medical Center,
Pearlman Cancer Center.
Taxi
A one-way taxi ride from the airport to downtown is
a flat rate of $30, with $2 for each additional
passenger. All areas within a 11-mile radius of
downtown Atlanta are charged a flat rate of $8,
with $2 for each additional passenger. If you are
departing to a hotel outside the 11-mile radius of
downtown Atlanta your taxi fare will be metered.
MARTA
MARTA is Atlanta’s public transportation system that
provides rail and bus services throughout downtown
and to and from the airport. There is a MARTA station
connected to the Hartsfield-Jackson Atlanta
International Airport located right off of baggage
claim. The one-way fare to downtown on MARTA is
$2.50 and will get you downtown in 20 minutes.
27
VIRTUAL MEETING
All full conference attendees receive the Virtual
Meeting with their registration at no additional
cost. With the Virtual Meeting, you can extend your
learning experience with access to the 2013 ASTRO
sessions long after the meeting is over. You will
receive streaming content that has been digitally
recorded live and published as audio synchronized
to the speaker presentations*. Approximately three
weeks after the meeting, full conference attendees
will receive an email with a link providing access to
the Virtual Meeting.
*Presentations are included in the Virtual Meeting as
approved per faculty.
VIRTUAL POSTERS
Hall B4, Building B
Computer terminals and seating are available to
view the virtual poster displays at your leisure.
Correspond with presenters or forward a
presentation to a colleague or your home office.
Hours of Operation:
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 5:00 p.m.
10:00 a.m. - 5:00 p.m.
WIRELESS INTERNET ACCESS
Complimentary wireless Internet access is provided
in all common areas and session rooms throughout
the Georgia World Congress Center. Please note that
this does not include the Exhibit Hall. Attendees
can bring their laptop to check email, complete the
evaluation or surf the Internet. Laptops must have a
Wi-Fi card to connect.
Tweet
#ASTRO13
28
Y
Shuttle Buss
Overall View
Building A
Level 2
Building B
Level 3
Shuttle Drop off
Level 5 - General Session
Level 1 - Exhibit Hall and Posters
Level 4
Building B
Y
Attendee/Exhibitor Registration
and ASTRO Information Booth
Level 4, Building A
To Omni
Hotel
Floor Plans
29
30
b
c
b
c
§
F
§
b
c Restrooms
E
§
E
§
Elevator
b
c
E
§
Escalator
b
c
c
§ Æb
§
EXHIBIT HALL
Halls B1-B3
c
§ Æ b
Level 1, Building B
Æ
§
Telephone
E
§
E
First Aid
Exhibit Hall
§
Posters
b
c
F
Æ
Æ Concessions
§
Hall B4
POSTERS
b
cb
cb
c §
Floor Plans
B203
b
c E
B204
B205
B206
Æ
b
c Restrooms
E Elevator
Level 2, Building B
b
c
B202
B207
ASTRO
Career Fair
Escalator
b
c
§
Æ
Telephone
Exhibit Hall Entrance
b
c
B211
E
Æ Concessions
Poster Hall Entrance
b
c
B213
Other
Session Room
E
Æ
b
c E
B215
B216
Poster Printing Office
Floor Plans
31
32
ASTRO PAC Lounge
Æ
B306
b
c Restrooms
E Elevator
Level 3, Building B
B301
B302 - 305
Escalator
ASTRO Job Interview Rooms
B319 B318 B317
B308
B310
E
B311
B313
Office/Other
Session Room
b
c
Fellows Ready Room
Æ Concessions
eContouring
Learning Lab
b
c
E
Floor Plans
b
c Restrooms
E Elevator
Level 4, Building B
CE Central
ASTRO
Information
and Technology
Help Desk
Æ
B402
Radio Tour Room
B411
B401
Escalator
ROI Booth
Æ
Æ Concessions
B403
E
B404
Office/Other
Session Room
b
c
B405
b
c
B406
Faculty/ VIP Office
Press Office
Speaker Ready Room
Press News Briefing Room
E
Floor Plans
33
34
b
c Restrooms
E Elevator
§
b
c
Auditorium
Level 4, Building A
Y
Andrew Young
International
Boulevard
Entrance
Y
Escalator
A412
Y Shuttle Bus
East Plaza Entrance
Coat Check
ASTRO Connect
§
Telephone
A411
Attendee and Exhibitor Registration
E
ASTRO Information Booth and Housing Desk
Hallway to Building B
Office/Other
Session Room
Floor Plans
b
c Restrooms
E Elevator
Level 5, Building B
Escalator
b
c
Session Room
General Session
Thomas B. Murphy Ballroom
1-3
GENERAL SESSION
E
Thomas B.
Murphy
Ballroom
4
b
c
Floor Plans
35
NOTES
36
NOTES
37
NOTES
38
INSIDE:
Schedule of Events
Live SAM Sessions
Meeting Highlights
ARRO Program
Young Physicians’ Workshop
Nurses’ Program
Schedule of Events by Day
Schedule of Events
THE SAFEST WAY TO COMPACT IMPT
Proteus®ONE is a compact single-room solution that offers the most advanced treatment modalities in proton
therapy. It enhances the patient and staff experience by fostering a soothing environment.
Having helped treat over 20 000 patients, IBA, the world’s leading manufacturer in proton therapy, makes this
compassionate treatment possible to more patients worldwide.
Experience Proteus®ONE at ASTRO | IBA BOOTH #1543
WWW.IBA-PROTEUSONE.COM
6RPHIHDWXUHVDUHXQGHUGHYHORSPHQWDQGZLOOEHVXEMHFWWRUHYLHZE\FRPSHWHQWDXWKRULWLHV)'$1RWL¿HGERGLHVHWDO
These sessions are designed to provide crucial, hands-on education for professionals. Attendees will have an
opportunity to discuss issues such as imaging, target delineation, quality assurance and its frequency and
achievable accuracy.
After the sessions, attendees should be able to:
• Identify basic anatomy in the cases presented.
• Evaluate normal tissue dose constraints versus target dose objectives.
• Demonstrate improvement in contouring skills in the cases presented between pre- and post-activity.
• Self-assess where additional contouring skills training may be needed.
• Apply newly acquired contouring skills to his/her own practice.
Sarah Hoffe, MD, Program Chairman
Steven Finkelstein, MD, Program Vice-chairman
Room: B308
Schedule
8:00 a.m. - 9:30 a.m.
Esophageal Cancers
8:00 a.m. - 9:30 a.m.
Lung Cancer
Ravi Shridhar, MD, PhD, Moffitt Cancer Center
Ken Meredith, MD, Moffitt Cancer Center
Billy W. Loo, MD, PhD, Stanford University
10:00 a.m. - 11:30 a.m.
Gynecologic Cancers
Arno J. Mundt III, MD, FASTRO, University of
California San Diego
Beth A. Erickson, MD, FASTRO, Medical
College of Wisconsin
1:30 p.m. - 3:00 p.m.
Lymphoma and Breast Cancer
Stephanie Terezakis, MD, Johns Hopkins
University
Frank Vicini, MD, 21st Century Oncology
3:30 p.m. - 5:00 p.m.
Gastrointestinal Cancers
(SBRT/Abdominal)
Karyn Goodman, MD, Memorial Sloan-Kettering
Cancer Center
Corinne Winston, MD, Memorial SloanKettering Cancer Center
10:00 a.m. - 11:30 a.m.
Lung SBRT/Sarcoma
Steven Finkelstein, MD, 21st Century Oncology
Amalia De Comas, MD, The Core Institute
1:45 p.m. - 3:15 p.m.
Head and Neck Cancers
Avraham Eisbruch, MD, University of Michigan
Health Systems
Suresh Mukherji, MD, University of Michigan
Health Systems
Matthew Stenmark, MD, University of Michigan
Health Systems
4:00 p.m. - 5:30 p.m.
Prostate Cancers
Michael J. Zelefsky, MD, Memorial SloanKettering Cancer Center
Ticketed event/Separate registration required.
41
Live Self-Assessment Module Sessions
Special sessions have been designated as Live SAMs to help physician attendees meet the
requirements of the American Board of Radiology’s Maintenance of Certification program.
Attendance at the Live SAM sessions is open to the general public, but only Live SAM ticket holders
are eligible to earn SA-CME credit. On-site registration is available at the registration desk if seats
are still available.
How to Participate On-site
Live SAM registrants have two ways to participate in a Live SAM: a personal mobile device (smartphone, tablet
or laptop) or a paper assessment. All registrants will receive the same assessment and evaluation questions
regardless of the method they use to participate.
1.
2.
3.
4.
5.
6.
15 minutes prior to the start of the session, visit the Live SAM table outside the designated session room.
Give your Live SAM ticket to ASTRO staff at the Live SAM table. In return for your ticket, ASTRO staff will
give you a two-sided handout. One side of the handout contains the Live SAM Participant Directions for
both the paper and mobile options and the other contains the required assessment and evaluation
questions for those registrants wishing to use the paper method of participation.
Find any available seat in the session room and attend the entire session.
At the conclusion of the session, follow the directions to complete the assessment and evaluation
questions on paper or via your personal mobile device.
Complete the required assessment and evaluation questions. A minimum score of 70 percent must be
achieved on the assessment in order to receive credit.
ASTRO staff will email you approximately 30 days post-meeting with your individual score and directions
on how to print your certificate of completion from the ASTRO website.
Live SAM Policy
•
•
•
•
Live SAM registrants MUST be in the designated Live SAM room 15 minutes prior to the start of
the session. If you are not in the room at this time, your seat may be given away to another attendee.
Registrants interested in using the mobile device option will need to bring their own mobile device
and are responsible for ensuring that it is charged and can connect to the Internet via Wi-Fi or a
cellular network connection.
No refunds, extensions or substitutions will be made for those registrants who, for any reason, were
unable to attend or were tardy for the session.
Registrants must earn a minimum score of 70 percent on the assessment to earn credit. Participants
who do not earn a minimum of 70 percent on the assessment questions will NOT receive SAM credit
and will NOT receive a refund.
If you have any questions about the Live SAM sessions, SA-CME requirements or MOC, please visit the CE
Central Booth off the Main Lobby, Building B.
Tweet
#ASTRO13
42
Live SAM Sessions
7:45 a.m. - 9:00 a.m.
Educational Session 210: Controversies in the Optimal Management of Regional Nodes
Room: B405
Jennifer R. Bellon, MD, Dana-Farber Cancer Institute
E. Shelley Hwang, MD, MPH, Duke University School of Medicine
Julie R. Gralow, MD, University of Washington
4:00 p.m. - 5:30 p.m.
Educational Session 214: Laryngeal Preservation in Larynx and Hypopharynx Cancer
Room: B405
Robert J. Amdur, MD, University of Florida
Christopher Holsinger, MD, Stanford University
Quynh-Thu Le, MD, Stanford University
7:45 a.m. - 9:00 a.m.
Educational Session 301: Controversies on the Role of Radiation Therapy in the
Management of Hodgkin Lymphoma (HL)
Room: B405
Peter M. Mauch, MD, FASTRO, Harvard Medical School
Lena Specht, MD, PhD, Rigshopitalet, University of Copenhagen
7:45 a.m. - 9:00 a.m.
Educational Session 404: Treatment Options for Patients with Early-stage Non-small Cell
Lung Cancer
Room: B405
Jeffrey A. Bogart, MD, State University of New York
Abraham Lebenthal, MD, Brigham and Women’s Hospital
2:45 p.m. - 4:15 p.m.
Educational Session 415: Management of High-risk Prostate Cancer (Including
Post-operative XRT)
Room: B313
Alan Pollack, MD, PhD, University of Miami - Miller School of Medicine
Richard K. Valicenti, MD, University of California Davis Medical Center
Yoshiya Yamada, MD, Memorial Sloan-Kettering Cancer Center
Symbol Key:
A
ARON
Ticketed Event/ Nurses’
Separate
Session
registration
required
Award
Recipient
Live
Interactive
SAM/
Session
Separate
registration
required
43
“Prostate Cancer: Patient Focused Advances”
8:15 a.m. - 4:30 p.m. |
8:15 a.m. - 8:25 a.m.
Room: Thomas Murphy Ballroom 1-3
Welcome to Atlanta
Walter J. Curran Jr., MD, Winship Cancer Institute of Emory University, Atlanta
8:25 a.m. - 8:30 a.m.
Presidential Symposium – Introduction
Colleen A. F. Lawton, MD, FASTRO, President, ASTRO Board of Directors
8:30 a.m. - 9:45 a.m.
Presidential Symposium – Session I
Moderators: Deborah A. Kuban, MD, FASTRO, and Anthony L. Zietman, MD, FASTRO
Speakers:
PSA Screening – Freddie Hamdy, MB, ChB, University of Oxford, Headington, Oxford,
United Kingdom
Low Risk Debate – Active Surveillance vs. Treatment – Timothy J. Wilt, MD, MPH,
Minneapolis VA Center for Chronic Disease Outcomes Research, University of Minnesota School of
Medicine, Minneapolis vs. Michael J. Zelefsky, MD, Memorial Sloan-Kettering Cancer Center,
New York
Quality of Life – Jeff M. Michalski, MD, MBA, FASTRO, Washington University School of
Medicine, St. Louis
9:45 a.m. - 10:15 a.m.
Break – Exhibit Hall Opens
10:15 a.m. - 11:30 a.m.
Presidential Symposium – Session II
Speakers:
Intermediate-risk Disease Debate – Surgery vs. Radiation –
David Dearnaley, MD, Institute of Cancer Research, Royal Marsden Hospital, Surry, United Kingdom
vs. Freddie Hamdy, MB, ChB, University of Oxford, Headington, Oxford, United Kingdom
Fractionation for Organ Confined Disease – Søren M. Bentzen, DSc, PhD, University of
Wisconsin School of Medicine and Public Health, Madison, Wis.
Postoperative Irradiation – Chris Parker, MD, Royal Marsden Hospital, Surrey, United Kingdom
11:30 a.m. - 12:35 p.m.
Presidential Symposium – Session III
Speakers:
High-risk/Locally Advanced Disease – Padraig Warde, MD, Princess Margaret Hospital,
Toronto, Ontario
Systemic Agents/Chemotherapy What’s New – Matthew R. Smith, MD, PhD, Harvard
Medical School, Massachusetts General Hospital, Boston
Radiation for Metastatic Disease Dose/Fractionation and Systemic Agents – Howard M.
Sandler, MD, MS, FASTRO, Cedars-Sinai Medical Center, Los Angeles
Wrap Up – Deborah A. Kuban, MD, FASTRO, MD Anderson Cancer Center, Houston
3:45 p.m. - 4:30 p.m.
Presidential Symposium – Session IV
Patient-reported Outcomes - Making it Real
Introduction by: Benjamin Movsas, MD, FASTRO
Speaker:
Jeff A. Sloan, PhD, Mayo Clinic, Rochester, Minn.
44
Meeting Highlights
8:00 a.m. - 9:00 a.m.
Featured Lecture – “Patient Safety Organizations: An Overview” *
Room: B406
William B. Munier, MD, Director, Center for Quality Improvement and
Patient Safety, Agency for Healthcare Research and Quality
Introduced by: Lawrence B. Marks, MD, FASTRO, University of North Carolina
at Chapel Hill
Please join us for this timely presentation on patient safety organizations (PSOs). Dr. Munier is the director of the
Center for Quality Improvement and Patient Safety at the Agency for Healthcare Research and Quality, where
he is responsible for overseeing the implementation of the Patient Safety and Quality Improvement Act of 2005,
which includes the oversight of PSOs. Dr. Munier’s perspective on PSOs is particularly relevant as ASTRO moves to
implement a radiation oncology-specific PSO.
*This session is not accredited for continuing medical education credits.
9:15 a.m. - 10:15 a.m.
Keynote Address I
“Is there Hope for ‘Healing’ Health Care?”
Darrell G. Kirch, MD, President and CEO, Association of American Medical
Colleges
Introduced by: Theodore L. DeWeese, MD, Johns Hopkins School
of Medicine
Darrell G. Kirch, MD, is president and CEO of the Association of American Medical Colleges (AAMC),
which represents the nation’s medical schools, teaching hospitals and academic societies. A distinguished
physician, educator and medical scientist, Dr. Kirch speaks and publishes widely on the need for
transformation in the nation’s health care system and how academic medicine can lead that change
across medical education, medical research and patient care. Prior to becoming AAMC president in 2006,
Dr. Kirch served as the dean and academic health system leader of two institutions, the Medical College of
Georgia and the Penn State Milton S. Hershey Medical Center. He has co-chaired the Liaison Committee on
Medical Education, the accrediting body for U.S. medical schools, and now serves as a member-at-large of the
National Board of Medical Examiners and as chairman of the Department of Veterans Affairs Special Medical
Advisory Group. Dr. Kirch also is a member of the Institute of Medicine of the National Academies. A
psychiatrist and clinical neuroscientist by training, Dr. Kirch began his career at the National Institute of
Mental Health, becoming the acting scientific director in 1993 and receiving the Outstanding Service Medal
of the United States Public Health Service. A native of Denver, he earned his BA and MD degrees from the
University of Colorado.
Great speaker?
Tweet
#ASTRO13
45
Meeting Highlights
1:15 p.m. - 2:00 p.m.
Presidential Address – “Hope, Faith, Cancer: Keeping Patients First”
Introduced by: J. Frank Wilson, MD, FASTRO, Medical College of Wisconsin
4:00 p.m. - 5:00 p.m.
Featured Lecture – “Update on Self-referral”*
Room: B406
James Cosgrove, PhD, Director, U.S. Government Accountability Office
Introduced by: Michael L. Steinberg, MD, FASTRO, Chairman, ASTRO Board of Directors
At ASTRO’s urging in 2010, Congress requested that the Government Accountability Office, Congress’
investigative arm, report on the clinical and economic impact of self-referral in radiation oncology.
Dr. Cosgrove will discuss the radiation oncology report, as well as other GAO reports on self-referral in
diagnostic imaging and anatomic pathology.
9:15 am. - 10:15 a.m.
Keynote Address II
“Cancer Survivorship and Quality of Life”
Otis W. Brawley, MD, Chief Medical Officer, American Cancer Society
Otis W. Brawley, MD, serves as the chief medical officer and executive vice-president of the American Cancer
Society (ACS) and as a professor of hematology, oncology, medicine and epidemiology at Emory University.
At the ACS Dr. Brawley is responsible for promoting the goals of cancer prevention, early detection and
quality treatment through cancer research and education. He champions efforts to decrease smoking,
improve diet, detect cancer at the earliest stage and provide the critical support cancer patients need. He also
guides efforts to enhance and focus the research program, upgrade the society’s advocacy capacity and
concentrate community cancer control efforts in areas where they will be most effective. Further, as an
acknowledged global leader in the field of health disparities research, Dr. Brawley is a key leader in the
society’s work to eliminate disparities in access to quality cancer care.
46
Meeting Highlights
9:15 am. - 10:15 a.m.
Keynote Address III – Steven L. Leibel, MD, Memorial Lecture
“Identification and Targeting of Radioresistance Niches”
Peter Friedl, MD, PhD, St. Radboud University Nijmegen Medical Centre,
University of Nijmegen, and MD Anderson Cancer Center
Introduced by: Catherine C. Park, MD, University of California San Francisco
The research activities of Peter Friedl, MD, PhD, aim to identify the mechanisms of immune cell and cancer cell
migration, with emphasis on routes, plasticity and outcome of migration in physiological (immune cell
migration) and pathological context (cancer invasion and metastasis). Specific mechanisms of interest include
the function of cell adhesion receptors (integrins, surface glycans), cell surface proteases (MMPs, MT-MMPs)
and microenvironmental signals (tissue microanatomy, hypoxia, nutrient deprivation) and their impact on
cancer invasion and metastasis, tissue destruction and anti-tumor immune defense.
The findings of his laboratory contributed to establish a classification on different types of cell migration, their
main molecular adhesion and protease pathways, and types and mechanisms of plasticity of cell migration.
The data show cancer invasion and metastasis as an adaptive process in response to the microenvironment.
Current basic themes include the cellular, molecular and physical plasticity of cell migration in leukocytes and
cancer cells in vitro and in vivo. Therefore, Dr. Friedl’s lab monitors the preclinical response to anti-cancer
therapy by intravital multiphoton microscopy. The data show the resistance of tumor microniches and
highlight strategies to overcome resistance, particularly by combining radiation therapy and molecular
therapy targeting integrin adhesion receptors.
47
ARRO Program
ARRO Annual Seminar*
9:00 a.m. - 5:00 p.m.
Room: B313
Refer to page 49 for program schedule.
6:30 p.m. - 8:30 p.m.
ARRO Reception
STATS
300 Marietta St., N.W.
Atlanta, GA 30313
Shuttle service will not be provided to the ARRO Reception. STATS is approximately a 5-minute walk from the
Georgia World Congress Center.
12:35 p.m. - 1:45 p.m.
ARRO Annual Luncheon
Room: B313
Guest Speaker: Michael L. Steinberg, MD, FASTRO, Chairman, ASTRO Board of Directors
12:15 p.m. - 1:15 p.m.
ARRO Poster Walk with a Professor (Box Lunch)
Room: Hall B4 – Poster Lounge
12:15 p.m. - 1:15 p.m.
How to Review a Scientific Paper Workshop (Box Lunch)*
Room: B203
W. Robert Lee, MD, MS, MEd, Moderator, Duke University
Workshop Faculty:
Søren M. Bentzen, DSc, PhD, University of Wisconsin School of Medicine and Public Health
Anthony V. D’Amico, MD, PhD, FASTRO, Brigham and Women’s Hospital
Lynn D. Wilson, MD, MPH, FASTRO, Yale University School of Medicine
Anthony L. Zietman, MD, FASTRO, Massachusetts General Hospital
5:30 p.m. - 6:30 p.m.
Poster Viewing Session and Reception*
Meet and Greet – Residents and Medical Students*
Room: Hall B4 – Poster Lounge
12:00 p.m. - 1:00 p.m.
ARRO Meet the Professor Luncheon
Room: B302-B305
48
9:00 a.m. - 5:00 p.m. | Room: B313
This year’s program combines a variety of timely topics for residents at all stages of training. Using the audience
interactive system, presentations are intended to facilitate interaction among participants from different
communities.
9:00 a.m. - 9:10 a.m.
Opening Remarks – ARRO Executive Committee
Jordan Kharofa, MD, ARRO Chairman, Medical College of Wisconsin
Seth Miller, MD, University of North Carolina at Chapel Hill
9:10 a.m. - 9:40 a.m.
Global Health Scholar Award Presentations
Rachel Jimenez, MD, Harvard University, 2012 recipient - New Delhi, India
Sarah Milgrom, MD, Memorial Sloan-Kettering Cancer Center, 2013 recipient - Dakar,
Senegal
Youssef Zeidan, MD, PhD, Stanford University, 2013 recipient - Beirut, Lebanon
9:40 a.m. - 10:00 a.m.
Residency Research Time and Resources: Survey Results
Josh Mackenzie, MD, University of Cincinnati
10:00 a.m. - 10:45 a.m. Legal Aspects of Entering Practice
Terry Wall, MD, JD, FASTRO, St. Luke’s Cancer Institute
Break
10:50 a.m. - 11:50 a.m.
Keynote Address: Radiation Oncology: Lessons from the Past to Help
Guide Your Future
10:45 a.m. - 10:50 a.m.
11:50 a.m. - 1:00 p.m.
J. Frank Wilson, MD, FASTRO, Medical College of Wisconsin
1:00 p.m. - 1:30 p.m.
Break - Box Lunch
Fellowships in Radiation Oncology
Subhakar Mutyala, MD, Texas A and M College of Medicine
Panelists:
Brian E. Lally, MD, University of Miami Health System
Kunal Saigal, MD, Fellow, Beth Israel Deaconess Medical Center
1:30 p.m. - 2:30 p.m.
Applying for Jobs: A Panel Discussion
Moderator: Lisa A. Kachnic, MD, Boston Medical Center
Panelists:
Randy Kimple, MD, PhD, University of Wisconsin School of Medicine and Public Health
Shannon Fogh, MD, University of California San Francisco
Larry Daughtery, MD, Mayo Clinic, Jacksonville
Anmed Ali, MD, Peachtree Radiation Oncology
2:30 p.m. - 3:30 p.m.
Manuscript Writing
Katherine Bennett, ASTRO
3:30 p.m. - 4:20 p.m.
Radiation Oncology Economics Series: Process of Care, Coding and
Reimbursement in Radiation Oncology
Najeeb Mohideen, MD, Northwest Community Hospital
4:20 p.m. - 5:00 p.m.
Professional Evaluation of Radiation Oncology Academic and Private
Practices
49
Young Physicians’ Workshop*
1:00 p.m. - 5:00 p.m. | Room: B216
This workshop will address several key issues facing early career physicians and will provide an open forum for
discussion among peers. The educational focus is targeted toward young physicians, less than 10 years in
practice. Distinguished faculty will share their experience and insights on several exciting topics.
1:00 p.m. - 1:05 p.m.
Welcome
Shilpen Patel, MD, University of Washington
1:05 p.m. - 1:25 p.m.
Keeping Your Sword Sharp – How to Stay Abreast of the Latest
Developments with a Busy Practice and Life
Patty Hardenberg, MD, Vail Valley Medical Center
1:25 p.m. - 1:45 p.m.
Difficult Conversations with Patients
Beth A. Erickson, MD, Medical College of Wisconsin and Akila N. Viswanaknan, MD,
MPH, Brigham and Women’s Hospital
1:45 p.m. - 2:05 p.m.
Negotiating a Contract When You are Established in the Field
2:05 p.m. - 2:25 p.m.
Jumping Ship - How to Make the Transition When Changing Jobs
Michael L. Steinberg, MD, FASTRO, Chairman, ASTRO Board of Directors
2:25 p.m. - 2:45 p.m.
Maintenance of Certification - How? What? Where? When?
Paul E. Wallner, DO, FASTRO, 21st Century Oncology
2:45 p.m. - 3:00 p.m.
Break
3:00 p.m. - 3:20p.m.
Getting Involved in Your Specialty or Organized Medicine/Leadership
Development
Tim R. Williams, MD, FASTRO, Lynn Cancer Institute
3:20 p.m. - 3:40 p.m.
Starting Protocols and Getting Funding: The How, When and Where
Walter J. Curran Jr., MD, Winship Cancer Institute of Emory University
3:40 p.m. - 4:00 p.m.
Work/Life Balance
Leonard L. Gunderson, MD, MS, FASTRO, Immediate Past Chairman, ASTRO Board of
Directors, and Mayo Clinic Scottsdale
4:00 p.m. - 4:20 p.m.
How to Build a Clinical Practice
David C. Beyer, MD, FASTRO, Arizona Oncology Services
4:20 p.m. - 4:40 p.m.
Case Presentations
Reshma Jagsi, MD, University of Michigan
4:40 p.m. - 5:00 p.m.
How to Critique, Write and Review a Scientific Paper
W. Robert Lee, MD, MS, MEd, Duke University
50
Nurses’ Program A
ARON
The Annual Meeting Nurses’ Committee has designed a program with sessions that are pertinent to radiation
oncology nurses. The Nurses’ Luncheon is open to all Annual Meeting nurse registrants, but the option must
have been added at the time of registration; therefore, you must have a ticket to attend.
10:45 a.m. - 12:00 p.m.
Nurses’ Welcome and Orientation Luncheon
Room: B206
Joanne Moar, RN, OCN, Massachusetts General Hospital
Cindy Tomlinson, ASTRO’s New Medical Error Reporting Program
The Annual Meeting Nurse Abstract Award will be presented during the luncheon.
12:00 p.m. - 1:30 p.m.
HPV Changing the Paradigm in Head and Neck Cancer
Room: B203
Jeanne Parzuchowski, RN, MS, OCN, William Beaumont Hospital
1:45 p.m. - 2:45 p.m.
Wound and Skin Update: What’s Skin Got to Do With It
Room: B203
Carole Bauer, RN, MSN, ANP-BC, OCN, CWOCN, Karmanos Cancer Center
2:45 p.m. - 3:45 p.m.
Role of the Radiation Oncology Nurse in GI Oncology
Room: B203
Gloria Wood, RN, MS, OCN, Moffitt Cancer Center
1:45 p.m. - 2:45 p.m.
RT the Gift That Keeps on Giving
Room: B203
Vanna M. Dest, MSN, APRN, BC, AOCN, Hospital of Saint Rafael
Pamela Devine, MSN, RN, Philadelphia VA Medical Center
2:45 p.m. - 3:45 p.m.
Geriatric Focus in the Radiation Oncology Setting
Room: B203
Diane Cope, PhD, ARNP, Florida Cancer Specialists and Research Institute
Lynn Heup, MSN, BSN, Emory Healthcare
4:00 p.m. - 5:00 p.m.
Integrative Health Modalities
Room: B203
Marilyn Haas, PhD, Carepartners
Symbol Key:
A
ARON
Separate
Session
registration
required
Award
Recipient
Live
Interactive
SAM/
Session
Separate
registration
required
51
A series of sessions have been identified throughout the Annual Meeting Program as pertinent to our
international attendees. The International Attendee Welcome Breakfast is open to all international attendees,
and you must have an international attendee badge holder (black) to be admitted. The Foreign Language Poster
Walks are ticketed event; therefore, you must register for them and have a ticket to attend.
7:00 a.m. - 8:15 a.m.
International Attendee Welcome Breakfast
Room: B302-B305
The International Abstract Award will be presented during the breakfast.
1:45 p.m. - 3:15 p.m.
Best of ESTRO at ASTRO*
Room: B213
Moderators:
Vincenzo Valentini, MD, President, ESTRO
Panelists:
Phillip Poortmans, MD, President-elect, ESTRO
Tommy Knöös, PhD, Physics Committee Chairman, ESTRO
Vincenzo Valentini, MD, President, ESTRO
11:00 a.m. - 12:00 p.m.
Foreign Language Poster Walks
Room: Hall B4, Poster Information Desk
Foreign Language Poster Walks will be offered in Chinese and Spanish, and will review selected abstracts based
on disease site. Please note that this event is open to international attendees only. Please refer to the details
below for further information.
CHINESE POSTER WALK
Faculty: W. Ken Zhen, MD
Disease Site: Head and Neck
SPANISH POSTER WALK
Faculty: Adela Poitevin, MD
Disease Site: Breast, CNS and Prostate
Connect with Attendees.
Tweet
#ASTRO13
52
International Symposium*
1:00 p.m. - 4:15 p.m.
Room: B206
*This Symposium is not accredited for continuing medical education credits.
1:00 p.m. - 2:30 p.m.
International Symposium: Global Health and Radiation Oncology- Part I*
Where is the Challenge and What Can We Do?
Radiation Oncology in Latin America, India and Africa
Moderator:
Nina A. Mayr, MD, FASTRO, University of Washington
Speakers:
Global Health - The Big Picture - Bhadrasain Vikram, MD, National Cancer Institute
Latin America - Beatriz Amendola, MD, FASTRO, Innovative Cancer Institute
Africa - Terry J. Wall, MD, JD, FASTRO, St. Luke’s Cancer Institute
India - Prabhakar Tripuraneni, MD, FASTRO, Scripps Clinic
2:45 p.m. - 4:15 p.m.
International Symposium II - Global Health and Radiation Oncology Part II:
What are the Barriers to Delivery Optimal Therapy?
Radiation Oncology in Asia
Moderator:
Kenneth Shung Hu, MD, Beth Israel Medical Center of New York
Speakers:
Clinical and Societal Challenges - Mack Roach, MD, University of California San Francisco
Infrastructure and Ancillary Services - Cynthia L. Eccles, CMD, RT, BS,
University of Oxford, Gray Institute
China - Nancy Lee, MD, Memorial Sloan-Kettering Cancer Center
South East Asia - Miriam Calaguas, MD, St. Luke’s Medical Center
Symbol Key:
A
ARON
Separate
Session
registration
required
Award
Recipient
Live
Interactive
SAM/
Session
Separate
registration
required
53
ASTRO Accreditation Program for
Excellence (APEx)
ASTRO’s practice accreditation program highlights the Society’s commitment to safety and quality. The program
uses evidence-based guidelines and consensus statements on the practice of radiation oncology to establish
standards of performance. ASTRO’s practice accreditation program will provide an objective peer review of
essential functions and processes of radiation oncology practices, in addition to an on-site visit from a
multidisciplinary team. The practice accreditation program consists of five key areas: patient-centered care, the
process of care, the radiation oncology team, safety, and quality management and assurance.
1:00 p.m. - 4:00 p.m.
ASTRO Accreditation Program for Excellence (APEx) – Prospective Surveyor Training*
Room: B213
This interactive session is designed to provide an overview of the program and guidance on the surveyor’s
role. The target audiences for this session are radiation oncologists, physicists and radiation therapists who
are interested in becoming surveyors for ASTRO’s practice accreditation program.
Participants of this session will be able to:
•
Discuss the mission, vision and goals of the program.
•
Discuss the radiation oncology practice accreditation model.
•
Identify and discuss the program standards.
•
Identify the steps of the survey process.
•
Discuss eligibility criteria for surveyors.
•
Discuss surveyor training requirements.
Surveyors must be an ASTRO member; licensed; board certified; experienced (five years); currently practicing and
flexible to conduct one survey per quarter. Surveyors cannot conduct radiation oncology surveys for other
accrediting bodies while surveying for ASTRO.
12:15 p.m. - 1:15 p.m.
ASTRO Accreditation Program for Excellence (APEx) Highlights Luncheon
Room: B405
This luncheon is designed to provide highlights of ASTRO’s practice accreditation program. Attend this session
and learn about the accreditation process from the perspectives of a radiation oncologist, a physicist and a
radiation therapist.
Symbol Key:
A
Separate
Session
registration
required
54
ARON
Award
Recipient
Live
Interactive
SAM/
Session
Separate
registration
required
Tweet
#ASTRO13
Schedule of Events
Saturday | September 21
8:00 a.m. - 9:30 a.m.
eContouring Learning Lab – Esophageal Cancers
Room: B308
9:00 a.m. - 5:00 p.m.
Room: B313
10:00 a.m. - 11:30 a.m.
eContouring Learning Lab – Gynecologic Cancers
Room: B308
10:45 a.m. - 12:00 p.m.
Nurses’ Welcome and Orientation Luncheon
Room: B206
12:00 p.m. - 3:45 p.m.
Nurses’ Program
Room: B203
1:00 p.m. - 6:00 p.m.
ASTRO Career Fair
Room: B207
1:00 p.m. - 2:30 p.m.
The New Accreditation System from the ACGME – A Program Director Workshop*
Room: B211
This workshop is intended to provide Program Directors a comprehensive overview of the new accreditation
system that will be rolled out in July 2014. The workshop will describe the Radiation Oncology Milestones and
outline a process for programs to create their own Clinical Competency Committee as required by the ACGME.
Additionally the workshop will highlight how to provide learners with effective feedback and useful evaluations.
Speakers:
Alisa Nagler, JD, EdD, Duke University
Ticketed Event/Separate registration required
55
Saturday | September 21
1:00 p.m. - 4:00 p.m.
ASTRO Accreditation Program for Excellence (APEx) – Prospective Surveyor Training*
Room: B213
This session is designed to provide an overview of the program and guidance on the surveyor’s role. The target
audiences for this session are radiation oncologists, physicists and radiation therapists who are interested in
becoming surveyors for ASTRO’s practice accreditation program.
1:00 p.m. - 5:00 p.m.
Young Physicians’ Workshop*
Room: B216
1:30 p.m. - 3:00 p.m.
eContouring Learning Lab – Lymphoma and Breast Cancer
Room: B308
3:30 p.m. - 5:00 p.m.
eContouring Learning Lab – Gastrointestinal Cancers (SBRT/Abdominal)
Room: B308
6:30 p.m. - 8:30 p.m.
ARRO Reception – STATS
300 Marietta St., N.W.
Atlanta, GA 30313
Shuttle service will not be provided to the ARRO Reception. STATS is approximately a 5-minute walk from the
Georgia World Congress Center.
Tweet
#ASTRO13
56
Sunday | September 22
7:00 a.m. - 8:15 a.m.
International Attendee Welcome Breakfast
Room: B302-B305
Open to international attendees. You must have a black badge holder to be admitted.
8:00 a.m. - 9:30 a.m.
eContouring Learning Lab – Lung Cancer
Room: B308
8:00 a.m. - 6:00 p.m.
ASTRO Career Fair
Room: B207
8:15 a.m. - 8:25 a.m.
Welcome Address*
Walter J. Curran Jr., MD, Winship Cancer Institute of Emory University
8:25 a.m. - 4:30 p.m.
Presidential Symposium – “Prostate Cancer: Patient Focused Advances”
10:00 a.m. - 5:00 p.m.
Exhibit Hall Open
Room: Halls B1–B3
10:00 a.m. - 5:00 p.m.
Poster Viewing
Room: Hall B4
10:00 a.m. - 11:30 a.m.
eContouring Learning Lab – Lung SBRT/Sarcoma
Room: B308
57
12:35 p.m. - 1:45 p.m.
ARRO Annual Luncheon
Room: B313
Guest Speaker: Michael L. Steinberg, MD, FASTRO, Chairman, ASTRO Board of Directors
12:35 p.m. - 1:45 p.m.
Health Policy Socioeconomic Luncheon*
2014 Radiation Oncology Coding and Reimbursement Update
Room: Thomas Murphy Ballroom 4
Box Lunch Provided
A preview of the 2014 proposed rule changes to the Medicare Physician Fee Schedule and Hospital Outpatient
Prospective Payment System, as well as other payment and coding changes for 2014, will be presented. This
update will be followed by a review of the current payment environment, which is dominated by concerns about
Medicare spending growth and the instability of the sustainable growth rate (SGR). The session will conclude
with a discussion of actions taken by the Medicare agency and private payers to control health care spending and
how ASTRO has actively engaged with them and other stakeholders to address these concerns.
Moderators:
Joel Cherlow, MD, PhD, Long Beach Memorial Medical Center
Thomas Eichler, MD, Thomas Johns Cancer Center
Speakers:
David C. Beyer, MD, FASTRO, Arizona Oncology Services
Najeeb Mohideen, MD, Northwest Community Hospital
12:35 p.m. - 1:45 p.m.
Financial Planning Luncheon Hosted by the Radiation Oncology Institute (ROI)*
Learn how Recent Tax Law Changes and the Health Care Reimbursement Climate Impact
your Personal Financial Planning
Room: B310
Box Lunch Provided
This session will be aimed at educating attendees on the impact of the American Taxpayer Relief Act of 2012
and relevant planning topics that may be appropriate given the changes. Concepts such as evaluating current
retirement plans and determining whether there may be an opportunity to increase deductible contributions
will be explored, as well as tax efficient investment vehicles like Roth IRAs, annuities, municipal bonds and master
limited partnerships. Attendees will hear from financial and estate planners who understand what planning and
charitable giving strategies are available to benefit them and the tax advantages available to effectively transfer
wealth intergenerationally and support organizations like the Radiation Oncology Institute (ROI) that champion
their profession.
Speakers:
Theodore Lawrence, MD, PhD, FASTRO, President, ROI Board of Trustees
Russell M. LaGreca and/or James K. Meek, Morgan Stanley Smith Barney LLC
James R. Robinson,Esq. Barnes and Thornburg LLP
J. Frank Wilson, MD, FASTRO, Medical College of Wisconsin
58
1:45 p.m. - 3:15 p.m.
Scientific Session A – Clinical Trials
Moderators: Lynn Wilson, Benjamin Movsas
1:45 p.m.
Maria Grazia Ghi
4
A Phase II-III Study Comparing Concomitant Chemoradiation Therapy (CRT) vs. Cetuximab/RT (CET/RT) With or
Without Induction Docetaxel/Cisplatin/5Fluorouracil (TPF) in Locally Advanced Head and Neck Squamous Cell
Carcinoma (LASCCHN). Efficacy Results of the GSTTC Italian Study (NCT01086826)
1:53 p.m.
Michael Folkert
5
Predictive Modeling of Outcomes Following Definitive Chemoradiation Therapy for Oropharyngeal Cancer
Based on FDG-PET Image Characteristics
Resident Clinical/Basic Science Research Award – Radiation Physics
2:01 p.m.
Gregory Videtic
6
Radiation Therapy Oncology Group (RTOG) Protocol 0915: A Randomized Phase II Study Comparing Two
Stereotactic Body Radiation Therapy (SBRT) Schedules for Medically Inoperable Patients with Stage I Peripheral
Non-small Cell Lung Cancer
2:09 p.m.
David Palma
7
Predicting Esophagitis After Chemoradiation Therapy for Non-small Cell Lung Cancer: An Individual Patient Data
Meta-Analysis of >1000 Patients
2:18 p.m.
Antonio Zuliani
8
Efficacy of Concomitant Cisplatin Plus Radiation Therapy and High-dose-rate Brachytherapy vs. Radiotherapy
Alone for Stage IIIB Epidermoid Cervical Cancer: A Ten-Year Randomized Controlled Trial
International Award Winner
2:26 p.m.
Akila Viswanathan
9
A Phase II Study of Postoperative Intensity Modulated Radiation Therapy (IMRT) with Concurrent Cisplatin and
Bevacizumab (Bev) Followed by Carboplatin and Paclitaxel for Patients with Endometrial Cancer: One-year
Results from RTOG 0921
2:34 p.m.
Raymond Mailhot Vega
10
Cost Effectiveness of Proton Therapy Compared to Photon Therapy in the Management of Pediatric
Medulloblastoma
2:42 p.m.
Jan Kriz
11
Relapse Analysis After Radiotherapy of PET-Positive Residual Tumors of Patients with Advanced Stage Hodgkin
Lymphoma Treated in the HD15 Trial of the German Hodgkin Study Group (GHSG)
2:50 p.m.
Edward Chow
12
Response and Quality of Life (QoL) Outcomes in a Randomized Trial of Single vs. Multiple Fractions (Fx) for
Re-Irradiation (RE-RT) of Painful Bone Metastases (PBM): NCIC CTG SC.20
2:58 p.m.
Robert Miller
LBA2
N08C9 (Alliance) - A Phase III Randomized Study of Sulfasalazine vs. Placebo in the Prevention of Acute Diarrhea
in Patients Receiving Pelvic Radiation Therapy
3:06 p.m.
Arjun Sahgal
LBA3
Individual Patient Data (IPD) Meta-Analysis of Randomized Controlled Trials (RCT) Comparing Stereotactic
Radiosurgery Alone (SRS) to SRS Plus Whole Brain Radiotherapy (WBRT) in Patients with Brain Metastasis
59
1:45 p.m. - 3:15 p.m.
Scientific Session B – Breast – Loco-regional Control
Room: B302-B305
Moderators: Jennifer Yu, Youlia Kirova
1:45 p.m.
Rachel Abrams Rabinovitch 13
Long Term Update of RTOG 0319: A Phase I/II Trial to Evaluate Three-dimensional Conformal Radiation Therapy
(3-D CRT) Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma (BrCa)
1:55 p.m.
Jessica Wobb
14
Accelerated Partial Breast Irradiation Provides Equivalent 10-Year Outcomes to Whole Breast Irradiation: A
Matched-Pair Analysis
2:05 p.m.
Jayant Vaidya
15
Omitting Whole Breast Radiotherapy Did Not Increase Axillary Recurrence in the Targit-a Trial
2:15 p.m.
Samuel Shin
16
Analysis of Prone Accelerated Partial Breast Irradiation After Breast-Conserving Surgery: 50 Months Follow-Up
Results of 200 Patients
2:25 p.m.
Atif Khan
Discussant
2:35 p.m.
Shulian Wang
17
Interim Analysis of 455 Breast Cancer Patients Randomly Treated with Hypofractionated or Conventional
Fractionated Radiotherapy After Mastectomy
2:45 p.m.
Yu-Chen Tsai
18
Post Mastectomy Radiotherapy Improves Survivals of N1 Breast Cancer Patients
2:55 p.m.
Andrea Russo
19
Margin Status and the Risk of Local Recurrence (LR) in Patients with Early-stage Breast Cancer Treated with
Breast-Conserving Therapy (BCT)
3:05 p.m.
Betro Sadek
20
Higher Boost Dose of Radiation Instead of Mastectomy for Patients with Final Positive/Close Margins After Breast
Conserving Therapy
1:45 p.m. - 3:15 p.m.
Scientific Session C – Lung – SBRT
Room: B405
Moderators: Megan Daly, Jeffrey Bogart
1:45 p.m.
Hiroshi Onishi
21
Japanese Multi-institutional Study of Stereotactic Body Radiotherapy for More Than 2000 Patients with Stage I
1:55 p.m.
Rikiya Onimaru
22
A Phase I Study of Stereotactic Body Radiotherapy (SBRT) for Peripheral T2N0M0 Non-small Cell Lung Cancer
(NSCLC): Japan Clinical Oncology Group Study (JCOG0702)
2:05 p.m.
Richard Hymas
23
A Matched Pair Analysis of Stage I Non-small Cell Lung Cancer Treated with Lobectomy, Stereotactic
Radiotherapy (SBRT) or Wedge Resection
2:15 p.m.
Inga Grills
Discussant
2:25 p.m.
Jeremy Harris
24
Performance of PET in Evaluating Local Recurrence after Stereotactic Ablative Radiotherapy for Early Lung Cancer
2:35 p.m.
Sarah Mattonen
25
Assessment of Response After Stereotactic Ablative Radiotherapy (SABR) for Lung Cancer: Can Advanced CT
Image Feature Analysis Predict Recurrence?
2:45 p.m.
Brandon Mancini
26
PET Predicts Survival Following Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer
2:55 p.m.
Zachary Kohutek
27
Pre-Treatment SUVmax on [18F]FDG-PET is Associated with Recurrence and Survival After SBRT for Early-stage
NSCLC
3:05 p.m.
Houda Bahig
28
Tumoricidal Robotic Radiation: 96% 2-Year Disease-Specific Survival Following Cyberknife Stereotactic Body
Radiotherapy for Early-stage Non-small Cell Lung Cancer
1:45 p.m. - 3:15 p.m.
Scientific Session D – Physics – MRI in Radiation Therapy
Room: Sidney Marcus Auditorium
Moderators: Daniel Low, Carri Glide-Hurst
1:45 p.m.
David Jaffray
29
Development of a Novel Platform for MR-guided Radiation Therapy
1:55 p.m.
Yanle Hu
30
Image Performance Characterization of an MRI-Guided Radiotherapy System
2:05 p.m.
Tony Tadic
31
A Novel Harmonic Analysis for Quantifying MRI Performance in MRIgRT
2:15 p.m.
Olga Green
32
Realizing the QUANTEC Vision by Applying iWeighted Hybrid Iterative Spiral K-space Encoding Estimation
(WHISKEE) to Actual dose (DA) Accumulation via Image Deformation (DAAvID)
2:25 p.m.
Louise Murray
33
Isotoxic Simultaneous Integrated Boost to Dominant Intra-prostatic Lesions Using Stereotactic Ablative
Radiotherapy and Volumetric Modulated Arc Therapy
61
2:35 p.m.
Timothy Craig
34
A Clinical Process for Imaging, Planning and Delivery of Dose Escalation for Intraprostatic Gross Tumor Volumes
2:45 p.m.
Alexander Chin
35
Dosimetric Accuracy of Bulk Density Assignment on MRI for Head and Neck IMRT Treatment Planning
2:55 p.m.
Elisabeth Weiss
36
Diffusion-weighted MRI for Response Assessment During Radiotherapy of Lung Cancer
1:45 p.m. - 3:15 p.m.
Scientific Session E – CNS – Glioblastomas and High Grade Gliomas
Room: B406
Moderators: Charles Simone, Christina Tsien
1:45 p.m.
Frank Saran
37
The Addition of Bevacizumab (BEV) to Temozolomide (TMZ) and Radiotherapy (RT) in Newly Diagnosed
Glioblastoma (GBM) Improves Progression-free Survival (PFS) Without Adding to RT Toxicity
1:55 p.m.
Moses Tam
38
Phase II Trial of Temozolomide Plus Bevacizumab, Lithium and Radiation Treatment for Newly Diagnosed High
Grade Gliomas: Interim Analysis
2:05 p.m.
Nils Arvold
39
Disconnect Between Recurrence-Free Survival and Overall Survival for Newly Diagnosed Glioblastoma Patients
Receiving Adjuvant Bevacizumab
2:15 p.m.
Linda Chen
40
Characterization of Glioblastoma Subventricular Recurrence Patterns
2:25 p.m.
Penny Fang
41
Phase I Study of Nelfinavir Concurrent with Temozolomide and Radiation Therapy in Patients with Glioblastoma
Multiforme
2:35 p.m.
Daniel Spratt
42
A Validation Study of the Temporal Relation of Post-operative Radiotherapy with Temozolomide for Glioblastoma
Multiforme: Is the RTOG RPA Enough?
2:45 p.m.
Mekhail Anwar
43
Identifying Voxels at Risk for Progression in GBM Based on Dosimetry, Physiologic and Metabolic MRI
Basic Science Abstract Award – Radiation and Cancer Biology
2:55 p.m.
Hasan Danish
44
Post-radiation Diffusion MRIs May Distinguish True Progression from Pseudoprogression in GBM Patients
3:05 p.m.
62
Kevin Camphausen
Discussant
Interesting session?
Tweet
#ASTRO13
1:45 p.m. - 3:15 p.m.
Digital Poster Discussion 01 – Physics – Novel Applications
Room: A411
Discussants: Kristy Brock, Laurence Court
Ruby Meredith
1001
Early Results of Phase I Trial with New Anti-HER-2 Radionuclide Conjugate
Diana Shvydka
1002
Design of a Novel Multilayer Detector Based on Thin-Film Cadmium Telluride for High Energy Photon Imaging in
Radiation Therapy Applications
Rafal Tarnawski
1003
Integration of PET/CT (68) Ga-Dotate for Robotic Radiotherapy Treatment Planning in Meningioma Patients
Javad Rahimian
1004
Prediction of Pelvic Lymph Node Involvement in Patients with Prostate Cancer Using an Artificial Neural Network
Kristofer Kainz
1005
Deriving a Virtual Respiratory Phase-Specific PET Contour from Free-Breathing PET Using Respiratory Information
from 4-D CT
Tsuyoshi Takanaka
1006
Breath Holding Volumetric Modulated Radiotherapy Based on Implanted Fiducial Marks Using the Image-guided
Radiotherapy System with Fluoroscopic Function
Houari Korideck
1007
Dosimetric Verification of the Small Animal Radiation Research Platform (SARRP) Treatment Planning System
(TPS) in Mice
Bashar Al-Qaisieh
1008
Dosimetry Modeling for Focal LDR Prostate Brachytherapy
Wilfred Ngwa
1009
Towards Customizable Radiotherapy Enhancement (CuRE), with Gold Nanoparticles released, in situ, from
Gold-loaded Brachytherapy Spacers
Mu-Han Lin
1010
Clinical Implementation of a Comprehensive EPID-Based 3-D/4-D Patient Dose Reconstruction Framework for
Complex Treatment Validations
Resident Digital Poster Discussion Award
Shungo Akita
1011
Establishment of an Easy-to-Handle Quality Assurance (QA) Tool Using Plastic Scintillator for Dynamic Parameters
of VMAT
Xin Ming
1012
Monte Carlo Estimation of Dose to the Cardiac Implantable Electronic Devices from a kVCBCT System Used in
Image-Guided Radiation Therapy
63
1:45 p.m. - 3:15 p.m.
Digital Poster Discussion 02 – GU – Fractionation, Protons, Prognostic Factors and
Hormones
Room: A412
Discussants: Neil Martin, Mack Roach
Michael Weller
1013
Hypofractionated Intensity Modulated Radiotherapy for Localized Prostate Cancer: Long Term Outcomes and a
Comparison to Standard Dose-escalated RT
Nadia Di Muzio
1014
High Dose Moderately Hypofractionated Tomotherapy for Prostate Cancer: Five Year Results
James Yu
1015
Stereotactic Radiosurgery versus Intensity Modulated Radiotherapy for Prostate Cancer: Comparison of Early
Toxicity
Paul Romesser
1016
Prostate-specific Antigen (PSA) Doubling Time at Time of PSA Relapse is an Independent Predictor for Distant
Metastasis and Survival After External Beam Radiation Therapy
Randal Henderson
1017
Early Gastrointestinal Toxicity Outcomes from a Prospective Trial of Accelerated Hypofractionation with Proton
Therapy for Prostate Cancer
Tamara Smith
1018
Grade 3 Genitourinary Toxicities in Men After Proton Therapy for Prostate Cancer
Nancy Mendenhall
1019
Five-year Outcomes of Proton Therapy in Localized Prostate Cancer on Three Prospective Trials for Low-,
Intermediate- and High-Risk Prostate Cancer
Tamim Niazi
1020
Testosterone Breakthrough During Luteinizing Hormone-Releasing Hormone Agonist Therapy Impacts
Biochemical Disease Progression: Fact or Myth?
Jason Hearn
1021
Prostate Cancer in the Era of High-Dose Radiotherapy: Presence of Multiple Intermediate-risk Factors is Not a
Valid Surrogate for High-risk Disease
Miranda Kim
1022
Defining the Optimal Approach to the Patient with Post-Radiation Prostate-Specific Antigen Recurrence Using
Outcome Data from a Prospective Randomized Trial
Sindy Magnan
1023
Intermittent vs. Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and
Meta-Analysis
64
William Jackson
1024
Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy
Following Radical Prostatectomy
1:45 p.m. - 3:15 p.m.
Educational Session 101 – Stem Cells, Bystander and Cell Death Mechanisms
Room: B211
Frank Pajonk, MD, PhD, University of California Los Angeles Health System
Kevin Prise, PhD, Queen’s University Belfast
Paul F. Wilson, PhD, Brookhaven National Labratory
1:45 p.m. - 3:15 p.m.
Educational Session 102 – ASTRO/PROS Session: Current Approaches for Childhood Brain
Tumors
Room: B206
Daniel A. Hamstra, MD, PhD, University of Michigan
Nadia N. Laack, MD, MS, Mayo Clinic
Anita Mahajan, MD, MD Anderson Cancer Center
1:45 p.m. - 3:15 p.m.
eContouring Learning Lab – Head and Neck Cancers
Room: B308
1:45 p.m. - 3:15 p.m.
Best of ESTRO at ASTRO*
Room: B213
1:45 p.m. - 5:00 p.m.
Nurses’ Program
Room: B203
3:45 p.m. - 4:30 p.m.
Presidential Symposium – Session IV
Patient-reported Outcomes - Making it Real
Introduction by: Benjamin Movsas, MD, FASTRO
Speaker: Jeff A. Sloan, PhD, Mayo Clinic, Rochester, Minn.
65
4:00 p.m. - 5:30 p.m.
eContouring Learning Lab – Prostate Cancers
Room: B308
4:30 p.m. - 6:00 p.m.
Panel 01 - Optimal Approach to Breast Cancer in Women > 70 Years Old
Room: B211
Moderator:
Janet Horton, MD, Duke University Medical Center
Panelists:
Kevin Hughes, MD, University of North Carolina at Chapel Hill
Benjamin Smith, MD, MD Anderson Cancer Center
Hyman Muss, MD, University of North Carolina at Chapel Hill
4:30 p.m. - 6:00 p.m.
Panel 02 – Patient-reported Quality of Life Following Radiation Therapy for Prostate
Cancer
Room: B302-B305
Moderators:
Daniel Hamstra, MD, PhD, University of Michigan
Martin Sanda, MD, Beth Israel Deaconess Medical Center
Panelists:
Deborah Watkins Bruner, PhD, RN, Emory University
Martin Sanda, MD, Emory University School of Medicine
Daniel Hamstra, MD, PhD, University of Michigan
Jason Efstathiou, MD, PhD, Massachusetts General Hospital
4:30 p.m. - 6:00 p.m.
Panel 03 – Stereotactic Body Radiation Therapy for Lung Cancer
Moderators:
Andrea Bezjak, MD, Princess Margaret Hospital
Joe Chang, MD, MS, PhD, MD Anderson Cancer Center
Panelists:
Indrin J. Chetty, PhD, Henry Ford Health System
Ben Slotman, MD, PhD, VU University Hospital Center
4:30 p.m. - 6:00 p.m.
Panel 04 – Overcoming the Resistance of Glioblastoma to Conventional Radiation Therapy
Room: B216
Moderators:
Brian Marples, PhD, William Beaumont Hospital
Kevin Camphausen, MD, National Cancer Institute
66
Panelists:
Peter Huber, MD, PhD, KDFZ University Hospital, Germany
William Phillips, MD, University of Texas Health Science Center San Antonio
Kevin Camphausen, MD, National Cancer Institute
4:30 p.m. - 6:00 p.m.
Panel 05 – The Role of Radiotherapy in Radical/Adjuvant Non-small Cell Lung Cancer:
ASTRO Practice Guideline Evidentiary Base
Moderator:
George Rodrigues, MD, MSc, London Regional Cancer Program
Panelists:
Gregory Videtic, MD, Cleveland Clinic
Alexander Louie, MD, London Regional Cancer Program
Maria Werner-Wasik, MD, Thomas Jefferson University Hospital
Hak Choy, MD, UT Southwestern Medical Center
Jeffrey Bogart, MD, State University of New York
4:30 p.m. - 6:00 p.m.
Educational Session 103 – Challenging Cases of Hodgkin’s Lymphoma and
Non-Hodgkin’s Lymphoma
Room: B206
Bouthaina Dabaja, MD, MD Anderson Cancer Center
David Hodgson, MD, Princess Margaret Hospital
Richard T. Hoppe, MD, FASTRO, Stanford University
Ann LaCasce, MD, Harvard Medical School
Peter Mauch, MD, FASTRO, Harvard Medical School
4:30 p.m. - 6:00 p.m.
Educational Session 104 – Head and Neck Case Presentations
Room: B313
Robert Amdur, MD, University of Florida
Avraham Eisbruch, MD, University of Michigan Health Systems
Robert I. Haddad, MD, Dana-Farber Cancer Institute
Louis B. Harrison, MD, FASTRO, Beth Israel Medical Center
Adam Jacobson, MD, Beth Israel Medical Center
Great Speaker?
Tweet
#ASTRO13
67
Monday | September 23
7:45 a.m. - 9:00 a.m.
Educational Session 201 – Clinical Radiobiology of Hypofractionation
Michael C. Joiner, PhD, Wayne State University
Robert D. Timmerman, MD, University of Texas Southwestern Medical Center
7:45 a.m. - 9:00 a.m.
Educational Session 202 – Interstitial Brachytherapy for Prostate Cancer:
LDR and HDR, Alone and with External Beam Radiotherapy
Room: B206
Michael Ghilezan, MD, PhD, Michigan Health Professionals/21st Century Oncology
I-Chow J. Hsu, MD, University of California San Francisco
Mira Keyes, MD, British Columbia Cancer Agency
Al V. Taira, MD, Western Radiation Oncology
7:45 a.m. - 9:00 a.m.
Educational Session 203 – Updated Roles and Rules for Radiation Therapy of Indolent and
Aggressive Lymphomas
Room: B216
Andrea K. Ng, MD, Brigham and Women’s Hospital
Joachim Yahalom, MD, FASTRO, Memorial Sloan-Kettering Cancer Center
7:45 a.m. - 9:00 a.m.
Educational Session 204 – Low/High Grade Gliomas – An Update
Room: B302-B305
Changhu Chen, MD, University of Toledo Medical Center
Daphne Haas-Kogan, MD, University of California San Francisco
John P. Kirkpatrick, MD, PhD, Duke University
7:45 a.m. - 9:00 a.m.
Educational Session 205 – Proton Therapy: Basic Physics and Practice
Room: B313
Annelise Giebeler, PhD, Scripps Proton Therapy Center
Baldev Patyal, PhD, Loma Linda University Medical Center
7:45 a.m. - 9:00 a.m.
Educational Session 206 – Controversies in the Management of Endometrial Cancer
Room: B213
Ann H. Klopp, MD, PhD, MD Anderson Cancer Center
Catheryn M. Yashar, MD, University of California San Diego
7:45 a.m. - 9:00 a.m.
Educational Session 207 – Management of Oral Cavity Cancer and Nasopharyngeal
Cancer focusing on IMRT and IGRT
Nancy Lee, MD, Memorial Sloan-Kettering Cancer Center
Min Yao, MD, PhD, University Hospitals Case Medical Center
68
7:45 a.m. - 9:00 a.m.
Educational Session 208 – Evolution of Radiation Oncology: Technology, Techniques and
Outcomes
Room: B211
George T.Y. Chen, MD, FASTRO, Massachusetts General Hospital
Patricia J. Eifel, MD, FASTRO, MD Anderson Cancer Center
David A. Larson, MD, PhD, FASTRO, University of California San Francisco
Theodore L. Phillips, MD, FASTRO, University of Arizona
7:45 a.m. - 9:00 a.m.
Educational Session 209 – Advanced Treatment of Non-small Cell Lung Cancer: Using All
the Tools (Imaging, Motion Correction and IMRT) Promises and Pitfalls – A Case Based
Approach
Room: B308
Jeffrey D. Bradley, MD, Washington University School of Medicine
Indrin J. Chetty, PhD, Henry Ford Health System
James J. Urbanic, MD, Wake Forest University School of Medicine
7:45 a.m. - 9:00 a.m.
Educational Session 210 – Controversies in the Optimal Management of Regional Nodes
Room: B405
Jennifer R. Bellon, MD, Dana-Farber Cancer Institute
E. Shelley Hwang, MD, MPH, Duke University School of Medicine
Julie R. Gralow, MD, University of Washington School of Medicine
8:00 a.m. - 6:00 p.m.
ASTRO Career Fair
Room: B207
8:00 a.m. – 9:00 a.m.
Featured Lecture- Patient Safety Organizations: An Overview
Room: B406
William Munier, MD, Director, Center for Quality Improvement and Patient Safety, Agency for Healthcare Research and Quality
9:15 a.m. - 10:15 a.m.
Keynote Address I
“Is there Hope for ‘Healing’ Health Care?”
Darrell G. Kirch, MD, President and CEO, Association of American Medical Colleges
Introduced by: Theodore L. DeWeese, MD, Johns Hopkins School of Medicine
69
10:00 a.m. - 5:00 p.m.
Exhibit Hall Open
Room: Halls B1–B3
10:00 a.m. - 5:00 p.m.
Poster Viewing
Room: Hall B4
10:45 a.m. - 12:15 p.m.
Scientific Session F – Biology – DNA Damage and Repair: Novel Biological Principles and
Targeted Radiosensitization Strategies
Room: B213
Moderators: Phouc Tran, Simon Powell
10:45 a.m.
Adam Schmitt
45
Regulation of the DNA Damage Response by an Inducible Long Noncoding RNA
10:55 a.m.
Sean Pitroda
46
RPS Predicts DNA Repair Pathway Preference and Cancer Patient Outcome
11:05 a.m.
Chen-Pang Soong
47
Development of a Novel Method to Create Double-strand Break Repair Fingerprints Using Next-Generation
Sequencing
11:15 a.m.
Robert Bristow
Discussant
11:25 a.m.
Gerben Borst
48
Using BRCA 1/2-Deficient Mouse Mammary Tumors and μIGRT to Investigate Underlying
Mechanisms Causing Radioresistance
11:35 a.m.
Derek Zachman
49
Endothelial Cells Mitigate DNA Damage and Restore Function in Irradiated Hematopoietic Stem Cells
11:45 a.m.
David Kozono
50
Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-small Cell Lung Cancer
11:55 a.m.
Ikuno Nishibuchi
51
SUMO E3-ligase Regulates DNA Damage-Dependent Exchange of the Histone Variant H2A.Z-2
12:05 p.m.
Hebist Berhane
52
Radiobiologic Differences Between Bone Marrow Stromal and Hematopoietic Progenitor Cells from Fanconi
Anemia (FancD2-/-) Mice
Connect with Attendees.
Tweet
#ASTRO13
70
10:45 a.m. - 12:15 p.m.
Scientific Session G – GU – Prostate Cancer: Prognostic Factors, Hormones,
Hypofractionation
Room: B206
Moderators: May Abdel-Wahab, Ashesh Jani
10:45 a.m.
Zachary Zumsteg
53
The Natural History and Patterns of Failure Following Biochemical Relapse in Prostate Cancer (PC) Patients
Treated with Dose Escalated External Beam Radiotherapy (EBRT)
10:55 a.m.
Daniel Krauss
54
Inferior Clinical Outcomes for Patients with Positive Post-Radiotherapy Prostate Biopsy: Results from
Prospective Randomized Trial RTOG 94-08
11:05 a.m.
Mitchell Kamrava
55
Do Targeted Ultrasound/MRI Fusion Biopsies Significantly Change Maximum Prostate Gleason Score
Compared with Systematic Biopsies?
11:15 a.m.
Nicholas Zaorsky
56
Evaluation of Biologically Equivalent Dose Escalation, Clinical Outcome and Toxicity in Prostate Cancer
Radiotherapy: A Meta-Analysis of 12,000 Patients from 40 Institutions
11:25 a.m.
Alan Katz
57
Stereotactic Body Radiation Therapy for Low-, Intermediate- and High-risk Prostate Cancer:
Disease Control and Quality of Life at Six Years
11:35 a.m.
Robert Meier
58
Patient-reported Quality of Life Outcomes in Intermediate-risk Prostate Cancer Patients Treated with
Stereotactic Body Radiotherapy
11:45 a.m.
Joseph Kang
59
Hypofractionated Proton Therapy for Low-risk Prostate Cancer: Preliminary Results of a Phase I/II Study
11:55 a.m.
Perakaa Sethukavalan
60
Comparison of Biochemical and Toxicity Outcomes from a Contemporaneous Cohort Study of Low-risk
Prostate Cancer Treated with Different Radiation Techniques
12:05 p.m.
Amin Mirhadi
61
Effect of Long-term Hormonal Therapy (vs. Short-term Hormonal Therapy): A Secondary Analysis of
Intermediate-risk Prostate Cancer Patients Treated on RTOG 9202
10:45 a.m. - 12:15 p.m.
Scientific Session H – GI – SBRT and Hypofractionation
Room: B308
Moderators: Sarah Hoffe, Gary Yang
10:45 a.m.
Yue Cao
62
Indocyanine Green for Individualized Assessment of Functional Liver Reserve in Patients Undergoing Liver
Radiotherapy
71
10:55 a.m.
Mary Feng
63
A Phase II Trial of Individualized Adaptive Stereotactic Body Radiotherapy (SBRT) for Patients at High-risk for
Liver Damage
11:05 a.m.
Foster Lasley
64
Relationship of Hepatic Toxicity to Advancement of Child-Pugh Score and Overall Survival for Patients Treated
with SBRT to the Liver
11:15 a.m.
Theodore Hong
65
Interobserver Variability in Target Definition for Hepatocellular Carcinoma (Hcc) with and without Portal Vein
Thrombus: Radiation Therapy Oncology Group (RTOG) Hcc Consensus Panel
11:25 a.m.
Joseph Herman
66
A Phase II Multi-center Study to Evaluate Gemcitabine and Fractionated Stereotactic Body
Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma
11:35 a.m.
Aaron Wild
67
Stereotactic Body Radiation Therapy Results in Less Severe Treatment-related Lymphopenia Than
Conventional Chemoradiation Therapy in Patients with Locally Advanced Pancreatic Cancer
11:45 a.m.
Chi Lin
68
A Dosimetric Analysis of Duodenal Toxicity After Hypofractionated Stereotactic Body Radiotherapy for
Pancreatic Cancer
11:55 a.m.
Daniel Chang
Discussant
12:05 p.m.
Florence Huguet
69
Investigation of Relation of Radiation Therapy Quality Assurance Scores (RTQASc) with Toxicity and Survival in
LAP07 Phase III Trial for Locally Advanced Pancreatic Carcinoma (LAPC)
10:45 a.m. - 12:15 p.m.
Scientific Session I – GYN – Cervical Cancer
Room: B211
Moderators: Charles Kunos, Matt Biagioli
10:45 a.m.
Kathy Han
70
Trends in the Utilization of Brachytherapy in Cervical Cancer in the U.S.
10:55 a.m.
David Gaffney
71
Consensus Contours for CT vs. MRI in Image-based Brachytherapy for Cervix Cancer to Generate an
RTOG Atlas
11:05 a.m.
Junzo Chino
72
Vaginal Dose and Toxicity with Image Guided Brachytherapy
11:15 a.m.
Beant Gill
73
Clinical Outcomes for 3-D High-dose-rate Intracavitary Brachytherapy with MRI-Based Planning for the
Treatment of Cervical Cancer
11:25 a.m.
72
Kaled Alektiar
Discussant
11:35 a.m.
Eric Leung
74
Neutrophils Modulate Vascular Function in Locally Advanced Cervical Cancer and Impair Response to
Radiotherapy
11:45 a.m.
Nina Mayr
75
Is Cellular Radiosensivity Influenced by Tumor Perfusion Status During Radiation Therapy of Cervical Cancer?
11:55 a.m.
Olgun Elicin
76
The Use of 18FDG-PET Standard Uptake Value as a Metabolic Predictor of Bone Marrow Response to
Radiation: Impact on Acute and Late Hematological Toxicity in Cervical Cancer Patients Treated with
Chemo-radiotherapy
12:05 p.m.
Ajeet Gandhi
77
Chronic Gastrointestinal Toxicity in Locally Advanced Carcinoma Cervix Treated with Intensity-modulated vs.
Conventional Pelvic Radiotherapy: Results from a Prospective Randomized Study
10:45 a.m. - 12:15 p.m.
Scientific Session J – Lung – Toxicity and Other Topics
Room: B405
Moderators: Yolanda Garces, Andreas Rimner
10:45 a.m.
Ankit Modh
78
Survival and Toxicity after Stereotactic Body Radiotherapy for Central Lung Tumors
10:55 a.m.
Stuart Samuels
79
Changes in DLCO Instead of FEV1 During Treatment are Correlated with Post-Treatment
Reduction in Pulmonary Function and Toxicity After SBRT or 3-D CRT for Non-small Cell Lung Cancer
11:05 a.m.
Andrew Aneese
80
Toxicity After Central versus Peripheral Stereotactic Lung Radiotherapy (SBRT): A Propensity Score
Matched-Pair Analysis
11:15 a.m.
Taro Murai
81
Stereotactic Body Radiotherapy Using a Radiobiology-based Regimen for Stage I Non-small Cell Lung Cancer:
5-Year Mature Results
11:25 a.m.
Gregory Videtic
Discussant
11:35 a.m.
Alexandros Papachristofilou 82
Clinical Utilization of Electromagnetic Real-time Lung Tumor Localization During Radiotherapy: A Prospective
International Multicenter Study
11:45 a.m.
Jean-Claude Rwigema
83
Incidental Mediastinal Dose Does Not Explain Low Mediastinal Nodal Recurrence Rates in Early-stage NSCLC
Patients Treated with SBRT
11:55 a.m.
Zachary Morris
84
Impact of Contralateral Tumor Nodules on Survival in Non-small Cell Lung Cancer: A SEER Database Analysis
73
12:05 p.m.
James Urbanic
85
Multiple Courses of Thoracic Radiotherapy (XRT) Using Stereotactic Body Radiotherapy (SBRT) as the First or
Second Course of Treatment for Tumors Outside the Original High Dose Region
10:45 a.m. - 12:15 p.m.
Scientific Session K – Pediatric Brain and Retinoblastoma
Room: B406
Moderators: Ashwatha Narayana
10:45 a.m.
Jacqueline Emrich
86
Episcleral Plaque Radiotherapy for Retinoblastoma: Treatment and Outcomes
10:55 a.m.
Kent Mouw
87
Proton Radiotherapy for the Treatment of Pediatric Retinoblastoma
11:05 a.m.
Anita Mahajan
Discussant
11:15 a.m.
Klaus Müller
88
Role of Craniospinal Radiotherapy in the Management of Recurrent Medulloblastoma - Experiences from the
Prospective German HIT-REZ 1997 and 2005 Studies
11:25 a.m.
Kristin Redmond
89
Prospective Study of Proton MR Spectroscopy (MRS) and Neuro-psychological Dysfunction Following Cranial
Irradiation for Pediatric Malignancies
11:35 a.m.
Daniel Indelicato
90
Incidence and Dosimetric Parameters of Brainstem Toxicity Following Proton Therapy
11:45 a.m.
Thomas Merchant
91
Longitudinal Models of Cognitive Function in Children with Craniopharyngioma Demonstrate the Effect of
Radiation Dose
11:55 a.m.
Susan Hiniker
92
Survival and Neurocognitive Outcomes Following Addition of a Cranial or Craniospinal Boost to Total Body
Irradiation Prior to Stem Cell Transplantation in Pediatric Leukemia Patients with CNS Involvement
10:45 a.m. - 12:15 p.m.
Scientific Session L – Health Services Research
Moderators: Samuel Swisher-McClure, Ashleigh Guadagnolo
10:45 a.m.
Kristina Maletz
93
Comparison of NCCN and ACR Guidelines Regarding Treatment of Lung, Prostate, and Head and Neck Cancers
10:55 a.m.
Barbara Fowble
94
Implementing Patient-oriented Decision Support into Breast Cancer Care
11:05 a.m.
Aaron Falchook
95
Multiple Pathology Reviews in Prostate Cancer Diagnosis, Prevalence of Use in the Medicare Population and
Cost Implications
74
11:15 a.m.
Justin Bekelman
96
Androgen Deprivation Therapy and Radiotherapy: Comparative Effectiveness in Real-world Clinical Practice
11:25 a.m.
Lia Halasz
97
Comparative Effectiveness of Stereotactic Radiosurgery (SRS) vs. Whole Brain Radiation Therapy (WBRT) for
Patients with Brain Metastases from Non-small Cell Lung Cancer (NSCLC)
11:35 a.m.
Anand Shah
98
Cost Effectiveness of Stereotactic Body Radiation Therapy vs. Surgical Resection for Stage I Non-small Cell
Lung Cancer
11:45 a.m.
Michaela Dinan
99
Changes in Radiotherapy, Surgery and Costs for Treatment of Non-small Cell Lung Cancer After the Adoption
of Positron Emission Tomography, 1998-2005
11:55 a.m.
Ruben Carmona
100
Risk Stratification for Non-cancer Mortality in Early-stage Endometrial Cancer
12:05 p.m.
James B. Yu
Discussant
10:45 a.m. - 12:15 p.m.
Scientific Session M – Best of Physics
Moderators: David Jaffray, Indrin Chetty
10:45 a.m.
Jan-Jakob Sonke
101
Improved Modeling of Radiation Pneumonitis Risk in Lung SBRT by Incorporating a Local Dose Effect Relation
for Perfusion Reduction
10:55 a.m.
Victor Mangona
102
Predictors of Chest Wall and Extrapulmonary Soft Tissue Toxicity After Stereotactic Lung Radiotherapy: A
Dosimetric Analysis
11:05 a.m.
Zhibin Huang
103
Patient Specific TCP Based on the gLQ Model - A Strong Outcome Predictor in Radiation Therapy for Cervical
Cancer
11:15 a.m.
Teo Stanescu
104
Quantification of Magnetic Field Compatibility of Subcomponents in an MRI-Guided Radiotherapy System
Basic Science Abstract Award – Radiation Physics
11:25 a.m.
Reinhard Schulte
105
First Experience with an Experimental Proton CT Scanner
11:35 a.m.
Eric Williams
106
Using gEUD to Model Volume Effects for Pneumonitis in Prospective Data from four Non-small Cell Lung
Cancer (NSCLC) Dose-escalation Trials
75
11:45 a.m.
Per Poulsen
107
Experimentally Validated Simulator of Dynamic MLC Tracking Treatments: A Tool for Tracking QA
11:55 a.m.
Annemarie Fernandes
108
Comparative Assessment of Liver Tumor Motion Using CineMRI vs. 4-D CT
12:05 p.m.
Ruijiang Li
109
First Clinical Study of On-treatment Volumetric Imaging During Respiratory Gated VMAT
10:45 a.m. - 12:15 p.m.
Digital Poster Discussion 03 – CNS – Meningiomas, Gliomas and Metastases
Room: A411
Discussants: Paul Brown, Stephanie Weiss
Martin Pavelic
1025
Distinguishing Grade I Meningioma from Higher Grade Meningiomas Without Biopsy
Steve Braunstein
1026
Benefit of Adjuvant Radiotherapy (RT) in Management of Recurrent Atypical Meningioma (AM)
Robert Press
1027
Patterns of Failure for Grade II/III Meningioma Treated with Reduced Margin Intensity Modulated Radiation
Therapy
Helen Shih
1028
Mixed Proton and Photon Therapy for Benign Meningiomas: Long Term Results of a Prospective Randomized
Dose Escalation Study
Ariel Marciscano
1029
Benign Meningiomas with Atypical Features: Correlation of Histopathological Features with Clinical Outcomes
Joshua Siglin
1030
Combining Fractionated Stereotactic Radiotherapy and Bevacizumab for Recurrent High Grade Glioma:
Outcomes Analysis
George Shenouda
1031
Results of a Phase II Clinical Trial of Neo-Adjuvant Temozolomide (TMZ), Followed by Concurrent TMZ and
Hypofractionated Accelerated External Beam Radiotherapy (Ac-EBRT) with Limited Margins, and Adjuvant
TMZ for Patients with Glioblastoma Multiforme (GBM)
Joshua Palmer
1032
Re-resection for Recurrent High Grade Glioma in the Setting of Re-irradiation
Kapila Kalakota
1033
Time to Intracranial Failure Following Post-resection Cavity Radiosurgery for Patients with a Single Intracranial
Metastasis
Jonathan Pai
1034
Brain Metastases and Resection Cavities from Colorectal Carcinoma Treated with Stereotactic Radiosurgery
Have Poor Local Control Compared to Non-colorectal Histology
76
Jennifer Rosenberg
1035
Factors Influencing Local Control and Survival in Patients Treated with Radiosurgery Following Surgical
Resection of CNS Metastases
Menachem Yondorf
1036
Resection Cavity Dynamics Following Implantation of Cesium-131 (Cs-131) Brachytherapy for Resection Brain
Metastases Based on CT-Planning
10:45 a.m. - 12:15 p.m.
Digital Poster Discussion 04 – Sarcoma/Lymphoma
Room: A412
Discussants: Jonathan Ashman, Stephanie Terezakis
Kyle Denniston
1037
Quantification of the Effect of Arm Position on Normal Tissue Location and Dosimetry in Pediatric Hodgkin
Lymphoma
Bradford Hoppe
1038
Phase II Study of Consolidative Involved-node Proton Therapy in Patients with Hodgkin Lymphoma: Early
Outcomes
Amanda Walker
1039
18F-FDG PET SUV Thresholding for Target Volume Delineation in Pediatric Hodgkin Lymphoma
He Wang
1040
Image Guided Radiation Therapy Proves Its Benefit in Detecting the Daily Unpredictable Shape Change of the
Stomach, a Study of Patients Treated for Stomach Lymphoma
K.Ranh Voong
1041
Intensity Modulated Radiation Therapy (IMRT) Using Butterfly Technique Offers a Dosimetric Advantage to
Critical Organs in Young Female Patients with Mediastinal Hodgkin’s Lymphoma
Gabriele Reinartz
1042
Contribution of 4-D CT and Listmode-PET-CT for Evaluation of PTV for Whole Stomach Radiation: Inter- and
Intra-fractional Gastric Motion During IMRT in Gastric Lymphoma
Luke Miller
1043
Mesna-Ifosfamide Doxorubicin Chemoradiotherapy (MAI-XRT) for Large, High Grade Extremity Soft Tissue
Sarcoma: Reduced Toxicity and Encouraging Early Results
Hayashi Kazuhiko
1044
Long-term Results of Intraoperative Extracorporeal Irradiation to the Autogenous Bone Grafts in Primary Bone
and Soft Tissue Malignancies
Addison Willett
1045
Comparison of HDR Brachytherapy, Orthovoltage X-ray and Electron Beam Radiation in the
Treatment of Non-melanoma Skin Cancers: A Single Institution Experience of Individualized Radiation
Therapy
Andrew Bishop
1046
Head and Neck Merkel Cell Carcinoma: Favorable Outcomes with Radiotherapy
77
Alfredo Polo
1047
A Dose-Response Relationship Exists for Soft Tissue Sarcomas of the Extremities Treated with Maximum
Surgery and Intraoperative Electron Therapy, with or without External Beam Radiotherapy: Results of a
Multicentric Pooled Analysis
Aashish Bhatt
1048
Reduction in Wound Complications with Low vs. High Dose Pre-operative Radiotherapy for Sacro-Coccygeal
Chordomas
10:45 a.m. - 12:15 p.m.
Educational Session 211 – Difficult Cases in Breast Cancer
Room: B313
Thomas A. Buchholz, MD, FASTRO, MD Anderson Cancer Center
Jay R. Harris, MD, FASTRO, Dana-Farber Cancer Institute
Terry Mamounas, MD, MD Anderson Cancer Center Orlando
Julia R. White, MD, The Ohio State University Cancer Center
Eric Winer, MD, Dana-Farber Cancer Institute
10:45 a.m. – 12:15 p.m.
Educational Session 212: Overuse, Underuse and Misuse of Radiation Therapy and the
Future of Radiation Oncology - Impact on Quality, Payment Reform and Patient Care
Announcement of ASTRO’s List for “Choosing Wisely” Initiative
Room: B216
Moderator: Bharat B. Mittal, MD, FASTRO, Northwestern University
Daniel B. Wolfson, MHSA, ABIM Foundation
James Alan Hayman, MD, University of Michigan
Brian Kavanagh, MD, MPH, University of Colorado Denver
11:00 a.m. – 12:00 p.m.
Foreign Language Poster Walks
Room: Hall B4, Poster Information Desk
12:15 p.m. - 1:15 p.m.
AAWR/ASTRO Luncheon* – A Mentorship Panel for Women in Radiation Oncology
Room: B302-B305
Join us for the annual AAWR/ASTRO Luncheon Panel. This diverse panel of accomplished women radiation
oncologists will discuss and answer questions on professional advancement in academic and community
practice, opportunities and challenges, and involvement in health care politics, for women in radiation
oncology.
Moderator:
Chelsea Pinnix, MD, PhD, MD Anderson Cancer Center
Interesting Session?
78
Tweet
#ASTRO13
Panelists:
Reshma Jagsi, MD, PhD, University of Michigan
Nancy S. Tarbell, MD, FASTRO, Harvard Medical School
Jacqueline P. Williams PhD, FASTRO, University of Rochester Medical Center
Geraldine M Jacobson MD, MPH, MBA, West Virginia University
12:15 p.m. - 1:15 p.m.
ARRO Poster Walk with a Professor (Box Lunch)
Room: Hall B4, Poster Lounge
12:15 p.m. - 1:15 p.m.
How to Review a Scientific Paper Workshop (Box Lunch)
Room: B203
12:15 p.m. – 1:15 p.m.
ASTRO Accreditation Program for Excellence (APEx) Highlights Luncheon*
Room: B405
*This session is not accredited for continuing medical education.
1:15 p.m. - 2:00 p.m.
Presidential Address – “Hope, Faith, Cancer: Keeping Patients First”
Great Speaker?
Tweet
#ASTRO13
79
2:00 p.m. - 3:10 p.m.
PLENARY SESSION
Moderators: Theodore DeWeese, Lynn Wilson
2:00 p.m.
Thomas Pisansky
1
RTOG 9910: Phase III Trial to Evaluate the Duration of Neoadjuvant Total Androgen Suppression and
Radiation Therapy in Intermediate-risk Prostate Cancer
2:10 p.m.
Daniel Hamstra
Discussant
2:15 p.m.
Benjamin Movsas
2
Quality of Life Analysis of the Randomized Radiation Dose Escalation NSCLC Trial (RTOG 0617): The
Rest of the Story
2:25 p.m.
Andrea Bezjak
Discussant
2:30 p.m.
William Small
3
RTOG 0841: Two Item Questionnaire Effectively Screens for Depression in Cancer Patients
Receiving Radiotherapy
2:40 p.m
Andrew Miller
Discussant
2:45 p.m.
Vinai Gondi
LBA1
Memory Preservation with Conformal Avoidance of the Hippocampus during Whole-Brain Radiotherapy (WBRT)
for Patients with Brain Metastases: Primary Endpoint Results of RTOG 0933
2:55 p.m.
Laurie Gaspar
Discussant
3:10 p.m. - 3:30 p.m.
ASTRO Guidelines Highlight – The Adjuvant and Salvage Radiotherapy After
Prostatectomy: ASTRO/AUA Guideline
Moderators: Benjamin Movas, Lynn Wilson
Presenter: Richard K. Valicenti, MD, University of California Davis Medical Center
Discussant: Carol Hahn, MD, Duke University Medical Center
80
4:00 p.m. - 5:00 p.m.
Featured Lecture – “Update on Self-referral*”
Room: B406
James Cosgrove, PhD, Director, U.S. Government Accountability Office
Introduced by Michael L. Steinberg, MD, FASTRO, Chairman, ASTRO Board of
Directors
4:00 p.m. - 5:30 p.m.
Panel 06 – The Confluence of Radiation and Immunotherapy: From Bench to Bedside and
Back Again
Room: B211
Moderator:
Panelists:
William McBride, DSc, PhD, University of California Los Angeles Health System
Sylvia Formenti, MD, NYU School of Medicine
Neal Shore, MD, Carolina Urologic Research Center
4:00 p.m. - 5:30 p.m.
Panel 07 – Bringing Forth Evidence to Put Patients First: How Guidelines will Impact
Practice of Radiation Oncology
Room: B308
Moderator:
Joshua Petit, MD, University of Colorado Health System
Panelists:
Benjamin Smith, MD, MD Anderson Cancer Center
Carol Hahn, MD, Duke University
George Rodrigues, MD, MSc, London Regional Cancer Program
William Sause, MD, International Healthcare Radiation Oncology
Bryan Loy, MD, MBA, Humana Hospital-Audubon
Lee Newcomer, MD, United Healthcare
4:00 p.m. - 5:30 p.m.
Panel 08 – Innovative Clinical Trial Designs*
Room: B206
Moderators:
Brian Alexander, MD, Dana-Farber/Brigham and Women’s Cancer Center
Giovanni Parmigiani, PhD, Dana-Farber/Brigham and Women’s Cancer Center
Panelists:
Donald Berry, PhD, MD Anderson Cancer Center
Michael Krams, MD, Janssen Pharmaceuticals
Daniel Normolle, PhD, University of Pittsburgh Medical Center
Lorenzo Trippa, PhD, Dana-Farber/Brigham and Women’s Cancer Center
4:00 p.m. - 5:30 p.m.
Panel 09 – Fractionated Radiotherapy for Prostate Cancer: What is the Standard of Care?
Room: B313
Moderator:
Mark Buyyounouski, MD, MS, Fox Chase Cancer Center
Panelists:
Eric Hall, DSc, FASTRO, New York Presbyterian Hospital
Howard Sandler, MD, MS, FASTRO, Cedars-Sinai Medical Center
Alan Pollack, MD, PhD, University of Miami Miller School of Medicine
4:00 p.m. - 5:30 p.m.
Panel 10 – Safety First: Using a National Patient Safety Organization to Improve the
Quality of Care
Moderator:
Adam Dicker, MD, PhD, Jefferson Medical College of Thomas Jefferson University
Panelists:
Eric Ford, PhD, University of Washington
Thomas Piotrowski, RN, MSN, Clarity PSO
Lawrence Marks, MD, FASTRO, University of North Carolina at Chapel Hill
Sasa Mutic, PhD, Washington University School of Medicine
4:00 p.m. - 5:30 p.m.
Educational Session 213 – Integration of Safety in Quality Assurance Programs
Room: B216
Benedick A. Fraass, PhD, FASTRO, Cedars-Sinai Medical Center
Ramon Alfredo C. Siochi, PhD, University of Iowa
4:00 p.m. - 5:30 p.m.
Educational Session 214 – Laryngeal Preservation in Larynx and Hypopharynx Cancer
Room: B405
Christopher Holsinger, MD, Stanford University
Quynh-Thu Le, MD, Stanford University
#ASTRO13
82
5:30 p.m. - 6:30 p.m.
Poster Viewing Session and Reception*
Room: Hall B4
During this session, poster presenters will be available at their
poster to answer questions and explain their research. Again this
year there will be a presentation area where poster award winners
will provide highlights of their research and be available for
questions. The presentation schedule will be available in the poster
viewing area.
Meet and Greet - Residents and Medical Students
Room: Hall B4, Poster Lounge
5:30 p.m. - 6:30 p.m.
2013 NCI/ASTRO Diversity Symposium and Reception* – Improving Cancer Care Globally:
A Call to Service in Radiation Oncology
Room: B203
Members of the National Cancer Institute and Cancer Disparities Research Partnership project invite you to
join them for a disconcerting look at disparities in cancer care around the globe. Expert speakers who have
completed groundbreaking work to improve the delivery of radiation oncology services in developing
nations will share their stories and insights.
Moderator:
Bhadrasain Vikram, MD, National Cancer Institute
ASTRO-ARRO Resident Experience in the Global Health Scholarship Program
Introduction: Bhadrasain Vikram, MD, National Cancer Institute
Speaker: Nina A. Mayr, MD, FASTRO, University of Washington
Desperate and Disparate in a Time of Many Transitions: Improving Research and
Practice in Radiation Oncology
Introduction: Nina A. Mayr, MD, FASTRO, University of Washington
Speaker: Glenn Jones, MD, Credit Valley Hospital
Possible Business Models for Radiation Therapy Facilities in Bangladesh
Introduction: Nina A. Mayr, MD, FASTRO, University of Washington
Speaker: Richard Love, MD, MS, International Breast Cancer Research Foundation
Interesting session?
Tweet
#ASTRO13
Symbol Key:
A
ARON
Separate
Session
registration
required
Award
Recipient
Live
Interactive
SAM/
Session
Separate
registration
required
83
Tuesday | September 24
7:45 a.m. - 9:00 a.m.
Educational Session 301 – Controversies on the Role of Radiation Therapy in the
Management of Hodgkin Lymphoma (HL)
Room: B405
Peter M. Mauch, MD, FASTRO, Harvard Medical School
Lena Specht, MD, PhD, Rigshospitalet, University of Copenhagen
7:45 a.m. - 9:00 a.m.
Educational Session 302 – Oncofertility and Fertility Preservation Treatment: Patient
Needs and Opportunities for Radiation Oncologists
Room: B206
Clarisa Gracia, MD, University of Pennsylvania
Farzan Siddiqui, MD, PhD, Henry Ford Health System
William Small, MD, FASTRO, Loyola University
Raphael Yechieli, MD, Henry Ford Health System
7:45 a.m. - 9:00 a.m.
Educational Session 303 – Best Practices in Radiation Oncology Education
Room: B213
Joanne Alfieri, MDCM, McGill University Health Centre
Junzo P. Chino, MD, Duke University
Nicholas DeNunzio, BS, Boston University School of Medicine
Eric L. Khoo, MB, ChB, Radiation Oncology Queensland - Toowoomba
James D. Mitchell, MD, David Grant Medical Center
7:45 a.m. - 9:00 a.m.
Educational Session 304 – Molecular Radiobiology – Concepts and Clinical Applications
Room: B203
Anthony Chalmers, MD, PhD, Beatson West of Scotland Cancer Centre
7:45 a.m. - 9:00 a.m.
Educational Session 305 – Advanced Treatment Technologies: Design, Control Systems,
Commissioning and Clinical Applications
Room: B406
James Balter, PhD, University of Michigan
Timothy D. Solberg, PhD, University of Pennsylvania
Lei Xing, PhD, Stanford University
7:45 a.m. - 9:00 a.m.
Educational Session 306 – Cervical Cancer Management
Room: B211
Nina A. Mayr, MD, FASTRO, University of Washington Medical Center
Akila N. Viswanathan, MD, Brigham and Women’s Hospital
84
7:45 a.m. - 9:00 a.m.
Educational Session 307 – Esophagus and Gastric Cancer: Contemporary Treatment
Approaches
Michael G. Haddock, MD, Mayo Clinic
Harvey J. Mamon, MD, PhD, Brigham and Women’s Hospital
7:45 a.m. - 9:00 a.m.
Educational Session 308 – External Beam Radiotherapy for Prostate Cancer: Dose, Volume,
Fractionation
Jason A. Efstathiou, MD, PhD, Massachusetts General Hospital
Eric M. Horwitz, MD, Fox Chase Cancer Center
7:45 a.m. - 9:00 a.m.
Educational Session 309 – An Overview of the End-to-End Use of Images for IGRT
from Simulation to Treatment – How To Make IGRT better
Room: B313
Peter Balter, PhD, MD Anderson Cancer Center
Mary Kara Bucci, MD, Anchorage Radiation Therapy Center
7:45 a.m. - 9:00 a.m.
Educational Session 310 – Management of Adult Sarcoma
Room: B216
Elizabeth H. Baldini, MD, MPH, Brigham and Women’s Hospital
B. Ashleigh Guadagnolo, MD, MPH, MD Anderson Cancer Center
8:00 am. - 6:00 p.m.
ASTRO Career Fair
Room: B207
9:15 am. - 10:15 a.m.
Keynote Address II
“Cancer Survivorship and Quality Of Life”
Otis W. Brawley, MD, Chief Medical Officer, American Cancer Society
10:00 a.m. - 5:00 p.m.
Exhibit Hall Open
Room: Halls B1–B3
10:00 a.m. - 5:00 p.m.
Poster Viewing
Room: Hall B4
85
10:15 a.m. - 11:30 a.m.
AWARDS CEREMONY* – Gold Medal, Fellows, Honorary Member and Survivor Circle
The Awards Ceremony is held in honor of ASTRO’s 2013 award recipients and Fellows. Show your
appreciation for these premier leaders by joining in the celebration of their accomplishments.
11:30 a.m. - 1:00 p.m.
Business Meeting
Room: B302-B305
ASTRO voting members (Active, Affiliate, Allied and International members) are invited to attend the
Business Meeting. Leaders of the Society will discuss important topics of interest to ASTRO members. You
should not miss this important meeting. Lunch will be served.
1:00 p.m. - 2:30 p.m.
Scientific Session N – Breast – Toxicity
Room: B313
Moderators: Ozer Algan, Welela Tereffe
1:00 p.m.
Jason Ye
110
Breast Cancer (BC), Second Cancer and Cardiac Mortality in Stage T1aN0 Breast Cancer Patients with or
without External Beam Radiation Therapy (XRT): NCI SEER Study
1:10 p.m.
Jiayi Chen
111
Dosimetric Analysis of Cardiac Substructure Related to Cardiac Safety in Patients with Her-2 Positive Breast
Cancer Receiving Concurrent Trastuaumab and Adjuvant Radiotherapy
1:20 p.m.
Sagar Patel
112
Protons with Free Breathing vs. Photons with Deep Inspiration Breath Hold in Post-mastectomy Patients: A
Dosimetric Comparative Analysis
1:30 p.m.
Richard Zellars
Discussant
1:40 p.m.
Laura Warren
113
Risk of Lymphedema with the Addition of Regional Lymph Node Irradiation for Breast Cancer Therapy: A
Prospective Cohort Study
1:50 p.m.
Tu Dan
114
Cosmetic Outcomes and Quality of Life are Similar in Patients Receiving Breast Conservation vs.
Mastectomy: 25 Year Follow-Up of the NCI Randomized Trial
2:00 p.m.
Xiaofeng Yang
115
Hypofractionated Breast Cancer Radiotherapy Does Not Increase Cutaneous Toxicity: A Prospective
Comparative Study Between Standard and Hypofractionated Radiotherapy Using Quantitative Ultrasound
Imaging
2:10 p.m.
Alice Ho
116
Pneumonitis Rates Following Comprehensive Nodal Irradiation in Breast Cancer Patients: Results of a
Phase I Feasibility Trial of Intensity Modulated Radiation Therapy
86
2:20 p.m.
Ben Wilkinson
117
Six-year Outcomes for Phase I/II Study Evaluating Hypofractionated Accelerated Partial Breast Irradiation
Using a Two-day Dose Schedule
1:00 p.m. - 2:30 p.m.
Scientific Session O – CNS – Brain Metastases
Room: B211
Moderators: Baldassarre Stea, May Tsao
1:00 p.m.
George Rodrigues
18
When Should Whole Brain Radiotherapy (WBRT) Be Utilized with Stereotactic Radiosurgery to Reduce
Regional Failure in the Treatment of Oligometastatic Brain Disease?: Clinical Nomogram and Recursive
Partitioning Analysis
1:10 p.m.
John Kirkpatrick
119
Early Results of a Randomized Trial to Identify an Optimal PTV in Stereotactic Radiosurgery of Brain Metastases
1:20 p.m.
Marina Kushnirsky
120
Brain Metastasis Detection Improved by Time Delayed Contrast Enhanced MRI
1:30 p.m.
Christopher Tinkle
121
Lesion Location as a Predictor of Adverse Radiation Effect after Stereotactic Radiosurgery for Brain Metastasis
1:40 p.m.
Kimberley Mak
122
Radiotherapy for Brain Metastases in Non-small Cell Lung Cancer: Significance of Mutations in EGFR, ALK or
KRAS on Radiotherapy Response and Survival
1:50 p.m.
Paul Sperduto
123
Secondary Analysis of RTOG 9508, a Phase III Randomized Trial of Whole Brain Radiation Therapy (WBRT) vs.
WBRT Plus Stereotactic Radiosurgery (SRS) in Patients with 1-3 Brain Metastases; Post-Stratified by the Graded
Prognostic Assessment (GPA)
2:00 p.m.
John Lucas
124
A Competing Risk Analysis of Neurologic vs. Non-neurologic Death in Patients Undergoing Radiosurgical
Salvage Following Whole Brain Radiotherapy (WBRT) Failure: Who Actually Dies of Their Brain Metastases?
2:10 p.m.
Tzu-I Jonathan Yang
125
Prognostic Implications of Receptor Status and Extracranial Disease in Patients with Breast Cancer Brain
Metastases Treated with Stereotactic Radiosurgery
2:20 p.m.
Penny Sneed
Discussant
87
1:00 p.m. - 2:30 p.m.
Scientific Session P – Physics – Dose Effect Relationships
Moderators: Lakshmi Santanam, Mary Martel
1:00 p.m.
Joel Greenberger
126
Gene Transcript Responses in 10MV Photon at 2400 MU/min Total Body Irradiated C57BL/6NTac Mice
Correlate with Increased Survival Compared to the Same TBI Dose Using 6MV Photons or Lower Dose Rates
1:10 p.m.
Mark Hallman
127
Dose Conformity Predictors of Symptomatic Toxicity in Patients Treated with Stereotactic Body Radiation
(SBRT)
1:20 p.m.
Ellen Yorke
128
Linear-quadratic Dose Correction for Chest Wall Pain in Thoracic Stereotactic Body Radiation
1:30 p.m.
Katharine Aitken
129
Evaluating Small Bowel Dose Volume Tolerance Limits for SBRT Using a Pre-operative Rectal Radiotherapy
Model: Are We Setting the Bar Too High?
1:40 p.m.
Yelin Suh
130
Duodenal Dose Sparing with Varying Stomach Volume During IG-IMRT Treatment
1:50 p.m.
Gunnar Steineck
131
Relationships Between Rectal Dose and Patient-reported Late Gastrointestinal Toxicity after Prostate Cancer
Radiation Therapy
2:00 p.m.
Dawn Owen
132
Cord and Thecal Sac Dosimetric Correlation with Toxicity for Spine SBRT
2:10 p.m.
Yun Yang
133
Quantitative Comparison of Knowledge-guided IMRT Planning to Expert Planning for Prostate Cancer
Basic Science Abstract Award - Radiation Physics
2:20 p.m.
Jun Lian
134
Inter-Technique and Inter-Institutional Modeling of the Dosimetry of Organs-at-Risk in Head and Neck IMRT
Plans
1:00 p.m. - 2:30 p.m.
Scientific Session Q – Head and Neck – Clinical Trials/Target Delineation
Moderators: Allen Chen, Vishal Gupta
1:00 p.m.
Phuc Felix Nguyen-Tan
135
A Phase III Trial to Test Accelerated versus Standard Fractionation in Combination with Concurrent Cisplatin for
Head and Neck Carcinomas (RTOG 0129): Long Term Report of Efficacy and Toxicity
1:10 p.m.
Brian O’Sullivan
136
The Changing Profile of Outcome in Long Term Follow-up of a Randomized Trial for Locally Advanced Head
and Neck Cancer
88
1:20 p.m.
Anupam Rishi
137
Comparison of Concomitant Boost Radiotherapy and Concurrent Chemoradiation in Locally Advanced
Oropharyngeal Cancers - A Phase III Randomized Trial from a Single Institute in India
1:30 p.m.
Alexandra Jensen
138
Combined IMRT and C12-Heavy Ion Boost for Malignant Salivary Gland Tumors: COSMIC
1:40 p.m.
Lucien Nedzi
139
Toxicity of Continuous Course Re-irradiation Concurrent with Weekly Cisplatinum and Cetuximab for
Recurrent Squamous Cell Carcinoma of the Head and Neck: Report of a Phase II Trial
1:50 p.m.
Adam Garden
Discussant
2:00 p.m.
Peter Ahn
140
Risk of Lymph Node Metastasis and Nodal Level Involvement Based on Site and Histology in the Paranasal
Sinus: A SEER Analysis
2:10 p.m.
Michael Gensheimer
141
Safety of Submandibular Gland-Sparing Intensity Modulated Radiation Therapy for Head and Neck Cancer
2:20 p.m.
Cornelis Raaijmakers
142
Gross Tumor Volume of Laryngeal/Hypopharyngeal Cancer Delineated on MRI is Doubled Compared to
Pathology
1:00 p.m. - 2:30 p.m.
Scientific Session R – Lymphoma – Radiation Therapy as a Critical Component of
Lymphoma Therapy
Room: B203
Moderators: Brad Hoppe, Karen Winkfield
1:00 p.m.
Carolina Fasola
143
Low-dose Radiotherapy (2 Gy x 2) in the Treatment of Non-Hodgkin’s Lymphoma of the Ocular Adnexa
1:10 p.m.
Andrea Ng
144
Rates and Durability of Response to Salvage Radiotherapy Among Patients with Refractory or Relapsed
Aggressive Non-Hodgkin Lymphoma
1:20 p.m.
Abhishek Solanki
145
Excellent Long-term Outcomes in Patients with Early-stage Nodular Lymphocyte-predominant Hodgkins
Lymphoma Treated with Radiotherapy
1:30 p.m.
Tobin Strom
146
Combining Low-dose External Beam with Radioimmunotherapy for Patients with Relapsed/Refractory B-Cell
Lymphoma
1:40 p.m.
George Mikhaeel
Discussant
1:50 p.m.
Sewit Teckie
147
Clinical Outcomes and Patterns of Relapse in 300 Patients with Early- and Advanced-Stage Marginal Zone
Lymphoma
89
2:00 p.m.
Chen Bo
148
Late Relapse in Early-stage Extranodal Natural Killer/T-cell Lymphoma, Nasal Type
2:10 p.m.
Gary Walker
149
Controlling Central Nervous System Leukemia: Does the Extent of the Radiation Therapy Field Influence
Outcomes?
2:20 p.m.
Peter Petersen
150
Deep Inspiration Breath Hold Radiation Therapy Reduces Radiation Dose to the Lungs and Heart in Patients
Treated for Mediastinal Hodgkin Lymphoma
1:00 p.m. - 2:30 p.m.
Scientific Session S – Sarcoma/Cutaneous Tumors
Room: B405
Moderators: Jadranka Dragovic
1:00 p.m.
Dian Wang
151
Significant Reduction of Radiation Related Morbidities in the Extremity Sarcoma Patients Treated with Image
Guided Radiotherapy to Reduced Target Volume: Results of RTOG 0630
1:10 p.m.
Kaled Alektiar
152
Local Control Comparison of Conventional and Intensity Modulated Radiation Therapy (IMRT) for Primary
Soft-Tissue Sarcomas of the Extremity
1:20 p.m.
Colleen Dickie
153
Dosimetric Consequences of Tumor Volume Changes During Preoperative IMRT for Lower Extremity Soft
Tissue Sarcoma
1:30 p.m.
Falk Roeder
154
Excellent Local Control with IOERT and Postoperative EBRT in High-grade Extremity Sarcoma: Results from a
Subgroup Analysis of a Prospective Trial
1:40 p.m.
Jianyang Wang
155
Postoperative Intensity Modulated Radiation Therapy Provided Favorable Local Control in Patients with Soft
Tissue Sarcoma of Extremities and Trunk
1:50 p.m.
Thomas Delaney
Discussant
2:00 p.m.
Elizabeth Pan
156
Role of Postoperative Radiation (RT) Boost for Soft Tissue Sarcomas with Positive Margins Following
Preoperative RT and Resection
2:10 p.m.
Ajay Bhatnagar
157
Electronic Brachytherapy for the Treatment of Non-melanoma Skin Cancer: Results at Three Years
2:20 p.m.
Ulrike Hoeller
158
Treatment Planning for Merkel Cell Carcinoma Based on the Relapse Pattern
90
1:00 p.m. - 2:30 p.m.
Scientific Session T – Physics – Motion Assessment and Management
Room: B406
Moderators: Ying Xiao, Geoffrey Hugo
1:00 p.m.
Mario Romano
159
Does Pre-radiation Oxygen Breathing Prolong Deep Inspiration Breath Hold?
1:10 p.m.
Derek Tsang
160
A Randomized Controlled Trial of Lorazepam to Reduce Organ Motion in Patients Receiving Upper Abdominal
Radiotherapy
1:20 p.m.
Seishin Takao
161
Baseline Shift of Intrafractional Lung Tumor Motion in a Real-time Tumor-tracking Radiotherapy
1:30 p.m.
Keiichi Harada
162
Can 4-D CT Imaging Predict Lung Motion During Stereotactic Body Radiation Therapy?
1:40 p.m.
Xiutao Shi
163
Margins Determined Using 4-D CT Often Underestimate Tumor Motion in Thoracic Tumors
1:50 p.m.
Samer Salamekh
164
Inter-fraction Tumor Volume Changes During Lung Stereotactic Body Radiation Therapy
2:00 p.m.
Katelyn Atkins
165
Interfraction Regional Variation of Tumor Breathing Motion in Lung Stereotactic Body
Radiation Therapy (SBRT)
2:10 p.m.
Li-Ming Christine Fang
166
Novel Method of Cardiac Sparing with Deep-inspiration Breath Hold Utilizing Surface Electromagnetic
Transponders in Women with Left-sided Breast Cancer
2:20 p.m.
Carri Glide-Hurst
167
Intra-fraction Variability and Deformation Quantification for Accelerated Partial Breast Irradiation (APBI)
1:00 p.m. - 2:30 p.m.
Scientific Session U – Peds – Sarcoma and Neuroblastoma
Room: B213
Moderators: Daniel Indelicato, Mary McAleer
1:00 p.m.
Matthew Krasin
168
Long-term Toxicities of a Prospective Trial Delivering Limited Margin 3-D CRT/IMRT in Children with
Rhabdomyosarcoma
1:10 p.m.
Henry Mandeville
169
Local Failure in Parameningeal Rhabdomyosarcoma: Does Response to Induction Chemotherapy Matter?
1:20 p.m.
William Tong
170
High-dose-rate Intraoperative Radiation Therapy for Pediatric Sarcoma: Outcomes, Toxicity and Practice
Recommendations
91
1:30 p.m.
Timothy Waxweiler
171
Non-rhabdomyosarcoma Soft Tissue Sarcomas in Children: A Surveillance, Epidemiology and End Results
Analysis
1:40 p.m.
Lindsay Brown
172
Stereotactic Body Radiotherapy (SBRT) for Pediatric Bone Tumors
1:50 p.m.
Jaipreet Suri
173
Subsequent Malignancies in Patients with Li-Fraumeni Syndrome Treated with Radiotherapy
2:00 p.m.
Alexei Polishchuk
174
Predilection for First Relapse in Previous Sites of Bony Disease in Patients with Metastatic High-risk
Neuroblastoma
2:10 p.m.
Ali Mazloom
175
Radiotherapy to the Primary and Post-induction Chemotherapy MIBG-avid Sites in High-risk Neuroblastoma
2:20 p.m.
Natia Esiashvili
Discussant
1:00 p.m. - 2:30 p.m.
Digital Poster Discussion 05 – Biology
Room: A411
Discussants: Robert Den, Henning Willers
Nan Bi
1049
Serum MicroRNA Signature Predicts Survival in Patients with Unresectable/Inoperable Non-small Cell Lung
Cancer Treated with Definitive Radiation Therapy
Daniel Bracey
1050
The Endogenous Peptide Angiotensin-(1-7) Prevents Radiation-induced Muscle Fibrosis: An In Vivo Murine
Model
Alexander Stessin
1051
Fty720, Sphingosine 1-Phosphate Receptor Modulator, Attenuates Radiation-induced Neurocognitive Deficits
in Young Mice
Carmen Perez
1052
Interleukin-7 as a Candidate Agent for Mitigating Radiation-induced Hematologic Injury
Sanath Kumar
1053
Transforming Growth Factor-β1 Increases Lethality of Total Body Irradiation
Gregory Vlacich
1054
Lrig1 Marks a Basal Subpopulation in the Esophagus Epithelium that Function as Stem Cells
Basic Science Abstract Award - Radiation and Cancer Biology
92
Phuoc Tran
1055
Twist1 Induces the Step-wise Malignant Progression of Liver Cancer in Transgenic Mice Revealing a Prognostic
19-Gene Signature for Humans
Sivarajan Thiruganasambandam 1056
Structure-function Studies of the Phosphorylated bHLH Domain of the Twist1 Oncoprotein for Prostate
Cancer Metastasis
Amit Maity
1057
Targeting the PI3K/mTOR Pathway Reduces Tumor Hypoxia and Decreases Oxygen Consumption
Alan Dal Pra
1058
Metformin and Prostate Cancer Radiotherapy: Improved Outcomes Due to Enhanced Tumor Oxygenation
Michael Spiotto
1059
Image Guided Radiotherapy for Mice Developing Autochthonous Human Papillomavirus Head and Neck
Tumors
Mekhail Anwar
1060
Development of a Real-time Intraoperative Fluorescent Imager for Microscopic Residual Tumor in Breast
Cancer
1:00 p.m. - 2:30 p.m.
Digital Poster Discussion 06 – GU – Prostate - Novel Approaches, Hormones and Postop
Room: A412
Discussants: Drew Moghanaki, Neha Vapiwala
Stephen Bravo
1061
Safety and Efficacy of Feraheme as a Lymphatic Contrast Agent
Skyler Johnson
1062
Dose to the Inferior Rectum Has the Strongest Association with Patient-reported Bowel Quality of Life (QOL)
After External Beam Radiation Therapy (EBRT) for Prostate Cancer
Gaurav Shukla
1063
Dominant Intraprostatic Lesion Size is Correlated with Rate of Biochemical Relapse in Patients with High- and
Intermediate-risk Prostate Cancer Treated with Intensity Modulated Radiation Therapy
Kenneth Tokita
1064
Acute Rectal Toxicities for 180 Prostate Carcinoma Patients Administered Spacer Material in Conjunction with
Radiation Therapy
Olivier Chapet
1065
Hypofractionated Intensity-modulated Radiotherapy with Injection of Hyaluronic Acid for Localized Prostate
Cancer: Results of a Phase II study (RPAH1)
93
Warren Foltz
1066
Improved Geometric Performance of Diffusion-weighted Imaging for Prostate Tumor Delineation Using A
Readout-segmented Echo-planar-imaging Technique
Aaron Wagner
1067
Adjuvant Radiotherapy after Prostatectomy: Have Randomized Clinical Trials Had Any Impact?
Sravana Chennupati
1068
Late Gastrointestinal and Genitourinary Toxicity and Quality of Life After Treatment for Localized Prostate
Cancer: Redefining Optimal Rectal DVH parameters for Intensity Modulated Radiation Therapy
David Elliott
1069
Who Needs Adaptive Radiation Therapy When You Can Do Internal Anatomy Positioning?: A Review of Daily
Cone Beam Computed Tomography (CBDT) Scans to Analyze Geometric Dose Variation Due to Daily Rectal
Variation and Distension in Post-prostatectomy Radiation Therapy
Christina Son
1070
High-risk Prostate Cancer Treated with Dose Escalated RT: An Analysis of Hormonal Therapy Use and Duration,
and Prognostic Implications of PSA Nadir ≤0.2 to Select Men for Short-term Hormonal Therapy
Daniel Spratt
1071
Predictors of Castration Resistant Prostate Cancer After Definitive Radiotherapy: Impact of Failing Neoadjuvant Androgen Deprivation Therapy
Nathan Tonlaar
1072
Use of Weekly Cone Beam CT for Adaptive Radiotherapy Decreases Toxicity for Prostate Cancer Patients
Treated with IMRT
1:00 p.m. - 2:30 p.m.
Educational Session 311 – Challenging Lung Cancer Cases
Room: B206
Zane Hammoud, MD, Henry Ford Hospital
Branislav Jeremic, MD, PhD, Stellenbosch University
Corey Langer, MD, University of Pennsylvania
Benjamin Movsas, MD, FASTRO, Henry Ford Health System
Kenneth Rosenzweig, MD, Icahn School of Medicine at Mount Sinai
1:00 p.m. - 2:30 p.m.
Educational Session 312 – Patients First: Cancer Care from the Patients’ View
Room: B216
Tamika Felder, Founder and CEO, Tamika and Friends Inc.
Jonny Imerman, Chief Mission Office, Imerman Angels
Matthew Zachary, Founder and CEO, Stupid Cancer
Raphael Yechieli, MD, Henry Ford Health System
Interesting Session?
Tweet
#ASTRO13
94
2:45 p.m. - 4:15 p.m.
Scientific Session V – Patient-reported Outcomes – Pelvic Malignancies
Room: B405
Moderators: Lawrence Berk, Robert Miller
2:45 p.m.
Marie-Adele Kress
176
External Beam Radiotherapy Combined with Stereotactic Body Radiation Therapy Boost: Minimal Impact on
Quality of Life with Recovery by Two Years Post-treatment
2:55 p.m.
Don Fuller
177
Quality of Life (QOL) Outcomes Through 3 Years After Stereotactic Body Radiation Therapy (SBRT) for Early
Prostate Cancer, Results from a Multi-institutional Phase II Trial
3:05 p.m.
Olusola Obayomi-Davies
178
Preserved Sexual Function After Stereotactic Body Radiation Therapy for Prostate Cancer
3:15 p.m.
Andrew Lee
179
Prospective Long-term Patient-Reported Quality of Life After Proton Therapy for Prostate Cancer
3:25p.m.
Howard Sandler
Discussant
3:35 p.m.
Kristina Mirabeau-Beale
180
Clinical and Treatment Factors Associated with Vaginal Stenosis After Definitive Chemoradiation for Anal
Cancer
3:45 p.m.
Karyn Goodman
181
Prospective Study of Vaginal Dilator Use Following Pelvic Radiotherapy for Gastrointestinal Malignancies
3:55 p.m.
Surbhi Grover
182
Psychological and Social Work Encounters Predict Higher Patient-reported Functional Quality of Life in
Gynecological Cancer Treatment
4:05 p.m.
Deborah Watkins-Bruner
Discussant
2:45 p.m. - 4:15 p.m.
Scientific Session W – Lung – Locally Advanced Disease and Other Topics
Room: B406
Moderators: Kevin Stephans, Daniel Gomez
2:45 p.m.
Sung-Ja Ahn
183
Randomized, Multicenter Phase III Study of Accelerated Fraction with Concomitant Boost to the Gross Tumor
Volume Compared with Conventional Fraction in Concurrent Chemoradiation in Patients with Unresectable
Stage III Non-small Cell Lung Cancer: KROG 0903
2:55 p.m.
Feng-Ming Kong
184
A Phase II Trial of Mid-treatment FDG-PET Adaptive, Individualized Radiation Therapy Plus Concurrent
Chemotherapy in Patients with Non-small Cell Lung Cancer (NSCLC)
95
3:05 p.m.
Saju Rajan
185
Concurrent Carboplatin, Paclitaxel and Selenomethionine in Combination with Radiation for Patients with
Unresectable Stage III Non-small Cell Lung Cancer: A Phase II, Multi-center Trial
3:15 p.m.
Maria Werner-Wasik
Discussant
3:25 p.m.
Ling Li
186
FDG Pulmonary Uptake Changes During and Post-radiotherapy Compared to Pre-treatment in Predicting
Radiation Induced Lung Toxicity in Non-small Cell Lung Cancer
3:35 p.m.
Chad Tang
187
Post Radiation White Blood Cell Count is a Novel Marker of Radiation Pneumonitis in Non-small Cell Lung
Cancer
3:45 p.m.
Brian Lally
188
Non-small Cell Lung Cancer Disparities in a Tri-racial/Ethnic Population
3:55 p.m.
Suchit Patel
189
A Meta Analysis of the Effect of Post-operative Radiation Therapy (PORT) Using Linear Accelerators on Patients
with N2 Lung Cancer
4:05 p.m.
Quynh Nguyen
190
Risk Factors Predicting Failure and Survival in Lung Cancer Patients Treated with Definitive Dose Escalated
Proton Radiation Therapy
2:45 p.m. - 4:15 p.m.
Scientific Session X – Head and Neck – Outcomes
Moderators: Randall Kimple, Danielle Margalit
2:45 p.m.
Nadeem Riaz
191
Multi-institution Analysis of Concurrent Chemo-radiotherapy with Cisplatin (CDDP) vs. Cetuximab (C225) in
Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-HNSCC): Can HPV Help Decide Which
Agent?
2:55 p.m.
Clayton Hess
192
Competing Causes of Death and Medical Comorbidities Among Patients with Human Papillomavirus-Positive
vs. Negative Oropharyngeal Carcinoma and Its Impact on Compliance to Radiotherapy
3:05 p.m.
Beth Beadle
193
Improved Survival Using IMRT in Head and Neck Cancers: A SEER-Medicare Analysis
3:15 p.m.
Matthew Stenmark
194
High Frequency of HPV-associated Nasopharyngeal Carcinoma (NPC) in North American Patients: Association
with Poor Prognosis
3:25 p.m.
Kenneth Shung Hu
195
Prospective Multidisciplinary Treatment Algorithm for Head and Neck Paragangliomas
3:35 p.m.
Gene-Fu Liu
196
Racial Parities in Outcomes after Radiotherapy for Head and Neck Cancer
96
3:45 p.m.
Moses Tam
197
Long-Term Outcomes of Definitive Radiotherapy for Nasopharyngeal Carcinoma at a North American
Institution
3:55 p.m.
Joseph Lee
198
Nasopharynx Carcinoma : Outcomes with Transitioning to IMRT and Chemotherapy
4:05 p.m.
Alexander Lin
Discussant
2:45 p.m. - 4:15 p.m.
Scientific Session Y – GU – Bladder, Renal, Adrenal, Testes
Room: B213
Moderators: Jason Efstathiou, Javier Torres-Roca
2:45 p.m.
Brian Baumann
199
Robust Risk Stratification Model Predicts Local-regional Recurrence After Radical Cystectomy in Different
Patient Cohorts
2:55 p.m.
Phillip Gray
200
Presentation, Treatment and Outcomes for Bladder Cancer Patients with Non-urothelial Histologies Treated by
Radical Cystectomy: Implications for Adjuvant Radiotherapy
3:05 p.m.
Shafak Aluwini
201
Bladder Preservation with Brachytherapy, External Beam Radiotherapy and Limited Surgery in Bladder Cancer
Patients; Long Term Results
3:15 p.m.
Rebecca Clayman
202
Outcomes of Selective Bladder Preservation in the Elderly Treated with Conservative Surgery and
Chemoradiation
3:25 p.m.
Ferran Ferrer
203
Acute Toxicity Report for Combined Sorafenib and Radiation Treatment in Phase I Multicentric Trial for
Conservative Management of Bladder Cancer
3:35 p.m.
Libni Eapen
Discussant
3:45 p.m.
Sean McBride
204
A Phase I Dose Escalation Study of Cyberknife Radiosurgery in Inoperable Primary Renal Cell Carcinoma
3:55 p.m.
Aaron Sabolch
205
Improved Local Control with Adjuvant Radiotherapy in Localized Adrenocortical Carcinoma: A Case-Matched
Retrospective Study
4:05 p.m.
Swetha Sridharan
206
Contemporary Management of Stage I and Stage II Seminoma
97
2:45 p.m. - 4:15 p.m.
Scientific Session Z – GI – Prospective Clinical Trials and Retrospective Correlations
Room: B216
Moderators: Ross Abrams, Join Luh
2:45 p.m.
Jennifer Wo
207
Mutational Profile of Gastroesophageal Cancer Compared to Gastric and Esophageal Cancers
2:55 p.m.
Tracey Schefter
208
A Phase II Study of Neoadjuvant Therapy with Cisplatin, Docetaxel, Panitumumab Plus Radiation Therapy
Followed by Surgery in Patients with Locally Advanced Adenocarcinoma of the Distal Esophagus. Results of
ACOSOG Z4051 (Alliance)
3:05 p.m.
Christine Min
209
Chemo-radiation Therapy vs. Chemotherapy Alone for Gastric Cancer After R0 Surgical Resection: A
Meta-analysis of Randomized Trials
3:15 p.m.
Jingya Wang
210
Nomogram Score of Pathologic Complete Response to Neoadjuvant Chemoradiation Predicts for Survival
Outcomes in Esophageal Cancer Patients Treated with Definitive Chemoradiation
3:25 p.m.
Bapsi Chakravarthy
Discussant
3:35 p.m.
Avani Dholakia
211
Mapping Patterns of Local Failure Following Pancreaticoduodenectomy for Pancreatic Cancer: A New
Approach to Adjuvant Radiation Fields
3:45 p.m.
Pranshu Mohindra
212
Impact of Neoadjuvant Therapy on Peri-operative Morbidity and Mortality After Pancreaticoduodectomy for
Pancreatic Cancer
3:55 p.m.
Jeff Olsen
213
Sequential Short Course Radiation and FOLFOX as Preoperative Therapy for Rectal Cancer: Favorable LC, PFS
and QOL at 2 Years
4:05 p.m.
Charles Thomas
214
Phase 2 Timing of Rectal Cancer Response to Chemoradiation: Analysis of Radiotherapy (RT)
2:45 p.m. - 4:15 p.m.
Scientific Session AA – Palliative/Quality of Life – Quality of Care in Metastatic Cancer
Room: B203
Moderators: Tracy Balboni
2:45 p.m.
Robert Olson
215
Use of Single Fraction Palliative Radiotherapy for Bone Metastases: Population Based Practice Patterns in
British Columbia Over a Five Year Period
2:55 p.m.
Ehsan Balagamwala
216
Incidence and Risk Factors for Vertebral Compression Fractures from Spine Stereotactic Body Radiotherapy:
Results of a Large Institutional Series
98
3:05 p.m.
David Howell
217
Daily Assessment of Patient Quality of Life During 100 Courses of Radiation: Pain, Anxiety, Distress, Problems
or Concerns, and Need to See Physician
3:15 p.m.
Luluel Khan
218
Fatigue Scores in Patients with Brain Metastases Receiving Whole Brain Radiotherapy
3:25 p.m.
Yolanda Tseng
219
How Radiation Oncologists Evaluate and Incorporate Life Expectancy Estimates into the Palliative Treatment
of Cancer Patients: A Survey-Based Study
3:35 p.m.
Monica Krishnan
220
The Supportive and Palliative Radiation Oncology Service: The Impact of a Dedicated Service on Palliative
Cancer Care
3:45 p.m.
Christopher Barker
221
Palliative Local Therapy for Skin Metastases: A Meta-analysis
3:55 p.m.
Payal Soni
222
Use of Anticoagulants Predict Late Rectal Bleeding Following Definitive External Beam Radiation Therapy for
Prostate Cancer
4:05 p.m.
Candice Johnstone
Discussant
2:45 p.m. - 4:15 p.m.
Scientific Session BB – Biology – Biomarkers, Detection of Prognosis and Progression
Room: B211
Moderators: Fei-Fei Liu, Hiram Gay
2:45 p.m.
Scott Bratman
223
Noninvasive and Ultrasensitive Quantitation of Circulating Tumor DNA by Hybrid Capture and Deep
Sequencing
2:55 p.m.
Sanjay Chandrasekaran
224
Detection of Circulating Tumor Cells of Non-epithelial Origin: A Bench to Bedside Approach
3:05 p.m.
Fadlo Khuri
Discussant
3:15 p.m.
Lauren Colbert
225
Chromodomain-Helicase-DNA-Binding Protein 7 (CHD7), a Novel Gemcitabine Sensitivity Gene, is a
Prognostic Biomarker in Patients with Early-stage Resected Pancreatic Adenocarcinoma
3:25 p.m.
Ting Xu
226
Serum TGF- TGF-β1 and VEGF are Associated with Tumor Burden and Tumor Response on PET to
Radio(chemo)therapy in Patients with Non-small Cell Lung Cancer
99
3:35 p.m.
Nan Bi
227
Serum MicroRNA as a Predictive Marker for Radiation Pneumonitis in Patients with Inoperable/Unresectable
Non-small Cell Lung Cancer (NSCLC)
3:45 p.m.
Ting Xu
228
Circulating miR-155 Predicts for Acute Esophageal Toxicity in Patients with Non-small Cell Lung Cancer
Treated with Radiation Therapy
3:55 p.m.
Jose Bazan
229
Novel Human Radiation Exposure Biomarker Panel Applicable for Patient Triage
4:05 p.m.
Yoko Harima
230
Prediction of Outcome for the Patients with Advanced Cervical Cancers After Chemoradiotherapy Using Micro
RNA Analysis
2:45 p.m. - 4:15 p.m.
Scientific Session CC – Physics – Response Imaging and Modeling
Room: B302-305
Moderators: Jan-Jakob Sonke, Lei Xing
2:45 p.m.
Jeho Jeong
231
An Estimation of the Radiotherapy Dose-response Differences between FDG-avid vs. FDG-non-avid Head and
Neck Tumors
2:55 p.m.
Qiyong Fan
232
Simultaneous Tracking of Multiple Metastases Using FDG-PET Emission Guided Radiation Therapy (EGRT) in a
Breast Cancer Patient
3:05 p.m.
Carryn Anderson
233
Early Analysis of a Phase II Prospective Trial Evaluating Accuracy of Triphasic PET/CT After RT for Head and
Neck Squamous Cell Carcinoma
3:15 p.m.
Lifei Zhang
234
Large Tumor Shrinkage is Preceded by the Appearance of a Cavity Inside the Tumor for NSCLC Patients Treated
with Chemo-radiation Therapy
3:25 p.m.
Martin King
235
Validation of Image-based Biomarkers for Analyzing Long-term Pulmonary Toxicity After Radiation Therapy
3:35 p.m.
Frank Van Den Heuvel
236
Using a Closed Analytical Expression to Determine Biological Effects Depending on Radiation Spectrum and
Oxygen Level
3:45 p.m.
Gilmer Valdes
237
Derivation of Optimum Biological Parameters for Non-small Cell Lung Tumors with Consideration of
Interpatient Heterogeneity
3:55 p.m.
Thomas Zilli
238
Salvage Reirradiation for Local Failure of Prostate Cancer After Curative Radiotherapy: Dosimetric and
Radiobiological Modeling of Rectal Toxicity
100
4:05 p.m.
Phillip Prior
239
Modeling Tumor Control Probability Based on Compiled Clinical Data from Radiotherapy for Skin Cancer
2:45 p.m. - 4:15 p.m.
Digital Poster Discussion 07 – Health Services Research
Room: A411
Discussants: Susan McCloskey, David Sher
Kevin Pearlstein
1073
Patient-level Characteristics of Medicare Cancer Patients in the United States, Implications for Treatment and
Survivorship
Samuel Swisher-McClure
1074
Limited Use of Guideline Concordant External Beam Radiotherapy Dose for Non-metastatic Prostate Cancer in
the United States
John Byun
1075
Readability Levels of Patient Education Materials in Professional Radiation Oncology Organizations
Nataniel Lester-Coll
1076
Stereotactic Radiosurgery vs. Stereotactic Radiosurgery and Whole Brain Radiation Therapy for One to Three
Brain Metastases
Ann Raldow
1077
The Dissemination of New Technologies and Temporal Trends in Curative Therapy for Prostate Cancer Patients
with Low Likelihood of Clinical Benefit
Mark Mishra
1078
An Evaluation of Worldwide Proton Beam Therapy Clinical Trials
Jeffrey Kuremsky
1079
Clinical and Economic Outcomes of Patients with Brain Metastases Based on Whether Metastases are
Symptomatic or Not: An Argument for Routine Brain Screening
Marsha Laufer
1080
Trends in Intensity Modulated Radiotherapy Use for Locally Advanced Rectal Cancer at National
Comprehensive Cancer Network (NCCN) Centers
Ronald Chen
1081
Barriers to Receiving Radiation Therapy for Localized Prostate Cancer (CaP), Results from the North Carolina
Prostate Cancer Comparative Effectiveness and Survivorship Study (NC ProCESS)
David Sher
1082
Patient and Institutional Predictors of Trimodality Therapy for Stage III Non-small Cell Lung Cancer (NSCLC) in
the National Cancer Database
Daniel Wattson
1083
Low-dose Chest CT for Lung Cancer Screening Among Hodgkin Lymphoma Survivors: A Cost Effectiveness
Analysis
101
Jacob Shabason
1084
The Role of Shared Decision Making in Patient Experiences in Radiation Oncology
2:45 p.m. - 4:15 p.m.
Digital Poster Discussion 08 – Physics – SBRT Outcomes and Particle Therapies
Room: A412
Discussants: Sonja Dieterich, Harald Paganetti
Jing Wang
1085
Primary Outcomes in Phase II Study of Hypofractionated Patterns by Stereotactic Ablative Radiotherapy
(SABR) Understanding the Clinical Results from Contemporary Stereotactic Radiotherapy
Withdrawn
1086
Withdrawn
1087
Christy Goldsmith
1088
Stereotactic Ablative Body Radiotherapy (SABR) to Lymph Node Oligometastases - UK Experience and Clinical
Outcome
Roi Dagan
1089
Initial Outcomes from the University of Florida Experience with Stereotactic Ablative Radiotherapy (SABR) for
Oligometastases
Daniel Richter
1090
4-D Treatment Dose Reconstruction for Scanned Ion Beam Therapy
Huanmei Wu
1091
An Integrated Image Guided Proton Therapy Monitoring System with Real-time Imaging Processing and
Treatment Intervention
Maryam Moteabbed
1092
When Does Pencil Beam Scanning Improve the Treatment Outcome of Pediatric Head and Neck/CNS Patients
Over Passive Scattered Proton Therapy?
Wataru Takahashi
1093
Carbon-Ion Scanning Lung Therapy (with Respiratory-Gated Phase Controlled Rescanning): Simulation Study
for 4-D Treatment Planning
Jonathan Farr
1094
In Vivo Proton Beam Centroid and Range Uncertainties Determined Empirically from Positron Emission
Tomography Due to Single Uniform Field Patient Treatment Activation
Jonathan Ashman
1095
Scanning Beam Stereotactic Body Proton Therapy (SBPT) for Pancreatic Cancer: A Dosimetric Feasibility Study
Vadim Moskvin
1096
Reduced Secondary Neutrons and Occupational Exposure with Optimization of Beam Shaping Device
Material in Proton Therapy
102
2:45 p.m. - 4:15 p.m.
Educational Session 313 – Challenging Cases in the Management of Newly Diagnosed
and Recurrent Prostate Cancer
Room: B313
Gerald L. Andriole, MD, Washington University
Juanita M. Crook, MD, University of British Columbia
Anthony V. D’Amico, MD, PhD, FASTRO, Brigham and Women’s Hospital
Thomas Wiegel, MD, University Hospital ulm
Michael J. Zelefsky, MD, Memorial Sloan-Kettering Cancer Center
2:45 p.m. - 4:15 p.m.
Educational Session 314 – Difficult Cases in Vulvar and Vaginal Cancer
Room: B206
Patricia J. Eifel, MD, FASTRO, MD Anderson Cancer Center
Beth A. Erickson, MD, FASTRO, Medical College of Wisconsin
Michael Frumovitz, MD, MPH, MD Anderson Cancer Center
William Small, MD, FASTRO, Loyola University
Akila N. Viswanathan, MD, Brigham and Women’s Hospital
4:30 p.m. - 6:00 p.m.
Panel 11 – Integrated Urology and Radiation Oncology Practices: An Analysis of the
Self-Referral Landscape
Room: B216
Moderator:
Mitchell Anscher, MD, FASTRO, Virginia Commonwealth University Medical Center
Panelists:
Jean Mitchell, PhD, Georgetown University
Benjamin Falit, MD, JD, Harvard Radiation Oncology Program
Michael Kuettel, MD, PhD, MBA, FASTRO, Roswell Park Cancer Institute
Paul Wallner, DO, FASTRO, 21st Century Oncology
4:30 p.m. - 6:00 p.m.
Panel 12 – Patient-reported Outcomes: “Hearing the Patient’s Voice” in a User-friendly and
Meaningful Way
Room: B203
Moderator:
Benjamin Movsas, MD, FASTRO, Henry Ford Health System
Panelists:
Deborah Watkins Bruner, PhD, RN, Emory University
Jeff Sloan, PhD, Mayo Clinic
Ronald Chen, MD, University of North Carolina at Chapel Hill
Benjamin Movsas, MD, Henry Ford Health System
103
4:30 p.m. - 6:00 p.m.
Panel 13 – Brachytherapy Fundamentals and Evolving Paradigms
Room: B211
Moderator:
Robert Cormack, PhD, Harvard Medical School
Panelists:
Beth A. Erickson, MD, FASTRO, Medical College of Wisconsin
Atif Khan, MD, Cancer Institute of New Jersey
Paul Nguyen, MD, Dana-Farber/Brigham and Women’s Cancer Center
4:30 p.m. - 6:00 p.m.
Panel 14 – Medical Error Disclosure in Radiation Oncology
Room: B313
Moderator:
Suzanne Evans, MD, Yale University
Panelists:
John Banja, PhD, Emory University
Andrew White, MD, University of Washington Medical Center
Kristin Hiscutt, Esq., Bendin, Sumrall and Ladner LLC
4:30 p.m. - 6:00 p.m.
Panel 15 – Cancer Genesis, Treatment and Late Effects Across the Age Spectrum
Room: B213
Moderator:
Louis S. Constine, MD, FASTRO, University of Rochester Medical Center
Panelists:
Jacqueline Williams, PhD, FASTRO, University of Rochester Medical Center
Louis S. Constine, MD, FASTRO, University of Rochester Medical Center
Lawrence Marks, MD, FASTRO, University of North Carolina at Chapel Hill
Lois Travis, MD, University of Rochester Medical Center
4:30 p.m. - 6:00 p.m.
Educational Session 315 – Practical Use of Image Registration and Data Fusion for
Planning, Delivery and Adaptation of Radiation Therapy
Room: B302-B305
Kristy K. Brock, PhD, University of Michigan
Marc L. Kessler, PhD, University of Michigan
Patrick A. Kupelian, MD, University of California Los Angeles Health System
4:30 p.m. - 6:00 p.m.
Educational Session 316 – Challenging Cases in GI Malignancies
Room: B206
Prajnan Das, MD, MS, MD Anderson Cancer Center
Theodore S. Hong, MD, Massachusetts General Hospital
Caio Rocha-Lima, MD, University of Miami
Sam S. Yoon, MD, Memorial Sloan-Kettering Cancer Center
104
Wednesday | September 25
7:45 a.m. - 9:00 a.m.
Educational Session 401 – Volumetric Modulated Arc Therapy: Planning and Quality
Assurance
Charles Mayo, PhD, Mayo Clinic
Jean M. Moran, PhD, University of Michigan
Todd Pawlicki, PhD, University of California San Diego
7:45 a.m. - 9:00 a.m.
Educational Session 402 – Pediatric Tumors: Update on Neuroblastoma, Wilms Tumor and
Retinoblastoma
Room: B203
Ranjit S. Bindra, MD, PhD, Yale School of Medicine
Christopher Barker, MD, Memorial Sloan-Kettering Cancer Center
John A. Kalapurakal, MD, Northwestern Memorial Hospital
7:45 a.m. - 9:00 a.m.
Educational Session 403 – Advances in Treatment Planning for Prostate Cancer
Room: B313
Mark K. Buyyounouski, MD, MS, Fox Chase Cancer Center
Peter Chung, MB, ChB, Princess Margaret Hospital
7:45 a.m. - 9:00 a.m.
Educational Session 404 – Treatment Option for Patients with Early-stage Non-small Cell
Lung Cancer
Room: B405
Jeffrey A. Bogart, MD, State University of New York
Abraham Lebenthal, MD, Brigham and Women’s Hospital
7:45 a.m. - 9:00 a.m.
Educational Session 405 – Radiation/Chemoradiation and Biological Targeting
Room: B213
Robert G. Bristow, MD, PhD, Princess Margaret Hospital
George D. Wilson, PhD, William Beaumont Hospital
7:45 a.m. - 9:00 a.m.
Educational Session 406 – Breast Cancer Management: Early-stage Disease
Room: B211
Meena S. Moran, MD, Yale University School of Medicine
Julia S. Wong, MD, Dana-Farber Cancer Institute
Symbol Key:
A
ARON
Separate
Session
registration
required
Award
Recipient
Live
Interactive
SAM/
Session
Separate
registration
required
105
7:45 a.m. - 9:00 a.m.
Educational Session 407 – Radiation Treatment for Hepatic Tumors: Current Treatment
Approaches and Controversies
Room: B302-B305
Laura A. Dawson, MD, Princess Margaret Hospital
7:45 a.m. - 9:00 a.m.
Educational Session 408 – Survivorship Issues for Radiation Therapy Patients
Room: B406
Ronald C. Chen, MD, MPH, University of North Carolina at Chapel Hill
Bridget F. Koontz, MD, Duke University Medical Center
Deborah Mayer, PhD, RN, UNC School of Medicine
Kevin D. Stein, PhD, American Cancer Society
7:45 a.m. - 9:00 a.m.
Educational Session 409 – Integration of Systemic Treatment with Radiation Therapy for
Head and Neck Cancer
Room: B216
Ezra Cohen, MD, University of Chicago
David I. Rosenthal, MD, MD Anderson Cancer Center
Roy B. Tishler, MD, PhD, Dana-Farber Cancer Institute
7:45 a.m. - 9:00 a.m.
Educational Session 410 – Hypofractionation in the Management of CNS Tumors
Room: B308
Eric Lin Chang, MD, University of Southern California Keck School of Medicine
Michael T. Milano, MD, PhD, University of Rochester
Timothy D. Solberg, PhD, University of Pennsylvania
9:15 am. - 10:15 a.m.
Keynote Address III – Steven L. Leibel, MD Memorial Lecture
“Identification and Targeting of Radioresistance Niches“
Peter Friedl, MD, PhD, St. Radboud University Nijmegen Medical Centre,
University of Nijmegen; MD Anderson Cancer Center
Introduced by: Catherine C. Park, MD, University of California San Francisco
Refer to page 47 for details.
Great speaker?
Tweet
#ASTRO13
106
10:30 a.m. - 12:00 p.m.
Scientific Session DD – Breast – Biology of Breast Cancers
Moderators: Simona Shaitelman, John Einck
10:30 a.m.
Markus Bredel
240
Deletion of the Tumor Suppressor NFKBIA in Triple-negative Breast Cancer
10:40 a.m.
Shreya Prasad
241
Patterns of Failure in Triple Negative Breast Cancer: A Retrospective Analysis in 476 women
10:50 a.m.
Chi Zhang
242
Triple Negative Breast Cancer is Associated with Higher Rate of Locoregional Recurrence for Patient Achieving
Less than a pCR Following Neoadjuvant Chemotherapy, Surgery and Radiotherapy
11:00 a.m.
Tithi Biswas
243
Treatment Related Outcome in Triple Negative Breast Cancer (TNBC): A Multi-institutional Retrospective
Analysis
11:10 a.m.
Wendy Woodward
Discussant
11:20 a.m.
Corey Speers
244
Identification and Validation of a Radiation Sensitivity Signature in Human Breast Cancer
11:30 a.m.
Wil Santivasi
245
Cytosolic Mislocalization of BRCA1 is Associated with Increased Metastatic Risk in Breast Cancer
11:40 a.m.
Wendy Woodward
246
Complementing Ipsilateral Breast Tumor Recurrence (IBTR) Estimates with the 21-Gene Recurrence Score (RS)
in Early-stage, Hormone Receptor Positive, Her2-Normal, Lymph Node-negative Breast Cancers
11:50 a.m.
Naresh Jegadeesh
247
21-Gene Recurrence Score Predicts Local Recurrence in Breast Cancer Patients Treated with Mastectomy
Alone but Not in Patients Treated with Radiation
10:30 a.m. - 12:00 p.m.
Scientific Session EE – CNS – Outcomes and Survival
Room: B213
Moderators: Ben Slotman, Peter Chen
10:30 a.m.
C. Ronald Kersh
248
Re-Irradiation with Stereotactic Radiosurgery Treatment for Spinal Metastases - Results from an International
Multicenter Database
10:40 a.m.
Matthias Guckenberger
249
Radiosurgery as Primary Treatment for Vertebral Metastases - Results from an International Multicenter
Database
10:50 a.m.
Samuel Ryu
250
Neurological Outcome and Survival After Radiosurgery of High-grade Epidural Spinal Cord Compression
107
11:00 a.m.
Stephanie E. Combs
251
Multicentric Evaluation of Long-term Outcome After Highly Advanced Single-dose or Fractionated
Radiotherapy in Patients with Vestibular Schwanommas - Pooled Results from three Large German Centers
11:10 a.m.
Daniel Bernad
252
Analysis of Structural Changes in Hippocampal and Amygdala Volume After Systemic Therapy and
Prophylactic Cranial Irradiation in Patients with Limited Stage Small Cell Lung Cancer
11:20 a.m.
Frank Giordano
253
Mapping of Brain Metastases to Evaluate the Risk of Hippocampus-sparing Prophylactic and Therapeutic
Cranial Irradiation
11:30 a.m.
Amol Narang
254
Predictors of High-Grade Histology in Patients with Progressive Low-grade Gliomas: Is Histology Needed to
Guide Therapy?
11:40 a.m.
John Hardie
255
Factors Contributing to Survival in Patients with Anaplastic Astrocytoma: A Retrospective Study of Patients
Treated at One Institution
11:50 a.m.
Yuta Shibamoto
256
Analysis of Radiation Therapy in 1,054 Patients with Primary Central Nervous System Lymphoma (PCNSL)
Treated During 1985-2009
10:30 a.m. - 12:00 p.m.
Scientific Session FF – GU – Prostate Cancer: High Risk, Postop and Metastatic Disease
Room: B211
Moderators: Danny Song, James Yu
10:30 a.m.
Xavier Maldonado
257
Late Side Effects in Men with Intermediate- and High-risk Prostate Cancer Treated with High-dose
Radiotherapy and Androgen Deprivation (DART 01/05): Secondary Endpoints from a Phase III Clinical Trial
10:40 a.m.
Alex Gottschalk
258
Outcomes of Hypofractionated SBRT Boost for Intermediate- and High-risk Prostate Cancer: A Single
Institutional Prospective Study
10:50 a.m.
Patrick Cheung
259
Concomitant Hypofractionated IMRT Boost for High-risk Prostate Cancer: 5 Year Results
11:00 a.m.
Mack Roach
260
Radiation Therapy Oncology Group (RTOG) 9413: A Randomized Trial Comparing Whole Pelvic Radiotherapy
(WPRT) to Prostate Only (PORT); Neoadjuvant Hormonal Therapy (NHT) to Adjuvant Hormonal Therapy (AHT)
11:10 a.m.
Paul Nguyen
261
Meta-analysis of Long-term Results of Randomized Trials of the Impact of Adjuvant Radiation on Overall,
Metastasis-free, and Biochemical Recurrence-free Survival for pT3N0 or Margin Positive Prostate Cancer
11:20 a.m.
John Watkins
262
Demon in the Details: Width of Involved Margin at Prostatectomy Correlates with PSA Control
108
11:30 a.m.
Monica Shukla
263
Redefining Stage IV Prostate Cancer – Is There a Subset Who May be Cured?
11:40 a.m.
Piotr Milecki
264
A Comparison of the Analgesic Effect and Toxicity of 153sm Radioisotope Treatment in Monotherapy and
Combined Therapy Including Local External Beam Radiotherapy (EBRT) Among Metastatic Castrate
Resistance Prostate Cancer (MCRPC) Patients with Painful Bone Metastases
11:50 a.m.
Jeff Michalski
265
Radium-223 Dichloride (Ra-223) Impact on Skeletal-related Events, External Beam Radiotherapy (EBRT) and
Pain in Patients with Castration-resistant Prostate Cancer (CRPC) with Bone Metastases: Updated Results from
the Phase 3 ALSYMPCA Trial
10:30 a.m. - 12:00 p.m.
Scientific Session GG – Biology – The Interplay Between Radiation and the Immune
System
Room: B203
Moderators: Christopher Barker, James Hansen
10:30 a.m.
Matthew Witek
266
Single Dose Tumor Irradiation Primes the Immune System for Therapeutic Cancer Vaccination
10:40 a.m.
Timothy Harris
267
Tumor Vaccination Combined with Radiotherapy Mitigates Development and Progression of Metastatic
Prostate Cancer: Studies in an Autochthonous Murine Prostate Cancer Model
Resident Clinical/Basic Science Research Award – Radiation and Cancer Biology
10:50 a.m.
Timothy Harris
268
Immune Checkpoint Upregulation Following Radiotherapy: Rationale for Combining Radiotherapy with
Multiple Immune Checkpoint Blockades
11:00 a.m.
Michael Bernstein
269
Radiation Therapy Alters Tumor Cell Phenotypes and Enhances the Immune Response
11:10 a.m.
Adam Dicker
Discussant
11:20 a.m.
Anita Aiyer
270
Preparative Hepatic Irradiation (HIR) for Transplantation of Human Induced Pluripotent Stem Cell
(iPSC)-Derived Hepatocyte-Like Cells (iHep) in Mouse Livers
11:30 a.m.
Ralph Vatner
271
Novel Combination of Toll-like Receptor (TLR)-7 Agonist Imiquimod and Local Radiotherapy in the Treatment
of Metastatic Breast Cancer Involving the Skin or Chest Wall
11:40 a.m.
Arta Monjazeb
272
Combined Radiotherapy and Immunotherapy Using CPG Oligodeoxynucleotides and Indolamine 2,3
Dioxygenase (IDO) Blockade
109
11:50 a.m.
Jeremy Price
273
Unraveling the Mechanisms of Langerhans Cell Irradiation Resistance
10:30 a.m. - 12:00 p.m.
Scientific Session HH – Lung – Biology and Mesothelioma
Room: B405
Moderators: Heath Skinner, Roy Decker
10:30 a.m.
Steven Lin
274
Circulating Tumor Cells with Markers of Epithelial-Mesenchymal Transition are Associated with Distant
Metastatic Failures in Lung Cancer Patients Treated with Definitive Chemoradiation
10:40 a.m.
Ronny Kalash
275
Significant Differences in Thoracic Irradiation Induced Pulmonary Gene Transcripts Between Fibrosis-prone
C57BL/6 Hnsd Mice and Fibrosis-resistant C3H/Hen Mice
10:50 a.m.
Dmitriy Meshkov
276
ATM Gene Variations Predict Differences in Pretreatment Lung Inflammation in Non-small Cell Lung Cancer
(NSCLC) Patients
11:00 a.m.
Lucas Gilbride
277
A Novel Circulating Tumor Cell Assay for Non-small Cell Lung Cancer Patients Undergoing Radiation Therapy
11:10 a.m.
Michael Epperly
278
Late Pulmonary Fibrotic Phase Specific Homing of Luciferase+ Bone Marrow Stromal Cells to the Irradiated
C57bl/6Hnsd Mouse Lung
11:20 a.m.
Russell Hales
Discussant
11:30 a.m.
Marco Trovo
279
Radical Pleurectomy/Decortication Followed by High Dose of Radiation Therapy Delivered with Tomotherapy
for Malignant Pleural Mesothelioma. Final Results with Long-term Follow-up
11:40 a.m.
Malcolm Feigen
280
Outcomes from Radiation Pneumonectomy for Locally Advanced Malignant Pleural Mesothelioma - High
Locoregional Control Rate with Acceptable Toxicity
11:50 a.m.
Andreas Rimner
281
Interim Analysis of a Phase II Toxicity Study on Hemithoracic Pleural Intensity Modulated Radiation Therapy
(IMRT) for Malignant Pleural Mesothelioma (MPM)
10:30 a.m. - 12:00 p.m.
Scientific Session II – Patient-reported Outcomes – Head/Neck, Thoracic and Breast
Cancers
Room: B308
Moderators: Aileen Chen, Ronald Chen
10:30 a.m.
Kerry Dunn
282
Mometasone Furoate Significantly Reduces Radiation Dermatitis in Patients Undergoing Breast Radiotherapy:
A Double-blind Randomized Control Trial in 120 Patients
10:40 a.m.
Karna Sura
283
Factors Affecting Breast Cancer Patient Quality of Life in Association with Radiation
10:50 a.m.
Michele Halyard
Discussant
11:00 a.m.
Raimond Wong
284
RTOG 0537 Phase 2/3 Study Comparing Acupuncture-like Transcutaneous Electrical Nerve Stimulation
(ALTENS) vs. Pilocarpine (PC) in Treating Early Radiation-induced Xerostomia (RIX): Phase 3 Preliminary
Analysis
11:10 a.m.
G. Gunn
285
Drivers of Patient-reported Symptom Interference During Radiation or Chemoradiation as Detected by the
MD Anderson Symptom Inventory – Head and Neck Module
11:20 a.m.
Roy Tishler
Discussant
11:30 a.m.
David Schwartz
286
Repeated Measure Analysis of Dermatitis Symptoms Evolution and Patient-reported Outcome in N06C4: A
Phase III Randomized Trial of Mometasone Furoate in Breast Cancer Patients Receiving Radiotherapy
11:40 a.m.
Abram Recht
287
Esophageal Symptoms Before, During, and One Year After Treatment and Sequencing of Chemotherapy (CT)
and Mediastinal Radiation Therapy (MRT)
11:50 a.m.
Christine Hill-Kayser
288
Patient-reported Outcomes After Treatment for Lung Cancer
10:30 a.m. - 12:00 p.m.
Scientific Session JJ – Patient Safety
Room: B216
Moderators: James Hayman, Suzanne Evans
10:30 a.m.
Brett Cox
289
Prospective Contouring Rounds: A Novel, High-impact Tool for Optimizing Quality Assurance
10:40 a.m.
Prithima Mosaly
290
Quantifying the Impact of Cross-coverageon Physicians Workload and Performance During Radiation Therapy
Treatment Planning
10:50 a.m.
David Hoopes
291
Early Results from the ASTRO Practice Patterns in Peer Review Survey Project
11:00 a.m.
Eric Ford
Discussant
11:10 a.m.
Douglas Rahn
292
A Real-time Safety and Quality Reporting System: Initial Clinical Outcomes and Survey Results
11:20 a.m.
Jing Zeng
293
Patient Safety Improvement Related to Repeat Irradiation Identified with Near-miss Incidents Reporting
111
11:30 a.m.
Lakshmi Santanam
294
Model for Estimating Severity of Errors in Radiation Therapy
11:40 a.m.
Peter Greer
295
Real-time EPID-based Dose Verification System for Detection of Gross Radiation Treatment Delivery Errors
11:50 a.m.
Bisham Chera
Discussant
10:30 a.m. - 12:00 p.m.
Scientific Session KK – Physics – Emerging Observations and Technologies
Room: B406
Moderators: Michael Sharpe, Laura Cervino
10:30 a.m.
Anna Rodrigues
296
Dynamic Electron Arc Radiotherapy (DEAR): A New Conformal Technique in Delivering Electron Beam Therapy
10:40 a.m.
Bin Han
297
Meeting the Challenge of SBRT QA: Development of a High-resolution and High-speed Dosimetry Strategy
10:50 a.m.
Aaron Kusano
298
Measurable Improvements in Patient Safety Culture: A First-year Department Experience with Incident
Learning
11:00 a.m.
Ke Sheng
299
4π Non-Coplanar SBRT for Centrally Located or Larger Lung Tumors
11:10 a.m.
Seungjong Oh
300
Modelling of Anisotropic PTV Margin of Cervix Cancer under Severe Target Deformation and Shrinkage using
Deformable Image Registration
11:20 a.m.
Dan Ruan
301
Robust Optimization for Head and Neck Cancer Radiotherapy
11:30 a.m.
Lana de Souza-Lawrence
302
A Novel Radio-opaque Hydrogel Marker Can Be Used to Decrease Inter-observer Variability in the Delineation
of the Lumpectomy Cavity
11:40 a.m.
Rachel Sarabia-Estrada
303
Feasibility Study of Nanoparticle Thermal Therapy in a Model of Spinal
11:50 a.m.
Naichang Yu
304
Effect of Patient Breathing on Y90 PET Dosimetry for Y90 Radioembolization of Liver Cancer
112
10:30 a.m. - 12:00 p.m.
Digital Poster Discussion 09 – Gastrointestinal
Room: A411
Discussants: Christopher Crane, Charles Thomas
Rachit Kumar
1097
ALDH-Expressing Cancer Stem Cells are Associated with Inferior Survival in Patients with Resected Pancreatic
Adenocarcinoma Treated with Adjuvant Chemoradiation
Sarah Fisher
1098
Pro-necrotic Mixed Lineage Kinase Domain-Like (MLKL) Protein Expression is a Prognostic Biomarker in
Patients with Resected Pancreatic Adenocarcinoma
Shawn Shao-Lun Lu
1099
Non-dosimetric Biomarker of Serum Transforming Growth Factor-β1 Change After Neoadjuvant
Chemoradiotherapy Predicts Postoperative Pulmonary Complications in Esophageal Cancer Patients
Receiving Combined Modality Therapy
Keisuke Otani
1100
Preoperative Chemoradiotherapy with Gemcitabine for Pancreatic Cancer Encountered Vertebral
Compression Fractures: Multivariate Analysis for Its Risk Factors
Howard Hsu
1101
Radiation Therapy Improves Survival in Small Cell Rectal Cancer - Analysis of Surveillance Epidemiology and
End Results (SEER) Data
Xiao Liu
1102
The High Expression of Epidermal Growth Factor Receptor (EGFR) is an Indicator for Poor Prognosis, Though is
a Potential Indicator for Positive Outcome of Postoperative Radiation Therapy for Esophageal Squamous Cell
Carcinoma
Bassem Zaki
1103
Chromosome Segregation Errors Predict Pathological Response of Rectal Adenocarcinoma to
Chemoradiation
Michael Rutenberg
1104
A Comparison between Consensus Guidelines Based PTVs and 4-D CT Based PTVs for Locally Advanced
Pancreatic Cancer: Implications for Therapy
Jordan Kharofa
1105
Local Control in Resectable and Borderline Resectable Pancreatic Cancer (PCa) Treated with Preoperative
Chemoradiation or Chemotherapy Alone
Kelly Erickson
1106
Post-Treatment FDG-PET/CT Response is Predictive of Tumor Progression and Survival in Anal Carcinoma
Ben Goodman
1107
Survival Efficacy Following Stereotactic Body Radiation Therapy for Limited Liver Metastases
Xiao Liu
1108
Patterns of Recurrence after Radical Esophagectomy and Impact of Postoperative Radiation for Thoracic
Esophageal Squamous Cell Carcinoma with pT2-T3N0M0 Disease
113
10:30 a.m. - 12:00 p.m.
Digital Poster Discussion 10 – Head and Neck
Room: A412
Discussants: Beth Beadle, Annie Chan
Yu-Wei Lin
1109
Patterns of Failure After Postoperative Intensity Modulated Radiotherapy for Locally-advanced Buccal Cancer
Christopher Spencer
1110
Reduction in Radiotherapy Volumes for Patients with Head and Neck Squamous Cell Carcinoma Improves
Patient-reported Quality of Life
Sheela Hanasoge
1111
Predictive Accuracy of CT Imaging for Nodal Extracapsular Extension in Patients with Laryngeal or Oral Cavity
Cancer Managed with Initial Surgery
Hebist Berhane
1112
Radiosensitivity of Oropharyngeal Mucosa of FancD2-/- Mice Correlates with Novel Gene Expression
Response to Head and Neck Irradiation
David Louis Schwartz
1113
Metabolic Tumor Volume as a Predictive Imaging Biomarker in Head and Neck Cancer – Pilot Results from
RTOG 0522
XiaoShen Wang
1114
Selective Nodal Irradiation by Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma Aiming to
Reduce Dysphagia and Xerostomia
Goupei Zhu
1115
Induction Chemotherapy Followed by Concomitant Chemoradiation vs. Cetuximab with Radiation in Locally
Advanced Nasopharyngeal Carcinoma: Initial Results of a Randomized Phase II Study
Noam VanderWalde
1116
The Effectiveness of Chemoradiation for Head and Neck Cancer in an Older Patient Population
Dorothy Gujral
1117
Arterial Stiffness and Elasticity as Markers of Radiation-induced Atherosclerosis
Salem Alshehri
1118
Comparison of Palliative Radiotherapy Regimens for Head and Neck Cancer: A Population-based Analysis
Dominique Rash
1119
Comparison of Clinical Outcomes Among Patients Treated by Primary Surgery vs. Chemoradiation for
Locally Advanced, HPV-Negative Squamous Cell Carcinoma of the Oropharynx
Michael Marquardt
1120
Analysis of Pathologic Factors from Surgical Resection Influences Accuracy of 3 Month Post-Radiotherapy FDG
PET/CT in Resected Oral Cavity Cancer Patients
114
10:30 a.m. - 12:00 p.m.
Educational Session 411 – Difficult Cases in Cervical Cancer Management
Room: B206
Kristin A. Bradley, MD, University of Wisconsin School of Medicine and Public Health
Colleen M. Feltmate, MD, Brigham and Women’s Hospital
David K. Gaffney, MD, PhD, University of Utah
Susan Higgins, MD, MS, Yale University
Catheryn M. Yashar, MD, University of California San Diego
10:30 a.m. - 12:00 p.m.
Educational Session 412 – Image Guidance in the Treatment Room: Technology and
Strategies
Room: B313
Jean-Pierre Bissonnette, PhD, Princess Margaret Hospital
Larry L. Kestin, MD, Michigan Healthcare Professionals
Sasa Mutic, PhD, Washington University School of Medicine
12:00 p.m. - 1:00 p.m.
ARRO Meet the Professor Luncheon
Room: B302-B305
1:00 p.m. - 2:30 p.m.
Scientific Session LL – GU – Prostate Cancer: Translational, Brachytherapy
Room: B213
Moderators: Katherine Tzou, Jay Ciezki
1:00 p.m.
Alireza Fotouhi Ghiam
305
Genomic Instability in Common Fragile Sites (CFSs) is Associated with Less Favorable Outcome in Patients
with Intermediate-risk Prostate Cancer (IR-CaP)
Resident Clinical/Basic Science Research Award – Clinical
1:10 p.m.
Joseph Salama
306
Cell Cycle Progression Score Significantly Predicts PSA Failure After EBRT
1:20 p.m.
Felix Feng
307
Validation of a Genomic Classifier that Predicts Metastatic Disease Progression in Men with Biochemical
Recurrence Post Radical Prostatectomy
1:30 p.m.
Chandan Guha
Discussant
1:40 p.m.
R. Charles Nichols
308
Serum Testosterone Changes in Patients Treated with Radiotherapy Alone for Prostate Cancer on
RTOG 9408
Symbol Key:
A
ARON
Separate
Session
registration
required
Award
Recipient
Live
Interactive
SAM/
Session
Separate
registration
required
115
1:50 p.m.
Seth Blacksburg
309
Seminal Vesicle Implantation Does Not Significantly Affect Prostate Cancer Treatment Related Outcomes
2:00 p.m.
Razvan Galalae
310
Combined High-dose-rate (HDR) Brachytherapy and External Beam Radiotherapy (EBRT) for Prostate Cancer:
5 and 10 Years Outcomes of Kiel Protocols 1 Versus 2
2:10 p.m.
Daniel Spratt
311
Comparison of High-dose IMRT (86.4 Gy) to Combined Brachytherapy Plus IMRT for Intermediate-risk Prostate
Cancer
2:20 p.m.
Matthew Ferris
312
Interim Results of a Prospective Phase II Trial of Pelvic IMRT, Cesium-131 Brachytherapy Boost, Adjuvant
Docetaxel Chemotherapy and Long Term Androgen Ablation for Patients with High-risk Prostate Cancer
1:00 p.m. - 2:30 p.m.
Scientific Session MM – GYN – Endometrial/Vulvar Cancer
Room: B211
Moderators: Sushil Beriwal, Sheida Mani
1:00 p.m.
Miran Blanchard
313
Lymph Node Positive Endometrial Carcinoma (EC): There is a Role for Vaginal Brachytherapy (VB)
1:10 p.m.
Sarah Milgrom
314
Quantifying the Risk of Recurrence and Death in Stage III (FIGO 2009) Endometrial Cancer
1:20 p.m.
Jacob Shin
315
Secondary Uterine Corpus Cancer After Prior Pelvic Radiation Therapy is Associated with Worse Survival than
Sporadic Secondary Uterine Malignancies: A SEER Population Based Study
1:30 p.m.
Eric Xanthopoulos
316
Adjuvant Radiation Therapy in Node Positive Vulvar Cancer
1:40 p.m.
Nikhil Thaker
317
Survival Outcomes for Patients with Pelvic Lymph Node Positive Stage IVB Vulvar Cancer: Time To Reconsider
the FIGO Staging System?
1:50 p.m.
Eugene Koay
318
Factors Associated with Long Term Survival in Locally Advanced Squamous Cell Carcinoma of the Vulva
Treated with Definitive Radiotherapy
2:00 p.m.
Peyman Kabolizadeh
319
Are RTOG Para-aortic Contouring Guidelines for Pancreatic Neoplasm Applicable to Other Malignancies Assessment of Nodal Distribution in Gynecological Malignancies
2:10 p.m.
Takashi Kawanaka
320
Prognostic Significance of UROD Expression on Cervical Cancer with Radiotherapy
2:20 p.m.
Julie Greenwalt
321
Outcomes of Definitive Radiation Therapy for Primary Vaginal Carcinoma
116
1:00 p.m. - 2:30 p.m.
Scientific Session NN – Palliative/Quality of Life – Symptom Management of Primary
Cancers
Room: B216
Moderators: Anand Mahadevan, Mark Henderson
1:00 p.m.
Tahir Mehmood
322
Palliative Quad Shot Radiotherapy in Advanced Oral Cancer
1:10 p.m.
Paul Romesser
323
Prospective Dysphagia Quality of Life Scores and Treatment Outcomes in Oropharyngeal Cancer Patients: Is it
Time to Reconsider the Prophylactic Percutaneous Endoscopic Gastrostomy?
1:20 p.m.
Michele Halyard
324
Real-time Assessment of Patient Reported Outcomes in Head and Neck Cancer Patients Undergoing
Radiotherapy
1:30 p.m.
Kenneth Niermann
325
The Vanderbilt Head and Neck Symptom Survey Version 2.0: Responsiveness to Change Over Time
1:40 p.m.
Benjamin Kann
326
Dysphagia and Dose Reduction to Dysphagia/Aspiration-Related Structures (DARS) in Patients Receiving
Induction Chemotherapy (IC) Followed by Concurrent Chemoradiation Therapy (CCRT) for Locally Advanced
Squamous Cell Carcinoma of the Head and Neck (LASCCHN)
1:50 p.m.
Sarah Kerns
327
Genome-wide Association Study Identifies a Region on Chromosome 11q14.3 Associated with Late Rectal
Bleeding Following Radiation Therapy for Prostate Cancer
2:00 p.m.
Terence Sio
328
Initial Quality of Life Deficit in Patient-reported Outcome is Related to Cancer Stage: A Mayo Clinic
Esophageal Adenocarcinoma Registry Study
2:10 p.m.
William Hall
329
Health Related Quality of Life Outcomes Following Definitive Therapy Compared with Watchful Waiting in
Localized Adenocarcinoma of the Prostate: An Analysis of the Atlanta Veterans Affairs Prostate Database
2:20 p.m.
Joshua Jones
Discussant
1:00 p.m. - 2:30 p.m.
Scientific Session OO – Physics – Automated Planning for ART
Moderators: John Wong, Q. Jackie Wu
1:00 p.m.
Ergun Ahunbay
330
A Fast Adaptive Replanning Method that Only Requires Target Delineation
1:10 p.m.
Xiangrong Qi
331
Real Time Assessment of Dosimetric Variations in Head and Neck Radiotherapy
117
1:20 p.m.
Omar Mahmoud
332
Prospective Pilot Study Assessing the Need for Adaptive Radiotherapy in Unresected Bulky Disease and in
Postoperative Head/Neck Cancer Patients
1:30 p.m.
Irene Hazell
333
Automatic Planning of Head and Neck Treatment Plans - A Way to Optimize the Plan Quality and Reduce
Workload
1:40 p.m.
Jessica Schuster
334
Automatic IMRT Treatment Planning Using Templates with Automated Optimization Tuning Methods
1:50 p.m.
Joseph Moore
335
Clinical Deployment of Automatic Treatment Planning for Pancreas SBRT Patients
2:00 p.m.
An Qin
336
Evaluation of Three IGRT/Adaptive Approaches for Prostate Cancer Treatment
2:10 p.m.
Andrew Godley
337
Automatic CBCT-Based Online Adaptive Prostate Therapy
2:20 p.m.
Weiguo Lu
338
An Efficient Workflow for Volume Dose Reconstruction and In Vivo Treatment Verification
1:00 p.m. - 2:30 p.m.
Scientific Session PP – Biology – Targeted Radiosensitizers
Room: B203
Moderators: Nicole Simone, Roberto Diaz
1:00 p.m.
Henning Willers
339
Identification of Radiosensitizing Targeted Drugs and Associated Genomic Biomarkers by a Cell Line
Screening Platform
1:10 p.m.
Mohamed Abazeed
340
Integrative Radiogenomic Profiling of Squamous Cell Lung Cancer
1:20 p.m.
Ranjit Bindra
Discussant
1:30 p.m.
Srilakshmi Reddy
341
NQO1-Mediated Synergistic Lethality in Combination with β-lapachone (Tgfβ-lap) and Ionizing Radiation (IR)
in Head and Neck Cancer (HNC)
1:40 p.m.
Raju Raval
342
Systemic Delivery of Synthesized Aptamer-siRNA Chimeras Results in Prostate-targeted Radiosensitization
1:50 p.m.
Shisuo Du
343
Biologically Augmenting Radiation Therapy by Inhibiting Tgfβ; in NSCLC from Molecular to
Microenvironment
2:00 p.m.
Ilenia Pellicciotta
344
Concomitant Radiotherapy and Tgfβ; Neutralizing Antibodies Alters Tumor Microenvironment and Promotes
Tumor Regression
118
2:10 p.m.
Waleed Arafat
345
Triple Therapy Using Radiotherapy (RT), Temozolamide (TMZ) and TRAIL Agonist (TRA-8) Enhances Cell Killing
in Primary Glioma Cancer Stem Cells is Associated with Changes in Distinct Tyrosine Kinase Signaling
Cascades Identified through Kinomic Analysis
2:20 p.m.
Gregory Gan
346
The Hedgehog Pathway Modulates Radiotherapy Resistance in Head and Neck Cancer
1:00 p.m. - 2:30 p.m.
Scientific Session QQ – Head and Neck – Toxicity
Moderators: Thomas Galloway, Peter Ahn
1:00 p.m.
Jermey Setton
347
A Multi-Institution Pooled Analysis of G-Tube Dependence in Patients with Oropharyngeal Cancer Treated
with Definitive IMRT
1:10 p.m.
Harry Quon
348
Swallow Function in Patients with Oropharyngeal Sqaumous Cell Carcinomas Treated with Radiotherapy
Dose De-escalation (JHU 0988)
1:20 p.m.
Chris Terhaard
349
Is Radiosensitivity of Parotid and Submandibular Glands Comparable?
1:30 p.m.
Ahmed Chaudhary
350
Dysphagia and Aspiration after Chemoradiotherapy for Locoregionally Advanced Head and Neck Cancer: A
Prospective Study of the Dose Effect Relationship in Accelerated Fractionation by Concomitant Boost with
Cisplatin and Cetuximab from the Epic Trial
1:40 p.m.
Harvey Quon
351
Impact of Feeding Tubes on Prospective Functional Outcomes in Patients with Locally Advanced Head and
Neck Cancer Undergoing Radiotherapy
1:50 p.m.
Katherine Hutcheson
352
Late Radiation-associated Dysphagia (RAD) and Lower Cranial Neuropathy After Oropharyngeal
Radiotherapy: A Case-control Dosimetric Comparison
2:00 p.m.
Ramadas Kunnambath
353
Management of Radiation Induced Oral Mucositis with an Herbal Mouthwash
2:10 p.m.
Steven Frank
354
Gastrostomy Tubes Decrease by Over 50% with Intensity Modulated Proton Therapy (IMPT) During the
Treatment of Oropharyngeal Cancer Patients - A Case-control Study
2:20 p.m.
Andy Trotti
Discussant
119
1:00 p.m. - 2:30 p.m.
Scientific Session RR – Physics – IGRT Process and Technologies
Room: B313
Moderators: Gikas Mageras, Michaela Rosu
1:00 p.m.
Jonathan Piper
355
A Novel Framework for User-intervened Correction of Deformable Registration
1:10 p.m.
Bernard Jones
356
IV Contrast-Enhanced Cone-Beam CT to Enhance Image Guidance for Liver SBRT
1:20 p.m.
Daniel Low
357
Improved Imaging Quality for Megavoltage CT on TomoTherapy via a Novel Iterative Reconstruction Method
Based on Tensor Framelet
1:30 p.m.
Lei Ren
358
A Limited-angle Intrafractional Verification (LIVE) System for Intrafractional Positioning Verification of Lung
SBRT Treatment
1:40 p.m.
Bowen Meng
359
Non-coplanar Cone Beam CT Reconstruction with Limited Angle of Projections Using Rigid Image
Registration Facilitated Prior Image Constrained Compressed Sensing
1:50 p.m.
John van Sornsen de Koste
360
Digital Tomosynthesis for Verifying Lung Tumor Position
2:00 p.m.
Juan Diego Azcona
361
Three-dimensional Prostate Motion Assessment During VMAT with Cine-Mv Images
2:10 p.m.
Russell Kincaid
362
Evaluation of Respiratory Motion-corrected Cone Beam CT in Abdominal Sites: A Prospective Study
2:20 p.m.
Stephen Gardner
363
Cone-beam Computed Tomography Contouring Variability on Derivative Contours Generated with an
Automated Deformable Registration Workflow for Prostate Cancer
1:00 p.m. - 2:30 p.m.
Digital Poster Discussion 11 – Breast
Room: A411
Discussants: Reshma Jagsi, Julia Wong
Shahed Badiyan
1121
Treatment Efficacy with Accelerated Partial Breast Irradiation (APBI): Final Analysis of the American Society of
Breast Surgeons MammoSite Breast Brachytherapy Registry Trial
Sigolene Galland
1122
Long Term Cosmetic Outcomes and Toxicities of Proton Compared to Photon 3-D Conformal Accelerated
Partial Breast Irradiation (3-D APBI)
120
Rachel Lei
1123
Disease Control Efficacy of Ductal Carcinoma in Situ (DCIS) Treated with Accelerated Partial Breast Irradiation
(APBI)
Steve Braunstein
1124
Outcome in Women with Ductal Carcinoma in Situ (DCIS) > 4 cm Treated with Breast Conservation Therapy
Manjeet Chadha
1125
Frequency of Breast Conserving Therapy Following an Ipsilateral Local Relapse in Patients with Ductal
Carcinoma in Situ (DCIS) Treated with Lumpectomy (l) + Radiation Therapy (RT)
Sonny Batra
1126
An analysis of Three-dimensional Breast Motion During Normal Respiration: What CTV to PTV Margin is
Needed?
Nathalie Rochet
1127
Deep Inspiration Breath-hold Technique in Left Sided Breast Cancer Radiotherapy: Evaluating Cardiac Contact
Distance as a Predictor of Cardiac Exposure
Michelle Gentile
1128
Contouring Guidelines for the Axillary Lymph Nodes for the Delivery of Radiotherapy in Breast Cancer:
Validation of the RTOG Breast Cancer Atlas
Amany Keruakous
1129
Outcome of Patients with Breast Cancer Treated with Breast Conserving Treatment or
Mastectomy and No Post-mastectomy Radiation and with Isolated Tumor Cells
Jae Myoung Noh
1130
Is Elective Nodal Irradiation Necessary in Patients with Negative Pathologic Lymph Node Status After
Neoadjuvant Chemotherapy Followed by Breast Conserving Surgery for Clinically Stage II-III Breast Cancer?
A Multicenter Retrospective Study (KROG 12-05)
Andrew Sharabi
1131
Dosimetric Impact and 3-D Non-deformable Modeling of Metallic Breast Expander Ports During
Post-mastectomy Radiation Therapy
Sanjay Aneja
1132
The Impact of Proximity to Radiation Oncologists and General Surgeons on Receipt of Postmastectomy Radiation Therapy
1:00 p.m. - 2:30 p.m.
Digital Poster Discussion 12 – Lung
Room: A412
Discussants: Thomas DiPetrillo, Shilpen Patel
John Grecula
1133
Stereotactic Body Radiation Therapy for Stage I Non-small Cell Lung Cancer: Relationship between Biological
Equivalent Dose Based on the Generalized LQ Model and Local Control
121
Jacob Wynne
1134
Analysis of Circulating Tumor Cells in Early-stage Non-small Cell Lung Cancer Patients Treated with
Stereotactic Ablative Radiotherapy
Carey Myers
1135
Inhibition of Nit1 Decreases Growth of K-Ras-Driven Tumors
Yevgeniy Vinogradskiy
1136
Using 4-D CT-based Ventilation Imaging to Evaluate Major Ventilation Defects for Lung Cancer Patients: A
Clinical Validation Study
Paul Stanton
1137
Prediction of Late Pulmonary Function Reduction and Radiation Induced Toxicity From During RT Ventilation
and Perfusion Imaging in Non-small Cell Lung Cancer (NSCLC)
Ravi Parikh
1138
Factors Associated with Survival in Patients with Oligometastatic Non-small Cell Lung Cancer (NSCLC)
Daniel Gomez
1139
The Influence of Positron Emission Tomography Scanning on Delay in Treatment of Non-small Cell Lung
Cancer
Mary Fidler
1140
Association between Trimodality Therapy and Survival in Patients with Stage III Non-small Cell Lung Cancer
(NSCLC) in the National Cancer Database
Lisa McGee
1141
Pulmonary Toxicity Following Proton Therapy for Patients with Non-small Cell Lung Cancer
Bhupesh Parashar
1142
Comparison Of Wedge Resection Versus Wedge Resection Plus Cesium-131 Brachytherapy vs. Stereotactic
Body Radiation Therapy In Management Of Early-stage Lung Cancer Patients That Are Not Candidates For A
Standard Lobectomy
Kitty Huang
1143
High-risk CT Features for Detection of Local Recurrence after Stereotactic Ablative Radiotherapy for Lung
Cancer
Guangying Zhu
1144
A Randomized Phase ll Trial Comparing Weekly Usage And Every Tri-weekly Usage Of Docetaxel And Platinum
In Concurrent Chemoradiotherapy For Patients With Locally Advanced Non-small Cell Lung Cancer
1:00 p.m. - 2:30 p.m.
Educational Session 413 – Difficult Cases in CNS
Room: B405
Tracy Batchelor, MD, MPH, Massachusetts General Hospital
Clark Chen, MD, PhD, University of California San Diego
Minesh P. Mehta, MB, ChB, FASTRO, University of Maryland
James B. Yu, MD, Yale University School of Medicine
122
1:00 p.m. - 2:30 p.m.
Educational Session 414 – Cancer of the Colon, Rectum, Anus
Room: B406
Brian Czito, MD, Duke University Medical Center
Karyn A. Goodman, MD, MS, Memorial Sloan-Kettering Cancer Center
1:00 p.m. - 2:30 p.m.
International Symposium: Global Health and Radiation Oncology — Part I
Where is the Challenge and What Can We Do?
Radiation Oncology in Latin America, India and Africa
Room: B206
*This session is not accredited for CME credit.
2:45 p.m. - 4:15 p.m.
Panel 16 – Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy: Update on
Indications for Treatment
Room: B308
Moderator:
Catherine Park, MD, University of California San Francisco
Panelists:
Barbara Fowble, MD, FASTRO, University of California San Francisco
Yunn-Yi Chen, MD, PhD, University of California San Francisco
Eleftherios Mamounas, MD, MD Anderson Cancer Center, Orlando
Thomas Buchholz, MD, FASTRO, MD Anderson Cancer Center
2:45 p.m. - 4:15 p.m.
Panel 17 – Radiosurgery for Metastases – Improved Patient Care or Unnecessary Cost?
Room: B211
Moderator:
Carol Hahn, MD, Duke University Medical Center
Panelists:
Simon Lo, MB, ChB, Case Western Reserve University School of Medicine
Eric Lin Chang, MD, University of Southern California Keck School of Medicine
Carol Hahn, MD, Duke University Medical Center
2:45 p.m. - 4:15 p.m.
Panel 18 – Altering the Metabolic Achilles Heel of Cancer
Room: B203
Moderator:
Nicole Simone, MD, Jefferson Hospital
Panelists:
David Gius, MD, PhD, Northwestern Medical School
Neil Martin, MD, Brigham and Women’s Hospital
William Dahut, MD, National Cancer Institute
123
2:45 p.m. - 4:15 p.m.
Panel 19 – Payment Reform in Radiation Oncology: The Transition from Resource-based
Reimbursement to Value-based Compensation
Room: B302-B305
Moderators:
Brian Alexander, MD, Brigham and Women’s Hospital
Panelists:
Benjamin Falit, MD, JD, Harvard Radiation Oncology Program
Constantine Mantz, MD, 21st Century Oncology
Prajnan Das, MD, MS, MD Anderson Cancer Center
Lee Newcomer, MD, United Healthcare
2:45 p.m. - 4:15 p.m.
Educational Session 415 – Management of High-risk Prostate Cancer (including
postoperative XRT)
Room: B313
Alan Pollack, MD, PhD, University of Miami-Miller School of Medicine
Richard K. Valicenti, MD, University of Califormia Davis Medical Center
Yoshiya Yamada, MD, Memorial Sloan-Kettering Cancer Center
2:45 p.m. - 4:15 p.m.
Educational Session 416 – Stereotactic Body RT: Clinical, Biological and Physics/QA
Update
Roy H. Decker, MD, PhD, Yale University
Teamour S. Nurushev, PhD, Henry Ford Health System
Jan-Jakob Sonke, PhD, The Netherlands Cancer Institute (NKI-AVL)
2:45 p.m. - 4:15 p.m.
International Symposium: Global Health and Radiation Oncology — Part II
What are the Barriers to Delivering Optimal Therapy?
Radiation Oncology in Asia
Room: B206
*This session is not accredited for CME credit.
Symbol Key:
A
ARON
Separate
Session
registration
required
124
Award
Recipient
Live
Interactive
SAM/
Session
Separate
registration
required
INSIDE:
Poster Presentations
Poster Viewing Hours
Posters are located in Hall B, Building B
10:00 a.m. – 5:00 p.m.
10:00 a.m. – 5:00 p.m.
Poster Viewing Session and Reception 5:30 p.m. – 6:30 p.m.
10:00 a.m. – 5:00 p.m.
NEW!!
Join us during the
Reception on
Monday for the Poster
Award Winner
Presentations.
Starting at 5:40 p.m. in the Poster Hall
2013 ANNUAL MEETING
SUPPORTERS
Special thanks to the following companies for supporting ASTRO’s
55th Annual Meeting with an unrestricted educational grant.
&
Poster Presentations by Track
BREAST CANCER
2001
Naoki Nakamura
Fatigue During Breast Radiation
Therapy and Its Predictive Factors
2002
Christiane Matuschek
Long-term Outcome After
Neoadjuvant Chemoradiation
Therapy in Locally-Advanced
Noninflammatory Breast Cancer and
Predictive Factors for a Pathologic
Complete Remission: Results of a
Multivariate Analysis
2003
Eric Mellon
Impact of Radiation Treatment
Parameters and Adjuvant Systemic
Therapy on Cosmetic Outcomes after
Accelerated Partial Breast
Irradiation using 3-Dimensional
Conformal Radiation Therapy
Technique
2004
Naoto Shikama
Validation of the Utility of
Cranio-Caudal Clip Distance (CCD) for
Identifying Candidates for
Accelerated Partial Breast Irradiation
(APBI) Using 3-dimensional
Conformal External Beam
Radiotherapy (3D-CRT)
2005
Mayuraa Vaiduriam
Dosimetric Comparison Between
Electrons And Tangential Photons In
Postmastectomy Chest Wall
Irradiation
2006
Shariq Khwaja
Long-term Cosmesis and Toxicity
Profile Following Accelerated
Partial Breast Irradiation (APBI): Final
Analysis of the American Society of
Breast Surgeons Single Lumen Device
Breast Brachytherapy Registry Trial
2007
Naoto Shikama
Preliminary Results From a
Multi-center Prospective Study
(JROSG 05-5) on Postoperative
Radiation Therapy for Patients With
High-Risk Ductal Carcinoma In Situ
(DCIS) With Involved Margins or
Margin Widths Not More Than 1 mm
2008
Jinli Ma
A Linac IMRT Technique versus
Conventional Technique for
Post-mastectomy Irradiation of Chest
Wall and Regional Nodes: A
Case-Control Study of Acute Toxicities
2009
Ya Zhu
Lymphedema After Radical
Mastectomy For Breast Cancer In
Chinese Women
2010
Nitesh Paryani
The Incidence Of Fat Necrosis In
Balloon-based Breast Brachytherapy
2011
V. Elayne Arterbery
with Electronic Brachytherapy for
Treatment of Early Stage Breast
Cancer - Short-term Clinical and
Cosmetic results
2018
Bree Eaton
Long-term Outcomes Following
Oncoplastic Reduction Mammaplasty:
Implications for Radiation Therapy
2019
Dominihemberg
Ferreira
Correlation Between Dose in the
Hypopharynx and Cervical Esophagus
and Odynophagia in Patients
Undergoing Regional 3DCRT for
Breast Cancer
2020
Jyoti Mayadev
The Role of a Post Mastectomy
Radiation Boost: Does a Higher Dose
Improve Survival?
2021
Julian Jacob
Cardiotoxicity of the Association
Trastuzumab-Locoregional Breast
Radiation Therapy: A Prospective
Monocentric Study
2012
Anna Petoukhova
Optimal Registration Method of MRI
and CT for Delineation in Radiation
Therapy Planning of Breast Cancer
Patients Treated With Breast
Conserving Therapy
2022
Juergen Dunst
Adjuvant Hypofractionated Radiation
Therapy With Simultaneous Boost
After Breast-Conserving Therapy: First
Results of a Multicentric Phase 2 Study
2014
Yasuhiro Ogawa
PET-CT-guided Non-surgical
Chemo-radiosensitization Treatment
(KORTUC II) for Patients with Locally
Advanced Breast Cancer
2023
Sameer Nath
Using Skin Dose Parameters Predicts
Low Skin Toxicity in a Phase 2 Trial of
Multiple Dwell Position Single Lumen
Device Brachytherapy
2015
Pierre-Yves Bondiau
Final Result of Phase 1 Clinical Trial of
Stereotactic Body Radiation Therapy
Concomitant With Neoadjuvant
Chemotherapy for Breast Cancer
2024
Yasser Abo-Madyan
Cosmetic Outcome of
Hypofractionated Breast Cancer
Intensity Modulated Radiation
Therapy: A Preliminary Report of a
Prospective Trial
2016
Yun Ding
Comparative Study On The
Displacement Of Surgical Cavity
Center Defined Separately By Clips
And Seroma Based On 4dct Scan For
External-beam Partial Breast
Irradiation After Breast Conserving
Surgery
2017
Charles Rutter
Dosimetric and Clinical Predictors of
the Development of Moist
Desquamation in Breast Cancer
Irradiation
2025
Radhika Sreeraman
Preliminary Toxicity Analysis of
3D-Conformal and Intraoperative
2026
Jose Pardo
Radiation Recall Dermatitis
Development. An Observational
Study In 350 Breast Cancer Patients
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
127
2027
Marco Trovo
Delivering Adjuvant Radiation
Therapy beyond Six Months after
Breast-conserving Surgery does not
Jeopardize the Loco-regional Control
in Early Stage Breast Cancer Patients
2028
Marco Trovo
Loco-Regional Failure in Early-Stage
Breast Cancer Patients Treated with
Breast Conserving Therapy: Which
Patients Benefit from Supraclavicular
Nodal Irradiation?
2029
Sua Yoo
Comparison Of Pre-operative Partial
Breast Radiosurgery Treatment
Techniques: 3D-CRT, Non-coplanar
IMRT, Coplanar IMRT, and VMAT
2030
Huma Chaudhry
A Prospective Trial of Preoperative
(APBI): Predictors of Asymptomatic
and Symptomatic Seroma Formation
2031
Juan Yu
A Predictive Clinical Metric to
Quantitate Radiation Dose to the
Heart and the Left Anterior
Descending Artery in Left-sided
Breast Cancer Patients
2032
Adam Liss
Decline of Cosmetic Outcomes
Following Accelerated Partial Breast
Irradiation (APBI) Using Intensity
Modulated Radiation Therapy (IMRT):
Results of a Single-Institution
Prospective Clinical Trial
2033
Tae Ryool Koo
Prognostic Value of Nodal Ratio and
Ki-67 Expression in Breast Cancer
Patients Treated With
Postmastectomy Radiation Therapy
2034
Karolien Verhoeven
Is There Benefit of Using a
Preoperative Computed Tomography
to Reduce the Interobserver
Variability of the Boost CTV
Delineation for Breast Radiation
Therapy?
2035
Himanshu Nagar
Predictors of All Recurrence for Breast
Cancer Patients Treated with
Neoadjuvant Chemotherapy and
Surgery With and Without Radiation
Therapy
2036
Thierry Muanza
Does the Breast Cancer Molecular
Subtype Affect the Post Radiation
Therapy Pattern of Recurrence?
2037
Debra Yeboa
Impact of the Recession on Radiation
Therapy After Lumpectomy for
Invasive Breast Cancer
2038
Ronny Kalash
Breast Cancer Luminal Status Predicts
Survival Following Stereotactic
Radiosurgery of Brain Metastasis
2039
Jeffrey Kuo
In-Vivo Dose Measurements in the
Post-Mastectomy Irradiation Of a
Patient With a Gas-Based Tissue
Expander
2040
Adam Ferro
Prevention of Radiation Dermatitis in
2047
Ashraf Youssef
Does Accelerated Partial Breast Irradiation Decreases Scattered Fetal Dose
in Pregnant Women as compared to
External Beam Radiation?
2048
Masahiro Yoshida
Is Re-excision Necessary For Patients
With Positive Surgical Margin (0 Mm)
Before Post-operative Breast
Radiation Therapy?
2049
Adam Reese
Marriage is Associated with Choice
of Mastectomy in Patients Eligible for
Breast Conservation Therapy
2050
Pierfrancesco Franco
Hypofractionated Adjuvant Breast
Radiation and Simultaneous
Integrated Boost Delivered With Static
Angle Tomotherapy: A Prospective
Phase 2 Trial
2041
Kimberly Thomas
Survey on Radiation Practice Patterns
Among US Radiation Oncologists for
Post-mastectomy Breast Cancer and
Reconstruction
2051
Peter Chen
Brachytherapy-Based Accelerated
Partial Breast Irradiation Versus
Canadian Whole Breast
Hypofractionation: A Matched-Pair
Analysis of Comparative Effectiveness
2042
Alexander Geng
Early Results of a Prospective Cohort
Study on Intraoperative Radiation
Therapy for Early Breast Cancer at a
Single Institution
2052
Olivia Barrett
The Influence of Race on Locoregional
Recurrence (LRR) in BRCA
Mutation-Positive Triple Negative
2043
Catheryn Yashar
Outcomes For APBI With Strut-based
Brachytherapy: 101 Patients At 4.5
Years Median Follow-up
2053
Monica Shukla
Influence of Receptor Status and
Response to Neoadjuvant
Chemotherapy on Outcomes of
Patients Treated with Mastectomy for
Invasive Breast Cancer
2044
Su Jung Shim
The Role of Postmastectomy
Radiation Therapy(PMRT) in Clinical
Stage II-III Breast Cancer Patients With
pN0 After Neoadjuvant Chemotherapy: A Multicenter, Retrospective Study
(KROG 12-05)
2045
Patience Obasaju
National Surgical Patterns of Care:
Racial Disparities in the Surgical
Staging of Women with Breast Cancer
2046
Reshma Jagsi
Use of Breast Reconstruction
and Early Complication Rates in
a Working-Age, Insured, National
Cohort of Breast Cancer Patients
Undergoing Mastectomy with and
without Radiation
2054
Masahiko Oguchi
Radiation Therapy For Breast Cancer
After Chemotherapy Induced
Pneumonitis
2055
Sameer Nath
Immediate DIEP Breast
Reconstruction and Postmastectomy
Radiation Therapy: Clinical Experience
at a Tertiary Care Institution
2056
Samuel Marcrom
Partial Breast Radiation Using Strut
Adjusted Volume Implant: Radiation
Necrosis Is Associated With
Dosimetric Parameters and Can
Induce Biopsy
128
2057
Jeffrey Eshleman
Retrospective Study of Ipsilateral
Breast Tumor Recurrence in Patients
Undergoing Accelerated Partial Breast
Irradiation Delivered via
Balloon Brachytherapy in a
Community Hospital
2058
Steven Register
Deep Inspiration Breath Hold
Technique in Women with Left Sided
Breast Cancer: An Analysis of OAR
Sparing
2059
Linda Smith
A Comparison of Acute and Subacute
Toxicity for High Upper Outer
Quadrant Breast Cancers Treated by
Whole Breast Irradiation (WBI) Versus
(APBI)
2060
Quan Chen
Static Angle Tomotherapy 3DCRT for
Accelerated Whole Breast Irradiation
With Concomitant Boost
2061
Mina Shenouda
Clinical Outcome of Isolate
Local-Regional Recurrence in Breast
Cancer Patients According to their
Primary Local Treatment
2062
Sharad Goyal
Three-Year Outcomes of a Once-Daily
Fractionation Scheme for Accelerated
Partial Breast Irradiation (APBI) Using
3-D Conformal Radiation Therapy
(3D-CRT)
2063
Allen Li
An Analysis of Rapid Review Cases
That Failed to Meet the RTOG 1005
Contouring and Dose-Volume Criteria
2064
Bradford Perez
Evaluating Radiation Dose to the
Heart With Left Whole Breast
Radiation Therapy in Prone, Supine
Breath-Hold, and Supine FreeBreathing Positions
2065
Janet Horton
Preoperative Single-Fraction Partial
Breast Radiation Therapy: A Novel
Phase 1 Dose-Escalation Protocol and
Exploration of Breast Cancer
Radiation Response
2066
Qian Zhang
Both Anti-HER2 Treatment and
Chemotherapy After Whole-Brain
Radiation Therapy Improve Survival in
Patients With Brain Metastases From
HER2-Positive Breast Cancer
2067
Mariam Korah
The Impact of Postmastectomy
Radiation Therapy in Intermediate
Risk Breast Cancer Patients with
Limited Axillary Disease
2068
Yu Chen
The Impact Of Breast
Reconstruction On Post-mastectomy
Radiation Therapy
2077
Siavash Atrchian
Improvement Of Consistency In
Delineating Breast Lumpectomy
Cavity Using Surgical Clips
2078
Manjeet Chadha
Evaluating a role for Oncotype Dx
Breast cancer Assay in the
management of Ductal Carcinoma
in situ
2079
Olivier Riou
Irradiation With Volumetric
Modulated Arc Therapy:
Feasibility And Early Clinical Results At
The Montpellier Cancer Institute
2080
Julie Bradley
Pilot Study of Proton Therapy for
Treatment of Regional Lymphatics in
2069
Jay Reiff
Dosimetric Analysis of 1007
Strut-Based APBI Treatments
2070
Nalini Rao
Patterns of FDG PET CT use in Breast
Cancer and its Impact on Treatment
Decisions: Experience from a
Developing Country
2071
Gabor Jozsef
Tangential Breast Fields Placement:
Evaluation of Two Automatic Beam
Placement Algorithms
2072
Randi Cohen
Adjuvant Radiation Improves Breast
Cancer Specific Survival in the Eldest
Early-Stage Breast Cancer Patients
2073
Mariska Den Hartogh
Small Treatment Volumes and a Low
Interobserver Variability in
Preoperative MRI-guided Target
Volume Delineation for Accelerated
Partial Breast Irradiation
2074
Kenneth Merrell
A Comparison of Standard
Fractionation and Stereotactic Body
Radiotherapy in the Treatment of
Metastatic Breast Cancer
2075
Jiho Nam
Quantitative Analysis of Lung CT
Density Changes in Early Breast Cancer Patients Treated With
Hypofractionated Whole Breast
Radiation Therapy
2076
Robert Hong
Outcomes for APBI with the
Strut-Based Brachytherapy Applicator
in 430 Patients
2081
Tiffany Chow
Radiation-Induced Lung Injury
Following Neoadjuvant Concurrent
Chemoradiation Therapy for
Locally-Advanced Breast Cancer
2082
Kunal Saigal
Traditional Risk Factors For
Locoregional Recurrence May Not
Be Predictive In Post-Menopausal
Women With ER Positive Breast
Cancer Treated With Neoadjuvant
Therapy
2083
Martin Hinse
Achieving a Uniform Breast Junction
With the 160 Leaf Multileaf Collimator
2084
Sigolene Galland
Long-term Outcomes in Breast Cancer
Patients With 10 or More Positive
Axillary Nodes: Is Conservative
Treatment an Optimal Option?
2085
Anneyuko Saito
Is Bra Cup Size a Reliable Confounding
Factor for the Evaluation of Acute Skin
Toxicity Caused by Radiation Therapy
in Breast Therapy?
2086
Olga Vujovic
The Time Interval From Conservative
Breast Surgery To Breast Irradiation
In Early Stage Node Negative Breast
Cancer: 17-Year Follow-Up Results
And Patterns Of Recurrence
129
2087
Tian Liu
Acute Toxicity Can Be Used to
Predict Late Toxicity in Breast-Cancer
Radiation Therapy: A Prospective
Longitudinal Study With Quantitative
Ultrasound Imaging
2088
Niranjan Bhandare
A Comparison of the Early Toxicities of
a Single Lumen Device and
Intraoperative Radiation Therapy
2089
Shariq Khwaja
Analysis of Locally Advanced Breast
Cancer in Young Women
2090
Bethany Anderson
for Ductal Carcinoma In Situ: Single
Institution Experience With Median
Follow-up Time of Over 5 Years
2091
Michael Roach
Upper Extremity Toxicity with
Adjuvant Comprehensive Radiation
Therapy for Locally Advanced Breast
Cancer
2092
Victor Pernin
Early and Late Toxicity of Adjuvant
Radiation Therapy Associated With
Concurrent Bevacizumab in Patients
With Breast Cancer
2093
Michael Roach
Early Results of 3D Conformal External
Beam Accelerated Partial Breast
Irradiation
2094
Jayant Vaidya
The Lower Non-Breast Cancer
Mortality With TARGIT in the TARGITA
Trial Could Be a Systemic Effect of
TARGIT on Tumor
Microenvironment
2097
Peng Zhou
Factors Affecting Contra-Lateral
Breast Dose in Radiation Therapy of
Breast Cancer
2106
Robert Kuske
Utility of A Novel 3-D Marker in
Postoperative Treatment Planning for
Breast Cancer
2098
Fatimah Alfaraj
Incidence And Factors Associated
With The Development Of
Extremity And Truncal Lymphedema
In A Prospective Cohort Of Women
With Locally Advanced Breast Cancer
Receiving Multimodality Therapy
2107
Marcio Fagundes
Cardiac-Sparing Postmastectomy
Proton Radiation Therapy for Women
With Stage III, Loco-Regional, Breast
Cancer: A Dosimetric Comparison
Study
2099
Matthew C. Bradbury
Factors Effecting Breast
Reconstruction in Post-Mastectomy
Radiation Therapy Patients
2100
David Pearson
Dose Modification Factor Analysis of
Multi-Lumen Brachytherapy
Applicator with Monte Carlo
Simulation
2101
Petra Grendarova
Low Risk of Locoregional Recurrence
in the Absence of Regional Radiation
Therapy in Node-Positive Breast
Cancer Patients Treated With
Chemotherapy, Breast Conserving
Surgery, and Adjuvant Breast
Radiation Therapy
2102
Shihfan Lai
Brain Re-irradiation for Breast Cancer
Patients With Brain Metastasis After
Whole Brain Radiation Therapy: Effect
of Epidermal Growth Factor
Receptor-2 Status on Clinical Outcome
2103
Sophia EdwardsBennett
Is there Justification for the Utilization
of IMRT in the Treatment of Early
Stage Right Breast Cancer?
2095
Xiao Zhao
Acute Radiation Induced Skin Toxicity
in Breast Intensity Modulated
Radiation Therapy (IMRT): A
Dosimetric Analysis
2104
David Horowitz
Implications of Prone Versus Supine
Positioning on Breast and Target
Volume Delineation in Partial Breast
Irradiation
2096
Frederik Wenz
Local Recurrence and Survival for
The German Centers in the TARGIT-A
(TARGeted Intraoperative Radiation
Therapy - Alone) Trial
2105
Jay Reddy
Antiepileptic Drug Use Improves
Overall Survival in Breast Cancer
Patients With Brain Metastases in
the Setting of Whole Brain Radiation
Therapy
2108
Abhishek Solanki
Predictive Model for the Utilization
of Radiation Therapy in the Adjuvant
Therapy of Women With Breast
Cancer Following Breast Conserving
Surgery: Results From a National
Commercial and Supplemental
Medicare Claims Database
2109
Shane Stecklein
Utilization and Outcomes of
Post-Mastectomy Radiation Therapy
for Locally-Advanced Invasive Lobular
Carcinoma: A SEER Study
2110
Abhishek Solanki
Predictive Factors in the Utilization
of Intensity Modulated Radiation
Therapy Among Young Women
Following Breast Conserving Surgery
in the United States: Analysis of a
National Commercial and
Supplemental Claims Database
2111
John Einck
Residual Disease in the Breast or
Lymph Nodes Following Neoadjuvant
Chemotherapy for Triple-Negative
Breast Cancer Results in a High Risk of
Locoregional Failure Despite the Use
of Radiation Therapy
2112
Lindsay Burt
Comparison of Treatments for Breast
Cancer Arising after Radiation
Treatment for Hodgkin Lymphoma
CENTRAL NERVOUS SYSTEM
2113
Kazuhiro Miwa
Metabolically Positive Lesion Before
Hypofractionated Radiation Therapy
and Its Impact on Outcome for
Patients With Glioblastoma
Multiforme
130
2114
Christine ChangHalpenny
Elderly Patients With Glioblastoma
Multiforme Treated With Concurrent
Temozolomide and Standard
Radiation Therapy or
Hypofractionated Radiation Therapy
With Subset MGMT Analysis
2115
Lawrence Kleinberg
Adult Brain Tumor Consortium (ABTC)
Prospective Dose Finding Trials Of
I-125 Balloon Brachytherapy In
Glioblastoma (GBM): The Problems In
Trial Design When MRI Treatment
Effect And Recurrence Appear Similar
2116
Sridhar Susheela
Characterization of Glioblastoma
Multiforme Non-Distant Failures
After Intensity Modulated Radiation
Therapy in Relation to Pre-irradiation
Carbon 11-Methionine Positron
Emission Tomography
2117
Kiyoshi Nakamatsu
High-Dose Intensity Modulated
Radiation Therapy (IMRT) Using a
Simultaneous Integrated Boost (SIB)
Method Combined With
Temozolomide (TMZ) For Malignant
Gliomas
2118
Steven Oh
Reirradiation of Recurrent Gliomas
2119
Jason Ye
Hypofractionated Stereotactic
Radiation Therapy (HFSRT) With
Concurrent Chemotherapy (CTX) in
Patients With Newly Diagnosed Poor
Prognosis GBM: Early Results
2120
Edward Marchan
Impact of FACBC PET in Imaging and
GTV Design of Cerebral Gliomas
2121
James Cordova
The Development of an Unbiased,
Semi-automated Method for
Perioperative Tumor Volume
Measurement Using VelocityAI in
Glioblastoma
2122
Lee Jeongshim
Re-irradiation for Recurrent Gliomas:
Treatment Outcomes and Prognostic
Factors
2123
Yujin Lim
Hypofractionated Chemoradiation
Therapy With Temozolomide for
Glioblastoma Patients With Poor
Prognostic Features
2125
Haresh Kunhiparambath
A Dosimetric Comparison Of VMAT,
IMRT and 3DCRT In The Reirradiation
Of Recurrent Gliomas
2126
Shravan Kandula
Patterns Of Presentation And Failure
In Patients With Gliomatosis Cerebri
Treated With Partial Brain Radiation
Therapy
2127
Sabin Motwani
Glioblastoma Multiforme of the
Elderly: A Multi-institutional
Experience Comparing Conventional
Versus Accelerated Radiation Therapy
With Concurrent Temozolomide
2128
Dante Amelio
Intensity-modulated Radiation
Therapy (IMRT) Vs
Intensity-modulated Proton Therapy
(IMPT) In Low-grade Gliomas: A
Dosimetrical Study
2129
Christopher Corso
Factors Predicting Survival In Grade
I-III Astrocytomas
2130
Menachem Yondorf
NTCP Modeling Proves
Dose-Escalation (DE)
Radiation Therapy (HSRT) a Safe
Treatment Option for Patients with
Subtotal Resection of WHO Grade II-III
Meningioma
2131
Chandler Sours
Feasibility Study Testing the
Incorporation of Resting State fMRI
Data in Radiation Therapy Planning
to Limit Dose to Cognitive Function
Networks in Patients with Primary
Brain Tumors
2132
Weining Zhen
MRI Based Volumetric Analysis of
Postoperative Disease Progression of
Glioblastoma Prior to the Radiation
Therapy
2133
Sophie Zerounian
Evaluation Of Survival And Prognostic
Factors For Elderly Patients Of 65 With
Glioblastoma Multiforme
2134
Radka Stoyanova
3D Spectroscopy Evaluation of GBM
Treatment Volumes
2135
Ayal Aizer
Adjuvant Radiation Therapy Is
Associated With Survival Benefit in
WHO Grade 3 Astrocytomas But Not
Oligodendrogliomas: Results From a
Population-Based Study
2136
Stefanie Lazow
Temporal Changes in MRI Edema and
Resection Cavity Dynamics
Subsequent to Implantation of
Cesium-131 (Cs-131) Brachytherapy
in Patients with Brain Metastases: a
Volumetric Analysis from a
Prospective Study
2138
Timothy Harris
Re-Irradiation for Recurrent Glioma: A
Single Institution Review
2139
David Corwin
Using A Patient-specific
Mathematical Model And A
Multi-objective Imrt Optimization
Algorithm In Treatment Planning For
Human Glioblastoma
2140
Melissa LeMieux
Racial Differences in Mortality in
Patients with Glioblastoma
Multiforme in the Pre- and
Post-Temozolomide Eras
2141
Martha Hosotani
Patterns of Failure: Detailed
Dosimetric Analysis of Glioblastoma
Recurrence in the Era of Modern
Chemoradiation Therapy
2142
Erin Murphy
Impact of 1p Status and Radiation
Therapy Timing on Long-term
Outcomes for Adults With Grade 2
Glioma Treated at a Single Institution
2143
Srinivas Chilukuri
Is It Time To Revise Imaging
Guidelines For Response Assessment
After Temoradiation And Surgery For
GBM ? Sensitivity, Specificity And
Predictive Value Of MR Spectroscopy
And Perfusion for the detection of
Tumor Progression after
temoradiation
131
2144
Elizabeth Kuhn
Adverse Toxicity After
Stereotactic Radiosurgery for
Treatment of Meningiomas
2145
Ryan Nowak
Factors Associated With Hearing Loss
in Patients With Vestibular
Schwannomas Treated With
Fractionated Stereotactic Radiation
Therapy
2146
Craig Grossman
A Population-Based Characterization
of Meningiomas in Breast Cancer
Patients
2148
Leoncio Arribas
Radiosurgery Outcomes In Vestibular
Schwannoma: Effect Of New
Technologies
2149
Koshi Tatewaki
Long-term Outcome of Robotic
Stereotactic Radiosurgery for
Vestibular Schwannomas
2150
William Wilson
Gamma Radiosurgery (GRS) for
Acoustic Neuroma: A Single
Institution Experience
2151
Emily Tanzler
Meningiomas: A Retrospective
Outcomes Analysis of the University
of Florida Proton Institute Experience
2152
Menachem Yondorf
NTCP Modeling of Hypofractionated
Stereotactic Radiation Therapy (HSRT)
for Patients with Subtotal Resection
(STR) of WHO Grade I Meningioma:
A Toxicity-Sparing More Convenient
Treatment Method
2153
Nathalie Nguyen
Impact of Radiation Therapy on
Clinical Outcome of Meningiomas
2154
Jennifer Shah
Evaluation of Tumor Expansion
Following 3-Fraction Stereotactic
Radiosurgery for Vestibular
Schwannomas
2155
Yoshimasa Mori
Stereotactic Radiosurgery As A
Salvage Treatment For Recurrent
Skull Base Chordoma After Surgical
Resection
2156
Prashant Desai
Feasibility Study of Toxicity and
Efficacy of Hypofractionated
Stereotactic Radiation Therapy
(HFSRT) for Patients With Meningioma
Based on NTCP Modeling: Early
Clinical Results
2157
Daniel Wattson
Outcomes of Proton Radiation
Therapy for Patients With Functional
Pituitary Adenomas
2158
Rasim Meral
Symptomatic Improvement in
Patients With Pituitary Adenoma
Diagnosed as Acromegaly Versus
Cushing’s Disease With Fractionated
Stereotactic Radiation Therapy
2159
Ameen Al-Omair
Postoperative Stereotactic Body
Radiation Therapy (SBRT) for Patients
With Spinal Metastasis: Predictive and
Prognostic Factors Analysis
2160
Kosj Yamoah
A Pilot Study on Spine Stereotactic
Body Radiation Therapy Residual
Setup Errors and Intrafraction Motion
using Stereotactic X-ray Image Guidance Verification System
2161
Nehaw Sarmey
Adjacent or Same Vertebral Body
Retreatment With Repeat SBRT
(Stereotactic Body Radiation Therapy)
Is Safe Despite High Cumulative Dose
to the Spinal Cord or Cauda Equina
2166
Maged Ghaly
The Role Of Spine Radiosurgery In
The Management Paradigm Of Spine
Metastases
2167
Sophia Kamran
Outcomes of Proton Therapy for the
Treatment of Uveal Metastases
2168
Di Zhou
103Pd versus 125I Plaque Radiation
Dose to Normal Ocular Structures in
the Treatment of 319 Uveal
Melanomas
2169
Blake Currier
Dosimetric Evaluation of a Shielded
Applicator for use with Low Energy
High Dose Rate Brachytherapy for
Treatment of Ocular Melanoma
2170
Jacqueline Esthappan
Post-Implant Magnetic Resonance
Imaging for Episcleral Plaque
Brachytherapy
2171
Anshu Jain
Malignant Tumors of the Lacrimal
Gland: A SEER Analysis
2172
Malay Rao
MRI-Guided Laser Ablation for
Post-SRS Locally Recurrent
Metastases: Initial Experience and
Outcomes
2173
Johnny Kao
Pilot Study of Tumor Directed, Scalp
Sparing IMRT for Brain Metastases
2162
Maha Jawad
A Dosimetric Evaluation of Target
Coverage as a Predictor of Local
Failure Following Stereotactic Body
Radiation Therapy for Spinal Tumors
2174
Arjun Sahgal
MRI Perfusion Biomarkers Predicting
Early Response for Brain Metastasis
Treated With High-Dose Radiation
Therapy
2163
Omar Mian
Timely Radiosurgery for Spine
Metastases per RTOG 0613 Guidelines
using a Rapidly Deployable
Automated Planning Script (FastPlan)
2175
Kyle Arneson
A Phase I Trial of Concurrent Sorafenib
and Stereotactic Radiosurgery for
Patients with 1-4 Brain Metastases
2164
Eva Christensen
Patterns of Failure in Stereotactic
Body Radiation Therapy for Spinal
Tumors
2176
Xueying Qiao
Whole Brain Radiation Therapy With
Local Simultaneous Integrated Boost
Conformal Radiation Therapy in the
Treatment for Patients With 1-3 Brain
Metastases
2165
Chia-Lin Tseng
Spinal Cord Tolerance Specific to
Re-irradiation Spine Stereotactic Body
Radiation Therapy (SBRT) Following at
Least 2 Courses of Prior Radiation
132
2177
Grant Clark
Phase 1 Dose Escalation/
De-escalation Study of Preoperative
Stereotactic Radiosurgery for Brain
Metastases: Preliminary Acute Toxicity
and Dosimetric Analysis
2178
Allan Chen
Frame versus Frameless Stereotactic
Radiosurgery for Drug-Refractory
Idiopathic Trigeminal Neuralgia
2179
Taro Murai
Fractionated Stereotactic Radiation
Therapy Using Robotic Radiosurgery
for the Treatment of Large Brain
Metastases
2180
Charles Rutter
Prognostic Factors in Patients with
Brain Metastases at Initial Non-Small
Cell Lung Cancer Diagnosis
2181
Steven Lau
Clinical Outcomes Of Single Isocenter
Frameless Radiosurgery For Multiple
Brain Metastases
2183
Isabelle Thibault
Local Control, Patterns of Failure, and
Vertebral Compression Fracture After
Spine Stereotactic Radiation Therapy
for Metastatic Renal Cell Cancer
2184
Hong-Yiou Lin
Gamma Knife Radiosurgery for Renal
Cell Carcinoma and Melanoma Brain
Metastases-Higher Doses to Treat
Melanoma <4ml to Improve Local
Control
2185
Henrique Faria Braga
Validation Of The Score Index For
Radiosurgery (SIR) In Predicting
Survival Of Patients With Brain
Metastases Submitted To
Radiosurgery
2186
Charles Rutter
Influence of BRAF and NRAS
Mutations on Distant Intracranial
Recurrence and Survival in Metastatic
Melanoma Following Radiosurgery
2187
Rachel Jimenez
The Impact of Different
Radiation Therapy Regimens for Brain
Metastases on Local Control and
Toxicity
2188
Roshan Sethi
Proton Radiation Therapy for Pediatric
Central Nervous System
Ependymoma: Clinical Outcomes for
70 patients
2199
Matthew Johnson
Analysis of Risk Factors for
Development of Radiation Necrosis
Following Stereotactic Radiosurgery
for Brain Metastases
2189
Selvan Rajakesari
Radiation Therapy for Brain
Metastases
2200
Nicholas Zaorsky
Treatment Of Brain Arteriovenous
Malformations With Stereotactic
Radiosurgery Following Embolization
2190
Arie Dosoretz
Long-Term Survivors After
Treatment of Intracranial Metastases
with Radiosurgery
2201
Bhisham Chera
Effect of Node and Beam-Reduction
Optimization on the Integral Dose to
the Brain for Robotic Radiosurgery
Brain Cases
2191
Rafael Moleron
Emerging Role of Fractionated
Stereotactic Radiation Therapy in
Brain Metastasis Treatment: Single
Institution Early Experience
2202
Tamara Santos
Predictive Factors For Local Control Of
Brain Metastases After Radiosurgery
2192
Julia Compton
Total Tumor Volume Predicts
Mortality Following Radiosurgery for
5 or More Brain Metastases
2203
David Ly
Local Control After Stereotactic
Radiosurgery (SRS) for Brain
Metastases (BM) in Melanoma
Patients With and Without BRAF
Mutation and Treatment
2193
Sara Alcorn
A Comparison of Clinical Outcomes of
Adult and Pediatric Medulloblastoma
2194
Mark McDonald
Initial Results of Proton Therapy for
Clival Chordoma
2204
Christian Okoye
Is Monte Carlo Calculation Necessary
in Patients With Thoracic Spinal
Tumors Treated With Robotic
(SBRT)?
2195
Kevin Shiue
Lack of Response is a Risk Factor for
Radiation Necrosis after Radiosurgery
for Brain Metastases
2205
Maria Luisa Figueiredo
Focal Hypofractionated Stereotactic
Radiation Therapy After Resection of
Brain Metastases
2196
Dong-Soo Lee
Patterns of Failure Following
Multimodal Treatment for
Medulloblastoma: A Single
Institution Experience with
Long-Term Follow-Up
2206
Waleed Mourad
Linac-Based SRS Dose-Volume
Relationship for Optimal Local Control
of Brain Metastases
2197
Wei Heng Kao
Simultaneously Integrated Boost for
Patients With Multiple Brain
Metastases by VMAT
2198
Kyung Hwan Kim
Hippocampus-Sparing Simultaneous
In-field Boost Using Helical
Tomotherapy for Brain Metastases
From Lung Adenocarcinoma: Early
Volume Response and Dosimetric
Evaluation
2207
Guy Savir
Experience Using Fractionated
Stereotactic Radiosurgery to Treat
Large CNS Metastases
2208
Lauren Tait
Enhanced Radiographic Response
and Re-Treatment Rates Following
Whole Brain Irradiation among
Non-Small Cell Lung Cancer Patients
with EGFR Activating Mutations
2209
Haoming Qiu
Optimization of Stereotactic
Radiosurgery Plans for Brain
Metastasis
133
GASTROINTESTINAL CANCER
2210
Keiichi Jingu
Prognostic Factors for Patients With
Loco-Regional Recurrent
Esophageal Cancer Who Were Treated
With Chemoradiation Therapy:
Results of Multivariate Analysis
2211
Chiramana Haritha
Quantification of Swallowing-Induced
Motion in Esophageal Cancers Using
Volume Shuttle Imaging Analysis
2212
Minghuan Li
Determine the Involved Lymph
Node Station for Cervical and Upper
Thoracic Esophageal Carcinoma in
Non-surgical Patients -A Data Analysis
Based on CT
2213
Minghuan Li
Pretreatment CT Perfusion Predicts
Early Response of Advanced
Esophageal Carcinoma Treated With
2214
Ravi Shridhar
Survival Impact of Esophagectomy
After Chemoradiation for
Adenocarcinoma of the Esophagus
2215
Chun Han
The Application Value Study of
Diffusion-weighted Magnetic
Resonance Imaging(DWI) in Target
Volume Determination of Esophageal
Carcinoma Treatment using 3DCRT
or IMRT
2216
Shuchai Zhu
Investigation of Using
Diffusion-weighted Magnetic
Resonance Imaging(DWI) to Evaluate
the Therapeutic Effect and Prognosis
of Esophageal Carcinoma Treatment
using 3DCRT
2217
Lan Wang
Prognosis Analysis of Different Site
Esophageal Squamous Cell Carcinoma
Received 3-Dimensional Radiation
Therapy
2218
Changsheng Ma
Quantitative Study of 18Ffluorodeoxyglucose and 18Ffluorothymidine PET Characteristics in
Staging
134
2219
Keisuke Tamari
Impact of Clinical and Dosimetric
Factors on Pericardial Effusion in
Patients With Stage I Esophageal
Cancer Treated With Definitive
2228
Jun Wang
Overexpression Of Epidermal Growth
Factor Receptor And Its
Clinicopathological Significance: A
Meta Analysis Of 1118 Cases With
2220
Gen Kawaguchi
A New Choice of Treatments for
Invasive Superficial Esophageal
Squamous Cell Carcinoma:
Investigation of Efficacy of
Prophylactic Chemoradiation Therapy
After Endoscopic Submucosal
Dissection
2229
Yuji Murakami
Twenty Years Treatment Results
Of Radiation Therapy For T1N0M0
Esophageal Cancer
2221
Masakazu Hori
Overexpression Of XRCC4 Predicts
Poor Clinical Outcome Of Patients
With Esophageal Squamous Cell
Carcinoma Treated With Definitive
Radiation Therapy
2222
Huiming Liu
Long-term Outcome of Cf-252
Neutron Intracavitary Brachytherapy
Combined With External Beam
Radiation Therapy and Concurrent
Chemotherapy for Esophageal
Squamous Cell Carcinoma
2230
Yufeng Cheng
Cancer-associated Fibroblasts, a
Parameter of the Tumor
Microenvironment, is Associated With
Poor Prognosis in Esophageal
Squamous Cell Cancer After Surgery
2231
Junichi Fukada
Symptomatic Pericardial Effusion
After Chemoradiation Therapy for
Esophageal Cancer: A Historical
Comparison
2232
Rei Umezawa
Magnetic Resonance Imaging
Findings of Radiation-induced
Myocardial Damage in Patients With
Esophageal Cancer
2223
Xin Huang
The Negative Expression of Annexin
A1 in Esophageal Squamous Cell
Carcinoma is Association with Poor
Outcome
2233
Jun Liang
Nimotuzumab Combined With
Radiation Therapy on Esophageal
Cancer: Preliminary Study of a Phase 2
Clinical Trial
2224
Hunter Boggs
Predictors of Pathologic Complete
Response Rates in Patients Receiving
Trimodality Therapy for Esophageal
Cancer
2234
Sagar Patel
Small Cell Carcinoma Of The
Esophagus: The (SEER) Experience
From 2000-2009
2225
Jun Wang
Prognostic Analysis In 182 Thoracic
Esophageal Carcinoma Patients With
Atypical Hyperplasia In Esophageal
Stump And Esophageal Stump Cancer
After Esophagectomy
2226
Che-yu Hsu
Definitive Concurrent
Chemoradiation Therapy via Intensity
Modulated Radiation Therapy for
Synchronous Esophageal Cancer in
Patients With Head-and-Neck Cancer
2227
Qi Liu
Pattern of Failure After Radical
Surgery in Patients With Thoracic
Esophageal Squamous Cell
Carcinoma: Implications for
Postoperative Radiation Therapy
2235
Abraham Wu
Generation of Consensus Contour
Atlas for Esophageal Cancer IMRT
2236
Miyako Myojin
The Common Late Toxicities
Observed After Definitive
Chemoradiation Therapy for
Esophageal Cancer
2237
Lotte Lutkenhaus
Reduction in Cardiac Volume During
Chemoradiation Therapy for Patients
With Esophageal Cancer: Magnitude
and Possible Implications for Adaptive
Radiation Therapy
2238
Hitoshi Ishikawa
Preliminary Results of Concurrent
Chemoradiation Therapy Using
Proton Beam Therapy for Esophageal
Cancer
2239
Wencheng Zhang
Postoperative Intensity Modulated
Radiation Therapy Improved Survival
of Lymph Node Positive or Stage III
Squamous Cell Carcinoma Esophagus
2240
Aditya Juloori
Dosimetric Predictors for Nausea
and Anorexia in Esophageal Cancer
Patients Treated with Neoadjuvant
Chemoradiation
2241
Faisal Siddiqui
Overall Survival Analysis of
Neoadjuvant Chemoradiation
Therapy and Esophagectomy for
Esophageal Cancer
2242
Shuchai Zhu
Effect Of Rnai Against 53bp1 Gene On
Radiosensitivity Of Human
Esophageal Carcinoma Eca109 Cell
2243
Christopher Anker
The Effect Of Stents On Acute Toxicity
In Esophageal Cancer
2244
Kyung Hwan Kim
Is Postoperative Radiation Therapy
Effective for Patients With Esophageal
Cancer?: An 8-Year Follow-up Study
2245
Shaleen Kumar
Clinical Target Volumes (CTV) for
Squamous Cell Cancer (SCC) of
Esophagus Treated With
Chemoradiation Therapy (CRT)
2246
Yuxin Shen
Management of Primary Thoracic
Small Cell Esophageal Carcinoma:
analysis of 20 consecutive cases
2247
Jiancheng Li
Analysis Of Relative Influencing
Factors About Recurrence Of
Esophageal Carcinoma After
Three-field Lymph Node Dissection
2248
Qi Liu
Characteristics of Lymph Node
Recurrence After Radical Surgery and
Their Value in Target Volume
Delineation in Postoperative
Radiation Therapy for Thoracic
2250
Steven Seyedin
Benefit of Adjuvant Chemoradiation
Therapy for Gastric Adenocarcinoma:
A SEER Population Analysis
2251
Alexander Stessin
Does Adjuvant Radiation Benefit
Patients with Diffuse Type Gastric
Cancer? Results from the Surveillance,
Epidemiology, and End Results (SEER)
Database
2252
Qiwen Li
Lymph Node Status as Predictive
Factor for Selective Adjuvant
Chemoradiation in Patients with
Locally Advanced Gastric Cancer with
D2 Dissection
2253
NingNing Lu
Safety And Clinical Outcome For
Phase II Study Of Nimotuzumab And
Concurrent Capecitabine And
Radiotherapy For Patients With
Locally Advanced Inoperable Or
Relapsed/ Residual Gastric Cancer
2254
Hua Ren
Prospective Efficacy Evaluation Of
Intensity-modulated Radiotherapy
(imrt) Combined With Capecitabine
As Adjuvant Concurrent
Chemoradiation In Stage II/III Gastric
Cancer
2255
Cem Misirlioglu
Adjuvant Radiotherapy For Gastric
Carcinoma: 10 Years Follow-up
Update Of 244 Cases From A Single
Institution
2256
Jennifer Shah
Clinical And Dosimetric Predictors Of
Peri-operative Pulmonary
Complications In Esophageal Cancer
Patients Treated With Neoadjuvant
Chemoradiation
2257
Andre Chen
Liver Irradiation Increases
Relapse-free Survival In Adjuvant
Gastric Cancer Treatment
2258
Rajal Patel
A Multi-Institutional
Retrospective Study of Radiation
Therapy Parameters and Outcomes in
Patients with Gastroesophageal
Junction Adenocarcinoma
2259
Guichao Li
Radiation Induced Liver Injury In
Three Dimensional Radiation Therapy
(3d-rt) For Postoperative Or
Locoregional Recurrent Gastric
Cancer: The Risk Factors And Dose
Limitation
2260
Ronica Hazariwala
Neoadjuvant FOLFIRINOX and
Radiation Therapy Improves
Resectability of Pancreas
Adenocarcinoma
2261
Eric Mellon
Survival Benefits of Adjuvant
Radiotherapy and Lymph Node
Dissection in Pancreatic Cancer
Treated with Surgery and
Chemotherapy
2262
Tingyi Xia
Dose Escalation to Target Volumes of
Helical Tomotherapy for Pancreatic
Cancer in the Phase I-II Clinical Trial
2263
Michael Baine
Radiation Therapy Improves Survival
Outcome in Pancreatic
Adenocarcinoma: Comparison of a
15-year institutional experience at
the University of Nebraska Medical
Center with SEER data
2264
Sophie Cai
Long-Term Outcomes and Prognostic
Factors for Locally Advanced
Pancreatic Cancer Patients Treated
with Intraoperative Radiation Therapy
2265
Brandon Mancini
Induction FOLFIRINOX Prior to
Chemoradiation for Borderline or
Locally Advanced Pancreatic Cancer
2266
David Sherr
Do Socio-Demographic Factors Affect
Overall Survival in Patients with
Unresectable Pancreatic Cancer?
Results of a Secondary Analysis of
RTOG Data
2267
Cato Chan
Anemia During Radiotherapy
Correlates With Outcomes In
Pancreatic Cancer
2268
Angelo Tozzi
2249
Ling Yipeng
Sbrt In Unresectable Advanced
Pattern of Lymph Node Metastases
Pancreatic Cancer. Preliminary Results
and its Implication in
Of A Monoinstitutional Experience
Radiotherapeutic Clinical Target
Volume in Patients With Upper
Thoracic Esophageal Squamous Cell
Carcinoma
135
2269
Raphael Yechieli
Stereotactic Body Radiotherapy for
the Treatment of Elderly Patients
with Medically Inoperable Pancreatic
Cancer
2279
Natalie Ausborn
53BP1 Expression is a Modifier of the
Prognostic Value of Lymph Node
Ratio and CA 19-9 in Pancreatic
Adenocarcinoma
2270
William Hall
The Influence of Radiation Therapy
Dose Escalation on Overall Survival in
Unresectable Pancreatic
Adenocarcinoma
2280
Maged Ghaly
Duodenal Sparing Stereotactic Body
Radiation Therapy For Locally
Advanced Pancreatic Cancer:
Technique, Toxicity, and local
Response
2271
Lisette Nixon
The SCALOP trial Plan Assessment
Form (PAF) as a tool for Radiotherapy
Trials Quality Assurance (RTTQA)
2272
Aryavarta Kumar
Influence of Adjuvant Treatment on
Outcomes in Resectable Pancreatic
Cancer
2273
Shreya Prasad
Intensity Modulated Radiotherapy
Reduces Gastrointestinal Toxicity in
Locally Advanced Pancreas Cancer
2274
Antonino Romeo
Hypofractionated
Radio-chemotherapy With
Gemcitabine Plus Oxaliplatin For
Unresectable Nonmetastatic Locally
Advanced Pancreatic Cancer
2275
Jessica Freilich
Outcomes of Adjuvant Radiotherapy
and Lymph Node Dissection in Elderly
Pancreatic Cancer Patients Treated
with Surgery and Chemotherapy
2276
Huma Chaudhry
Radiation Therapy in Pancreatic
Neuroendocrine Tumors: Favorable
Outcomes and Low Toxicity in a
Multi-Institutional Experience
2277
Avani Dholakia
18Flurodeoxyglucose-PET Baseline
Avidity Predicts for Inferior Outcomes
in Patients with Locally Advanced
Pancreatic Cancer Treated with
Gemcitabine and Stereotactic Body
Radiotherapy
2278
Takero Hirata
Dose-volume Analysis For Predicting
Histological Effects And
Gastrointestinal Complications After
Preoperative Chemoradiotherapy For
Pancreatic Cancer
2281
Hao Wang
Prognostic Factors for Intraoperative
125I Seeds Implantation for
Treatment of Locally Advanced
Pancreatic Carcinoma
2282
Reid Thompson
Linear Quadratic Extrapolated
Dosimetric Analysis of Proton Therapy
and IMRT in Unresectable Cancer of
the Head of Pancreas: Implications for
Dose Escalation
2283
Andre Konski
Preliminary Results of a Phase I Study
of Hyperfractionated Low-Dose
Radiotherapy (RT) as a
Chemotherapy sensitizer in
Combination With Gemcitabine (G)
and Erlobtinib (E) in Advanced
Pancreatic Cancer
2284
John Lukens
Acute Toxicity of Proton vs. Photon
Chemoradiotherapy for Pancreatic
Adenocarcinoma: a Cohort Study
2285
Jennifer Wo
Tolerability of Dose Painted
Neoadjuvant Chemoradiation to
Regions of Vessel Involvement in
Borderline or Locally Advanced
Pancreatic Cancer
2286
Mediha Ahmad
Is Ca19-9 Response Following
Chemoradiation Therapy For
Borderline Resectable Pancreatic
Cancer An Early Surrogate For
Eventual Survival Outcomes?
2287
Joong Yeol Woo
Evaluation Of Dose Summation
Method Using Deformable
Registration In Adaptive Planning For
2288
Ajay Patel
Postoperative Interval between
Surgery and Initiation of Adjuvant
Therapy Corresponds to Local
Recurrence in Resected Pancreatic
Cancer
2289
Abhijeet Bhirud
Dosimetric Analysis Of Kidney Toxicity
After Stereotactic Body Radiation
Therapy For Pancreatic Cancer
2290
Kotaro Terashima
Carbon-ion Radiotherapy for Patients
With Isolated Local Recurrence of
Primary Resected Pancreatic Cancer
2291
Sanjay Chandrasekaran
Neoadjuvant Therapy for Achieving
Margin Negative Resection in
Borderline Resectable Pancreatic
Ductal Adenocarcinoma
2292
Dandan Zheng
Respiratory-Correlated Duodenum
Motion and Its Implications in
Pancreatic SBRT
2293
David Shultz
Ca 19-9 Kinetics Following
Radiotherapy Correlate With
Outcomes In Patients With Pancreatic
Adenocarcinoma
2294
Alex Cruz
Outcomes And Toxicities In Postoperative Pancreatic Cancer Treated
With Chemotherapy And IMRT Vs.
3DCRT
2295
Sonia Skamene
Resectability After Concurrent
Gemcitabine-based
Chemoradiotherapy For Patients With
2296
Jenny Que
The Efficacy of Stereotactic Body
Radiation Therapy For Unresectable
Huge Hepatocellular Carcinoma Not
Eligible For Other Local Modalities
2297
Brandon Barney
Stereotactic Body Radiotherapy after
Other Minimally-Invasive Local
Therapies for Liver Tumors
2298
Kyung Su Kim
Clinical Characteristics And
Prognostic Factors Of Brain
Metastases From Hepatocellular
Carcinoma
136
2299
Jim Zhong
Patterns of failure for Stage I Ampulla
of Vater Adenocarcinoma: a Single
Institutional Experience
2300
Jinhong Jung
Normalization of Alpha-fetoprotein
Level in Patients with Hepatocellular
Carcinoma after Stereotactic Body
Radiation Therapy: A Prognostic
Surrogate of Progression and Survival
2301
Marie-Laure Camborde
Mean Liver Dose Evaluation By Lyman
NTCP Modeling With Stereotactic
Body Radiotherapy To Minimize
Radiation-induced Liver Disease For
Inoperable Hepatocellular Carcinoma
2302
Alejandra Mendez
Romero
Inter- and Intra-observer Variability in
Daily Tumor Set-up using
Contrast-enhanced CT-scans for
Patient Positioning during
for Liver Metastases
2303
Erik Lappinen
(SBRT) as a Bridge to Orthotropic Liver
Transplant (OLT) for
Hepatocellular Carcinoma (HCC):
Evaluation of Explant Pathology and
the Factors That Predict Outcomes
2304
Seth Blacksburg
Combined Transarterial
Chemoembolization (TACE) And
(SBRT) For Management Of Primary
Hepatocellular Carcinoma (HCC)
2305
Anand Mahadevan
Unresectable Large and Multiple
Hepatocellular Carcinoma
2306
Sang Min Yoon
Clinical Outcomes of Stereotactic
Body Radiation Therapy for Primary or
Recurrent Hepatocellular Carcinoma
2307
Christina Speirs
90Y Microsphere Hepatic Distribution
Can Be Evaluated Following
Radioembolization With PET/MRI
2309
Hideomi Yamashita
Comparison Bwtween Stereotactic
Body Radiotherapy For Liver
Metastases And Hepatocellular
Carcinoma
2310
Naoko Sanuki
Stereotactic Ablative Body Radiation
Therapy for Small Hepatocellular
Carcinoma: Outcomes in 185 Patients
2311
Toshiyuki Okumura
Long-term Survival in Patients with
Hepatocellular Carcinoma Initially
Treated with Definitive Proton Beam
Therapy
2312
Seung Won Seol
Treatment Outcome of Hepatic
Re-irradiation in Patients with HCC
2313
Jun Won Kim
Radiologic-Pathologic Correlation
in HCC Patients Undergoing Radical
Radiotherapy Followed by Surgical
Resection
2314
Kenneth Merrell
An Institutional Review of Stereotactic
Body Radiotherapy for Liver Tumors
2315
Katherine Fan
Neuroendocrine Tumor Liver
Metastases Treated with Yttrium-90
Radioembolization
2316
Jenny Shaffer
Predicting Liver Volume Changes
After Stereotactic Body Radiotherapy
for Liver Tumors
2317
Edward Mannina
Role of Stereotactic Body
Radiotherapy as a Bridge to
Orthotopic Liver Transplantation.
Evaluation of Pathological Response
and Outcome: Indiana University
Experience
2318
Charles Fang
Biliary Stricture After Radiotherapy for
2319
Yilin Liu
4D-MRI using Sagittal Acquisition and
Body Area as Respiratory Surrogate
2320
Iris Ernst
Individualized Stereotactic Body
Radiation Therapy (SBRT) by
Tomotherapy or VMAT in Liver
Malignancies - only Rank 3rd after
Surgery and Interventional
Radiology?
2321
Joseph Evans
Safety and LC of Repeat Liver
2322
May Abdel-Wahab
Assessment of Hepatocellular
Carcinoma Recurrence Risk after
Primary Treatment using Predictive
Nomograms
2323
Claudia Menichelli
Sbrt For Crc Liver Metastases:
Prognostic Factors Affecting Lc And
Os
2324
Saumil Gandhi
Development of a Decision Tree
Analysis Tool for Optimal Delivery
of Liver Stereotactic Body Radiation
Therapy: Photons versus Protons
2325
Joseph Waller
Outcomes of Stereotactic Body
Radiation Therapy (SBRT) for
2326
Pawel Dyk
Analysis Of Abdominal And Chest Wall
Toxicity Following Liver SBRT
2327
Navesh Sharma
Association Between K-ras Mutation
Status And Survival In mCRC Patients
Undergoing Selective Internal
Radiation Therapy (SIRT) to the
Liver Using Yttrium-90 Coated Resin
Microspheres
2329
Tony Wang
Selective Internal Radiation Therapy
to the Liver: High Tumor Dose and
Normal Liver Tolerance
2330
Evan Osmundson
Risk of Hepatobiliary Toxicity After
SBRT to the Liver for Central Liver
Tumors
2331
Martin Fuss
Outcomes of Hypofractionated
Radiation Therapy (HFxRT) for
2308
Atsuya Takeda
Stereotactic Ablative Body
Radiotherapy For Previously
Untreated Solitary Hepatocellular
Carcinoma In Patients With Liver
Disease
137
2332
Michael Lock
Phase I Study of Image-guided and
Radiobiologically-guided
Hepatic Lesions
2341
Joo Ho Lee
The Influence of the Treatment
Response on the Impact of Resection
Margin Status after Preoperative
Chemoradiotherapy in Rectal Cancer
2351
Maureen Rolfo
Simple Segment IMRT: Dosimetric and
Resource Implications of an
Innovative Rectal Cancer
Technique
2333
Maria Fernanda Diaz
Vazquez
Clinical Comparison of IMRT With
3D-CRT in Preoperative
Chemoradiotherapy for Locally
Advanced Rectal Cancer (LARC)
2342
Ovidiu Marina
Whole-Mount Pathologic Evaluation
of Specimens Following Preoperative
Radiotherapy (RT) for Rectal Cancer
Identifies More Lymph Nodes and
Greater Tumor (T) Stage
2352
Claudio Sole
Presacral Evolutive Events (Soft Tissue
Mass) After Neoadjuvant
Chemoradiation With or Without
Intraoperative Electron Beam
Radiation Therapy Boost For Locally
Advanced Rectal Cancer
2334
Annemarie Fernandes
Predicting Outcomes In
Locally-advanced Rectal Cancer Using
Pretreatment FDG-PET Imaging
2343
Ane Appelt
Dose-response Of Acute Bladder Side
Effects Of Long-course Preoperative
Radiotherapy For Rectal Cancer
2353
Shigeru Yamada
Carbon-ion Therapy For Patients With
Locally Recurrent Rectal Cancer
2335
Yong Cai
Clinical Analysis Of Comparing
Volumetric Modulated Arc Therapy
With Fixed Field Dynamic
Therapy On Preoperative
Chemoradiotherapy For Locally
Advanced Rectal Cancer
2344
Tzu-I Jonathan Yang
Impact of Clinical and Dosimetric
Factors on Weekly Toxicity Scores
during Pelvic Radiotherapy for Rectal
Cancer
2354
Jing Jin
A Phase I Study Of Postoperative
Capecitabine With Concurrent
Radiotherapy In Elderly Patients With
Rectal Cancer
2345
Albert DeNittis
Treatment Of Distal Rectal Cancer
With Preoperative Intensity
Modulated Radiation Therapy (IMRT)
Combined With Chemotherapy And
Transanal Endoscopic Microsurgery: 5
Year Results Of 12 Patients
2355
Xin Lei
The Combination of 252Cf Neutron
Intracavitary Brachytherapy Using
Off-Axis 4-Channel Intrarectal
Applicators and External Beam
Radiation Therapy on Low-Lying
Rectal Adenocarcinoma (Phase 2a
trial): The 3 Year Result for 118 Patients
2336
Sung Uk Lee
Comparison of Two Preoperative
Chemoradiotherapy Regimens for
Locally Advanced Rectal Cancer:
Short-term Tumor Response and
Long-term Clinical Outcome of
Capecitabine with or without
Irinotecan
2337
Evan White
Intensity-Modulated Radiation
Therapy for Anal Canal Cancer:
A Large Single-Institution Experience
2338
Daniel Yang
Changes In Early And Late Stage
Colorectal Cancer Incidence During
The Era Of Screening: 1976-2009
2339
Andrzej Wojcieszynski
Uncertainty in Rectal Tumor
Localization During Preoperative
Radiation and the Impact of Distal
Tumor Delineation on Normal Tissue
Dosimetry
2340
Qin Xiao
Using Apparent Diffusion Coefficient
to Predict Outcome of
Preoperative Chemoradiotherapy for
Locally Advanced Rectal Carcinoma
2346
Alexander Falk
High-dose Rate Interstitial
Brachytherapy as Boost for Anal Canal
Carcinoma : Dosimetric Results and
Clinical Outcome
2347
Joelle Helou
Vaginal Sparing Using A Mold In Anal
Cancer Female Patients Treated With
Intensity Modulated Radiotherapy: A
Dosimetric Feasibility Study
2348
Diana Rothenstein
Predictors of Outcome and Toxicities
of Definitive Chemoradiation with
Intensity Modulated Radiotherapy for
Anal Cancer
2349
Susannah Yovino
Sparing Circulating Lymphocyte
Populations with Endorectal
Brachytherapy
2350
Phuong Nguyen
Prolonging Surgical Resection after
Neoadjuvant Chemoradiation for
Rectal Cancer Is Associated with
Increased Risk of Distant Failure and
Decreased Survival
2356
Dolores M. De La Mata
Molecular Imaging (FDG-PET/CT)
Response to Neoadjuvant Oxaliplatin
and Chemoradiation in Rectal Cancer
as Prognostic Factor in Surveillance
2358
Bindu Manyam
The Impact of Radiation Therapy on
Locoregional Recurrence (LRR) in
Patients with Stage IV Rectal Cancer
Treated with Definitive Surgical
Resection and Modern Chemotherapy
2359
Jekwon Yeh
Primary Adenocarcinoma of the Anal
Canal: A Single-Institutional Report
on a Rare Malignancy
2360
Hao Li
Effects of PET Reconstruction
Parameters on Region-of-Interest
Contouring by SUV Threshold
2361
Olivier Riou
Brachytherapy For Anal Canal Cancer:
A Goco Multicenter Study
138
2362
Abdullah Alsuhaibani
External Beam Radiotherapy Versus
Image-guided High Dose Rate
Endorectal Brachytherapy In The
Management Of Rectal Cancer A
Retrospective Study
2363
Sonny Batra
Pencil Beam Scanning Proton Therapy
In The Treatment Of Rectal Cancer
2364
Abdullah Alsuhaibani
Effect Of Circumferential Resection
Margin (crm) On Local Recurrence
And Distant Metastases In Patients
Treated With Neoadjuvant
Chemo-radiation For Rectal Cancer
Updated Analysis
2365
Margaret Kozak
SMAD4 Inactivation and Prognosis in
Colorectal Cancer
2366
May Abdel-Wahab
The Impact of Radiation Therapy after
Resection on Survival in Squamous
and Adenosquamous Cell Carcinoma
of the Rectum
2367
Min Rex Cheung
Racial And Socioeconomic Disparities
In Malignant Carcinoid Cancer Cause
Specific Survival: An Analysis Of A
National Cancer Registry
2368
Jean-Claude Rwigema
for Abdominal and Retroperitoneal
Oligometastases
2369
Mira Shah
Stereotactic Radiation Therapy for
Adrenal Metastases
GENITOURINARY CANCER
2370
Kara Leonard
Effect Of Modern Radiotherapy
Techniques On Hematocrit In Patients
With Prostate Cancer
2371
Toshio Ohashi
Outcomes Following I-125 Prostate
Brachytherapy as Monotherapy
2372
Bettina Hentschel
Comparison of Intensity Modulated
Single Arc Therapy (VMAT) and
Standard IMRT: GI and GU Toxicity in
the Pelvic Nodal Treatment of
High-Risk Prostate Cancer
2373
Ron Allison
PSA Nadir Predicts Outcome
Following Radiation Therapy for
Gleason 8, 9, 10 Prostate Cancer
2383
Jennifer Logan
Salvage MR-guided Focal Laser
Ablation of Prostate Cancer after
Brachytherapy
2374
Bradford Hoppe
Comparative Effectiveness Study of
Proton Therapy versus IMRT for
Definitive Treatment of Prostate
Cancer Based on Patient-reported
Outcomes
2384
2375
Kasra Badiozamani
Does Pd-103 Prostate Brachytherapy
Lead to High Rates of Urinary
Retention and Morbidity?
2376
Hiromichi Ishiyama
A Prospective Quasi-randomized
Comparison Of Intraoperatively Built
Custom Linked Seeds Vs. Loose Seeds
For Prostate Brachytherapy
2377
Toshio Ohashi
Preliminary Report of Urinary and
Rectal Toxicity Profiles after
Permanent Iodine-125 Implant
Brachytherapy in Japanese Men:
J-POPS Multi-Institutional Cohort
Study
Eberechukwu
Onukwugha
Variation in the Length of Radiation
Therapy among Men Diagnosed with
Incident Metastatic Prostate Cancer
2385
Whoon Kil
Patient-reported Hip symptoms
following Treatment with Proton
2386
Jonathan Andrew Haas
Organ Confined Localized Prostate
Cancer
2387
Donald Fuller
HDR-like SBRT For Post-radiotherapy
Locally Recurrent Prostatic
Carcinoma: PSA Response, DFS And
Toxicity Assessment
2388
Gaurav Marwaha
Gleason Pattern 5: Is Adverse Really
Worse?
2378
Xu Tong
Real-time Measurement of Prostate
Intrafractional Motion during External
Beam Radiotherapy
2389
Adam Holtzman
Proton Therapy as Salvage Treatment
for Local Relapse of Prostate Cancer
following Cryosurgery or HIFU
2379
Michael Pinkawa
Learning Curve In The Application
Of A Hydrogel Spacer To Protect The
Rectal Wall During Radiotherapy Of
Localized Prostate Cancer
2390
Akane Sekiguchi
Eight-Year Experience of Iodine-125
Monotherapy for Japanese Men With
2380
Joen Sveistrup
Improvement in Toxicity in High Risk
Prostate Cancer Patients Treated with
Image Guided Intensity-Modulated
Radiotherapy compared to
Non-Image Guided Conformal
Radiotherapy
2381
John Kalapurakal
Improved Biochemical Control
(<0.2ng/ml) Following Androgen
Deprivation Therapy And Adjuvant
Or Salvage Whole Pelvis Radiation
Therapy After Prostatectomy
2382
Harold Wallace
Transperineal Ultrasound for Image
Guidance in the Treatment of Prostate
Cancer: A Comparison to
Fiducial-Based Imaging
2391
Atsunori Yorozu
Dose Escalation Impacts
Biochemical Outcomes of Inadequate
PSA Nadir during Neoadjuvant
Hormone Therapy before
Brachytherapy for Intermediate-risk
Prostate Cancer
2392
Jason Slater
The Prognostic Value Of Percentage
Of Positive Biopsies, Percentage Of
Cancer Volume, And Maximum
Involvement Of Biopsy Cores In
Prostate Cancer Patients Receiving
Proton Beam Therapy
2393
Haruo Inokuchi
Impact Of Mlc Leaf Width On
Incidence Of The Late Rectal
Bleeding After Intensity-modulated
Radiotherapy For Localized Prostate
Carcinoma
139
2394
Andrea Lo
Prognostic Utility Of The Prostate
Specific Antigen (PSA) Value 4-5 Years
After 125I Brachytherapy
2395
Shea Wilcox
Dose Escalated, Image-guided IMRT
And Androgen Deprivation As
Treatment For Gleason Pattern 5
Prostate Cancer: Encouraging Results
With Modern Techniques
2396
Daniel Krauss
Results of Image-Guided,
Dose-Escalated Radiotherapy for
Localized Prostate Cancer: 10-Year
Results Using an Off-Line, Adaptive
Technique
2397
Richard Lee
Update of Risk Factors for Biochemical
Recurrence of Prostate Cancer after
Salvage Radiotherapy Post-Radical
Prostatectomy
2398
Jeremy Price
Predictive Factors And Management
Of Rectal Bleeding Side Effects
Following Prostate Cancer
Brachytherapy
2403
Ajaykumar Patel
PSA Half-Life after Salvage Radiation
Therapy for Biochemical Failure of
Prostate Cancer after Radical
Prostatectomy
2404
Jeffrey Kittel
A Significant Cause of Variability in
Prostate Brachytherapy Outcomes as
Demonstrated from a Single
Institution Suggesting a Method for
Uniform Reporting among
Institutions
2405
Dong Wook Nathan Kim
Predictors of High Grade Rectal
Toxicity Observed in a Phase I/II Trial
of Stereotactic Body Radiotherapy for
Prostate Cancer
2406
Takashi Hanada
Assessment Of Release Criteria For
Patients Based On Various Dose Rate
Measurements Following 125I
Prostate Brachytherapy
2412
Julia Luisa Munoz Garcia
Whole Pelvic Radiotherapy versus
Prostate Only in Patients with
Intermediate, High and Very High Risk
Prostate Cancer according NCCN
Criteria Treated with Radical Intention:
Recap Data Base
2413
Hannah Nguyen
Common Errors found in Low Dose
Rate (LDR) Prostate Credentialing
2414
Yuting Lin
The Non-Gaussian Nature of Prostate
Motion Based on Real-Time
Intra-fraction Tracking
2415
Michael Hughes
The Long Term Effect of Definitive,
High-Dose IG-IMRT on Urinary
Function in Patients with High AUA
Scores Prior to Treatment
2416
Yuting Lin
Respiratory Induced Prostate Motion
Using Wavelet Decomposition of the
Real-time Electromagnetic Tracking
Signal
2407
Bryan Macrie
Implantation of Row One Needles
1-2mm Anterior to the Posterior
Margin of the Prostate Gland Results
in Excellent PSA Control and Minimal
Rectal Toxicity After I-125
Brachytherapy
2417
Bridget Koontz
Image Guidance affects Biochemical
Outcome for Post-Prostatectomy
Radiotherapy
2408
Kiyoshi Nakamatsu
Therapy (IMRT) For High-risk Prostate
Cancer: Effects Of Total Dose On Psa
Failure
2418
Akihiro Hayashi
Dose Volume Histogram Comparison
Between Static 5-field IMRT with
18-MX X Rays and Helical
Tomotherapy with 6-MX X Rays
2400
Colin Murphy
Inflammatory Bowel Disease is not an
Absolute Contraindication to
Definitive Radiation Therapy for
Prostate Cancer
2409
Yutaka Shiraishi
A Novel Parameter Predicting Grade
2 Rectal Bleeding After I-125 Prostate
Brachytherapy Combined With
External Beam Radiotherapy
2419
Wu Liu
Continuous Threshold-based
Monitoring vs. Periodic Surveillance
For Prostate Intrafraction Motion
Management
2401
Mack Roach
Radiation Therapy Oncology Group
(RTOG) 9408: A Secondary Analysis
Of The Risk Of Death From Second
Cancers Comparing Whole Pelvic (WP)
Radiotherapy (RT) To Prostate Only
(PO) RT & Neoadjuvant Hormonal
Therapy (NHT) + RT To RT Alone
2410
Kentaro Ishii
A Treatment Planning and Acute
Toxicity of RapidArc in the Treatment
of High-risk Prostate Cancer with
Whole Pelvic Radiotherapy
2420
Ziad Fawaz
Complication Rates in Fiducial Marker
Implantation for Prostate Radiation
Therapy
2399
Julia Luisa Munoz Garcia
Cross-sectional Observational Study
About Prevalence Of Metabolic
Syndrome And Osteoporosis In
Prostate Cancer Treated With
Androgen Deprivation Therapy And
Their Impact On Quality Of Life
(SIMBOSPROST): GICOR Group
2402
Raphael Yechieli
Segmental Analysis of Permanent
Prostate Implant Dosimetry and
Effects on Long-Term Clinical
Outcomes
2411
Tomer Heres
Perineal Biodegradable Balloon is
Effective for both Sparing the Rectum
and as a Fiducial Marker in Prostate
Cancer Patients Treated with Mild
Hypofractionation
2421
Alex Boychak
Phase II study: Feasibility and Acute
Toxicity of Dose Escalated
Hypofractionated IntensityModulated Radiotherapy with
Concurrent Treatment of Pelvic
Lymph Nodes in High-Risk Prostate
Cancer Patients
140
2422
Natsuo Tomita
Evaluation of Urinary Outcomes by
International Prostate Symptom
Scores (IPSS) in Intensity Modulated
Radiation Therapy Combined with
Androgen Deprivation Therapy for
Prostate Cancer
2423
Alison Tree
Successful Patient Acceptance Of
Randomization Within The Pace Study
(prostate Advances In Comparative
Evidence)
2424
Feliciano Garcia-Vicente
Predictors for Late Urinary Toxicity
after High-Dose Radiotherapy for
2432
Jay Ciezki
Patterns of Care for the Definitive
Management of Prostate Cancer in
the U.S.
2433
Tamim Niazi
Is Daily orthogonal KvKv images
sufficient for Image Guided
Radiotherapy of Prostate Cancer
Patients Post Radical Prostatectomy?
Final Analysis of a Pilot Phase II Study
2434
Seth Blacksburg
Predicting Long-term Disease State
Outcomes in Patients with Prostate
Cancer Treated with Definitive
Radiation
2425
Joan Lozano
A New Dietary and Laxative Protocol
Reduces Rectal Distension and Acute
Rectal Toxicity in Prostate Cancer
Patients Treated by Radiotherapy
2435
Angiolo Tagliagambe
Phase I study of Stereo-Ablative
Radiotherapy with the use of
SpaceOAR hydrogel as Definitive
Treatment of Prostate Cancer:
Preliminary Experience
2426
Nor Shazrina Sulaiman
Efficacy of Salvage Radiotherapy in
Men with Biochemical Recurrence
After Radical Prostatectomy: A
Comparison with Endocrine Therapy
2436
Mekhail Anwar
Hypofractionated SBRT versus
Conventionally Fractionated EBRT for
Prostate Cancer: Comparison of PSA
Slope and Nadir
2427
Viviana Carillo
Dosimetric and Clinical Predictors
of Acute Urinary Symptoms after
Radiotherapy for Prostate Cancer:
Preliminary Results of a Prospective
Cohort Study (DUE-01)
2437
Yuefeng Wang
Influence of Vascular Comorbidities
and Race on Erectile Dysfunction after
Prostate Cancer Radiotherapy
2428
Alfonso Gomez-Iturriaga
Multi-institutional outcomes
following External Beam Radiation
Therapy and Androgen Deprivation
Therapy in patients with Extreme-Risk
Prostate Cancer
2429
William Wilson
Re-implantation of Prostate
Brachytherapy Seeds for Salvage
Therapy: A Single Institution
Experience
2430
Zvi Symon
Rising Psa Following Prostatic Fossa
Only (PFO) Radiotherapy: Technique
And Results Of Salvage Pelvic Node
Radiation Therapy
2431
Lynn Chang
Toxicity And Biochemical Failure
Following Image-guided Prostate
Intensity-modulated Radiotherapy:
Fiducial Markers Versus
Electromagnetic Transponders
2438
Kevin Stephans
High Risk Prostate Cancer: Radiation
or Surgery?
2439
Xiaofeng Yang
Integration Of Intra-operative
Ultrasound-volume Into CT-based
Treatment Planning In Prostate HDR
Brachytherapy: A Pilot Study
2440
Charlene Kan
A Single Institution Experience with
Prostate Interstitial Brachytherapy
(1999-2009): Biochemical Outcomes
With and Without Molecular Image
Guided Dose Escalation
2441
Aparna Surapaneni
Radiation Therapy For Clinically
Localized Prostate Cancer: Long Term
Results From The Ny Harbor
Department Of Veteran’S
Administration In The Era Of Dose
Escalation
2442
Yeona Cho
Is There Benefit of Radiotherapy for
Primary Tumor in the Treatment of
Patients with Metastatic Prostate
Cancer?
2443
Yu-Wei Lin
The Early Result of Stereotactic Body
Radiotherapy Boost for High-risk
2444
Mark Gooding
Assessment Of Contour Fusion
Methods For Auto-contouring Of The
Male Pelvis
2445
Almudena Zapatero
Reduced Rectal And Urinary
Toxicity Following High-Dose
Intensity Modulated Radiotherapy
Using Intra-Prostate Gold Fiducial
Markers For Localized Prostate Cancer
2446
Ferran Ferrer
Quality of Life Impact of Treatments
for Localized Prostate Cancer
2447
Shiho Ayakawa
(VMAT) Versus Helical Tomotherapy
(HT) for Localized Prostate Cancer:
Dosimetric Comparison by Using the
Identical Prescription Dose to the
Prostate
2448
Junsu Park
Suggestion for Target Volume in
Salvage Radiation Therapy for
Locally-Recurrent Prostate Cancer
After Radical Prostatectomy
2449
Tonnis Nuver
HDR Prostate Brachytherapy Based on
Registered TRUS and In-Room
Cone-Beam CT Images
2450
Edwin Crandley
Treatment Related Toxicity Of
Radiation Therapy After Radical
Prostatectomy (RP): Comparative
Effectiveness Of Intensity Modulated
(IMRT) Versus Conformal Radiation
Therapy (CRT)
2451
Dominika Hempel
Testicular Doses In Image-guided
Step-and-shoot Intensity-modulated
Radiotherapy Of Prostate Cancer
Patients
141
2452
Brandon Stone
Inferior Clinical Outcomes in
Intermediate and High Grade Prostate
Cancer with Neuroendocrine
Differentiation is Not Solely Conferred
by Resistance to Androgen
Deprivation
2453
Lawrence Scharf
Correlation Between Bladder Filling
And Changes in IPSS Following High
Dose Prostate Radiation Therapy
2454
Manuj Agarwal
Concordance of Gleason Score
on Biopsy and Prostatectomy in a
Contemporary Cohort of U.S. Veterans
Undergoing Radical Prostatectomy
2455
Colin Murphy
Improved Outcomes in Men Treated
with Adjuvant or Early Salvage
Post-Prostatectomy IMRT or 3DCRT at
a Single Institution
2456
Hiram Gay
Evaluation of 3T Pelvic MRI Imaging
in Prostate Cancer Patients Receiving
Post-Prostatectomy IMRT
2457
Yi Le
Dynamic Dosimetry Using
Ultrasound-Fluoroscopy Registration
Identifies Cold Spots Intraoperatively
During LDR Prostate Brachytherapy
2458
Akash Parekh
Gastrointestinal And Genitourinary
Toxicity And Quality Of Life After
Post-prostatectomy Radiation
Therapy: Are Normal Tissue Dvh
Parameters For Intact Prostate Cancer
Applicable?
2459
William Jackson
Combining Prostate-specific Antigen
Nadir And Time To Nadir Allows For
Early Identification Of Patients At
Highest Risk For Development Of
Metastasis And Death Following
Salvage Radiation Therapy
2460
Kenshiro Shiraishi
(VMAT) in the Treatment of Localized
Prostate Cancer: Initial Experience in
200 Patients
2461
Zachary Nicholas
Comparison Of Intra-operative And
Post-operative Dosimetric Parameters
For The Urethra And Prostate In
Patients Undergoing Low-dose-rate
Prostate Brachytherapy
142
2462
Tiziana Rancati
External Validation of a Model for
the Prediction of Radiation-Induced
Acute GI Toxicity in Prostate Cancer
Patients
2472
Cem Onal
Testicular Doses in Prostate
Intensity-Modulated and
Volumetric-Arc Radiotherapy with
Different Energy Levels
2463
Michael Zelefsky
Predictors of Post Radiotherapy
Hip-Related Toxicity after
Radiotherapy for Prostate Cancer
2473
Amarjit Sen
(SBRT) for Low-Risk Prostate Cancer:
A 3 Way Comparison Between VMAT,
Helical Tomotherapy and Robotic
Radiosurgery Plans
2464
Dorin Todor
Towards A Meaningful Prescription
For Focal Treatments In Prostate
Brachytherapy
2465
Jesse Alexander
Pre-plan Dosimetry As A Predictor Of
Change In Urinary Symptoms After
125I Permanent Prostate Implants
(PPI)
2466
Qingyang Shang
Assessment Of Inter-fractional
Seminal Vesicle Motion And Planning
Margin Using Daily Diagnostic Quality
CT For Prostate Cancer
2467
Edward Obedian
The Risk of Urosepsis in Patients
Undergoing Fiducial Marker
Placement for Image Guided
Radiation Therapy (IGRT) of Prostate
Cancer
2468
Anusha Kalbasi
Early Outcomes and Treatment
Toxicity of Whole Pelvis
Intensity-Modulated Radiotherapy
(WP IMRT) in Node-Positive Prostate
Cancer (PCa)
2469
Mark Ashamalla
Dosimetric Outcome of LDR
Brachytherapy and Influence on
Long-Term Tumor Control and
Toxicity Outcomes in Patients Treated
for Localized Prostate Cancer
2470
Sean McGuire
The Association Of Patient, Tumor
And Treatment Characteristics With
Biochemical Response To
Neoadjuvant Androgen Deprivation
Therapy In Prostate Cancer Patients
2471
Ross Zeitlin
Fiducial Markers, Rectal Saline, and
Rectal Balloons as Prostate
Localization and Stabilization
Strategies in Patients Receiving
Proton Therapy
2474
Shakir Shakir
Migration Evaluation of Gold
Markers Implanted in a Prostate Bed
for Salvage Focal Irradiation
2475
Benjamin Guix
Quality of Life After IMRT or
IMRT+ HDR Brachytherapy for
Intermediate or High-Risk Prostate
Cancer: 8-Year Results of a
Prospective Trial
2476
Madeera Kathpal
Differences Between
Beacon-Localized and Cone-Beam CT
(CBCT)-Localized Radiation Therapy
to the Prostatic Fossa
2477
Sarah Hegarty
Does Post-prostatectomy Radiation
Therapy Expose Patients To Higher
Complications? A Large Medicare
Patient Cohort Study
2478
Nathan Tennyson
Short Term Androgen Deprivation
Therapy Does Not Cause Long Term
Testosterone Suppression Or
Increased Acute Side Effects In
Patients Treated With Brachytherapy
For Prostate Cancer
2479
Seungtaek Choi
Proton Therapy for Prostate Cancer
Does Not Affect Testosterone Level
after Treatment
2480
Ferran Ferrer
Early Toxicity Assessment Of Pelvic
(vmat) With Hypofractionated
Simultaneous Integrated Boost To
Prostate For High-risk Prostate Cancer
2481
Ragini Sindhwani
Quantitative Evaluation Of
Neurovascular Bundle Doses In
Low-dose-rate Prostate
Brachytherapy Using I-125 Seeds
2482
Shruthi Arora
Primary Radiation Therapy Is
Equivalent To Robotic Prostatectomy
Plus Adjuvant Radiation Therapy
In Patients With High Risk Prostate
Cancer
2491
Oleg Sostin
IPSS and SHIM Score Trends in
Prostate Cancer Patients after IMRT:
Effects of Pretreatment Urinary
Function and Electromagnetic
Tracking
2502
Skyler Johnson
The Interval to Biochemical Failure is
Prognostic for Metastasis, Prostate
Cancer Specific and Overall Mortality
Following Salvage Radiotherapy for
Prostate Cancer
2483
Andrew McDonald
Psa Response To Neoadjuvant
Androgen Deprivation Is An
Independent Prognostic Marker And
May Identify Patients Who Benefit
From Pelvic Lymph Node Irradiation
2493
Constantine Mantz
Real-Time Target Tracking Prostate
SBRT Utilizing Varian Trilogy and
the Calypso 4D Localization System:
5-Year Quality of Life and Disease
Outcomes
2503
Caspian Oliai
Prospective Quality Of Life And
Efficacy Of High-dose-rate
Brachytherapy Salvage For Recurrent
Prostate Cancer
2484
Parvesh Kumar
Preliminary Results of an On-Going
Phase I/II Trial of Tri-Modality Therapy
using Hormonal Therapy, Radiation
Therapy (RT) and concurrent
Docetaxel in Patients with High Risk
Pathologic T2-3N0M0 Prostate Cancer
2494
Jay Ciezki
Salvage Brachytherapy for Prostate
Bed Recurrence following Radical
Prostatectomy
2504
Kentaro Nishioka
Safety, Stability, and Location of
Implantation of Multiple Gold Markers
into the Soft Bladder Wall by Rigid
Cystoscopy
2495
Takuya Shimizuguchi
The Benefit Of IMRT On Rectal Late
Toxicity Following Definitive
Radiotherapy For Prostate
2505
Julie Jung Kang
Definitive Chemoradiation in Bladder
Cancer: Whole Bladder vs. Partial
Bladder Image-Guided IMRT
2496
Prachi Jain
Active Surveillance for Prostate
Cancer: A Single Institution
Experience
2506
Daniel Lindsay
Toxicities and Survival of Elderly
Patients with Muscle-invasive Bladder
Cancer Treated with Definitive
Bladder Preservation Therapy
2485
Stephanie Markovina
Risk of Biochemical Failure in Patients
with High Risk Prostate Cancer
Treated Definitively or
Post-operatively With Intensity
Modulated Radiation Therapy
2486
Maria Kelly
Intraprostatic Placement of Markers
and/or Electromagnetic Transponders
in the Radiation Oncology
Department is Associated with
Minimal Morbidity
2487
David Paul D’Souza
Prostate Cancer Brachytherapy:
Does Real-Time Dynamic Ultrasound
Planning with Continuous Feedback
Produce Dosimetry Predictive of the
Subsequent CT/MRI Dose
Distribution?
2488
Kevin Stephens
Salvage Radiation Therapy after
Post-Prostatectomy Failure: Benefits
of Hormonal Therapy and Pelvic
Nodal Radiation Are Not Necessarily
Limited to “High-Risk” Cases
2489
Akash Parekh
No Difference In Late Toxicity With
Postoperative Radiation Therapy
Following Open Or Robotic
Prostatectomy
2490
Matthew Schutzer
Simultaneous Integrated Boost for
Biochemical Failure after
Prostatectomy with a Recurrent
Nodule on Multiparametric MRI
2497
Daniel Shasha
Very High Potency Preservation Rates
in Young Men (< 60) after Radiation
2498
Oren Cahlon
Differences in Baseline Patient
Characteristics in Patients Receiving
Proton Beam Therapy and IMRT for
Prostate Cancer
2499
William Hartsell
Prostate Size Does Not Correlate With
Acute Genitourinary Symptoms In
Patients Treated With Proton Beam
Therapy
2500
Sarah Grabowski
Androgen Deprivation Therapy is
Associated with a Significant Change
in Prostate Volume Throughout
Definitive Radiotherapy for Localized
Prostate Cancer
2501
Skyler Johnson
The Impact Of Anticoagulant Use On
Clinical Outcomes In Men Treated
With Definitive And Salvage
Radiotherapy
2507
E.M. Van der
Steen-Banasi
Laparoscopic Bladder Implantations
In Solitary Bladder Cancer. Inevitable
Evolution?
2508
Curtis Bryant
Bladder-preservation Therapy for
Small Cell Carcinoma of the Bladder
2509
Francesca Caparrotti
Conservative Trimodality Treatment
For Invasive Bladder Cancer: A
Comparative Non-randomized
Study Of Two Chemoradiotherapy
Schedules
2510
Dayssy Diaz Pardo
Neoadjuvant Radiotherapy Improves
Survival In Patients With T2b/T3
Invasive Bladder Cancer
2511
Guy Turgeon
Hypofractionation IMRT in Combined
Modality Treatment for Bladder
Preservation in Elderly Patients With
2512
Javier Lopez-Araujo
Bladder Preservation using
Neoadjuvant Chemotherapy and
Continuous Definitive
Chemoradiotherapy for Muscle
143
2513
William Baquero
Is There Still A Role For Postoperative
Radiotherapy In High Risk Stage III
Renal Cell Carcinoma? A
Retrospective Study
2514
Aamer Mahmud
Management of Nodes in Patients
diagnosed With Penile Cancer Based
on Pathologic Indicators
2515
Yohann Rouscoff
High-dose Rate Interstitial
Brachytherapy For T1-2 Penile Cancer:
A Real Alternative
2516
Roger Macklis
Comparative Review of Radium
Toxicity and Physiology Data
Obtained From Historical DOE
Archives Analyzed in Reference to
Recent Clinical Info For ALSYMPCA
HRPC Bone Mets Ra223 Trial
2517
Abhilasha Patel
Clinical Outcomes of Primary Urethral
Cancer Treated with Multi-Modality
Therapy: A Single Institution
Experience
2518
Sigolene Galland
Multimodality Management In
Primary Urethral Cancer: The Role Of
Radiation Therapy
GYNECOLOGICAL CANCER
2519
Igor Sirak
Incidence of Retroperitoneal Failure
after Pelvic Chemoradiation in
Cervical Carcinoma with Negative
PET/CT Staging of Retroperitoneum
2520
Tamer Refaat
Two-dimensional Volume Based
Pulsed Dose Rate Brachytherapy
Boosting with Concurrent
Chemoradiation As A Definitive
Treatment Modality For Bulky Cervical
Cancer
2521
Omar Chibani
Heterogeneity Effects on
Dose-Volume Parameters used for
Planning Gynecologic High-DoseRate Brachytherapy: A retrospective
CT-based Monte Carlo study
2522
Guangyu Zhang
Adjuvant Pelvic Intensity-Modulated
Radiotherapy and Concurrent
Docetaxel and Cisplatin
Chemotherapy for Postoperative
Cervical Cancer With Adverse Risk
Factors: A Retrospective Report on
Toxicity and Outcomes
2523
Alexander Whitley
Effects of Full vs Empty Bladder on
Total Equivalent Dose to Organs at
Risk in 3D Image-Based Planning of
High-Dose-Rate Intracavitary
Brachytherapy for Cervical Cancer
2524
Yoo Kang Kwak
Comparison of IMRT versus
Conventional Radiotherapy
Concerning Acute Toxicities in
Cervical Cancer Treatment
2525
Emily Dunn
Risk And Benefit Analysis Of
Concurrent Chemoradiation (CRT)
Versus Radiotherapy Alone (RT) For
Cervical Cancer In Patients Age 60
And Older
2526
Jehee Choi
Radiobiological Evaluation of Cervical
Cancer Treatments with HDR
Brachytherapy
2527
Takahiro Oike
Can Combined Intracavitary/
interstitial Approach Be An
Alternative To Interstitial
Brachytherapy In Computed
Tomography-guided Adaptive
Brachytherapy For Gynecological
Malignancies: A Dosimetric Study
2528
Matthew Chin
Outcomes for High Dose Rate (HDR)
Brachytherapy in the Treatment of
Cervical Cancer
2529
Robert Kim
Image-Guided Brachytherapy for
Cervical Cancer: 3-D Analysis of D2cc
and Anatomical Factors Affecting
D2cc in OARs
2530
Marie-Anne Froment
Evolution of the Incidence Cervical
Cancer among Hispanics and Asians
in California between 1990 and 2004
2531
Goro Kasuya
Geometric Factors Predicting High
D2cc Values In Organs At Risk In
Patients With Cervical Cancer Treated
With Image-guided Brachytherapy
144
2532
Masaru Wakatsuki
Carbon Ion Radiotherapy For Locally
Advanced Adenocarcinoma Of The
Uterine Cervix
2533
Goura Rath
Role Of Pet-ct In Predicting Clinical
Outcome In Patients With Recurrent
Carcinoma Cervix Following Definitive
Radiation Therapy
2534
Jinyi Lang
Preliminary Clinical Outcomes and
Dosimetry Study on Adaptive IMRT
Integrated HDR Brachytherapy in
Local Advanced Uterine Cervical
Cancer
2535
Dominique Rash
Lumbosacral Plexus Dose with High
Dose Rate (HDR) Brachytherapy for
Locally Advanced Cervical Cancer
2536
Yang Bo
Dosimetric Comparison Of Volumetric
Arc Modulation With Rapidarc And
Fixed Field IMRT For Cervix Uteri
Radiotherapy
2537
Daisuke Irie
Dose Escalation Study of Carbon Ion
Radiotherapy for Locally Advanced
Squamous Cell Carcinoma of the
Uterine Cervix
2538
Hilary Bagshaw
Patterns of Care with Brachytherapy
for Cervical Cancer
2539
Mary Dean
Outcomes of Cervical Cancer Patients
with PET Positive Lymph Node
Metastases and Bulky Tumors
following PET Guided Intensive
Radiation Therapy and Chemotherapy
2540
Rafi Kabarriti
Therapy in the Treatment of Intact
Cervical Cancer Gives a Low Toxicity
Profile
2541
Takashi Uno
Failure Pattern in Patients with
Intermediate to High Risk Cervical
Cancer Treated with Postoperative
Chemoradiation Using CT-based
Nodal-CTV Delineation
2542
Ravindra Yaparpalvi
Contouring and Constraining Bowel
on a Full-bladder CT-scan as per RTOG
Protocol Guidelines May Not Reflect
Bowel Position and Dose Certainty In
Gynecological EBRT
2543
Wenjuan Chen
Large Tumor Volume Shrinkage For
Cervical Cancer During Imrt
Treatment
2544
Fumiaki Isohashi
Dose-volume Analysis Of Predictors
For Gastrointestinal Complications In
Patients With Cervical Cancer Treated
With Postoperative Pelvic
Radiotherapy And Concurrent
Nedaplatin-based Chemotherapy
2545
Aki Kanazawa
Outcomes of Concurrent
Chemoradiotherapy for
Neuroendocrine Carcinoma of Cervix
2546
Jenny Ling-Yu Chen
Preliminary Clinical Outcomes of
Definitive Intensity-Modulated
Radiation Therapy in Locally
Advanced Cervical Cancer with
Fusion of Full and Empty Bladder at
Computed Tomography Simulation as
Internal Target Volume
2547
Neeta Pandit-Taskar
FDG PET Imaging in Cervical Cancer
Patients Treated with Chemoradiation
Therapy
2548
Lei Ding
Volumetric Dose Summation Between
Brachytherapy Fractions In Patients
Treated For Cervical Cancer:
Feasibility Of Using Deformable
Registration
2549
Emma Fields
Dosimetric Comparison Of Tandem
And Ovoids Versus Tandem Alone
Intracavitary Applicators For
Treatment Of Locally Advanced
Cervical Cancer
2550
Craig Baden
Institutional Outcomes for Paraaortic
Node-Positive Cervical Cancer
Patients Treated with a Novel
Dynamic Field-Matching Technique
2551
Eva Lee
TCP-driven Biological Planning For
High-dose Rate Brachytherapy
2552
Nancy El-Bared
Robotic Radiosurgery Boost for
Cervical Cancer: A Dosimetric Study
2553
Min Rex Cheung
African American Race And Low
Income Neighborhoods Decreased
Cause Specific Survival Of
Endometrial Cancer: A Seer Analysis
2554
Himanshu Nagar
Administration of Concurrent Vaginal
Brachytherapy During Chemotherapy
for Treatment of Endometrial Cancer
2555
Audrey Tetreault
Adjuvant Chemotherapy and Vaginal
Vault Brachytherapy for Stage 1
Papillary Serous or Clear Cell
Endometrial Cancer
2556
Sean Szeja
Efficacy of Radiotherapy for Stage
III-B Endometrial Carcinoma: A SEER
Analysis
2557
Sebastia Sabater
Reduction Of Rectal Doses By
Removal Of Gas In The Rectum During
Vaginal Cuff Brachytherapy
2558
Rashmi Jadon
The Impact of Rectal & Bladder Filling
on Internal Target Volume Margins in
Postoperative Endometrial & Cervical
Cancer Patients
2559
David Guttmann
Outcomes of Patients with
Carcinosarcoma Treated with
Combined External Beam Radiation,
Brachytherapy, and Chemotherapy
2560
Christopher Platta
Daily Variation in Bladder and Rectal
Volume During Post-Operative Whole
Pelvic Intensity Modulated Radiation
Therapy
2561
Mohamed Elshaikh
The Impact of Adjuvant Radiation
Treatment on Survival of Patients with
High-Risk, Early Stage Endometrial
Carcinoma
2562
Shushan Rana
The Role Of Adjuvant Radiation
Therapy In Patients With
Carcinosarcoma Of The Uterus: A
Single Institution Analysis
2563
Yuko Kaneyasu
Ultrasound Sonographic Guided
High-Dose Rate Intracavitary
Brachytherapy for Medically
Inoperable Uterine Endometrial
Cancer
2564
William Magnuson
Impact of Adjuvant Pelvic
Radiotherapy in Stage I Uterine
Sarcoma
2565
Tosol Yu
The Role Of Adjuvant Therapy In
Uterine Sarcomas After Definitive
Surgery
2566
Adam Huddleston
Stage III Endometrial Cancer Treated
With Consolidative Pelvic Radiation:
The Impact of Additional Dose With
Vaginal Brachytherapy
2567
Shari Damast
7Gy x 2- An Effective Brachytherapy
Regimen for Stage I-II Uterine
Papillary Serous Carcinoma
2568
Robyn Banerjee
An Assessment of Organ At Risk
Dose and Inter-Fraction Variability
Using Four Different Applicators
For Intracavitary Gynecologic HDR
Brachytherapy
2569
Michael Dominello
Predictors of Outcome in Early Stage
Papillary Serous and Clear Cell
Endometrial Cancer
2570
Jelena Lukovic
Versus Four-field Box Radiotherapy
For Postoperative Gynecologic
Cancer: Are They Covering The Same
Planning Target Volume Adequately?
2572
Mariwan Baker
Three-dimensional Ultrasound
Assessment For Inter-fractional
Motion Of Uterus
2573
Israel Deutsch
Minimal Vaginal Displacement with
use of a Rectal Balloon During Pelvic
IMRT for Gynecologic Malignancies
2574
Christine ChangHalpenny
Early Stage Papillary Serous or Clear
Cell Carcinoma Confined to or
Involving Endometrial Polyp:
Outcomes With and Without Adjuvant
Chemotherapy or Radiation Therapy
145
2576
Neil Desai
Patterns Of Relapse In Stage I-II
Uterine Papillary Serous Carcinoma
Treated With Adjuvant Intravaginal
Radiation (IVRT)
2577
Nikhilesh Patil
Image Guided Re-irradiation With
High Dose Rate Interstitial
Brachytherapy For Locally Recurrent
Vaginal Tumors
2578
Sang-June Park
Optimal Design and Development of
a New Vaginal Multichannel Cylinder
Applicator for Gynecologic
Brachytherapy
2579
Larissa Lee
Salvage Radiotherapy For
Recurrent Vulvar SCC: Presentation
And Outcome
2580
Sujith Baliga
Sterotactic Body Radiation Therapy in
Oligo-Metastatic Recurrent Ovarian
Cancer
2581
Robert Taylor
High Dose Rate Interstitial
Brachytherapy for Gynecologic
Cancer: Differential Dose Tolerance
Between Proximal and Distal Vagina
2582
John Boyle
Initial Safety and Feasibility of Dose
Escalation Using a Simultaneous
Integrated Boost in Patients with
Locally Advanced Gynecologic
Malignancies
2583
Mazen Mislmani
Gastrointestinal Toxicity After Robotic
(SABR) For Treatment Of Metastatic
Gynecologic Malignancies
2584
Abhilasha Patel
Comparison of Conditional Survival in
Patients with Gynecologic
Malignancies Treated with Radiation:
A Population-based Analysis
2585
Charles Wooten
Low Dose Rate (LDR) Interstitial
Radiation for Gynecologic
Malignancies: A Single Institution
Experience
2586
Indranil Mallick
Prospective Evaluation Of
Dose-volume Parameters
Predicting Acute Diarrhea During
Pelvic Radiotherapy
146
2587
Xiaofeng Yang
Multi-parametric Ultrasound Imaging
Of Vaginal Fibrosis Following
Radiotherapy For GYN Malignancies
2588
Audrey Roux
Inter-Fraction Variation in Cylinder
Position and Dosimetry in Vaginal Cuff
HDR Brachytherapy
2597
Pinaki Dutta
To Evaluate the Role of PET/CT
Imaging in the Post-Operative Setting of Oral Cavity Squamous Cell
Cancers Prior to Adjuvant Radiation
Therapy
2598
Jessika Contreras
Limited Neck Volumes in
Post-Operative Radiotherapy for
Squamous Cell Carcinomas of the
Oral Cavity
HEAD AND NECK CANCER
2589
Naoki Kai
Assessment of Cervical Nodal-level
Involvement in Patients with
Advanced Oral Cancer Treated with
Preoperative Concurrent
2590
Yi-Liang Shen
Can The Contralateral Lower Neck Be
Spared From Postoperative
Radiotherapy For N0-1 Oral Tongue
Cancer?
2591
Jean Hamker
Supersaturated Calcium Phosphate
Rinse on Oral Mucositis in Head and
Neck Patients Receiving Radiation
and/or Chemotherapy
2592
Roshan Prabhu
Association of Preoperative
Radiographic Nodal Status in Addition
to Traditional Pathologic Factors with
Outcomes in Patients with Laryngeal
or Oral Cavity Cancer Managed with
Initial Surgery
2593
Mira Goldberg
A Preliminary Series of The Use of
Stereotactic Radiosurgery (SBRT) In
High Risk Head And Neck Cancer
2599
Jae Hong Han
The Incidence and Patterns of Failure
in Patients with Stage I/II Squamous
Cell Carcinoma of the Oral Cavity (SCC-OC) Treated with Surgery
Alone: Implications for Adjuvant
Radiotherapy
2600
Niranjan Bhandare
The Effect of Pre-existing
Hypertension on Parameters for
Radiation-induced Optic Neuropathy
2601
Edwin Boelke
Prediction Of Requirement Of
Artificial Nutrition By Dosimetric And
Clinical Factors In Head And Neck
Cancer Patients
2602
Tamer Refaat
Whole Field Sequential
(s-imrt) For Local-regional Advanced
Head-and-neck Squamous Cell
Carcinomas
2603
Andy Chen
Clinical Outcomes Associated with
Evolving Treatment Modalities and
Radiation Techniques for
Base-of-Tongue Carcinoma
2594
Michael Herman
Evidence of Efficacy from Radiation
Therapy following Surgery for Oral
Cavity Squamous Cell Carcinoma
2604
Takeshi Yanagi
Usefulness of Induction
Chemotherapy Followed by
Chemoradiation in the Treatment of
Oropharyngeal Carcinoma
2595
Juliette Thariat
Proton Therapy In Uveal Melanomas:
How Relevant Is It To Spare The
Macula When The Optic Disk Is
Involved?
2605
Re-I Chin
Outcomes of Diabetic Metformin
versus Non-Metformin Users with
Oropharynx Carcinoma Treated with
IMRT
2596
Takamasa Mitsuyoshi
Should The Contra-lateral Lower Neck
Nodes Be Irradiated In Postoperative
Radiotherapy For Tongue Cancer?
2606
Edwin Crandley
Analysis Of Treatment Costs And
Outcomes With The Addition Of
Induction Chemotherapy (IC) To
Concurrent Chemoradiation (CRT)
For Oropharyngeal Squamous Cell
Carcinoma (OPSCC)
2607
Ben Durkee
Adaptive Replanning Does Not
Inherently Improve Dose to
Pharyngeal Constrictors in Patients
with Cancer of the Oropharynx
2608
Rebekah Maymani
Unusual Metastatic Follow-Up Seen in
HPV Positive Squamous Cell
Carcinoma of the Oropharynx Treated
with Definitive Therapy
2609
Farzan Siddiqui
Oropharyngeal Cancer In Young
Adults: An Alarming National Trend
2610
Jeffrey Vainshtein
Utility of Post-Chemoradiotherapy
FDG-PET/CT Response for Prediction
of Locoregional Control in HPVrelated Oropharyngeal Cancer
2611
Jeffrey Vainshtein
Molecular Markers and Imaging:
Prognostic Implications for
HPV-related Oropharyngeal Cancer
2612
Moses Tam
Sparing Low-risk Nodes In Node
Positive (n+) Oropharyngeal
Carcinoma (OPC) Improves Dysphagia
Outcomes And Chronic PEG Rates
2613
Moses Tam
Sparing Bilateral Ib And Contralateral
High Level II Nodes In Node Positive
(n+) Oropharyngeal Carcinoma
(OPC) Improves Quality Of Life On A
Prospective Self-reported Xerostomia
Questionnaire
2617
Shahrokh Iganej
Triweekly Carboplatin Alone as
Concurrent Chemothearpy for
Oropharyngeal Carcinoma Treated
with Definitive Chemoradiation:
Outcomes of 120 Unselected patients
and a Comparison to the RTOG 0129
Regimen Results
2618
Umamaheswar Duvvuri
Transoral Robotic Surgery And The
Cervical Unknown Primary: The Utility
Of Discovering Occult Primary Lesions
2619
Junlin Yi
Significant Reduction of Salivary
Gland Volumes After the first
two-week standard fractionation
IMRT For Head and Neck Cancer
2620
Wendy Gao
Local Recurrence And Progression Is
Spatially Correlated With Focal
Pretreatment Fmiso Pet Uptake In
Head And Neck Scc
2621
Yao Yu
T-stage and Presence of Level III-V
Cervical Lymph Node Metastasis
Predict for Submandibular Nodal
Involvement in Patients with
Oropharyngeal Carcinoma:
Implications for Submandibular
Gland-Sparing Intensity-Modulated
Radiotherapy
2622
Laurence Bernier
Regional Outcome In N2-N3 Patients
With Head And Neck Carcinoma In
Function Of FDG PET/CT Results
2614
Abhinav Dewan
A Comparative Dosimetric Analysis
By Delivery Of Adaptive Radiotherapy
In Locally Advanced Head And Neck
Cancer
2623
Patrick Richard
Incidence and Impact of Dental
Amalgam Artifact on Radiotherapy
Target Volumes in Oropharyngeal and
Oral Cavity Cancer
2615
Tobin Strom
Prophylactic PEG Tube Placement
Does Not Decrease the Risk of
Hospitalization in Patients with
Oropharyngeal Squamous Cell
Carcinoma Treated with
Chemoradiotherapy
2624
Hasan Husaini
Eortc Qol Rating, Performance Status
And Oral Outcomes In Head And Neck
Chemoradiotherapy
2616
Todd Carpenter
Prevalence Of Histopathologic
Indications For Adjuvant Radiation
Following Transoral Robotic Surgery
(TORS) For Oropharyngeal Cancer
(OPC) And Its Relation To HPV Status
2625
Susan Guo
Patterns of Metastases in Patients
with Human Papillomavirus/
p16-Associated (HPV+) Squamous
Cell Carcinoma of the Oropharynx
(SCC-OP)
2626
Murat Surucu
Decision Tree Predicting the Tumor
Shrinkage for H&N Cancer:
Implications for Adaptive
Radiotherapy
2627
Patrick Richard
Discrepancy Between
Three-Dimensional Imaging and
Nasoendoscopy Exam for Head and
Neck Cancer: Implications for Staging
and Radiotherapy Target Delineation
2628
Wei Liu
Effectiveness of Robust Optimization
in Oropharynx IMPT Planning
2629
Uttam Sinha
Effects Of UES Dilatation On Head
And Neck Cancer Patients Post
Radiotherapy
2630
Wenyong Tan
Target Volume And Position Variations
During Intensity-modulated
Radiotherapy For Patients With
Locally Advanced Nasopharyngeal
Carcinoma
2631
Su Qiu
Re-irradiation Treatment In 168
Cases Recurrent T1-2 Nasopharyngeal
Carcinoma
2632
Takeshi Kodaira
Clinical Efficacy Of Helical
Tomotherapy For Nasopharyngeal
Cancer Treated With Definite
Concurrent Chemoradiotherapy
2633
Julie Greenwalt
Primary Radiation Therapy for
Adolescent and Young Adult Patients
with Nasopharyngeal Cancer
2634
Brandon Barney
External Beam Radiotherapy Followed
by Stereotactic Stereotactic
Radiosurgery for Primary
Nasopharyngeal Carcinoma with
Intracranial Extension
2635
Pin-I Huang
Efficacy And Factors Affecting
Outcomes Of Re-irradiation Using
Conformal Radiotherapy In Patients
With Locally Recurrent
Nasopharyngeal Carcinoma
147
2636
Sarah Hamilton
Nasopharyngeal Carcinoma (NPC) in
British Columbia (BC): a Population
Based Comparison of Asian and
Non-Asian Patients (pts)
2646
Qichao Zhou
Tumor Control Probability After
Re-Irradiation Using IntensityModulated Radiotherapy For Locally
Recurrent Nasopharyngeal Carcinoma
2637
Qi Shi
Preliminary Results of 18F-FLT PET
and 18F-FDG PET in Evaluating Tumor
Proliferation and Metabolism and
Predicting Response to
Chemoradiotherapy in
2647
Hassan Iqbal
Gemcitabine Cisplatin with
Concurrent Chemoradiation in
Locally Advanced Nasopharyngeal
Carcinoma
2638
Lin Ma
Treatment of Nasopharyngeal
Carcinoma with Helical Tomotherapy:
A Retrospective Study of 190 Cases
in China
2639
Tomohiro Matsuura
Clinical Outcomes Of Imrt Planned
With Or Without Pet/ct Simulation For
Patients With Pharyngeal Cancers
2640
Chiahsuan Lai
Estimation of Life Expectancy and
Quality Adjusted Life Expectancy
in Non-metastatic Nasopharyngeal
Cancer Patients Treated by Intensity
Modulated Radiotherapy With or
Without Chemotherapy
2641
Feng Jin
Induction Chrono-chemotherapy Plus
Radiotherapy For Nasopharyngeal
Carcinoma: A Phase Ii Prospective
Randomized Study
2642
Qichao Zhou
Radiation-Induced Trismus After
Re-Irradiation With IMRT For Locally
Recurrent Nasopharyngeal Carcinoma
2643
Qin Lin
The Value of FDG PET/CT for Early
Predicting the Efficacy of
Radiotherapy in Nasopharyngeal
Carcinoma
2644
Qichao Zhou
Radiation-Induced Massive
Hemorrhage After Re-Irradiation Of
Locally Recurred Nasopharyngeal
Carcinoma
2648
Fiori Alite
Need for Monte Carlo Treatment
Planning in Nasopharyngeal Tumors
2649
Charles Woods
Comparison Between IMRT and 3D
CRT in Laryngeal Cancer Patients
Treated on RTOG 0522
2650
Antonin Levy
Squamous Cell Carcinoma Of The
Larynx With Subglottic Extension: Is
Larynx Preservation Possible?
2651
Kurt Meyer
Patterns of Local Failure in Locally
Advanced Larynx and Hypopharynx
Cancers
2652
Jeffrey Lemons
Can It Stay Or Should It Go? A
Comparison Of T4 Laryngeal Cancer
Management
2653
Sherry Zhao
3DCRT and IMRT Improve Local
Control Versus Opposed Laterals In
Early-stage Squamous Cell
Carcinoma Of The Larynx
2654
Jun Won Kim
Comparison of Treatment
Outcome between Organ-Preserving
Chemoradiation and Radical Surgery
followed by Radiotherapy in Stage III/
IV Hypopharyngeal Cancer
2655
Newton Hurst
Radiographic Evidence of Cartilage
Invasion Does Not Predict Outcomes
for Patients Treated with
Laryngectomy and Adjuvant
Chemoradiation versus
Organ-Preservation Therapy
2645
Feng Mei
Tumor Volume Is An Independent
Prognostic Factor For Local Control Of
Nasopharyngeal Carcinoma Patients
Treated With Intensity-modulated
Radiotherapy
2656
Jolanta MrochemKwarciak
Potential Role Of Albumin And
C-reactive Protein As Prognostic
Factors For Radiotherapy (RT) In
Patients With Head And Neck Cancer
(HNC)
2657
Parag Sevak
Therapy for T1 Glottic Cancer: Initial
Clinical Outcomes
2658
Michael Scott
Toxicities of Radiation Therapy for
the Definitive Treatment of Early
Stage Glottic Carcinoma Comparing
Conventionally and Hypofractionated
Regimens
2659
Niranjan Bhandare
Voice Rehabilitation after Total
Laryngectomy and Postoperative
Radiation Therapy
2660
Vasanthan Sakthivel
Comparison Of Biological Based And
Physical Based Optimization
Algorithm In Treatment Of
Hypopharyngeal Tumors using VMAT
Technique
2661
Jason Sun
Anatomic And Dosimetric
Correlation In The Treatment Of
Advanced Larynx Cancer - When Is
The Brachial Plexus At Risk?
2662
Chunying Shen
Outcomes of Primary Mucosal
Melanoma Originated from
Sinonasal Tract
2663
Kaitlin Christopherson
Radiation Therapy for Sinonasal
Undifferentiated Carcinoma
2664
Justin Peacock
Risk of Delayed Lymph Node
Metastasis in Cases of
Esthesioneuroblastoma With a
Clinically N0 Neck
2665
Yukiko Hattori
Improved Prognosis of Patients with
Nasal N/K T-cell Lymphoma Treated
by Chemoradiotherapy
2666
Marcher Thompson
A Single Institution’s Experience with
Maxillary Sinus Cancer
148
2667
Andrea Russo
Long Term Outcomes after Proton
Beam Therapy for Sinonasal
Squamous Cell Carcinoma
2676
Jeanny Kwon
Role of Adjuvant Postoperative
External Beam Radiotherapy for Well
Differentiated Thyroid Cancer
2668
Makoto Saito
Treatment Outcome Of Combined
Radiation Therapy And Intra-arterial
(IA) Chemotherapy For Advanced
Maxillary Sinus Carcinoma
2677
Natasha Townsend
When do I Radiate? Age Implications
for Differentiated Thyroid Cancer
Management
2669
Mauricio Gamez
Excellent Outcomes and Orbital
Preservation for Advanced T4
Sino-Nasal Cancers using Combined
Chemotherapy, Intensity Modulated
Radiation Therapy and Surgery
2670
Jeffrey Wu
Excellent Long-term Outcomes for
Patients with Localized Low/
Intermediate Grade Parotid Cancers
with Close/Positive Margins
2671
Xiaofeng Yang
Quantitative Ultrasound Evaluation
of Post-Radiotherapy Sialadenitis
and Fibrosis of the Parotid Glands in
Patients following Head-and-Neck
Radiotherapy
2672
Cheng-En Hsieh
Postoperative Radiotherapy for
Salivary Gland Malignancies: Risk
Stratification for the Impact of
Concurrent Chemotherapy
2673
Aileen Kim
Adaptive Treatment Planning with
F-18 FDG-PET and CT Scans to
Optimize Parotid Sparing in Head and
Neck Cancer
2674
Osamu Muraoka
Functional Outcomes Of The Facial
Nerve After Post Operative Radiation
Therapy For High Risk Parotid Gland
Malignancies Underwent Radical
Surgery With Facial Nerve Resection
And Reconstructive Surgery
2675
Nagy Elsayyad
Clinico-Epidemiological
Characteristics and Patterns of
Locoregional Treatment of Soft Tissue
Sarcomas (STS) of the Major Salivary
Glands: A Surveillance
Epidemiology and End Results (SEER)
Database Analysis
2678
Juliette Thariat
External Beam Radiotherapy
Experience In Non-anaplastic Thyroid
Carcinoma, A Rare Cancer Network
Study
2679
Katsuyuki Karasawa
Radioactive Treatment in Patients
with Metastatic Well-differentiated
Thyroid Cancer
2680
Vangipuram Shankar
Deglutition Induced Dose
Deformations In Head And Neck
Cancer IMRT Treatments - Volume
Shuttle Imaging Analysis
2681
Christiane Matuschek
Feasibility Of 6 Months Maintenance
Cetuximab After Adjuvant Concurrent
Chemoradiation Plus Cetuximab In
Squamous Cell Carcinoma Of The
Head And Neck
2682
Bhishamjit Chera
External Beam Radiotherapy is
Associated With Increased Variability
in Retinal Venous Oxygenation
2683
John Vargo
Postoperative Adjuvant Stereotactic
Body Radiotherapy (SBRT) ±
Cetuximab Following Salvage Surgery
in Previously Irradiated Head and
Neck Cancer
2684
Dawn Owen
Stereotactic Radiosurgery for Head
and Neck Malignancies
2685
Yingjie Wang
The Inspiring Treatment of Body
Gamma Knife for Patients with
Pulmonary Metastases Derived From
Adenoid Cystic Carcinoma of the
Head and Neck
2687
Abhishek Solanki
Similar Outcomes in Hispanics and
Non-Hispanics After Radiotherapy
for Head and Neck Squamous Cell
Carcinoma
2688
Abimbola Orisamolu
Setup Uncertainty as Determined by
Daily Image-Guided Radiotherapy
(IGRT) for Head and Neck Cancer
(HNC): Evaluation of Safety and
Implications on Defining Planning
Target Volume (PTV) Margins
2689
Vinita Takiar
Reirradiation of Head and Neck
Cancers: An MD Anderson Update
2690
Marija Popovic
Three-Dimensional Rendering of
Mandibular Dose Distribution: an Aid
in Long-Term Dental Care
2691
Ziwei Wang
Prospective Analysis of Measured
Oral Mucosal Dose and Oral Mucositis
(OM) in Head and Neck Cancer (HNC)
Patients During IMRT
2692
Masaru Takagi
Treatment Outcomes of Proton or
Carbon Ion Radiotherapy for Adenoid
Cystic Carcinoma of the Head and
Neck
2693
Michael Mix
Randomized, Double-Blind,
Placebo-Controlled, Multi-Center
Phase II Trial of Selenomethionine as
a Modulator of Efficacy and Toxicity of
Chemoradiation in Locally-Advanced
Squamous Cell Carcinoma of the Head
and Neck
2694
Waleed Mourad
Lower Cranial Nerves contouring Atlas
for Head and Neck Cancer Radiotherapy
2695
Martin Vallieres
FDG-PET Image-derived Features can
Determine HPV Status in Head and
Neck Cancer
2696
Vinita Takiar
Disease Control and Toxicity
Outcomes Comparing Ruthenium and
Iodine Eye Plaque Brachytherapy in
the Treatment of Intraocular
Melanoma
2697
Randa Tao
Outcomes and Patterns of Recurrence
of Orbital Carcinomas Treated with
IMRT
149
2698
Maria Aguirre
Survival Outcomes of Reirradiation
with Intensity-Modulated Radiation
Therapy (IMRT) for Recurrent Head
and Neck Squamous Cell Carcinoma
2709
Jacob Rasmussen
Prognostic Value Of 18FFluorodeoxyglucose SUVmax in Head
and Neck Cancer Depends On The
Gross Tumor Volume
2699
Kang-Hsing Fan
Treatment Result of Advanced
Synchronous Head and Neck and
Esophageal Cancer
2710
Charlotte Brouwer
Differences In Delineation Guidelines
For Head & Neck Cancer Result In
Inconsistent Dose And Corresponding
NTCP-values
2700
Evrim Bayman
Patterns of Failure After
for Head and Neck Squamous Cell
Carcinoma
2701
Mark Ranck
Improved Local Control In Head And
Neck Cancer With Post-Radiotherapy
Neck Dissection
2702
Henrique Faria Braga
Radiotherapy in Very Advanced and
Unresectable Head and Neck Cancer
(IVB/IVC): When to Avoid Radical
Treatments?
2703
Xiangrong Qi
Feasibility of Margin Reduction for
Level II and III Planning Target Volume
in Head-and-Neck Image Guided
Radiotherapy
2704
Nigel Anderson
Creating Guidelines for Reactive
and Prophylactic Enteral Feeding in
Definitive (Chemo) IMRT for Head and
Neck Cancer
2705
Jonathan Glanzman
Long Term Outcome and Toxicity of
Patients With Head and Neck Cancer
and Coexisting HIV Infection Treated
With Radiation
2706
Azusa Hasegawa
Carbon Ion Radiotherapy for
Adenocarcinoma of the Head-andNeck
2707
Roel Kierkels
Optimizing Treatment Plans with
Multivariable NTCP Models Reduces
Complication Probabilities in Head
and Neck Cancer
2708
Daisuke Miyawaki
Radiation Induced Hypothyroidism
in Squamous Cell Carcinoma of the
Head and Neck: Comparison between
Concurrent Chemoradiotherapy and
Radiation Therapy Alone
2711
Richard Cardoso
A Retrospective Review of
Radiation-Induced Trismus In Head
And Neck Cancer: An M.D. Anderson
Experience
2712
Lauren Herman
Improved Outcomes With
Carboplatin-Paclitaxel Compared to
Docetaxel-Cisplatin-5-Fluorouracil
Induction Chemotherapy in Locally
Advanced Squamous Cell Cancer of
the Head and Neck
2713
Christopher Chapman
Dose-effect Relationship of MRI
Perfusion Changes in the Pharyngeal
Constrictors After Head and Neck
Radiation Therapy
2714
Bahman Emami
NTCP Based Adaptive Radiotherapy in
Head and Neck Cancers: A New Look
Into the Old Bottle
2715
Hee Ji Han
Outcome Of Dental Implants In
Patients With Previous Radiation
History To The Head And Neck Area
2716
Charlene Kan
Allows Better Swallowing Function
than Conventional Radiation in
Patients with Advanced Head and
Neck Squamous Cell Carcinoma
(HNSCC)
2717
Jonathan Glanzman
Patterns of Local Failure in Locally
Advanced Head and Neck Cancers
Treated Using PET-CT Based IMRT
Planning: Does Area of Recurrence
Correlate With Pre-Radiation PET?
2718
Jihye Cha
Cancer Of The External Auditory
Canal: Long-term Clinical Outcomes
Of T4 Patients Using External-beam
Radiotherapy From 1990 To 2012
2719
Cessal Kainickal
Phase IIB Randomized Trial
Comparing Concurrent
Chemoradiation To Six Fractions A
Week Accelerated Radiotherapy In
Advanced Squamous Cell Carcinomas
Of Head And Neck
2720
Nevine Hanna
Relationship of Osteoradionecrosis
of the Mandible to Radiation Dose,
Dmax, and Age in Oropharyngeal
Cancer Patients
2721
Shinn-yn Lin
Comparison of Repositioning
Accuracy and Comfort Survey in Two
Head Supports Used inside the Same
Available Immobilization Systems for
Treatment of Head and Neck Target
2722
Andrew Hoover
Sensitivity of 3 Month Surveillance
PET/CT Imaging Among Head and
Neck Cancer Patients Decreases
with Increasing Length of Clinical
Follow Up
2723
Indranil Mallick
The Planning Target Volume Is An
Important Predictive Factor For
Weight Loss During Curative Head
And Neck Cancer Radiotherapy - A
Derivation And Validation Study
2724
An Liu
Effect Of CT Contrast On Volumetric
Arc Therapy Planning For Head And
Neck Cancer
2725
Adavikolanu Kesava
Ramgopal
Comparitive Study Of Response,
Toxicity And Quality Of Life In
Locally Advanced Head And Neck
Cancers With Concurrent
Chemoradiotherapy With Three
Weekly Cisplatin Vs Weekly Cisplatin
Regimen
2726
Madhava Kanakamedala
Central Necrosis In Lymph Nodes On
CT Scan Predicting Extra Capsular
Extension In Nodes With Biopsy
Proven Head And Neck Malignancies
2727
Madhava Kanakamedala
Reirradiation Of Head And Neck
Cancers: Volume Reirradiated Predicts
For Long Term Complications
150
2728
Shivank Garg
Re-irradiation For Second Primary
Or Recurrent Cancers Of The Head
And Neck: Composite Dosimetric
Measures To Evaluate Dose To The
Carotid Arteries
2738
Shilpen Patel
Primary Tracheal Malignant
Neoplasms: a Single Institution
Retrospective Analysis of Treatment
and Outcomes
2729
Jennifer Logue
Comparing Acute Toxicity Outcome
of Chemoradiotherapy Regimens in
HEALTH SERVICES RESEARCH
2730
Clementina Ramos
Bilateral Neck Irradiation Confers a
Higher Risk of Developing
Hypothyroidism in Patients with Head
and Neck Cancer
2731
Manpreet Tiwana
Head and Neck Cancers as Second
Primary Following an Index Head
and Neck Cancer: Population-Based
Outcomes over a 25 Years Period
2732
Jasbir Jaswal
Teaching Oncology Residents
Anatomy: A Novel, Hands-on
Multidisciplinary Teaching
Intervention
2733
Pretesh Patel
Reduced Volume Irradiation for Head
and Neck Cancer of Unknown Primary
(HNCUP)
2734
Ava Golchin
Reduction In Tumor Volume
Following Induction Chemotherapy
For Locally Advanced Squamous Cell
Carcinoma Of The Head And Neck
Improves Parotid Dosimetry
2735
Nataliya Kovalchuk
Correlation between Long-Term
Outcome and Volumetric Changes
in Primary and Nodal Tumors during
Intensity Modulated Radiotherapy for
2736
Lihong Zhu
An Investigation of 125I Seed
Permanent Plantation for Recurrent
Carcinoma in the Head and Neck
after Surgery and External Beam
Radiotherapy
2737
Kaleigh Doke
Quantitative Effects Of Head And
Neck Lymphedema Therapy
2739
Ruben Quek
Determinants Of The Combined Use
Of External Beam Radiation Therapy
And Brachytherapy For Low-risk
2740
Andrew Pearce
Evaluation of Canada’s First Radiation
Oncology Treatment Facility Operated
by Telemedicine
2741
Ruben Quek
The Role Of The Urologist In Whether
Locoregional Prostate Cancer Patients
Consult With A Radiation Oncologist
2742
Daniel Chang
Factors that Determine Academic
versus Private Practice career interest
in Radiation Oncology Residents in
the United States: Results of a
Nationwide Survey
2743
Anand Shah
Malignant Pleural Mesothelioma
Patients’ Willingness to Participate
in a Randomized Controlled Trial of
Radical Pleurectomy With or Without
Intraoperative Photodynamic Therapy
2749
Marie Andree Fortin
Assessing The Benefits Of
Implementing An Oncology
Electronic Medical Record In A New
Cancer Center
2750
Aidan Leong
Integration Of A 3D Virtual
Radiotherapy Environment System
For Clinical Patient Education
2751
Timothy Robinson
Longitudinal Trends In Costs For
Palliative Radiation For Metastatic
Prostate Cancer
2752
Joshua Elson
Risk Of Unplanned Hospitalization
During Treatment With Concomitant
Radiochemotherapy
2753
David Grew
The Impact of Superstorm Sandy
on the Care of Radiation Oncology
Patients
2754
Benjamin DiPardo
Dramatic Variation in the Global
Burden of Esophageal Cancer: A
Disability-Adjusted Life Years
Approach
2755
Nadine Housri
Non-white Women Are As Likely As
White Women To Receive
Hypofractionated Radiotherapy For
Breast Cancer, But Less Likely To Enroll
In Hypofractionation Clinical Trials
2744
Malcolm Mattes
The Evolving Role of Regional
Radiation Oncology Societies in
Resident Education
2745
Zachary Seymour
Interval from Imaging and Treatment
in the Radiosurgery Era: How Long is
Too Long?
2746
Shayna Rich
Offering and Enrolling Patients in
Outcomes Tracking or Clinical Trials
2747
Rebecca Clayman
Addressing The Growing Cancer
Burden In The Wake Of The Aids
Epidemic In Botswana: A
Collaborative Partnership
2748
Abigail Berman
Standardizing the Radiation Oncology
Medical Student Elective: A Novel
Curriculum and Evaluation of Student
Satisfaction
2756
Abhilasha Patel
Persistent Disparities in Hispanics
with Cervical Cancer in a Major City
2757
Julie Carlson
Improving Quality Of Life and
Increasing Cost Effectiveness For
Cervical Cancer Patients
2758
Rishabh Kapoor
Development of the Veteran Health
Administration - Radiation Oncology
Quality and Safety initiative
(VHA-ROQSI)
151
2759
Gita Suneja
Cancer in Botswana: A Prospective
Cohort Study of Cancer Type,
Treatment, and Outcomes
2769
Sachin Gulaya
Population-based Study Of
Comorbidity And Non-cancer
Mortality In Head And Neck Cancer
2760
Justin Bekelman
The National Radiation Oncology
Registry: Approaches to
Regulatory Compliance to Promote
Wide Participation
2770
Nathan Sheets
Two-Year and Lifetime CostEffectiveness of Intensity Modulated
Radiotherapy versus 3-D Conformal
Radiotherapy for Head and Neck
Cancer
2761
Archie Bleyer
Breast Cancer Mortality Reduction in
the United States between 1969-2009
was Independent of Screening
Mammography in the Nine
Geographically Disperse SEER
Regions: More Evidence for Less
Benefit of Screening Mammography
2762
Christina Cramer
Decreased Radiation Utilization
During The Economic Crisis Of
2008-2009
2763
Ajay Kapur
Inter-rater Variability in the
Assessment of Skin Reactions in
Breast Cancer Radiation
Therapy-Impact of Grading Scales
2764
Jason Efstathiou
Practice-based Evidence To
Evidence-based Practice: Initial
Challenges In Building The Nror
2765
Benjamin Mou
Effect of Radiation Therapy on
Survival in Rectal Cancer Patients in a
Canadian Province: A
Population-based Analysis
2766
Nitika Thawani
Utilization Of Lean Process
Improvement During Introduction Of
Stereotactic Body Radiotherapy And
Radiosurgery To Decrease Patient
Rescheduling
2767
Nirav Kapadia
SBRT And Surgery For Stage I NSCLC
are Associated with Comparably Low
Rates Of Acute Toxicity
2768
Timothy Showalter
Complications of post-prostatectomy
radiation therapy for prostate cancer:
Outcomes from Longitudinal Health
Care Utilization Database of the
Regione Emilia-Romagna, Italy
2771
Mark Sittig
Therapy Represents a Cost-Effective
Modality to Deliver Whole Breast
Irradiation: A Toxicity Analysis
2772
Christine Min
Whole Brain Radiation Therapy with
Stereotactic Radiosurgery Boost
versus Stereotactic Radiosurgery
Alone for Brain Metastases: A
Cost-effectiveness Analysis
2773
Joseph Hodges
Cost-Effectiveness Analysis of
Versus Single-Fraction External Beam
Radiation in Painful Vertebral Body
Metastases
2774
Jeffrey Vainshtein
Collaborative Quality Initiative in the
Treatment of Breast and Lung Cancer:
An Important Step Toward High
Quality Cost-Effective Care
2775
Thomas Lanni
Cost Analysis of Alternative
Treatment Modalities Utilized in the
Management of Early-Stage Testicular
Seminoma
2776
Elayne V. Arterbery
Total Societal Cost Of Care: Analysis Of
Partial Breast With Apbi Or Iort Versus
Conventional Versus Accelerated
External Beam Regimens For Breast
Conservation
2777
Jennifer Dorth
A Decision Analysis of Primary
Radiotherapy and Androgen
Deprivation Therapy Versus Radical
Prostatectomy for High-Risk Prostate
Cancer
2778
Arie Dosoretz
Cost-Effectiveness Research and
Radiation Oncology: An Analysis of
the Published Literature
2779
Heather Curry
Utilization of Hypofractionation in an
Insured Population
2780
John Greskovich
Improving Healthcare Value in
Patients with Stage III-IV Squamous
Cell Carcinoma of Head and Neck
(HNSCC): Cost and Outcome
Comparison of Two Arms of a
Randomized, Phase III Trial of
Definitive ChemoRadiation
(ChemoRT)
2781
Ewa Szumacher
Decisional Support For Women 60
Years And Older During Their
Treatment For Stage I And Ii Breast
Cancer - Single Institutional Study
2782
Eli Furhang
Emergency Preparation For Radiation
Oncology: Lessons Learned From A
Natural Disaster
2783
Nicolas Goldstein
Impact of Expected Survival On
Decision Analysis For Single Versus
Multiple Fractions of Palliative
Radiation For Bone Metastases
HISTORY
2784
Emma Holliday
Standing on the shoulders of giants:
Initial Results from the Radiation
Oncology Academic Development
and Mentorship Assessment Project
(ROADMAP)
2785
Gurleen Dhami
Gender Distributions in Radiation
Oncology Residency Compared to
Other Specialty Residencies: A 20-year
Perspective
2786
Ann Morris
The Radiation Oncology In-Training
Exam: An Appeal for Better Testing
2787
Sudha Amarnath
Publication Misrepresentation Among
Radiation Oncology Residency
Applicants
2788
Christina Chapman
United States Radiation Oncology
Residency Diversity Over the Past
Twenty Years
152
INFORMATICS
3088
Rogier Janssen
Development Of A Protocol-Driven
Script Content Management System
For A Commercial Radiotherapy
Treatment Planning System
3089
Faisal Vali
A Software Architecture and
Application for Reporting on and
Analyzing Radiation Plans for
Concordance with Ideal Dose
Constraints as a Quality Assurance
Parameter
3090
Gary Walker
Prospective Randomized
Double-Blind Study of Atlas-Based
Autosegmentation Assisted Radiation
Treatment Planning in Head and Neck
Cancer
3091
Deshan Yang
A Computer Software Tool For
Comprehensive Plan Quality
Evaluation
3092
Seth Blacksburg
Characterizing the Adoption of
Automated, Decision-Based
Electronic Checklists in a Busy
Academic Practice
3093
Seth Blacksburg
Improving the Quality and
Composition of Electronic
Documentation in a Highly Utilized
Electronic Medical Record
3094
Yuliang Jiang
Normal Tissue Toxicity Criteria in
Radiation Therapy
3095
Tobias Fechter
Malignant Glioma Delineation in
Amino Acid PET-Images Using a 3D
Random Walk Approach
3096
Joseph Moore
Multi-institutional/technique Dose
Comparisons Using Overlap Volume
Histograms For Difficulty
Normalization
3097
Christine Ball
Three Years of RTDS - A British Success
Story
3098
Lindsey Appenzoller
Applicability of a General Predictive
DVH (pDVH) Model to Rare Treatment
Sites with No Prior Training Data
2792
Kaori Asai
Spontaneous Pneumothorax After
Stereotactic Body Radiotherapy For
Lung Tumor
3099
Lindsey Appenzoller
Efficient Method to Train pDVH
Models with Plan Quality Variation
Present in the Training Cohort
2793
Yongchun Song
Studies On The Mobility Rules Of Lung
Tumors And The Influencing Factors
3100
Lulin Yuan
Modeling Organs at Risk Dose Sparing
in Head and Neck TomoTherapy and
IMRT Plans: A Comparison Study
3101
Marc-Andre Renaud
WebTPS: A Complete Web
Application for Monte Carlo
Treatment Plan Recalculation
3102
Mark Izadbakhsh
Oncology Information system (OIS):
Building a Large Integrated and
Centralized Oncology System to
Improve Quality and Safety of Patient
Care
3103
Michael Fan
Design Of A Novel Django Web-based
Tool For IMRT/VMAT Treatment Plan
Verification And Evaluation
3104
Hao Zhang
Prostate Cancer Foci Detection and
Aggressiveness Identification Using
Multi-parametric MRI/MRS and
Supervised Learning
3105
William Yuh
Topology of DCE MR Perfusion
Pattern within Cervical Cancers
during Radiation Therapy
3106
Anil Pyakuryal
Clinical Application of the Histogram
Analysis in Radiation Therapy (HART):
An Open-Source Software System in
Radiation Oncology
LUNG CANCER
2790
Amar Kishan
Correlation of Clinical and Dosimetric
Parameters with Radiographic Lung
Injury Following Stereotactic Body
Radiotherapy
2791
Lin Zhou
Radiation Pneumonitis following
Simplified Intensity-modulated
Radiation Therapy for Lung Cancer
2794
Raymond Mak
Outcomes after Lung Stereotactic
Body Radiation Therapy in Patients
with KRAS-mutant Non-Small Cell
Lung Cancer
2795
Pengyue Shi
The Relationship Of Serum Nse Level
And Metabolic Tumor Volume Or Total
Lesion Glycolysis As Determined By
Fdg Pet In Patients With Recurrent
Small Cell Lung Cancer
2796
Suzhen Wang
Correlation Of Mediastinal Metastatic
Lymph Nodes Displacement With
Primary Tumor Displacement And
Adjacent Organs Based On 4dct In
2797
Norio Katoh
A Retrospective Multicenter Study of
Using a Real-time Tumor-tracking
Radiotherapy System for Stage I
2798
Aruna Turaka
Twice-daily versus Once Daily
Radiotherapy in an Unselected
Limited-Stage Small Cell Lung Cancer
Patients: “Medicine-Based” Evidence
2799
Maria Werner-Wasik
A Phase II Study of Erlotinib (ERL) and
Hypofractionated Thoracic
Radiotherapy (HRT) in Patients (Pts)
with Non-Small-Cell Lung Cancer
(NSCLC) and Comorbidities
2800
Cameron Swanick
Toxicity and Local Control with
Therapy (IMRT) Using a Simultaneous
Integrated Boost (SIB)
Hypofractionated Approach for
Non-small Cell Lung Cancer (NSCLC)
2801
Naamit Gerber
Brain Metastases in EGFR-Mutated
Lung Cancer: Is Radiotherapy
Necessary?
153
2812
Victor Mangona
Clinical Outcomes After Central versus
Peripheral Stereotactic Lung
Radiotherapy (SBRT): A Propensity
Score Matched-Pair Analysis
2822
Shalini Garg
Patterns Of Locoregional Failure In
Stage III Non-small Cell Lung Cancer
Managed With Definitive
Chemoradiotherapy
2803
Bing Lu
Concurrent Chemoradiotherapy For
Stage Iv Non-small Cell Lung Cancer:
Results Of A Prospective,
Single-center Study
2813
Marco Trovo
Plasmatic Cytokine Levels in Lung
Cancer Patients Undergoing
Definitive Radiation Therapy
2823
Yu Men
Clinical Analysis And Role Of
Radiotherapy In Combined Small Cell
Lung Cancer - A Report Of 44 Patients
2804
Bing Lu
The Role Of Thoracic Threedimensional Radiotherapy For
Non-small Cell Lung Cancer Patients
With Bone Oligometastases
2814
Daniel Arsenault
Are Insurance Companies Driving the
Decision Making Process for Stage I
Non-Small Cell Lung Cancer (NSCLC)
Patients?
2824
Aidan Cole
Impact Of 4-Dimensional CT (4D-CT)
On Toxicity, Outcomes And Dose
Escalation For Radical Lung Cancer
Radiotherapy
2805
Diana Lu
Comparison of Intensity-modulated
Radiotherapy, Adaptive Radiotherapy,
Proton Radiotherapy, and Adaptive
Proton Radiotherapy for Small Cell
Lung Cancer
2815
Matthew Orton
Evaluation of Diabetes as a Risk Factor
for the Development of Clinically
Symptomatic Pneumonitis Following
(SBRT)
2825
Omar Mahmoud
Thoracic-Only Extensive Stage Small
Cell Lung Cancer: Assessment of the
Benefit of Thoracic and Brain
Radiotherapy Using the SEER
Database
2806
Tetsuo Saito
Impact of Respiratory Gating on
Tumor Position Variability during
Lung Cancer
2816
Nicholas Zaorsky
Identification Of Kras Mutation In A
Patient With Non-small Cell Lung
Cancer Treated With
Chemoradiotherapy And
Panitumumab: A Possibility To
Personalize Cancer Therapy
2826
Richard Cattaneo
Differentially Dosed Stereotactic Body
Radiation Therapy for the Treatment
of Lung Cancer with Limited Nodal
Metastasis in Patients Unable to
Receive Chemotherapy
2802
Theo Sottero
The Role of Radiation and
Trimodality Treatment for Malignant
Pleural Mesothelioma
2807
Huanpeng Qi
Comparative Study Of The Position
and Volume Of Related Anatomical
Structures Between Quiet
End-inspiration and End-expiration
Three Dimensional CT Assisted With
Active Breathing Control and
Corresponding Phases in Four
Dimensional CT
2817
Joe Chang
Clinical Outcome and Toxicity in
Central Located Stage I or Isolated
Recurrent Non-Small Cell Lung Cancer
Treated with Stereotactic Ablative
Radiotherapy
2808
Jeremy Harris
Prognostic Metrics on Serial PET for
Lung Tumors Treated with
Hypofractionated Radiation
2818
Byounghyuck Kim
Factors Associated With
Radiation Pneumonitis After
Concurrent Chemoradiation For
2809
Steven Lau
in Octogenarians With Early Stage
Lung Cancer
2819
Benjamin Hinton
SBRT Lung: Fiducial Migration Based
on Fiducial Type and Anatomic
Location
2810
Michael Milano
Non-small Cell Lung Cancer (nsclc)
After Breast Cancer (bc): A
Population-based Analysis Of
Clinicopathologic Features And
Overall Survival (os) In 3,529 Women
2820
Wenjue Zhang
Thoracic radiation and Prophylactic
Cranial Irradiation in Extensive Small
Cell Lung Cancer: A Phase II Trial
2811
Ming Chen
A Study of the Correlations Between
the Irradiated Dose to Lymph Node
Regions and Lymph Node Recurrence
When Involved Field Radiotherapy
Was Used for Limited-stage Small Cell
Lung Cancer
154
2821
Zongmei Zhou
4D-CT-based Plan Target Volume
Definition In Imrt Of Lung Cancer:
Comparison With A Conventional
Technique Using General Margins
2827
Aruna Turaka
Effectiveness and Timing of
Prophylactic Cranial Irradiation (PCI)
in Limited Stage Small Cell Lung
Carcinoma (LS-SCLC) Patients: A
Single Institution Experience
2828
Shaun Din
Brachial Plexopathy After High Dose
(SBRT)
2829
Nilan Naik
High Local Failure Rates Despite
Dose Escalation May Support the
Metastatic Self-Seeding Phenomenon
in Non-Small Cell Lung Cancer
2830
Ellis Ziel
Survival Outcomes in Patients with
Non-Squamous Non-Small Cell Lung
Cancer Treated with Pemetrexed- vs
Non-Pemetrexed-based
Chemoradiotherapy
2831
Dhwani Parikh
The Role of PET/CT in Radiation
Treatment Planning for Non-Small
Cell Lung Cancer: Results of a National
Survey
2832
Chen Guanhao
Variation Of Background Activity
Effect Pet-based Gross Tumor Volume
In Non-small-cell Lung Cancer:
Individual Information Is Needed
2833
Jaehyeon Park
Postoperative Radiotherapy For
Incompletely-resection Non-small
Cell Lung Cancer
2834
Wen Feng
Patterns of Local-regional Failure in
Completely Resected Stage IIIa(N2)
Non-Small-Cell Lung Cancer Patients:
Implications for Postoperative
Radiotherapy Target Volumes
2835
Izumi Tachibana
Clinical Results of Definitive Radiation
Therapy for Postoperative
Loco-regional Recurrence of
Non-Small Cell Lung Cancer (NSCLC)
2836
Wenyang Liu
Functional Avoidance Of Lung In IMRT
Plan With SPECT Imaging
2837
Yoshiyuki Shioyama
Stage I Small-cell Lung Cancer:
Clinical outcomes in a Japanese
Multi-institutional Retrospective
Study
2842
Chisa Hashizume
Aggressive Treatment for T1/2N0M1
Lung Cancer (LC) with Metastasis
(MET) Only to the Brain: Stereotactic
Body Radiotherapy (SBRT) for Primary
Tumor Following Stereotactic
Radiosurgery (SRS) or Surgery for
Brain MET
2843
Kruti Patel
Addition of 4D CT Simulation
Decreases Normal Tissue Irradiation
and Target Exclusion Compared to 3D
CT Simulation Alone in NSCLC
2844
Hannah Yoon
Predictive Factors for Brain
Metastases and Relapse and
Prognostic Factors for Survival in
Stage III-IV Non-Small Cell Lung
Cancer
2845
Raj Rajpara
Increasing Pretreatment Tumor
SUVmean is Associated with Local
Regional Failure after Chemoradiation
for Locally Advanced Non-Small Cell
Lung Cancer
2846
Elisabetta Parisi
Tomotherapy In The Treatment Of
Malignant Pleural Mesothelioma
2838
Lauren Hertan
Evolution of and Predictors for
Pulmonary Fibrosis Following
Definitive Thoracic Radiation Therapy
2847
Stephen Bowen
Establishing Dose-volume
Associations With Grade 3+ Radiation
Pneumonitis Incidence: Implications
For VMAT Dose Painting Of Lung
Cancer
2839
Zhouguang Hui
Postoperative Radiotherapy for
Elderly Patients with Resected
Pathological Stage IIIA-N2 Nonsmall-cell Lung Cancer
2848
Nicolas ChristianPhase II Study of Hypofractionated
Radiotherapy in the Treatment of
Oligometastatic Non Small Cell Lung
Cancer
2840
Takaya Yamamoto
Reassessing The Prognostic Value Of
The Maximum Standardized Uptake
Value (suvmax) In Fdg-pet By
Correcting For The Partial Volume
Effect And Respiratory Motion Blur In
Stage I Non-small-cell Lung Cancer
Treated With Stereotactic Body
Radiotherapy
2849
Lu Bing
A Prospective Study with Concurrent
Chemotherapy and Thoracic
Three-dimensional Radiotherapy for
Stage IV Non-small Cell Lung Cancer:
The Impact of Response on Survival
2841
Lujun Zhao
Is Postoperative Radiotherapy
Necessary for Patients With
Completely Resected Small-Cell Lung
Cancer: A Retrospective Analysis
2850
Entesar Dalah
Partial Volume Effect Corrected
Metabolically Active Tumor Volume
From PET For Early-stage Lung Cancer
2851
Hualei Li
Automated Co-segmentation Of
Tumor Volume And Metabolic Activity
Using PET-CT In Non-small Cell Lung
Cancer (NSCLC)
2852
Neil Woody
Non Small Cell Lung Cancer With
Single Brain Metastasis At Initial
Presentation: Patterns Of Failure After
Radiosurgery Without Whole Brain
Radiation Therapy
2853
Jordan Torok
Patterns of Distant Metastases in
Surgically Managed Early Stage
Non-Small Cell Lung Cancer
2854
Stephanie Casey
The Impact of Respiratory Gating
on Toxicity Outcomes for Locally
Advanced Lung Cancer Treated With
Radical Intensity Modulated
Radiotherapy and Chemotherapy
2855
Shaun Din
Predictive Parameters of Stereotactic
Body Radiation Therapy Induced
Chest Wall Pain
2856
Yuki Mukai
Comparison of Intensity Modulated
Radiation Therapy planning using
TomoDirect and TomoHelical
methods in locally advanced
2857
Hong-Qing Zhuang
Primarily Analysis Of Radiation
Pneumonitis And Its Risk Factors In
Patients With Non-small Cell Lung
Cancer Treated With Concurrent
Erlotinib And Thoracic Radiotherapy
2858
Lujun Zhao
The Efficacy And Safety Of
Simultaneous Integrated Boost
Intensity-modulated Radiotherapy In
Patients With Stage III Small Cell Lung
Cancer
2859
Akihiro Haga
What Respiratory-Phase CT Is Optimal
In Treatment Planning Of Lung
Cancer?
2860
Sudha Amarnath
Toxicity and Outcomes with the Use
of Intensity Modulated Radiation
Therapy in Locally Advanced Lung
Cancer: The University of Washington
Experience
2861
Zhe Ji
Thoracic Re-Irradiation May Be an
Option for Recurrent, Metastatic or
Secondary Primary Non-Small Cell
Lung Cancer
155
2862
Lu Bing
The Study on Importance of
Three-dimensional Radiotherapy For
Elderly Patients With Stage IV
2863
Isabelle Thibault
(SBRT) for Primary Non-Small Cell
Lung Cancer (NSCLC) and Pulmonary
Metastases: Analysis of Outcomes and
Predictive Factors for Local Control
2864
John Varlotto
Is N-Level Associated with Local
Recurrence in Patients undergoing
Surgical Resection of Non-Small Cell
Lung Cancer?
2865
Kotoha Tatekawa
Focal Radiotherapy for Pleural
Dissemination of Thymic Epithelial
Tumors: Excellent Local Control and
Favorable Prognosis
2867
Fumiya Baba
Evaluation of the Reproducibility of
Lung Tumor Position in
Respiratory-Gated Stereotactic
Body Radiotherapy (SBRT) Using
Fluoroscopy of an On-Board Imager
(OBI) System
2868
Daniel Schanne
Pulmonary Changes In FDG-PET/CT
After Cure Of Small Lung Tumors With
(SBRT): Which Imaging Features Can
Be Expected?
2869
Ben Fischer-Valuck
Outcomes Following Stereotactic
Body Radiotherapy For Biopsy Proven
Versus Radiographically Diagnosed
Early-stage Non-small Cell Lung
Cancer
2870
Dean Shumway
Assessing The Predictive Value of
Cytokine Levels for Radiation-induced
Esophagitis In Combination With
Clinical and Dosimetric Parameters
In Patients Treated for Non-small Cell
Lung Cancer
2871
Anthony Michaud
Volumetric Changes in Gross Tumor
Volume during Thoracic Radiation
Therapy for Small Cell Lung Cancer:
Implications for Adaptive Re-Planning
2872
Bradley Stish
Patterns of Intrathoracic Recurrence
and the Impact of Adjuvant Thoracic
Radiation in Patients Undergoing
Definitive Resection of Small Cell
Lung Cancer
2873
Xiong Wei
Improved 5-year Disease FreeSurvival And Distant Metastasis-Free
Survival For Patients WithLimitedStage Small Cell Lung Cancer Who
Had 18F-fluorodeoxyglucose Positron
Emission Tomography (PET) Or PET/CT
Before Chemoradiation Therapy
2881
Dmitriy Meshkov
Pre-radiotherapy FDG PET Predicts
Radiation Pneumonitis In Non-Small
Cell Lung Cancer (NSCLC) Patients
2882
Elizabeth Garay
Prognostic Factors For Post-resection
Recurrent NSCLC Treated With
Definitive Radiotherapy
2883
Allison Ashworth
Is There an Oligometastatic State in
Non-small Cell Lung Cancer (NSCLC)?
A Systematic Review of Outcomes and
Prognostic Factors
2874
Jonathan Grant
Dosimetric Impact Of Induction
Chemotherapy On Subsequent
Radiation Treatment Planning In
Patients With Inoperable Non-small
Cell Lung Cancer
2884
Maria Werner-Wasik
Comparison of PET Contouring
Methods in Patients with Early Stage
Resected Non-Small Cell Lung Cancer
(NSCLC): A Pathologic-Imaging
Correlation
2875
Ritsuko Komaki
Duration of Thoracic Radiotherapy
with concurrent chemotherapy is
important for the outcome of Patients
with Limited Stage Small Cell Lung
Cancer (L-SCLC)
2885
Syed Haider
Correlation of Survival to CBCT-based
Tumor Response during
Chemoradiation in Patients with
Stage III Non-Small-Cell Lung Cancer
2876
Tarun Podder
Chest Wall and Rib Irradiation of Lung
Cancer Patients Treated With Robotic
Radiosurgery SBRT
2877
Leonard Ong
Prognostic Value Of Pre And
Post-radiotherapy [18F]FDG-PET/CT
Metrics In Limited-stage Small Cell
Lung Cancer
2878
Inga Grills
Prospective Phase II Trial of Moderate
Dose Image-guided Stereotactic Lung
Radiotherapy (SBRT) for Early Stage
Non-small cell lung cancer (NSCLC)
and Pulmonary Metastases with Serial
18FDG-PET Imaging and Pulmonary
Function Testing (PFT)
2879
Nathan Cannon
For Octogenarians With Lung Cancer:
A Single Institution Retrospective
Review
2880
ChengCheng Fan
Risk Factors For Locoregional
Recurrence In Patients With Completely Resected N1 Non-small Cell
Lung Cancer And Implications For
Adjuvant Radiotherapy
2886
Mei Ling Yap
Dosimetric Variations To Organs At
Risk Based On Serial 4D-CT Scans
During Radiotherapy Treatment For
Patients With Locally Advanced
2887
Min Li
Deformable Registration of Lung
Computed Tomography Images Using
Biomechanical Model
2888
Nian Xiao
Toward Individualized Fractionation
Schedule For Lung Cancer
Radiotherapy
2889
Yankhua Fan
The Dependence of Optimal
Fractionation Scheme on Dose
Distribution, Tissue Damage Model
and Prescription Dose in Radiation
Therapy of Lung Cancer
2890
Mirjana Josipovic
Deep Inspiration Breath Hold
Radiotherapy for Advanced Stage
Lung Cancer is Feasible and Facilitates
Lung Toxicity Reduction
2891
Luis Larrea
Experience In Stereotactic
Radiotherapy For Lung Cancer
156
2892
Scott Lester
Salvage Radiation For Mediastinal
Relapse After Treatment With
Accelerated Hypo-fractionated
Radiotherapy (AHRT) Or Stereotactic
Body Radiotherapy (SBRT) For Stage
I/II NSCLC
2893
Matthew Manning
An Overall Survival Comparison of
Sub-Lobar Resection with
Brachytherapy versus Stereotactic
Body Radiotherapy for Early Stage
2894
Carey Myers
Inhibition of Aurora A Increases
Sensitivity to Radiotherapy in
Selected Lung Cancer Cell Lines
2895
Trevor Lewis
Predictors of Symptomatic Radiation
Pneumonitis (SRP) in Lung Cancer
Patients Treated with
Hypofractionated Radiotherapy
(H-RT)
2896
Carey Myers
A Novel Radiation-Induced p53
Mutation is Not Implicated in the
Development of Radiation Resistance
2897
Julian Kim
Dose Escalated Hypofractionated
Intensity Modified Radiation Therapy
(IMRT) with Concurrent
Chemotherapy for Inoperable or
Unresectable Non-Small Cell Lung
Cancer (NSCLC)
2898
Michael Binkley
Lung Volume Reduction After
Stereotactic Ablative Radiotherapy of
Lung Tumors: Potential Application to
Emphysema
2899
Todd Aguilera
Novel Imaging Biomarkers In Stage I
Non-small Cell Lung Cancer Treated
With Stereotactic Ablative
Radiotherapy
2900
Matthew Schutzer
Re-Irradiation for Locally Recurrent
Non-Small Cell Lung Cancer with
Stereotactic Body Radiotherapy as
Initial or Salvage Treatment
2901
Weijun Chen
The Impact of The CT Dataset Used
for Dose Accumulation on Target
and Normal Tissue Doses in Adaptive
Radiotherapy for Lung Cancer
2902
Eric Xanthopoulos
Prophylactic Cranial Irradiation In
Extensive-stage Small-cell Lung
Cancer
2903
Michael Soike
Image Guided Radiotherapy Results In
Improved Local Control In Lung
Fractionated Radiotherapy For Stage
IIB-IIIB Disease
2904
Megan Daly
Does Early Post-Treatment
Surveillance Affect Subsequent
Management Following SBRT for Early
Stage Non-Small Cell Lung Cancer?
2905
Ling Li
Total Lesion Glycolysis (tlg) At
Baseline Fdg-pet/ct May Predict
Survival Better Than Maximum
Standard Uptake Value (suvmax) In
Non-small Cell Lung Cancer (nsclc)
2906
Fiori Alite
Does Conformality Matter In
Evaluating Plans For SBRT For Tumors
Of The Lung?
2907
Abdullah Rasheed
The Effects of Abdominal
Compression on the Motion and
Volume of the GTV, Lungs & Heart in
Lung Cancer Patients
2908
Jeremy Kilburn
Is A Clinical Target Volume (CTV)
Necessary In Treatment Of Thoracic
Malignancies Treated In The Modern
Era Combining 4-D Imaging And
Image Guided Radiotherapy (IGRT)?
2909
Nhu Tram Nguyen
Pulmonary Function Test and its
Predictive Factors in Patients with
Lung Malignancies Treated with
Stereotactic Radiotherapy: a
Retrospective Review from a Single
Institution
2910
Katsuyuki Karasawa
Three Dimensional Non-coplanar
Conformal Radiotherapy with
75Gy/25fr/5w Regimen for the
Treatment of Stage I NSCLC - 10-year
Experience
2911
Haoming Qiu
Esophageal Toxicity in Lung SBRT:
When it Happens and How to
Prevent it
2912
Mitsuhiko Oguri
Influence Of Interstitial Pneumonitis
In The Lung On Acute Exacerbation Of
Interstitial Pneumonia In The Patients
Treated With Stereotactic Body
Radiation Therapy For Lung Cancers
2913
Katarina Petras
Predicting Symptomatic Pneumonitis
in Lung SBRT Patients Using Decision
Tree Analysis
2914
Shilpen Patel
Clinical Outcomes of Radiotherapy for
Resected Thymoma
2915
Shilpen Patel
Improved Survival with Prophylactic
Cranial Irradiation in Modern Cohort
of Limited Stage Small Cell Lung
Cancer Patients with MRI Brain
Imaging
2916
Stefano Arcangeli
Is Hypofractionated (Chemo)
Radiation Delivered with Helical
Tomotherapy a Feasible Option to
Escalate the Dose in Locally Advanced
Inoperable NSCLC? Results from a
Phase II Trial
LYMPHOMA
2917
Mehmet Koc
18F-Fluorodeoxyglucose Positron
Emission Tomography/Computed
Tomography (18F-FDG PET/CT)
Maximum Standardized Uptake Value
(SUVmax) As A Prognostic Factor In
Adult Hodgkin’s Lymphoma Patients
2918
Fransisco Mestre
Prognostic Value Of Angiogenic
And Invasion Markers In Hodgkin
Lymphoma
2919
Jianzhong Cao
The Efficacy Of Chop Regimen Based
Concurrent Chemoradiotherapy In
Patients With Nasal Extranodal
Natural Killer/ T-cell Lymphoma: A
Comparison Among Treatment
Modalities
2920
Rahul Parikh
Long-term Outcomes and Patterns of
Failure in Orbital Lymphoma Treated
with Primary Radiotherapy
157
2930
Piera Navarria
Low Dose Total Marrow/total
Lymphoid Irradiation (tmi/tli) Instead
Of Tbi Induce Full Donor Chimerism
Before T-replete Haploidentical
Transplantation
2940
Yoshiro Matsuo
Impact of Symptom Rescue by
Fractionated Radiotherapy for Rare
Angiogenetic Neoplasm of the
Abdomen, Vertebra, and Head and
Neck Regions
2922
Xu Li-ming
Dosimetric Evaluation And Treatment
Outcome Of Intensity-modulated
Radiotherapy Following
Doxorubicin-based Chemotherapy
For Primary Mediastinal Large B-cell
Lymphoma
2931
Reem Ujaimi
Pulmonary Toxicity Following Total
Body Irradiation for Acute
Lymphoblastic Leukemia: The Ottawa
Hospital Cancer Centre (TOHCC)
Experience
2941
Arshin Sheybani
The Risk of Radiation Induced
Malignancy with Heterotopic
Ossification Prophylaxis: A Case
Control Analysis
2923
Qingfeng Liu
Immunophenotypic Analysis And
Clinical Heterogeneity In Patients
With Extranodal Nasal-type Nk/t-cell
Lymphoma Of The Upper
Aerodigestive Tract
2932
John Mikell
Similar Survival for Patients
Undergoing Reduced-Intensity TBI
versus Myeloablative TBI as
Conditioning for Allogeneic
Transplant in Acute Leukemia
2924
Ranh Voong
Radiation Therapy is a Very Effective
Modality in the Treatment of Mantle
Cell Lymphoma, > 80% Complete
Disppearance of Disease SIte in
Heavily Pretreated Patients
2933
Daniel Kim
Late Lung And Thyroid Toxicities From
Total Marrow And Lymphoid
Irradiation For Patients Undergoing
Hematopoietic Stem Cell
Transplantation
2925
Emiko Katayama
FDG-PET May Be Useful In
Radiotherapy For Indolent MALT
Lymphoma
2934
Sung-Hsin Kuo
Clinicopathologic Features and
Responses to Radiotherapy of
Granulocytic Sarcoma
PALLIATIAVE CARE
NON-MALIGNANT DISEASE
2945
Bryan Barriger
Poor Performance Status and
Transportation Requirements Predict
for Failing to Complete a Course of
Radiation Therapy
2921
Jessica Freilich
Combining Low-Dose Whole Brain
Radiation with Radioimmunotherapy
for Primary Central Nervous System
Lymphoma
2926
Mustafa Adli
(SUVmax) As A Prognostic Factor In
Non-Hodgkin’s Lymphoma Patients
2927
Chelsea Pinnix
Therapy using Frontal Technique with
Active Breathing Control in the
treatment of Gastric MALT lymphoma:
Implications for Normal Tissue
Sparing
2928
Samuel Shin
Feasibility and Efficacy of Local
Radiotherapy with Concurrent
Novel Agents in Patients with Multiple
Myeloma
2929
Shane Lloyd
Acute Treatment Toxicity and the Risk
of Infection during Total Skin Electron
Beam Therapy for Mycosis Fungoides
158
2935
Waleed Mourad
Twenty Five-year Outcome Of Benign
Lymphoepithelial Cysts Of The Parotid
Glands In Seropositive HIV Patients
2936
Oliver Blanck
Cardiac Radiosurgery: Preliminary
Results in a Porcine Model and
Possible Implications for the
Treatment of Atrial Fibrillation
2937
Juergen Dunst
Adjvant HDR-Brachytherapy for
Treatment of Recurrent Keloids
2938
Jonathan Glanzman
Surgical Resection Followed by High
Dose Rate Brachytherapy With
Iridium- 192 for Management of
Keloids at High Risk for Recurrence
2939
Florence Wright
A Renewed Application of
Intracoronary Brachytherapy for
In-Stent Restenosis at a High-Volume
Catheterization Center
2942
Michele Nedelka
Radiotherapy For Early Stage Palmar
And Plantar Fibromatosis: A
Treatment Option For Patients Who
Wish To Avoid Disease Progression
And Surgery
2943
Waleed Mourad
Clinically Predictive Nomogram for
Heterotopic Ossification Following
Surgical Repair and Radiotherapy for
Displaced Acetabular Fractures
2944
Sara Alcorn
Patterns of Fractionation of Palliative
Radiotherapy: A Single-Institution
Experience
2946
David Wilson
A Phase II Pilot Single Arm
Prospective Clinical Trial of the STAT
RAD Workflow for Osseous
Metastases: Preliminary Results
2947
Shane Lloyd
Radiation Oncologists’ Attitudes and
Intentions Regarding Palliative
Radiation Therapy near the End of Life
2948
Jeffrey Friedman
From Whole Brain to Hospice: Patterns
of Care in Radiation Oncology
2949
Ehsan Balagamwala
Which Factors Determine Pain Relief
from Spine Radiosurgery in Patients
with Spine Metastases? Results from a
Large Single Institution Series
2950
Jee Suk Chang
FDG-PET As A Predictor Of Outcome
Following Radiotherapy For Bone
Metastasis In Patients With
2951
Kirtesh Patel
Intracranial Control for Adjuvant
Whole Brain Radiotherapy Versus
Stereotactic Radiosurgery Alone for
Resected Brain Metastases
2952
Joshua Meyer
Pain Palliation Of Bone Metastases
Using Magnetic Resonance Guided
Focused Ultrasound - Analysis Of
Factors Predicting Success
2953
Jinyu Xue
Implication of Biological Doses in
Whole Brain Radiation and
Radiosurgery of Multiple Metastases
2954
Rebecca Wong
Palliative Radiation For Spinal
Metastases: Does The Presence Of
Soft Tissue Disease Affect The Choice
Of Treatment Dose And Fractionation?
2955
Isabel Prieto
Fentanyl Pectin Nasal Citrate, To
Control Breakthrough Pain Provoked
By Routine Radiotherapy Procedures
And Maneuvers In Advanced Cancer
Patients
2956
Alexandra Sherman
Does Palliative Radiation Improve
Performance Status?
2957
Luis Mariscal
Hypo-fractionated Stereotactic Body
Radiotherapy (SBRT) for Pelvic or
Sacral Recurrence
2958
Diandra Ayala-Peacock
(SBRT) and Image-Guided
Accelerated Hypofractionated
Radiotherapy (IGAHRT) for the
Treatment of Oligometastatic Cancers
2959
Shilo Lefresne
A Multidisciplinary Rapid Access
Clinic - Providing more than just Rapid
Access
PATIENT-REPORTED
OUTCOMES
2960
Winnifred Wong
L-lysine In The Treatment Of Oral
Mucositis In Head And Neck Cancer
Patients - A Pilot Study
2961
David Jung
Incidence and Risk Factors for Pain
Flare Following Spine Radiosurgery
2962
Dan Ou
Magnetic Resonance Sialography to
Evaluate Radiation-induced
Xerostomia in Patients with
Early-stage Nasopharyngeal
Carcinoma
2963
Jordan Kharofa
Patient Reported Outcomes in
Patients with Non-Melanomatous
Skin Cancers of the Head and Neck
(NMSCHN) Treated with Superficial
Radiation Therapy
2964
Jessica Zhou
The Effect Of Resistance Exercise
Training On Health-related Quality Of
Life Of Head And Neck Cancer
Patients Undergoing Definitive
Chemoradiation: Results Of A Pilot
Study
2965
Malolan Rajagopalan
Initial Report of a Prospective Phase
II Study Including Patient-Reported
Quality of Life Data of Stereotactic
Body Radiotherapy (SBRT) for Patients
with Oligometastatic Disease
2966
Ashlyn Tom
Prevalence of Patient-Reported
Gastrointestinal Symptoms and
Concordance with Clinician Toxicity
Assessments in Radiation Therapy for
Anal Cancer
2967
David Nowotnik
Results From The Multi-institutional,
Randomized, Double-blind,
Placebo-controlled Trial To Assess The
Efficacy Of A Mucoadhesive Hydrogel
Rinse In Mitigating Oral Mucositis
(OM) In Chemoradiation-treated (CRT)
Head And Neck Cancer (HNC) Patients
2968
Chika Nwachukwu
Health Related Quality of Life in
Pediatric Patients with Low Grade
Glioma
2969
Sheema Chawla
Geriatric Assessment In Radiation
Oncology Clinic: A Pilot Study
2970
Abhilasha Patel
Quality of Life Outcomes in Patients
with Prostate Cancer treated with
Nodal Irradiation
2971
Chenyang Wang
Health State Utilities for Patients
Who Underwent Stereotactic
Radiosurgery With or Without Whole
Brain Radiotherapy
2972
Daniel Bernad
Comparison of Bowel and Urinary
Function in Rectal Cancer Patients
Undergoing Pre-Operative Endorectal
Brachytherapy Or External Beam
Radiotherapy and Total Mesorectal
Excision
2973
Terence Sio
Dosimetric Correlate of Cancer and
Cardiac-specific Survival in 231
Patients Who Received Both External
Beam Radiation Therapy (EBRT) and
Percutaneous Coronary Intervention
2974
Robert Olson
Prospective Evaluation of Unmet
Needs of Rural Cancer Survivors:
Comparison between Rural
Aboriginal and non-Aboriginal
Communities
2975
Frank Vicini
The Use of Bioimpedance
Spectroscopy to Monitor Therapeutic
Intervention in Patients Treated for
Breast Cancer Related Lymphedema
2976
Ankit Agarwal
Demographic Determinants of
Mortality in Prostate Cancer Patients
at a Diverse Academic Medical Center
2977
Divya Ahuja
Demographic Determinants Of
Mortality In Breast Cancer Patients At
A Diverse Academic Medical Center
2978
Daniel Simpson
Racial Disparity In Consultation,
Treatment, And The Impact On
Survival In Metastatic Colorectal
Cancer
159
2979
Sommer Wild
Screening Practices And Factors
Impacting Screening Uptake In Breast
And Prostate Cancer Survivors
2989
Annette Souranis
Comparison of Setup Accuracy by
Immobilization Type in Image-Guided
Lung Radiotherapy
PATIENT SAFETY
2990
Jason Molitoris
Initial Findings With The Use Of A
Novel Performance Metric To Identify
Institutional Rates Of Radiation
Discontinuation
2980
Yunfeng Cui
Credentialing in Hippocampal (HC)
Sparing Techniques for RTOG 0933:
Quality Assurance (QA) Report
2981
Richard Valicenti
Effectiveness Of Hospital-based
Incident Reporting And Learning
System To Manage Radiation
Treatment Errors
2982
Hui Geng
The Impact of Thread Effect on
Tomotherapy Quality Assurance With
Cylindrical Diode Detector Array
2983
Daniel Letourneau
Linear Accelerator Performance
Monitoring and Improvement using
Semi-Automated Testing and
Statistical Process Control
2984
Pirus Ghadjar
Use Of Eortc Target Definition
Guidelines For Dose Intensified
Salvage Radiotherapy For
Recurrent Prostate Cancer. Results Of
The Quality Assurance Program Of
The Randomized Trial Sakk 09/10
2985
Wai Wang Lam
Quality Assurance of Helical
Tomotherapy Stereotactic
Radiosurgery Treatment Using
Cylindrical Diode Array System
2986
Tony Quang
Privilege and Immunity-An
Underutilized Tool in the Quality
Improvement Program
2987
Katsunori Yogo
Verification Of A Commercial
Monte-carlo Electron
Dose-calculation Algorithm Under
Clinical Use For Treatment Of Breast
And Total Scalp Irradiation
2988
Bin Yang
A Comparison of the Dosimetric
Properties of a Plastic Scintillator-CCD
and a Fluorescent Screen-CCD System
in QA of Radiotherapy Beams
2991
Lydia Handsfield
Pre- And Post-Treatment QA
Procedures Proposed To Eliminate
Phantom-Based QA On Tomotherapy
2992
Ingrid Marshall
HDR Plan Verification Of Source
Position And Dose Accuracy Using A
Fluence Detector
2993
Marjan Admiraal
Enhancing Quality and Safety of
VMAT using Failure Mode and Effect
Analysis
2994
Matthew Nyflot
Computerized End-of-planning
Checks To Improve Patient Safety
Based On One Year Of Near-miss
Incident Reporting Data
2995
Tingtian Pang
Quality Evaluation of An Automatic
VMAT Planning Method For Head And
Neck Cancer Cases
2996
Danny Duplan
Peer-review Chart Rounds as a
Component of the Automated
Workflow in a New Department
2997
Alexander Lin
Image Approval Rates for Daily
Image-Guided Radiotherapy (IGRT)
in a Large, Academic Group Setting:
Variation by Physician Familiarity with
the Patient
2998
Rohan Deraniyagala
Improving Patient Safety One Error at
a Time: Implementing an Electronic
Error-reporting System in a Radiation
Oncology Clinic
2999
Hamid Ghaffari
Assessing Tumor Coverage and
Organ-At-Risk Doses during
Intra-Fraction Motion via Probability
Mass Function of Real-Time
Respiratory Trajectories
3000
Katherine Fan
Impact of a Single-Day
Multidisciplinary Clinic on the
Management of Pancreatic Cancer:
3-Year Update
3001
James Lamb
Automated Patient Identification and
Localization Error Detection Using
X-Ray Setup Images
3002
Alexander Markovic
Using Multi-Criteria Plan Quality
Metrics to Perform an Objective,
Retrospective Analysis of Complex
Head and Neck Plan Quality
Differences Between Different VMAT
Vendors
3003
Musaddiq Awan
Interdisciplinary Variation in
Segmentation of High-Risk
Post-Operative Tumor Volumes in the
Head and Neck
3004
David Rosenthal
A Dosimetric Comparison of
Pharyngeal Constrictor Segmentation
Methods During Radiation Treatment
for Head and Neck Cancer
3005
David Eastham
The Impact of Standardized IMRT
Templates on Treatment Plan Quality
3006
James Mitchell
Prospective Peer Review in a
Non-Academic Radiation Oncology
3007
Wanbao Gao
Medical Event Threshold for
Permanent Brachytherapy Must be
Greater Than 20%
3008
Huong Pham
Use of the Patient Safety Alert (PSA)
System to Improve the Treatment
Verification Process
3009
Elayne V. Arterbery
Lean Thinking: A Comprehensive
Hospital Strategy for Implementing
State-of-the-Art Breast Intraoperative
Radiation Therapy (IORT) in a
Community Setting
3010
Neil Martin
Development And Implementation
Of Customized Software For Physician
Peer-review And Clinical Care
160
3011
Steve Braunstein
Increasing Compliance With
Documentation Using Modern
Electronic Health Record Systems
Towards Quality Improvement in
Radiation Practice Medical Coding
3012
Michael Gensheimer
Simple Rule for Prediction of Parotid
Gland Sparing Early in the Radiation
Treatment Planning Process
3013
Ryan Best
Automated Evaluation of Radiation
Treatment Plans for Protocol
Constraints to Reduce Planning Time
3014
Zachary Lopater
Selecting Ideal Patients to
Replan - Novel Use of IMRT QA
Software Aids in the Decision When
to Replan
3015
Pranshu Mohindra
Standardized Intensity Modulated
Radiotherapy (IMRT) Workflow to
Allow Adequate Scheduling Notice for
Patients Treated at a Busy Academic
Radiation Oncology Center: Results of
a Pilot Study
3016
Brian E. Butler
Standardization and Implementation
of IMRT Among Multiple Institutions
and Multiple Countries
3017
Srinath Sundararaman
Improving Patient Safety in the
Radiation Oncology Setting Through
Crew Resource Management
3018
Shereef Elnahal
Patient Factors that Predict Physician
Room Time and Downstream Clinical
Encounters in a Pancreatic
Multidisciplinary Clinic
3019
Dawn Henrich
An Innovative Collaboration And
Workflow Management Platform For
Surface Electronic Brachytherapy
PEDIATRIC CANCER
3020
Rimpa Basu Achari
Three Dimensional Conformal
Radiation Therapy, Volumetric
Intensity Modulated Arc Therapy and
Helical Tomotherapy for pediatric
craniospinal irradiation: Dosimetric
analysis of integral dose
3021
Chia-Ho Hua
Postoperative Metabolic Abnormality
in Craniopharyngioma Patients Before
Proton Therapy
3022
Kaitlin Christopherson
Factors Impacting Long-term Local
Control in Non-Metastatic
Medulloblastoma
3023
Andrew Hollander
Pencil Beam Scanning (PBS) Proton
Therapy in a Fixed Beam Room for
Treatment of Pediatric Brain Tumors
3024
Benjamin Greenberger
Mature Clinical Outcomes of Proton
Radiation for Pediatric Low-Grade
Gliomas
3025
Sean McBride
The Impact of Socioeconomic Factors
on Health-Related Quality-of-Life
(HR-QoL) After Proton Radiotherapy
for a Pediatric CNS cohort
3026
Noelle Williams
Late Effects Following Radiotherapy
for Childhood Low-Grade Glioma
3027
Joseph Panoff
The Role of Radiation Therapy
Technique and Dose for Pediatric
Patients with Diffuse Intrinsic Pontine
Glioma
3028
Patrik Brodin
Impact of Treatment Margins and
Treatment Technique in Hippocampal
Sparing Radiotherapy for Pediatric
Medulloblastoma
3029
Adam Willson
Estimating the Excess Lifetime Risk of
Radiation-Induced Secondary
Malignancy (SMN) in Pediatric
Patients Treated With Craniospinal
Irradiation (CSI): Tomotherapy (Tomo)
Versus Conventional (Conv) Beams
3030
Joanna Yang
Intensity-Modulated Radiation
Therapy with Dose-painting: A
Brain-sparing Technique for
Intracranial Germ Cell Tumors
3031
Ashwin Ram
A Prospective Study of Corpus
Callosum Regional Volumes and
Neurocognitive Outcomes Following
Cranial Radiation for Pediatric Brain
Malignancies
3032
Reid Thompson
A Study Of Dosimetry And
Radiation-induced Toxicity In The
Developing Dentition Of Pediatric
Patients With Head And Neck Cancer
3033
Christine Hill-Kayser
Outcomes after Proton Therapy for
Pediatric Patients with Cancers of the
Head & Neck Region
3034
Matthew Ladra
Proton Radiation Therapy for
Rhabdomyosarcoma: Preliminary
Results From a Multicenter
Prospective Study
3035
Amber Orman
The Essential Role of External Beam
Radiotherapy in the Management of
Advanced Stage Retinoblastoma
3036
Atmaram Pai Panandiker
Role of Radiotherapy in the
Management of Chemorefractory
Distant Metastatic Disease in Children
with High-Risk Neuroblastoma
3037
Shravan Kandula
Outcomes After Definitive Radiation
Treatment Of Metastatic Sites In
Patients With Stage IV Neuroblastoma
3038
Atmaram Pai Panandiker
4DMRI Provides More Accurate Renal
Motion Estimation for IMRT in Young
Children
3039
Maja Maraldo
Estimated Doses and Late Effects
Risks After Involved Node, Involved
Field and Mantle Field Treatment for
Pediatric Hodgkin lymphoma
3040
Mustafa Adli
(SUVmax) As A Prognostic Factor
In Pediatric Hodgkin’s Lymphoma
Patients
3041
Minh-Phuong Huynh-Le
A Comparison of Involved Field
Radiation Therapy Treatment
Outcomes in Pediatric and Young
Adult Hodgkin Lymphoma
161
3042
Steven Engel
The Role of Low Dose Radiation
Therapy in Adolescents/Young Adults
with Hodgkin’s Lymphoma
3043
Melissa LeMieux
Decrease in the Incidence of Second
Malignancies in Patients with Early
Stage Hodgkins Disease Treated in the
Modern Radiotherapeutic Era
3044
Omar Gayar
Pediatric Head And Neck Carcinoma:
Patient Demographics And Treatment
Outcomes: A SEER Database Study
3045
Milos Miljkovic
The Frequency, Severity, and Duration
of Treatment-Related Lymphopenia in
Children with Cancer
3046
Stephanie Terezakis
Clinical Practice Patterns of Pediatric
Image-Guided Radiation Treatment:
Results from an International Pediatric
Research Consortium
3047
David Barron
Radiation-induced Osteochondromas
Revisited: A Retrospective Update
3048
David Westerly
Proton Energy Requirements for
a Dedicated Pediatric Treatment
Machine
3053
Jonathan Klein
Health Related Quality of Life in
Head and Neck Cancer Treated with
Radiation Therapy With or Without
Chemotherapy: A Systematic Review
3054
Christina Son
The Impact of Hormonal Therapy on
Sexual Quality of Life in Men
Receiving Intensity Modulated
Radiotherapy for Prostate Cancer
3055
Tsz Kin Lee
Problems Encountered during
Cultural Adaptation of the EPIC
Questionnaire for Prostate Cancer
into Punjabi and Chinese
3056
Penny Fang
High BMI Associated with Worse
Quality of Life in Breast Cancer
Patients Receiving Radiotherapy
3057
Henry Wagner
Cancer Treatment Consent Forms Are
Still Difficult to Read
3058
Sarah Milgrom
The Acute Effects of Pelvic Irradiation
on the Adult Uterus by Dynamic
Contrast-Enhanced MRI
3059
Vipul Nautiyal
Assessment Of Salivary Output And
Quality Of Life In Patients Of Locally
Advanced Head And Neck Cancers
Treated By Intensity Modulated
Radiotherapy (IMRT)
QUALITY OF LIFE
3049
Katherine Hutcheson
Early Experience with IMPT for the
Treatment of Oropharyngeal Tumors:
Acute Toxicities and Swallowingrelated Outcomes
3050
Zachary Seymour
Toxicity and Quality of Life After
Hypofractionated Stereotactic Body
Radiotherapy for Low and
Intermediate Risk Prostate Cancer
3051
Yu Tang
Quality of Life after Intensity
Modulated Radiation Therapy (IMRT)
for Anal Cancer
3052
Stephen Lewis
An International Survey of
Definitive SABR for Extra-cranial
Limited Metastases
162
3060
Yoshiya Yamada
Clinically Meaningful Improvement In
Quality Of Life For Patients Who Have
Undergone Stereotactic Radiosurgery
For Spinal Metastases
3061
David Randolph
Impact of Radiosurgical
Management of Geriatric Patients
with Brain Metastases: Clinical and
Quality of Life Outcomes
3062
Allen Chen
Functional Outcomes and Quality of
Life after Definitive Chemoradiation
for Human Papillomavirus-Positive
Oropharyngeal Cancer: Implications
for Dose De-Escalation
3063
Dustin Boothe
Qualitative and Quantitative Distress
Assessment of Cancer Patients Using
the NCCN Distress Thermometer
SARCOMA AND SKIN CANCER
3064
Daniel Adam Jones
Management Of Unplanned Excision
For Soft-tissue Sarcoma With
Pre-operative Radiotherapy Followed
By Definitive Resection
3065
John Vargo
The Role of Radiation Therapy in
Primary and Radiation Induced
Angiosarcoma of the Breast: Impact
on Patterns of Failure
3066
Hubert Pan
Acute Skin Toxicity of Electronic
Brachytherapy for Non-Melanoma
Skin Cancer
3067
Richard Cassidy
Function Preservation after
Conservative Resection and
Radiotherapy for Soft Tissue Sarcoma
of the Distal Extremity as Evaluated
by the Toronto Extremity Salvage
Score (TESS)
3068
Michael Scott
Radiotherapy for
Hemangiopericytoma
3069
Tyler Hollen
Squamous Cell Carcinoma of the
Lip: A Retrospective Analysis of the
University of Florida Experience
3071
Omar Mahmoud
Timing of Adjuvant Chemotherapy/
External Beam Radiation Therapy and
Its Impact on Extremity Soft Tissue
Sarcomas Outcome
3072
Paul Menzel
Combined Ipilimumab and
Radiotherapy for Metastatic
Melanoma
3073
Masaharu Hata
Radiation Therapy for Extramammary
Paget’s Disease: Treatment Outcomes
and Prognostic Factors
3074
Adam Willson
Treatment Outcomes and Patterns of
Failure for Desmoplastic Melanoma
3075
Alexander Falk
Improved Outcomes with Iterative
Local Treatments of Oligometastases
in Sarcomas: a French Sarcoma Group
Study
3076
Daya Nand Sharma
Perioperative High-dose-rate
Interstitial Brachytherapy in Patients
with Soft Tissue Sarcomas
3087
Subhakar Mutyala
Clinical outcomes for 3 Dimensional
Topographic Applicator
Brachytherapy for Non-Melanoma
Skin Cancer
3077
Young Il Kim
Reproducibility Evaluation of Tissue
Expander in Patients with
Retroperitoneal Sarcomas Treated by
Postoperative Radiotherapy
RADIATION AND CANCER
BIOLOGY
3078
Laura Kollar
Solitary Fibrous Tumors: A
Multidisciplinary Approach
3107
Steve Braunstein
Operational Signaling Pathways in
Radiation-Induced Tumors
3079
Keith Cengel
External Beam Radiotherapy With Or
Without 131I-MIBG Systemic
Radiotherapy In The Therapy Of
Patients With Malignant
Pheochromocytoma And
Paraganglioma
3108
Kalash Ronny
Significant Epigenetic Changes in
Irradiated Lungs of Fibrosis -Prone
C57BL/6NHsd Compared to FibrosisResistant C3Hf/Kam Mice
3080
Beatriz Amendola
High Dose Rate (HDR) Brachytherapy
for Facial Non Melanoma Skin Cancer
(NMSC) Using Custom Made Molds
and a Shortened Fractionation
Schedule
3081
Jessica Rooney
Local Control and Functional
Outcomes of Limb Sparing
Multimodality Therapy for Hand and
Foot Soft Tissue Sarcoma: The Mayo
Clinic Experience
3082
Manpreet Bedi
Evaluation of Neoadjuvant Therapy
Response in Adult Soft Tissue
Sarcoma using Dynamic
Contrast-Enhanced MRI
3083
David Rainey
Treatment of Resectable Intrathoracic
Sarcomas: A Single Institution
Experience Over Twenty Years
3084
Lindsay Warner
Prognostic Value Of Tumor Response
In Pediatric And Adult Patients With
Ewing Sarcoma
3085
Upendra Parvathaneni
Non Regional Distant Nodal
Metastases in Merkel Cell CarcinomaA Common and Unappreciated
Pattern of Failure
3086
Upendra Parvathaneni
Novel Single Fraction Radiation
Therapy approach on Merkel Cell
Carcinoma Metastases - An Update
3116
Ji-Hong Hong
Temporal and Spatial Changes of
Myeloid-derived Suppressor Cells
(MDSCs) in the Tumors and Peripheral
Blood after High-dose Tumor
Irradiation
3117
Mary-Keara Boss
Radiation Induces Epithelialmesenchymal Transition In An In Vitro
Mammary Carcinoma Tumor Model
3109
Benjamin Greenberger
Characterizing Cell-Specific
Radiation Sensitization Induced by
HDAC Inhibition
3110
ShengJun Ji
Radiation-induced Hippocampal
Neurogenesis Impairment and
Cognitive Deficits Is Associated with
Inhibition of BDNF-Trk-B Signaling
3111
Sophia Bornstein
Investigation of the Tumor-Initiating
Cell Microenvironmental Niche in
Recurrent Head and Neck Squamous
Cell Carcinoma Using a Novel
Microenvironment Microarray
Platform
3112
Jiang Ji
Ionizing Radiation Induces Cell Cycle
G1 Arrest And Tumor Suppressor
Gene P16, P21, P27 Expression In
Keloid Fibroblasts
3113
Encouse Golden
The Immunogenic Signature of
Platinum and Radiation
3114
Richard Bakst
Are Schwann Cells a Target in
Radiation for Perineural Invasion?
3115
Anthony Apicelli
Reduced Brain Neurofibromatosis
Type 1 (Nf1) Tumor Suppressor Gene
Expression Confers Differential
Sensitivity To Ionizing Radiation In
Vivo
3118
Norma Ybarra
In Vitro Analysis of HPV-Dependent
Radiosensitivity of Head and Neck
Squamous Cell Carcinoma and
Normal Tissue Cell Lines
3119
Frank Houghton
Relative radiosensitivity of Human
Inducible Pluripotent Stem Cells
(hiPSC) compared to parent fibroblast
line and Cells of Differentiated Neural
Rosettes
3120
Mahesh Kudrimoti
Instantaneous Blood Flow And
Oxygenation Changes Noted In Real
Time During Radiation Therapy
Delivery In Head/neck Squamous
Cancers
3121
Sungjune Kim
Impact Of Radiation-induced
Autophagy On The Efficacy Of
Combination Radiotherapy And
Immunotherapy
3122
Jin-lu Ma
Role Of Hgk In Vasculogenic Mimicry
Formation In Non-small Cell Lung
Cancer
3123
Scott Bratman
Stromal Contributions To Radiation
Resistance Of Breast Cancer Stem
Cells
3124
Encouse Golden
Radiation Promotes a Dose-Response
Induction of Immunogenic Cell Death
3125
Encouse Golden
Paclitaxel Enhances the Immunogenic
Signature of Radiation
3126
Encouse Golden
Circulating HMGB1 Levels Increase
in Locally Advanced Breast Cancer
Patients Treated on a Protocol of
Neoadjuvant Paclitaxel and Radiation
163
3127
Carmen Perez
Acute Innate Immune Response
Profiles Following Cranial Irradiation
3139
Ola Maria
Investigation of Stem-like Cells Role in
Regional Radiosensitivity of the Lung
3128
Theodore Braun
Glucocorticoid Signaling in Skeletal
Muscle Is Critical for Cancer and
Endotoxin-Induced Cachexia
3140
Ippei Takahashi
The Mechanism of A Novel
Radioprotector, 8-Quinolinol
Derivative KH-3
3129
Kristina Young
Improved Efficacy of Radiation in
Combination with Systemic
Immunomodulatory Therapy in a
Syngeneic Mouse Model of Colorectal
Cancer
3141
Youssef Zeidan
Botulinum Toxin Confers
Radioprotection In Murine Salivary
Glands
3130
Jin Wang
Rad51 In Regulating The
Radosensitivity Of Nsclc With
Different Egfr Status
3131
Hiroaki Akasaka
A Novel Radiosensitizer of the
Functional Food Component,
Monogalactosyl Diacylglycerol
(MGDG) from Spinach, Enhanced the
Cytotoxic Effects for the Pancreatic
Cancer In Vitro and In Vivo
3132
Tommy Sheu
Possible Failure Of The LQ Model With
Large Fraction Sizes
3133
Andrea Fontana
Proton versus Photon Radiotherapy:
Differential Demands on the
Biological Level
3134
Samuel Bakhoum
A Mitotic Pathway For
Radiation-induced Genome Damage
3135
Takeshi Nishioka
HIF-1alpha Post Transcriptional mRNA
Regulation Under Normoxia: The
Significance Of UTRs
3136
Marcher Thompson
Screening For BRCA1-pathway
Inactivation In Sporadic Breast Cancer
Cell Lines
3142
Julie Goff
Reduction of Late Pulmonary Fibrosis
in Thoracic-Irradiated C57bl/6hnsd
Mice by a Water Soluble Radiation
Mitigator MMS-350
3143
Hiroshi Igaki
Inhibitory Effect Of Radiation-induced
Pulmonary Fibrosis By Spironolactone
3144
Michael Epperly
MMS350: A Water Soluble Radiation
Protector and Mitigator
3145
Nobuhiko Yoshikawa
Sivelestat Sodium Hydrate Reduces
Radiation-induced Lung Injury in Mice
by Inhibiting Neutrophil Elastase
3146
Ryohei Sasaki
A Novel method of
Radioprotection for the
Gastointestinal System: Efficacy of the
Reduced form of Coenzyme Q10
3147
Anita Aiyer
Human induced Pluripotent Stem Cell
(iPSC) Derived Intestinal Organoids
(iHIOs) to Screen Radiation Mitigators
3148
Akifumi Miyakawa
Applicability of the Linear-quadratic
Model to Single and Fractionated
Radiotherapy Schedules: An
Experimental Study
3137
Ang Qu
Direct Effects of 125I Seeds Irradiation
on A549 Lung Cancer Cells: G2/M
Arrest and Enhanced Cell Death
3149
Hiromitsu Iwata
Relative Biological Effectiveness Of
Passive-scattering Proton Therapy
Using A Range Modulation Wheel At
The Nagoya Proton Therapy Center:
An in vitro Study With Four Cell Lines
3138
Piotr Widlak
Radiotherapy-related Changes in
Serum Proteome Patterns Are
Affected by Medium Doses of
Radiation Delivered to Large Volumes
of Normal Tissue
3150
Ken Ando
Effective Suppression of Pulmonary
Metastasis in Combined Carbon Ion
Radiotherapy With Dendritic-cell
Immunotherapy in Murine Tumor
Models
3151
Robert Stewart
A Useful Strategy to Estimate
Tolerance Doses for Normal Tissues in
Particle Therapy
3152
Hasani Wooten
3D Visualization Of Radiobiological
Dose Distributions - A Novel Method
For Assessment Of Composite
Treatment With Alternate
Fractionation Schemes
3153
Masatoshi Hasegawa
Cancer Stem Cell Markers and Gene
Expression Profiles in Human Brain
Tumors Following Carbon Ion Beam
Irradiation
3154
Eric Diffenderfer
Personalized Space Radiation
Dosimetry Using Monte Carlo
Simulations Of CT-based Geometries
Exposed To Solar Particle Event
Radiation.
3155
Koichi Yasuda
The Impact of FMISO-PET before
treatment in Nasopharyngeal Cancer
Patients
3156
Masayuki Matsuo
Hypoxic and Acute Hypoxic
intra-tumor mapping by pO2 Imaging
3157
Jaden Evans
Cardiac Isodose Distributions and
Increases in Focal
18F-Fluorodeoxyglucose Uptake
on Positron Emission Tomography
after Thoracic Stereotactic Ablative
Radiotherapy
3158
Nils Arvold
FMISO-PET as Biomarker of Early
Response to Targeted Therapy in
EGFR-Mutant Non-Small Cell Lung
Cancer (NSCLC)
3159
Olga Volotskova
Development Of A Novel Optical
Imaging Probe For Cancer Detection:
X-ray Activated Gold Nanoclusters
3160
Magdalena Bazalova
X-ray Fluorescence Computed
Tomography (XFCT) For Highsensitivity Imaging Of Cisplatin
164
3161
Shin-ichiro Masunaga
Significance of Daily Fractionated
Administration of Wortmannin
Combined with Gamma-Ray
Irradiation in Terms of Local Tumor
Response and Lung Metastatic
Potential
3162
In Ah Kim
Inhibition of STAT3 Enhances the
Radiosensitizing Effect of
Temozolomide in Malignant Glioma
Cells
3163
Satoshi Harada
Nanoparticle Imaging and Treatment
for Micrometastasis Using Targeted
folate Receptor-Mediated
Endocytosis via Radiotherapy
3164
Adam Wolfe
Targeting Radiation Resistant Breast
Cancer Stem Cells With The
Combination Erlotinib And
Simvastatin
3165
John Thoms
YM155, a novel small-molecule
Survivin Suppressant, Combined with
Radiation Therapy in Prostate Cancer
Cell Lines
3166
Manish Sethi
Nanoparticle Chemosensitization
3167
Brittany Simone
Caloric Restriction Coupled with
Radiation Increases Overall Survival in
a Metastatic Breast Cancer Model
3168
Thierry Muanza
EGFR/DNA Targeting Molecule
Potentiates Radiation Response in a
Murine Breast Cancer Model
3169
Andrew Baschnagel
c-Met as a Target for Radiation
Enhancement in Head and Neck
Squamous Cell Carcinomas
3170
Javier Maldonado
Targeting CD44high/ID1+ Patient
Glioma Initiating Cells By TGFβ
Receptor I Inhibitor Could
Radiosensitize Glioblastoma
3171
Cody Schlaff
Radiosensitization Effects of Novel
Triple-Inhibitor CUDC-101 in
Glioblastoma Multiforme and Breast
Cancer Cells In Vitro
3172
Steven Lin
High Throughput Clonogenic Survival
Screen Identifies Novel Radiation
Sensitizers for KRAS Mutant
3173
Yu-Jen Chen
Design and Optimization for
Combination of 188Re-Liposome and
External Beam Radiotherapy against
Human Esophageal Adenocarcinoma
Xenograft
3174
Nicholas Nickols
Radiosensitization By High Affinity
Programmable Minor Groove Binders
3175
Naritoshi Mukumoto
Normal Tissue Tolerance Of
Microplanar Beam X-ray : A Long-term
Observation
3176
Hendrick Soh
Elevated Serum HGF is Associated
with Radioresistance and Local
Recurrence in Non-Small Cell Lung
Cancer
3177
Monica Kotler
Application Of Silicon Nanoparticles
(SI-NPs) For Radiation Induced
Cytotoxicity Via Generation Of
Reactive Oxygen Species (ROS)
3178
Andre Konski
The Mechanism Of Metformin
Induced Radiosensitization Of
Pancreatic Cancer Cells
3179
Jin Ho Kim
Influence Of ATM on DNA
Methyltransferase Inhibitor-induced
Radiosensitization
3180
Heon Joo Park
Metformin Potentiates The Effects Of
Radiation On Cancer Cells And Cancer
Stem Cells By Activating Ampk
3181
Ahmed Salem
High-content, High-Throughput
Screening For Novel Double-Strand
Break Repair Inhibitors
3184
Bryan Allen
Pharmacological Ascorbate Enhances
NSCLC Chemo-Radio-Sensitization
3185
Justin Tang
Profiling of Sonic Stress Effects on
Androgen Independent Prostate
Cancer Cells with RNA
Sequencing: Implications for Low
Intensity Focused Ultrasound Therapy
3186
Meng Welliver
Protein Arginine Methyltransferase-5
As A Novel Epigenetic Target In Lung
Cancer
3187
Mohammad Hedayati
Evaluation of Novel DNA Polymerase
Beta Inhibitors as Potential
Radiosensitizers of Prostate Cancer
Cells
3188
France Carrier
Investigation of Low Dose
Fractionated Radiation Therapy as a
Chemopotentiator in Advanced/
Metastatic Gastrointestinal
Carcinoma
3189
Austin Kirschner
Pim Kinase Inhibitor AZD1208 For
Treatment Of c-MYC-driven Prostate
Cancer
3190
Adam Smith
Preclinical Investigation of a Novel
Redox Modulator, Parthenolide, as a
Cytotoxic and Potential
Radiosensitizing Agent in Glioblastoma Multiforme
3191
Edina Wang
Differential Cellular Response To
Nanoparticle Docetaxel And
Docetaxel At Sub-therapeutic Dose
Range
3192
Tatiana Marques
Enhanced Radiosensitization by
Tumor-Targeting Gold NanoparticlesA Paradigm for Energy Modulated
Radiation Therapy (EMRT)
3193
Tim Lautenschlaeger
Cilengitide Inhibits Proliferation And
Shows Combined Effects With
Radiation In Breast Cancer Cell Lines
3182
Ye Yuan
EGFR-mediated Nuclear Delivery
Improves the Genotoxic Effect of
Fe3O4@TiO2 Nanoparticles
3183
Jennifer Yu
Thermoradiotherapy Targets
Glioblastoma Initiating Cells Through
Downregulation of AKT
3194
Harold Swartz
Repeated Direct Measurements of
Tumor Oxygen to Determine the
Therapeutic Potential of Hyperoxic
Therapy
165
3195
Aaron Wild
Twist1 Overexpression Induces
Increased Tumor Cell Aggressiveness
and Resistance to Sorafenib in
Hepatocellular Carcinoma Cells
3196
Eleni Liapi
Preliminary Assessment Of
Nanoparticle-lipiodol Formulation
For Image-guided Thermal Therapy In
Animal Models Of Liver Cancer
3197
Xin Qian
Precise Targeting for Small Animal
Study Using An Image-Guided
Micro-Irradiation Platform
3198
Marlon Veldwijk
A Novel Method for Efficient Transfer
of Small Gold Nanoparticles for the
Radiosensitization of Cells
3199
Justin Tang
Sonic Stress Down-Regulates STAT3
Activation in Prostate Cancer Cells
through Cytoskeleton Disruption
3200
Jasmina Cerne
Protein Kinase C Inhibitors As Novel
Radiosensitizing Agents In The
Treatment Of Primary GNAQ Mutant
Uveal Melanoma
3201
Zhiyong He
A Novel Regulatory Role Of CITED2 In
Non-Small-Cell Lung Cancer (NSCLC)
Stem Cells And In Modulating The
Effect Of HDACi Treatment On NSCLC
3202
Tithi Biswas
Enhanced Radiosensitization Of Lung
Adenocarcinoma Cells By Pemetrexed
When Combined With Methoxyamine
To Inhibit Base Excision Repair
3203
Almudena Zapatero
The Prognostic Value of Expression of
HIF1α, Pak-6 and PSMB4, in
Intermediate and High Risk Localized
Prostate Cancer Patients Treated with
Androgen Deprivation and Dose
Escalation Radiation Therapy
3204
Chiaojung Jillian Tsai
Tgf-β1 Single Nucleotide
Polymorphism At Rs1982073:t869c
Is Predictive Of Osteoradionecrosis
After Definitive Radiotherapy For
Oropharyngeal Carcinoma
3205
Melvin Lee Kiang Chua
Comparison Of In Vivo Skin And In
Vitro Blood Lymphocyte Models For
The Prediction Of Late Normal Tissue
Responses In Breast Radiotherapy
Patients
3206
Jinyi Lang
Expression of mEGFR, pEGFRThr654
and pPKN1Thr774 Predict Response
to Chemoradiation and Prognosis in
Patients with Cervical Cancer
3207
Timothy Robinson
Detection of Novel Hypoxia Induced
Changes in Alternative mRNA
Processing Associated with Clinical
Prognosis in Adenocarcinoma of the
Lung
3208
Zhen-Yu Hong
An Experimental Model-based
Biomarker Exploration Of
Radiation-induced Lung Injury In Vivo
And In Vitro
3209
Corbin Jacobs
Tumor Status of DAB2IP but Not EZH2
Correlates With Biochemical Failure,
Castrate Resistance, and Distant
Metastases in High-risk Prostate
Radiation Therapy
3210
William Hall
Chromodomain Helicase DNA Binding
Protein 5 (CHD5) is Associated with
Improved Overall Survival in Patients
Undergoing Adjuvant Therapy for
Resected Pancreatic Adenocarcinoma
3211
Laurence Court
Pre-treatment CT Image Features of
the Primary Tumor are a Significant
Predictor for Overall Survival in
Esophageal Cancer
3212
Andrew Baschnagel
Comparison of Gene Expression
Profiles of Pre-treatment and
Recurrent Locally Advanced Head
and Neck Squamous Cell Carcinomas
Treated with Chemoradiation
3213
Erik Sulman
A Molecular Signature To Predict
Meningioma Recurrence And
Progression
3214
Sung-Wei Lee
STMN1 Overexpression as a Poor
Prognostic Factor in Patients With
3215
Yuji Seo
Association between LinearQuadratic Model Parameters and
Basal Gene Expression Profiles in the
NCI-60 Cancer Cell Line Panel
3216
Andrew Trister
Gene Expression Changes At
Recurrence After Radiation In Patients
With High Grade Gliomas Predicts
Survival
3217
Mahesh Varia
Hypoxia and Differentiation Contrast Between Pimonidazole
Binding and CK19 Expression in
Tumors Derived from Stratified and
Simple Epithelia
3219
Jonathan Pai
Plasma SPARC Following Stereotactic
Body Radiotherapy (SBRT) Predicts for
Progression-Free Survival in Locally
Advanced Pancreatic Cancer
3220
Krishinima Jeyaseelan
Copy Number Variations As Predictors
Of Late Toxicities In Prostate Cancer
3221
Krishnan Thirumoorthy
Radiation Induced Metabolome
Delineates Glioblastoma And
Glioblastoma Stem Cell Subtypes And
Correlate With Their Relative
Radiation Sensitivities
3222
Rachel Jimenez
Feasibility of Gene Expression
Signature Analysis in Prostate Cancer
Biopsy Specimens To Predict
Outcomes Following Radiation
Therapy
RADIATION PHYSICS
3223
Tobias Wissel
Skin Thickness Estimation For High
Precession Optical Head Tracking
During Cranial Radiation Therapy A Simulation Study
3224
Karen Mooney
A Population-based Treatment
Margin for Respiratory Motion of
Lung Tumors
3225
Xiaoli Tang
Quantitative Assessment of the
Accuracy and Practicality of Deep
Inspiration Breath Hold Using Surface
Monitoring
166
3226
Bo Zhao
Assessment of Breast Motion during
Hypofractionated Robotic
Radiotherapy
3238
Guang Li
Development and Validation of 6-DOF
Patient Setup Using 2D Onboard
Imaging
3249
Charles Baron
The effect of Larynx Motion on Set
Up/Delivery Error during Radiation
Treatment for Head and Neck Cancer
3227
Hiromitsu Iwata
Evaluation of Dose Uncertainty
Associated With Real-Time Tracking
IMRT Using Robotic Radiosurgery
System
3239
Jun Li
Evaluation of 4D Cone-beam CT
Based Automatic Image
Registration for Radiation Treatment
of Lung Cancer
3250
Benjamin Cooper
A Clinical Planning Tool to Predict Left
Anterior Descending Coronary Artery
Maximum Dose Based on Distance to
the Tangent Field Edge
3228
Clemens Bos
MR Image Guidance of Brachytherapy
Needle Placement: Potential of 2D
Ultrashort Echo Time Imaging
3240
Brittany Simone
Evaluation of Treatment Planning
Modalities for Early Stage Left Sided
Breast Cancers Reveals Deep
Inspiration Breath Hold Comes Out
on Top
3251
Victor Gonzalez
Impact of Prone vs Supine Positioning
on Small Bowel Dose with Pelvic IMRT
3229
Daniel Low
A New 4DCT Technique
3241
3230
Wensha Yang
Dosimetric Effects of Rotational
Uncertainties in Fiducial-based
Treatment Setup for Pancreas SBRT
3231
Tracy Bray
Prospective Evaluation of Oblique
Dual-Energy Imaging in Patients
Undergoing Image-Guided
Radiotherapy for Lung Cancer
3232
Youngmin Choi
Prostate Intrafraction Motion During
Image Guided Radiotherapy After
Rectal Emptying
3233
Rongmao Li
Control of Respiratory Motion by
Hypnosis Intervention During
Radiotherapy of Lung Cancer
3234
Hsiang-Chi Kuo
Tumor Bed Variation During
Brachytherapy
3235
Nicos Nicolaou
Is An Immobilization Device
Necessary For Prostate Irradiation, In
The Era Of Image Guided Volumetric
Modulated Arc Therapy (VMAT)?
3236
Xiang Li
An Investigation Of Patient-specific
Respiratory Motion Effect In Lung
CBCT Imaging
3237
Abigail Stockham
Inter-Fraction Prostate Motion with
Endorectal Balloon Placement
Sathiya Narayanan
Vatyam
Comparison of PTV Margins for
Contouring Using MVCBCT and
Carbon Target Imaging: A Pilot Study
3242
Itaru Ikeda
Relationship Between Intra-fraction
Prostate Motion And Rectal Dilatation
3243
Michael Cheung
Geometric Accuracy Verification of
a Respiratory Gating System Using
Gated KV-CBCT and Gated MV-CBCT
3244
Pietro Mancosu
Dosimetric Effects Of Involuntary
Motion For Total Marrow
Irradiation With Volumetric
Modulated Arc Therapy
3245
Ho Jin Jeong
Estimation Of Optimal Margin For
Intra-fraction Movements During
Frameless Brain Radiosurgery
3246
Lauren Douglass
Utility of Remarking Regimens for
Improving Setup Accuracy in
Definitive Lung Radiotherapy
3247
Tianye Niu
Accelerated Barrier Optimization
Compressed Sensing (ABOCS) For
Ct Reconstruction With Improved
Convergence
3248
Tianye Niu
Quantitative Cone-beam CT In
Radiation Therapy: GPU
Implementation And Comprehensive
Evaluations On The State-of-the-art
On-board Imager
3252
Ruggero Ruggieri
Adaptive Re-planning after Five
Treatment Fractions in Prostate
Patients with Implanted Markers
Impacts on Setup Accuracy
3253
Koilpillai Joseph Maria
Das
Tracking Target Motion during
delivery of 3DCRT and IMRT
Treatment
3254
Kathryn Turner
Breathing Irregularity Induced
Uncertainties In Patient Positioning Of
Lung Sbrt: An Investigation Based On
A Digital Human Phantom
3255
Vorakarn Chanyavanich
Optical Imaging for Patient-Specific
Treatment Planning and Collision
Avoidance
3256
Tom Catron
Does Abdominal Compression
Through Prone Patient Position
Reduce Respiratory Motion In Lung
Cancer Radiotherapy?
3257
Matthew Abramowitz
Noninvasive Real-time Prostate
Tracking Using A Transperineal
Ultrasound: A Clinical Trial
Comparision to RF Transponders
with Visual Confirmation
3258
Alexandra Bourgouin
Reducing Radiation Doses Received
By Cardiac Devices
3259
Prithima Reddy Mosaly
Applying Human Factors Analysis and
Classification System (HFACS) to the
Analysis of Good Catches in Radiation
Oncology
167
3260
David Asher
Bite Blocks can reduce Setup
Uncertainty Related to Weight Loss
during Head and Neck IMRT:
Preliminary Results of a 3-Modality
Image Guidance Protocol
3271
Almut Troeller
Normal Tissue Complication
Probability (NTCP) Modeling of
Chronic Hematuria in Prostate Cancer
Patients Treated With 3D Conformal
Radiation Therapy
3261
Lichung Ku
Implementing In-room Visual
Guidance Using A Digital Projector
For Breath-hold Treatment Of Left
Breast Cancer
3272
Jiankui Yuan
Validation Of A Virtual Source Model
For Monte Carlo Simulations Of
Tomotherapy
3262
Lonika Majithia
Novel Tissue Compensation with
Photon Irradiation for Cutaneous
T-cell Lymphoma with Irregular
Surfaces
3263
Paikin Leung
Use of Diagnostic Quality CT for Daily
Prostate Localization with Soft Tissue
Registration
3264
Reshma Munbodh
Submillimeter 2D-3D Registration
for Brain Radiation Therapy using 3D
Cone-beam CT Data and a Single,
Limited Field-of-View 2D kV
Radiograph
3265
Weihua Mao
Real Time 3D Markerless Lung Tumor
Tracking
3266
Benjamin Williams
Rotational Patient Positioning
Corrections for Cervical Spine SBRT;
Evaluation of 6DOF Couch
Applicability
3267
Madeera Kathpal
Inter-Fraction Displacement of
Electromagnetic Beacons in Patients
Receiving Post-Prostatectomy
Radiation Therapy
3268
Karen Mooney
An Approximate Entropy-based
Method for Prediction of 4D-CT
Quality from Respiratory Signals
3269
Tianyu Zhao
A Novel Algorithm to Eliminate
Motion Artifacts from Thoracic PET
Images
3270
Andreas Richter
Development of a Voxel Based NTCP
Algorithm for Treatment Planning
3273
Dan Liu
18F-FLT Uptake Kinetics In Head And
Neck Squamous Cell Carcinoma: A Pet
Imaging Study
3274
Zhang Quanshi
The Preliminary Study for Detecting
Hypoxia With PET Imaging In Situ
Using 45MV X-ray Photonuclear
Reaction 16O(γ , N)15O in Tumor
3275
Christopher Chapman
Diffusion Imaging Biomarkers for
Predicting Brain Normal Tissue
Radiation Necrosis
3276
Maria Carmen De Santis
Spectrophotometric Evaluation Of
Skin Erythema In Patients Undergoing
Breast Irradiation
3277
Hualiang Zhong
Can We Use TCP to Predict Tumor
Local Control?
3278
An Tai
A method to determine Individualized
Prescription for Biologically Adaptive
Radiation Therapy of Lung Cancer
3279
Alexander Spektor
Early Volumetric Response to
Preoperative Chemoradiation for
Rectal Cancer Predicts for Pathologic
Complete Response, Allowing for
Selective Treatment Intensification
3280
Naomi Shin
Risk of Radiation-Induced Late
Effects for Pediatric Patients Receiving
Craniospinal Irradiation Comparing
3D-CRT, IMRT, and IMPT
3281
Hualin Zhang
Evaluation of Tumor Control
Probability of Stereotactic-Body
Radiation Therapy (SBRT) for Primary
Liver Cancers
3282
Geoffrey Zhang
Normalization Of 4D-CT Derived
Ventilation Data To Facilitate
Intra-patient Comparisons
3283
Reshma Munbodh
A Novel Method to Quantify Cell
Migration Distance and Determine
its Contribution to the
Development of Rectal Toxicity after
Prostate Radiotherapy
3284
Cungeng Yang
Dose Dependent CT Number Changes
in Both Tumor And Normal Lung
Observed During Radiotherapy for
Lung Cancer
3285
Ishmael E. Parsai
Dosimetric Analysis of Irregular
Surfaces Treated With the Leipzig and
Valencia HDR Skin Applicators
3286
Haksoo Kim
Case Studies Presenting Dosimetric
Uncertainties Using Fuzzy Set Theory
3287
Kristy Brock
Biomechanical Modeling of
Therapeutic Response in the Liver
3288
Joseph Deasy
A New Tumor Control Probability
Model Fitted To Head And Neck And
Lung Local Control Data And
Resulting Implications For The Impact
Of Dose Heterogeneity
3289
ChihYao Cheng
Radiobiological Impact Of Planning
Techniques For Prostate Cancer In
Terms Of Tumor Control Probability
And Normal Tissue Complication
Probability
3290
Yujiro Fujita
Interobserver and Intraobserver
Variability in Image Registration for
Image-Guided Radiotherapy
3291
Kai Yang
Treatment Dose Evaluation of IGRT
and Adaptive Plan Modifications for
Head-and-Neck Cancer Radiation
Therapy
3292
Adam Riegel
Deformable Image Registration
Accuracy in the Head-and-Neck
region: Comparison with
Interobserver Variation
168
3293
Guang Han
A Dosimetric Study of
for Locally Advanced Nasopharyngeal
Carcinoma With or Without
Hippocampal Sparing
3294
Yoshiko Doi
Functional Image-Guided
Radiotherapy Planning in Volumetric
Modulated Arc Therapy for Malignant
Pleural Mesothelioma Patients with
Pulmonary Emphysema
3295
Lili Zhou
Accelerating Popular CBCT
Reconstruction Algorithms on GPGPU
Using OpenCL
3296
Ping Wang
Comparative Study Of Tumor
Heterogeneity Modeling In [18f]fdg
Pet Images
3297
Yuanjie Cao
Optimization Of Treatment Planning
Parameters Used In Tomotherapy For
Prostate Cancer: Using Dosimetric
Physical Index And Plan Evaluation
Scoring Index
3298
Feng Li
Comparison of Gross Target Volumes
Based on 3-Dimensional CT, 4Dimensional CT, and Cone Beam CT
Images of Non-Small Cell Lung Cancer
3299
Malcolm Mattes
A Patient-Specific Approach To
Prostate Cancer Contouring Through
Assessment of the Overlap Volume
Between PTV and OARs
3300
Pengpeng Zhang
Incorporating the Prediction of
Residual Tumor Location into
Prospective Dose Painting for
Locally Advanced Non-Small-Cell
Lung Cancer
3301
Jian Liang
Variation of Parotid Delineation
Utilizing Auto-Segmentation
Technique
3302
Kyoung-Dal Lim
Dose Verification of 2D and 3D
Intra-fractional Tumor Motion for
Patient Specific Quality Assurance of
Respiratory-Gated Radiotherapy
3303
Vladimir Feygelman
Dynamic Dose Interplay Does Not
Meaningfully Affect Target Dose in
VMAT SBRT Treatments
3304
Nobuhide Wakai
Impact of Motion Interplay Effect on
Step and Shoot IMRT
3316
Angela Mohr
Accelerated GPU Based
Tomotherapy-Planning
3305
Farzan Siddiqui
CT-to-CT Contour Propagation Using
Deformable Image Registration For
Head And Neck Cancer Radiotherapy:
Investigation For Clinical Application
3317
Daniel Yeung
A Web Application For The
Management Of Clinical Workflow In
Image Guided And Adaptive Proton
Therapy For Prostate Cancer
Treatments
3306
Irina Vergalasova
Feasibility Of Using A Fourier
Markerless Technique For Clinical
4D-CBCT Reconstruction
3307
Keisuke Usui
A Study of 4D CBCT Reconstruction
using Detection of the Target Position
from 2D Projection Images
3308
Ilker Catan
The Evaluation of Rectum Dose
Associated by kV-CBCT Imaging in
IGRT
3309
Sohyun An
Design and Development of a
Practical Scatter Correction System
in CBCT
3310
Suk Lee
Development of Patient Specific 3D
Dose Evaluation Solution for Dose
Guided Adaptive Radiotherapy
3311
Winky Wing Ki Fung
Can Planned Dose Shifting Method Be
Used In Place Of Dose
Recalculation Method For Dose
Evaluation In Adaptive Radiotherapy
Of Head And Neck Cancer?
3312
HongSeok Jang
Evaluation Novel Look Up Table
Method For Mri-based Radiotherapy
Treatment Planning
3313
Kyung-Hwan Chang
Which Is An Optimal Dosimeter To
New Optical CT Scanner (P3DS)
Between BANGkitTM And
PRESAGETM A Feasibility Study For
Brain SRT Case
3314
Chi-Yuan Yeh
VMAT Radiation Therapy (VMAT)
Versus Intensity Modulated Radiation
Therapy (IMRT) for Small-Sized Breast
3315
Jim Tol
Towards Automated Treatment
Planning: Trade-offs in PTV
Homogeneity and OAR Dose in
Complex IMRT Plans
3318
Yan Ping
Clinical Confirmation of Direct
Non-invasive Ultrasonography
Respiration Monitoring System in
Improving Organ Motion Artifact of
4DCT
3319
Susu Yan
A Simulation Study Of Treatment
Verification Using On-board
Multi-pinhole SPECT
3320
Ellen Day
Intrafraction Motion During Lung
SBRT: Patient Motion Or Tumor
Motion? A Megavoltage Cone Beam
CT (MVCB) Study
3321
Zheng Wang
A New Algorithm for Tri-modality
Image Fusion for Target Delineation in
Radiotherapy
3322
David Jaffray
Clinical Implementation of
Automated Tangential Breast
Therapy
3323
Jing Jing Ye
Dosimetric Impact Of Treatment
Couch On Volumetric Modulated Arc
Therapy (VMAT)
3324
Guang-Pei Chen
Optimizing Ct Acquisition For Prostate
Cancer Radiation Treatment Planning
And Delivery
3325
Junaid Pasha
Deformable Contour Propagation in
Adaptive Re-planning for Cancers of
the Head and Neck
3326
Gustavo Olivera
Adaptive Dose Recalculation And
In-vivo Dosimetry As Clinical Tools
To Tailor Daily IGRT: Experience After
100,000 Fractions Delivered
169
3327
Hun-Joo Shin
A Comparison Between Pencil-beam
Versus Monte Carlo Calculations In
Arc Therapy
3328
Qiao Qiao
Changes in the Lumpectomy Cavity
from Initial Whole Breast Irradiation to
Sequential Boost
3329
Kazuhiro Arai
Comparison of Cumulative Dose in
the Spinal Cord Using Rigid
Registration and Non-rigid
Registration for Two-step Adaptive
Intensity-modulated Radiotherapy for
3330
Siu Keung Chan
An Application of Trajectory Log for
Volumetric Intensity Modulated
Arc Therapy(VIMAT) Plan Quality
Assurance in a Digitally Integrated
And Controlled Linear Accelerator
3331
Kyoungkeun Jeong
CT Image Reconstruction From IMRT
Treatment Beam
3332
Yusuke Onozato
Evaluation of On-board kV Cone Beam
CT-based Dose Calculation Using
Deformable Image Registration and
Modification of HU Values
3333
Michiel Van den Bosch
Optimizing PTV For IMRT Of Cervical
Cancer Using Structure-Specific
Margins
3334
Ken-Pin Hwang
Development Of A Semi-automated
Contouring Toolkit For Pelvic Organs
On An MR Image Series
3335
Jinkoo Kim
A Novel Approach for Establishing
Benchmark CBCT/CT Deformable
Image Registrations in Prostate
Cancer Radiotherapy
3336
Jason Pukala
Adaptive Radiotherapy Re-planning
for Head-and-Neck Cancers and the
Dosimetric Benefit to the Parotid
Glands
3338
Mark Gooding
Multi-center Clinical Assessment Of
Dir Atlas-based Auto-contouring
3339
Lulin Yuan
Incorporating Tradeoff in Knowledge
Modeling of Parotid Dose Sparing in
Head and Neck IMRT
3340
Feng Liu
Interfraction Relative Volume
Changes and Independent Motions
between Multiple Targets in Lung
Cancer Radiotherapy
3341
Lalit Chaudhari
Ideal Input Parameters For Organs
at risk On Monte-carlo Optimizer Should It Be DVH Based Or Biologic
Based?
3342
Antonio Damato
Planning of MR-Guided Gynecologic
Interstitial Brachytherapy Insertions
3343
Umesh Mahantshetty
A Prospective Study To Generate Ctv
To Itv Margins Using Cone Beam
Verification Ct For Pelvic Imrt In
Locally Advanced Cervical Cancers
3344
Guozhen Luo
Advantages Of Treating Skin Lesions
With Vmat Compared To Static Imrt
With Multiple Gantry Beams
3345
Mark Gooding
Multi-center Assessment Of
Auto-contouring Using Deformable
Image Registration For Adaptive
Therapy
3346
Bernard Lachance
Quantifying The Impact Of
Introducing Modulated Arc Therapy
In The Clinic
3347
Xiaoming Chen
CT-MRI Fusion Uncertainty in Prostate
Treatment Planning for Different
Image Guidance Techniques
3348
Richard Jennelle
Evaluation of PTV Margin in the
Treatment of Lung Cancer Simulated
with 4D CT and Validated with Daily
Cone Beam CT Guidance
3337
Colleen Schinkel
Dosimetric Effects of Daily Anatomic
Variations when Treating High Risk
Prostate with Whole Pelvis IMRT using
an Adaptive Strategy and Dual-Plan
Superposition
3349
Jonathan Piper
A Novel Framework for Deformable
Registration Evaluation and Quality
Assurance
3350
Jonathan Piper
Evaluation of Deformable Prostate
Cone-beam Computed Tomography
(CBCT) Contouring Methods for
Adaptive Radiation Therapy
3351
Yanle Hu
Improved Dosimetric Accuracy of Bulk
Density Overridden Plans for Prostate
Patients using Tissue Population
Average Electron Densities Obtained
within Radiation Beam Paths
3352
Meredith Semon
Adaptive Radiotherapy for
Therapy (IMRT) Treatment of Prostate
Adenocarcinoma
3353
Scott Hadley
Difficulty of Pancreas IGRT using CBCT
3354
Yasushi Ito
Dose Reconstruction In Considering
Of Respiratory Motion Of The Target
Using 4D-CT In VMAT
3355
Joanne Zhung
Does Rectal Distention Affect
Interfractional Dose To Prostate And
Rectum In Prostate IMRT Treatment?
Optimizing IGRT Techniques
3356
Yutaka Takahashi
Peripheral Dose Heterogeneity Due
To The Thread Effect In Total Marrow
Irradiation With Helical Tomotherapy
3357
Krishni Wijesooriya
Comparison of 3D Dose Delivery
Accuracy and Efficiency for VMAT
Between 2 Linear Accelerators Using
Linac Log Files
3358
Henry Wang
The Feasibility of Fully Automating
Treatment Planning Process Using
Knowledge Based System
3359
Gregory Perkins
MRI-based Radiotherapy Planning Of
Prostate Cancer: Clinical
Feasibility And Assessment Of
Dosimetric Accuracy For Different
Treatment Techniques
170
3360
Naruemon Tongtip
A Dosimetric Study of Volumetric
Modulated Arc Therapy (VMAT)
versus Intensity Modulated Radiation
Therapy (IMRT) in Locally Advanced
Nasopharyngeal Cancer Involving
Base of Skull
3361
Ravinder Clayton
Clinical Impact and Utility of Acuros
XB Dose Calculation Algorithm in
Lung Stereotactic Body Radiation
Therapy
3362
Dawn Owen
Outcomes and Toxicities of
(SBRT) for Non-Spine Osseous
Oligometastases
3363
Linda Hong
Spine SBRT Plans: Achieving Dose
Coverage, Conformity and Dose Fall
Off
3365
Piera Navarria
(sbrt) With Flattening Filter Free (ff f)
Mode For Treatment Of Lung
Metastases In Oligometastatic
Patients
3366
Virag Dandekar
Dosimetric Comparison Of Volumetric
Modulated Arc Therapy And Helical
Tomotherapy For Spine Stereotactic
Body Radiotherapy
3367
Thomas Kole
Hypofractionated Passively-Scattered
Proton Radiotherapy and
(SBRT) in the Definitive Treatment of
3368
Ruijiang Li
Clinical Implementation of
Intrafraction CBCT Imaging during
Lung Tumor SABR
3371
Hairong Chen
An Optical Tracking System for Uveal
Melanoma Radiosurgery
3372
Abhilasha Patel
Modeling the Loss of Tumor Control
Probability (TCP) due to Small
Geometrical Deviations of
LINAC-based Stereotactic
Radiosurgery (SRS)
3373
Dae Il Kim
Comparison Of Monitoring Unit
Efficiency Between With And Without
Flattening Filter Using Volumetric
Modulated Arc Therapy
3374
Maho Iwana
Dose Prescription to 40% to 90%
Isodose Lines for the Target in
Lung Tumors: Which Prescription Line
Is Optimal?
3375
Siete Koch
RapidArc or Multi-Angle Conformal
Fields for Stereotactic Radiosurgery
3376
Wen Min Luo
A Dosimetric Comparison of Helical
Tomotherapy versus
Volumetric-modulated Arc Therapy in
Radiosurgery for Multiple Intracranial
Lesions
3377
Aysen Dizman
Re-irradiation with Robotic
Locally Recurrent Nasopharyngeal
Carcinoma
3378
Prashantkumar Shinde
Dosimetric Characteristics of Dynamic
Micro Multileaf Collimator
3379
Christopher McGuinness
Standard Fractionation IMRT With a
MLC Equipped Robotic Radiosurgery
System
3369
Yasushi Nagata
Survey of Stereotactic Body Radiation
Therapy in Japan
3380
Tae Gyu Kim
Spine Metastases From Hepatocellular Carcinoma
3370
Long Huang
(SBRT) for Spinal Tumors - Evaluation
of Three Treatment Techniques:
HybridArc, VMAT and IMRT
3381
Khalil Mahjoubi
Preliminary Results Of A Randomized
Study Comparing Two Immobilization
Systems For Stereotactic Body
Radiation Therapy
3382
Mari Tsujii
Detectability of the Position of the
Diaphragm in the Exhale CBCT for
Patient Positioning in
Respiratory-Gated Stereotactic Body
Radiation Therapy
3383
Alejandro Mut
Lung Cancer And Lung Metastases
Using Megavoltage Cone-beam
(MVCB)
3384
Lijun Ma
Adaptive Treatment Planning And
Online Setup Measurements To Guide
Decision Of Margin Size For
Hypofractionated Intracranial
Radiosurgery
3385
Lucas Caussa
Linac-based Stereotactic
Radiotherapy With Micromultileaf
Collimators In The Treatment Of
Vestibular Schwannoma: Technique
And Preliminary Results
3386
Winnie Li
Deriving Planning Target Volume
Margins for Intracranial Stereotactic
Radiotherapy
3387
Heming Zhen
Evaluation of Acuros XB for SAbR
Planning of Thoracic Spinal Tumors
3388
James Picone
A Minimum Tumor To Spinal Cord
Distance of 3-4mm Is Needed For
Optimal Planning Of Spine SBRT
3389
Gregg Goldin
Early Stage Lung Cancer: Quantifying
the Effect of Tracking with Respiratory
Motion on Chestwall Dosimetry
3390
Tarek El Kaissi
Evaluation of a 3d Pre-treatment Plan
Verification Process for Stereotactic
Radiosurgery (SRS) Treatments
3391
Nima Nabavizadeh
Heterogeneous Dose Prescription for
Early Stage Lung Cancer Stereotactic
Body Radiation Therapy (SBRT):
Implications on Dose Gradient
171
3392
Haksoo Kim
Small Animal Irradiation Using
Robotic Radiosurgery and Micro-CT
Images
3393
Dustin Boothe
The Dosimetric Advantage Of
Stereotactic Hypofractionation Over
Conventional Radiation For
Post-prostatectomy Patients: NTCP
Modeling Of Intensity Modulated
Radiotherapy (IMRT) And Volumetric
Modulated Arc Therapy (VMAT)
Treatment Plans
3394
Jingdong Li
Evaluation of Dosimetric Accuracy of
Small Dynamic MLC Fields Using EPID
3395
Isaac Kaufman
Single Fraction Stereotactic Body
Radiation Therapy (SBRT) for Spine
Metastasis: A Dosimetric
Comparison of Multiple Treatment
Delivery Systems
3396
Lilie Wang
Dosimetric Effect of Onyx
Embolization on Radiation Treatment
of Arteriovenous Malformations With
Robotic Radiosurgery: A Monte Carlo
Simulation Study
3397
David Shultz
The Effect of Arm Position on The
Dosimetry of Thoracic Stereotactic
Ablative Radiotherapy
3398
Han Liu
Analysis of Local Failure of Lung
Cancer Patients Treated with
3399
Matthew Harkenrider
Should We Change Conformality
Index Recommendations Based on
Tumor Centricity for Lung SBRT?
3400
Shu-Jung Yu
Lung Tumor Stereotactic Ablative
Radiotherapy With Individualized
Anatomic Optimization
3401
Neil Jenkins
Can Stereotactic Body Radiotherapy
Be Used With Mediastinal
Chemoradiation For Stage III
Non-Small Cell Lung Cancer? A
Dosimetric Evaluation
172
3402
Witold Matysiak
Evaluation Of Geant4 For
Experimental Data Quality
Assessment In Commissioning Of
Treatment Planning System For
Proton Pencil Beam Scanning Mode
3403
Shikui Tang
A Quantitative Assessment of the
Interplay Effect of Prostate
Intrafraction Motion in Proton Pencil
Beam Scanning
3404
Ted Ling
Hepatocellular Carcinoma Treated by
Protons and IMRT
3405
Rui Zhang
Prediction of Relative Risks of
Radiogenic Second Cancer and
Cardiac Toxicity for 17 Pediatric
Medulloblastoma Patients Treated
With Photon or Proton Craniospinal
Irradiation
3406
Wen Hsi
Image-Guided Method For TLD-based
In-vivo Rectal Dose Verification With
Endorectal Balloon In Proton Therapy
For Prostate Cancer
3407
Yuanshui Zheng
Is Density Override for
Fiducial-induced CT Artifacts
Necessary in Proton Treatment
Planning of Prostate Cancer?
3408
Chin-Cheng Chen
A Method For In Vivo Intracavitary
Surface Dose Validation Using
Thermoluminescent Dosimeters (tlds)
Applied To Prostate Cancer Patients
Treated With Protons
3409
Kenneth Merrell
Dosimetric Effect of Intra-Treatment
Target Volume Reduction in Bulky
Head and Neck Cancer with Intensity
Modulated Proton Therapy
3410
Daniel Sanchez
Parcerisa
Fast Range Switching Of Passively
Scattered Proton Beams Using A
Modulation Wheel And Dynamic
Beam Current Modulation
3411
Caitlyn Yeager
Feasibility of Intensity Modulated
Proton Therapy for Base of Skull
Chordomas
3412
Eric Klein
Proton Therapy Delivery Uncertainties
for Single vs. Multiple Daily Fields
3413
Lilie Lin
Proton Beam Versus Photon Beam
Dose to the Heart and Left Anterior
Descending Artery for Left-Sided
Breast Cancer
3414
Yuanshui Zheng
Clinical Assessment of a Commercial
Patient Positioning & Verification
System in Proton Therapy
3415
Sandeep Dhanesar
Study of Robustness of Passive
Scattering Proton Therapy Plans for
Targets in Lung and Comparison with
IMRT Plans
3416
Marc-Andre Renaud
Pre-calculated Track Monte Carlo
using GPGPU
3417
Oren Cahlon
Feasibility of Using 3D Uniform
Conformal Scanning Proton Beam
Therapy for Locally Advanced
Oropharyngeal Carcinoma Requiring
Bilateral Neck Irradiation
3418
Ileana Iftimia
Standardized Procedure For Skin
HDR Cases Using The Varian Catheter
Flap Set
3419
Yun Yang
Design Of An Internally Shielded
D-shaped Breast Brachytherapy
Applicator Using Monte Carlo
Methods
3420
Mostafa El-Haddad
A Simple Method to Unify Target
Volume Delineation and Plan
Optimization in Clinical Trials (The
Boolean Method)
3421
Kaveh Maghsoudi
Dosimetric considerations of Total
Body Irradiation
3422
Lukasz Matulewicz
Effective and Efficient Technique for
Total Marrow Irradiation
3423
Nicole Schadewaldt
Artifact Correction on MR-Derived
Bulk-Density Maps
3424
Kimiya Noto
Comparison Of Dose Delivery
Between Original Arc And Split Short
Arcs Volumetric Modulated Arc
Therapy
3425
Huma Chaudhry
The Dosimetric Effect of Tumor Size
and Position in Prone Radiation
Therapy of Breast Using a Novel
Stereotactic Breast Irradiation Device
3426
Nathalie Rochet
Advances in Whole Abdominal
Irradiation: What Protons, VMAT and
IMRT using Multicriteria Optimization
Can Offer
3427
Cheng Peng
Dosimetric Comparison of Robotic
Radiosurgery and VMAT for
Hypofractionated Prostate Radiation
Therapy
3428
Thomas Kole
Improved Normal Tissue Sparing and
Reduced Treatment Time Using
Multileaf Collimator Robotic
Radiosurgery Stereotactic Body
Radiation Therapy (SBRT) Compared
to Iris Collimator SBRT in Treatment of
3429
Maria Clara Ferreira
Dosimetry of Rhenium-188,
Praseodymium-142, and Yttrium-90
using Monte Carlo simulation for
application in High Dose Rate Eye
Plaque Brachytherapy
3433
Yong Hum Na
Efficient VMAT Treatment Plan
Optimization Using Non-Uniformly
Distributed Control Points
3434
Charles Wooten
Permanent Interstitial Radiation with
Cs-131 Implants for Gynecologic
Malignancies: Analysis and Results of
an Initial 13 Applications
3435
Partha Pratim Mohanty
(vmat) Versus Intensity Modulated
Radiotherapy (imrt) In Pelvic
Malignancies: A Dosimetric Analysis
3436
John Yordy
(SAbR) and Limited Field IMRT Using a
Novel Treatment Delivery Platform
3437
Keiichi Nakagawa
Accuracy Verification of 4D
Cone-Beam CT (CBCT) Based Lung
Tumor Registration by Way of
In-Treatment 4D CBCT Analysis
3438
Ruijie Yang
Feasibility Study Of Volumetric
Modulated Arc Therapy With
Constant Dose Rate For Endometrial
Cancer
3439
Flemming Kjaer-Kristof
Fersen
A Combination Of Volumetric Arc
Therapy And Tangential Fields In
Challenging Breast Cancer Cases
3430
Lei Xing
An Adaptive Planning Strategy for
Station Parameter Optimized
Radiation Therapy (SPORT):
Segmentally Boosted VMAT
3440
Liu Zhikai
Low Dose Area Constrained Helical
Tomotherapy-based Whole Breast
Radiotherapy And Dosimetric
Comparison With Tangential IMRT
3431
Ying Zhang
Are Photons In The Energy Range Of
1-6 Mv A More Optimum Choice Than
Higher Energy Photons For Delivering
A Conformal Dose Distribution In The
Target Volume With Better Quality In
Portal Images?
3441
Yu Ra Cho
Development of Tissue Equivalent Gel
Dosimeter for Clinical Radiotherapy
System
3432
Daphne Levin
A Dosimetric Comparison Between
Volumetric Modulated Arc and 3D
Treatment Plans for Synchronous
Bilateral Breast Patients
3442
Niraj Mehta
Focal Stereotactic Body Radiation
Therapy for Prostate Cancer: A
Dosimetric Comparison Between
Whole and Hemi-Gland Treatment
3444
Zachary Wilson
Design, Development, And
Characterization Of Small Animal
Hemi-brain Irradiator Using 192Ir Hdr
Source
3445
Jonathan Thompson
Trajectory-based Radiation Therapy
With Linear Couch Motion For
Extended Spinal Treatments
3446
Lucy Nedialkova
Dosimetric Comparison of Cs-131 vs.
I-125 Intraoperative Brachytherapy for
Patients with Resected Brain
Metastasis Renders Cs-131 More
Sparing of Normal Brain
Tissue - Clinical Relevance for
Prevention of Radiation Necrosis From
a Prospective Trial
3447
DooKee Cho
Optimizing 3D Conformal plans for
4π Non-Coplanar Converging (4PiNC)
Beams using a Genetic Algorithm
3448
Evangelos Pappas
An Innovative Method For
Patient-specific Pre-treatment-planverification (PTPV) In Head & Neck
Radiotherapy Treatments: Preliminary
Results
3449
Angelica Perez-Andujar
Effect of Dose Gradient on the
Incident Probability of Brain
Metastases in Hippocampal-Sparing
Whole Brain Irradiation
3450
Hanako Farol
A Dosimetric Feasibility Study using
Forward Planning Segmental Field
Technique for Stationary Craniospinal
and Spinal-sacral Junctions in
Craniospinal Axis Irradiation
3451
Andrew Camarata
Dosimetric Evaluation Of Single
Versus Multi-isocenter Frameless
Radiosurgery For Multiple Brain
Metastases
3452
William Watkins
The Effects Of Interplay On
Accumulated Dose In High-dose Rate
Stereotactic Body Radiotherapy Of
Lung Cancer
3443
Lynsey Rice
Using 3D Surface Imaging Technology
to reduce Cardiac Dose in Left Breast
Radiotherapy: Plan comparison of 5
patients
173
3453
Frank Rafie
Fluctuations of Source Characteristics
of Electronic Brachytherapy: The
Importance of Quality Assurance
3454
Gwe-Ya Kim
VMAT Technique for the
Circumferential Treatment of a Limb
with Leukemia Cutis
3455
Susan Leuthold
3d Helical Tomotherapy Planning:
A Novel Technique With High
Conformality And Short Treatment
Times
3456
Gregory Warrell
Experimental Verification of Thermal
Dose Distributions of a Novel Thermo
Brachytherapy Seed for LDR Seed
Implants
3457
Song Wang
4-Pi Non-Coplanar Converging Beams
Yield Superior Therapeutic Ratio than
Conventional Coplanar Beams
3458
Bin Wang
Beam Selection For MLC-based
Robotic Radiotherapy
3459
Shiv Khandelwal
Helical 3D-Conformal Radiotherapy
for Rectal Cancer
3460
Vishruta Dumane
Comparison of VMAT, Partially Wide
Tangents and Photon/Electrons for
Treatment of Reconstructed
Chestwall, Supraclavicular, Axillary
and Internal Mammary Nodes
174
2014Meetings
A M E R I C A N S O C I E T Y F O R R A D I AT I O N O N C O LO G Y
Join Us at These
Important
Radiation Oncology Events
MULTIDISCIPLINARY HEAD AND NECK CANCER SYMPOSIUM
February 20-22, 2014
JW Marriott Camelback Inn Resort and Spa, Scottsdale, Ariz.
SPRING REFRESHER COURSE
March 7-9, 2014
The Roosevelt Hotel, New Orleans
STATE OF THE ART RADIATION THERAPY:
Practical Treatment, Biology and Imaging
May 16-18, 2014
Grand Hyatt San Antonio, San Antonio
Moscone Convention Center, San Francisco
BEST OF ASTRO
October 17-18, 2014
Eden Roc Hotel, Miami Beach
CHICAGO MULTIDISCIPLINARY SYMPOSIUM IN THORACIC ONCOLOGY
October 31-November 2, 2014
Chicago Marriott Downtown Magnificent Mile, Chicago
TA R G E T I N G C A N C E R C A R E
For more information visit www.astro.org.
175
NOTES
176
NOTES
177
NOTES
178
INSIDE:
Index by Author
Index by Track
Indexes
2014
Call for Abstracts
Deadline:
February 17, 2014
11:59 p.m. Eastern time
2013 ANNUAL MEETING
INDUSTRY PARTNERS
Special thanks to ASTRO’s 55th Annual Meeting Industry Partners
GOLD
Indexes
SILVER
BRONZE
CIVCO Medical Solutions
Xoft, Inc.
COPPER
Sun Nuclear
Vertual, Ltd.
Index by Author (Abstracts only)
A
Abazeed, Mohamed
Abdel-Wahab, May
Abdel-Wahab, May
Abo-Madyan, Yasser
Abramowitz, Matthew
Adli, Mustafa
Adli, Mustafa
Admiraal, Marjan
Agarwal, Manuj
Agarwal, Ankit
Aguilera, Todd
Aguirre, Maria
Ahmad, Mediha
Ahn, Peter
Ahn, Sung-Ja
Ahuja, Divya
Ahunbay, Ergun
Aitken, Katharine
Aiyer, Anita
Aiyer, Anita
Aizer, Ayal
Akasaka, Hiroaki
Akita, Shungo
Alcorn, Sara
Alcorn, Sara
Alektiar, Kaled
Alexander, Jesse
Alfaraj, Fatimah
Alite, Fiori
Alite, Fiori
Allen, Bryan
Allison, Ron
Al-Omair, Ameen
Al-Qaisieh, Bashar
Alshehri, Salem
Alsuhaibani, Abdullah
Aluwini, Shafak
Amarnath, Sudha
Amarnath, Sudha
Amelio, Dante
Amendola, Beatriz
An, Sohyun
Anderson, Bethany
Anderson, Carryn
Anderson, Nigel
Ando, Ken
Aneese, Andrew
Aneja, Sanjay
Anker, Christopher
Anwar, Mekhail
Anwar, Mekhail
Apicelli, Anthony
Appelt, Ane
Appenzoller, Lindsey
340
2322
2366
2024
3257
2926
3040
2993
2454
2976
2899
2698
2286
140
183
2977
330
129
270
3147
2135
3131
1011
2193
2944
152
2465
2098
2648
2906
3184
2373
2159
1008
1118
2362
2364
201
2787
2860
2128
3080
3309
2090
233
2704
3150
80
1132
2243
43
2436
3115
2343
3098
3099
Arafat, Waleed
Arai, Kazuhiro
Arcangeli, Stefano
Arneson, Kyle
Arora, Shruthi
Arribas, Leoncio
Arsenault, Daniel
Arterbery, V. Elayne
Arvold, Nils
Arvold, Nils
Asai, Kaori
Ashamalla, Mark
Asher, David
Ashman, Jonathan
Ashworth, Allison
Atkins, Katelyn
Atrchian, Siavash
Ausborn, Natalie
Awan, Musaddiq
Ayakawa, Shiho
Ayala-Peacock, Diandra
Azcona, Juan Diego
B
Baba, Fumiya
Baden, Craig
Badiozamani, Kasra
Badiyan, Shahed
Bagshaw, Hilary
Bahig, Houda
Baine, Michael
Baker, Mariwan
Bakhoum, Samuel
Bakst, Richard
Balagamwala, Ehsan
Balagamwala, Ehsan
Baliga, Sujith
Ball, Christine
Banerjee, Robyn
Baquero, William
Barker, Christopher
Barney, Brandon
Barney, Brandon
Baron, Charles
Barrett, Olivia
Barriger, Bryan
Barron, David
Baschnagel, Andrew
Baschnagel, Andrew
Basu Achari, Rimpa
Batra, Sonny
Batra, Sonny
Baumann, Brian
Bayman, Evrim
Bazalova, Magdalena
Bazan, Jose
345
3329
2916
2175
2482
2148
2814
2011
2776
3009
39
3158
2792
2469
3260
1095
2883
165
2077
2279
3003
2447
2958
361
2867
2550
2375
1121
2538
28
2263
2572
3134
3114
2949
216
2580
3097
2568
2513
221
2297
2634
3249
2052
2945
3047
3169
3212
3020
1126
2363
199
2700
3160
229
Beadle, Beth
Bedi, Manpreet
Bekelman, Justin
Bekelman, Justin
Berhane, Hebist
Berhane, Hebist
Berman, Abigail
Bernad, Daniel
Bernad, Daniel
Bernier, Laurence
Bernstein, Michael
Best, Ryan
Bhandare, Niranjan
Bhandare, Niranjan
Bhandare, Niranjan
Bhatnagar, Ajay
Bhatt, Aashish
Bhirud, Abhijeet
Bi, Nan
Bi, Nan
Bing, Lu
Bing, Lu
Binkley, Michael
Bishop, Andrew
Biswas, Tithi
Biswas, Tithi
Blacksburg, Seth
Blacksburg, Seth
Blacksburg, Seth
Blacksburg, Seth
Blacksburg, Seth
Blanchard, Miran
Blanck, Oliver
Bleyer, Archie
Bo, Yang
Bo, Chen
Boelke, Edwin
Boggs, Hunter
Bondiau, Pierre-Yves
Boothe, Dustin
Boothe, Dustin
Bornstein, Sophia
Borst, Gerben
Bos, Clemens
Boss, Mary-Keara
Bourgouin, Alexandra
Bowen, Stephen
Boychak, Alex
Boyle, John
Bracey, Daniel
Bradbury, C. Matthew
Bradley, Julie
Bratman, Scott
Bratman, Scott
Braun, Theodore
Braunstein, Steve
Braunstein, Steve
Braunstein, Steve
Braunstein, Steve
193
3082
96
2760
52
1112
2748
252
2972
2622
269
3013
2088
2600
2659
157
1048
2289
227
1049
2849
2862
2898
1046
243
3202
2304
309
2434
3092
3093
313
2936
2761
2536
148
2601
2224
2015
3063
3393
3111
48
3228
3117
3258
2847
2421
2582
1050
2099
2080
223
3123
3128
1124
1026
3011
3107
Bravo, Stephen
Bray, Tracy
Bredel, Markus
Brenner, David
Brock, Kristy
Brodin, Patrik
Brouwer, Charlotte
Brown, Lindsay
Bryant, Curtis
Burt, Lindsay
Butler, E. Brian
Byun, John
C
Cahlon, Oren
Cahlon, Oren
Cai, Sophie
Cai, Yong
Camarata, Andrew
Camborde, Marie-Laure
Cannon, Nathan
Cao, Yue
Cao, Jianzhong
Cao, Yuanjie
Caparrotti, Francesca
Cardoso, Richard
Carillo, Viviana
Carlson, Julie
Carmona, Ruben
Carpenter, Todd
Carrier, France
Casey, Stephanie
Cassidy, Richard
Catan, Ilker
Catron, Tom
Cattaneo, Richard
Caussa, Lucas
Cengel, Keith
Cerne, Jasmina
Cha, Jihye
Chadha, Manjeet
Chadha, Manjeet
Chan, Cato
Chan, Siu Keung
Chandrasekaran, Sanjay
Chang, Daniel
Chang, Jee Suk
Chang, Joe
Chang, Kyung-Hwan
Chang, Lynn
Chang-Halpenny, Christine
Chanyavanich, Vorakarn
Chapet, Olivier
Chapman, Christina
Chapman, Christopher
1061
3231
240
1087
3287
3028
2710
172
2508
2112
3016
1075
2498
3417
2264
2335
3451
2301
2879
62
2919
3297
2509
2711
2427
2757
100
2616
3188
2854
3067
3308
3256
2826
3385
3079
3200
2718
1125
2078
2267
3330
2291
224
2742
2950
2817
3313
2431
2114
2574
3255
1065
2788
2713
3275
181
Chaudhari, Lalit
Chaudhary, Ahmed
Chaudhry, Huma
Chaudhry, Huma
Chaudhry, Huma
Chawla, Sheema
Chen, Allan
Chen, Allen
Chen, Andrew
Chen, Andy
Chen, Chin-Cheng
Chen, Guang-Pei
Chen, Hairong
Chen, Jenny Ling-Yu
Chen, Jiayi
Chen, Linda
Chen, Ming
Chen, Peter
Chen, Quan
Chen, Ronald
Chen, Weijun
Chen, Wenjuan
Chen, Xiaoming
Chen, Yu-Jen
Chen, Yu
Cheng, ChihYao
Cheng, Yufeng
Chennupati, Sravana
Chera, Bhisham
Chera, Bhishamjit
Cheung, Michael
Cheung, Min Rex
Cheung, Min Rex
Cheung, Patrick
Chibani, Omar
Chilukuri, Srinivas
Chin, Matthew
Chin, Re-I
Chin, Alexander
Chino, Junzo
Cho, DooKee
Cho, Yeona
Cho, Yu Ra
Choi, Jehee
Choi, Seungtaek
Choi, Youngmin
Chow, Edward
Chow, Tiffany
Christensen, Eva
Christian, Nicolas
Christopherson, Kaitlin
Chua, Melvin Lee Kiang
Chung, Peter
Ciezki, Jay
Ciezki, Jay
Clark, Grant
Clayman, Rebecca
Clayman, Rebecca
Clayton, Ravinder
Cohen, Randi
Colbert, Lauren
Cole, Aidan
Combs, Stephanie E.
182
3341
350
2030
2276
3425
2969
2178
3062
2257
2603
3408
3324
3371
2546
111
40
2811
2051
2060
1081
2901
2543
3347
3173
2068
3289
2230
1068
2201
2682
3243
2367
2553
259
2521
2143
2528
2605
35
72
3447
2442
3441
2526
2479
3232
12
2081
2164
2848
2663
3022
3205
206
2432
2494
2177
202
2747
3361
2072
225
2824
251
Compton, Julia
Contreras, Jessika
Cooper, Benjamin
Cordova, James
Corso, Christopher
Corwin, David
Court, Laurence
Cox, Brett
Craig, Timothy
Cramer, Christina
Crandley, Edwin
Crandley, Edwin
Cruz, Alex
Cui, Yunfeng
Currier, Blake
Curry, Heather
D
Dagan, Roi
Dal Pra, Alan
Dalah, Entesar
Daly, Megan
Damast, Shari
Damato, Antonio
Dan, Tu
Dandekar, Virag
Danish, Hasan
Day, Ellen
De La Mata, M. Dolores
De Santis, Maria Carmen
De Souza-Lawrence, Lana
Dean, Mary
Deasy, Joseph
Den Hartogh, Mariska
DeNittis, Albert
Denniston, Kyle
Deraniyagala, Rohan
Desai, Neil
Desai, Prashant
Deutsch, Israel
Dewan, Abhinav
DeWeese, Theodore
Dhami, Gurleen
Dhanesar, Sandeep
Dholakia, Avani
Dholakia, Avani
Di Muzio, Nadia
Diaz Pardo, Dayssy
Diaz Vazquez, Maria
Fernanda
Dickie, Colleen
Diffenderfer, Eric
Din, Shaun
Din, Shaun
Dinan, Michaela
Ding, Yun
Ding, Lei
DiPardo, Benjamin
Dizman, Aysen
Doi, Yoshiko
Doke, Kaleigh
Dominello, Michael
Dorth, Jennifer
2192
2598
3250
2121
2129
2139
3211
289
34
2762
2450
2606
2294
2980
2169
2779
Dosoretz, Arie
Dosoretz, Arie
Douglass, Lauren
D’Souza, David Paul
Du, Shisuo
Dumane, Vishruta
Dunn, Emily
Dunn, Kerry
Dunst, Juergen
Dunst, Juergen
Duplan, Danny
2190
2778
3246
2487
343
3460
2525
282
2022
2937
2996
Durkee, Ben
Dutta, Pinaki
Duvvuri, Umamaheswar
Dyk, Pawel
2607
2597
2618
2326
E
1089
1058
2850
2904
2567
3342
114
3366
44
3320
2356
3276
302
2539
3288
2073
2345
1037
2998
2576
2156
2573
2614
267
2785
3415
211
2277
1014
2510
2333
153
3154
2828
2855
99
2016
2548
2754
3377
3294
2737
2569
2777
Eastham, David
3005
Eaton, Bree
2018
Edwards-Bennett, Sophia 2103
Efstathiou, Jason
2764
Einck, John
2111
El Kaissi, Tarek
3390
El-Bared, Nancy
2552
El-Haddad, Mostafa
3420
Elicin, Olgun
76
Elliott, David
1069
Elnahal, Shereef
3018
Elsayyad, Nagy
2675
Elshaikh, Mohamed
2561
Elson, Joshua
2752
Emami, Bahman
2714
Engel, Steven
3042
Epperly, Michael
278
Epperly, Michael
3144
Erickson, Kelly
1106
Ernst, Iris
2320
Eshleman, Jeffrey
2057
Esthappan, Jacqueline
2170
Evans, Jaden
3157
Evans, Joseph
2321
F
Fagundes, Marcio
Falchook, Aaron
Falk, Alexander
Falk, Alexander
Fan, ChengCheng
Fan, Kang-Hsing
Fan, Katherine
Fan, Katherine
Fan, Michael
Fan, Qiyong
Fan, Yankhua
Fang, Charles
Fang, Li-Ming Christine
Fang, Penny
Fang, Penny
Faria Braga, Henrique
Farol, Hanako
Farr, Jonathan
Fasola, Carolina
143
Fawaz, Ziad
2420
Fechter, Tobias
3095
Feigen, Malcolm
280
Feng, Felix
307
Feng, Mary
63
Feng, Wen
2834
Fernandes, Annemarie
2334
108
Ferreira, Dominihemberg 2019
Ferreira, Maria Clara
3429
Ferrer, Ferran
203
Ferrer, Ferran
2446
Ferrer, Ferran
2480
Ferris, Matthew
312
Ferro, Adam
2040
Feygelman, Vladimir
3303
Fidler, Mary
1140
Fields, Emma
2549
Figueiredo, Maria Luisa
2205
Fischer-Valuck, Ben
2869
Fisher, Sarah
1098
Folkert, Michael
5
Foltz, Warren
1066
Fontana, Andrea
3133
Fortin, Marie Andree
2749
Fotouhi Ghiam, Alireza
305
Fowble, Barbara
94
Franco, Pierfrancesco
2050
Frank, Steven
354
Freilich, Jessica
2275
Freilich, Jessica
2921
Friedman, Jeffrey
2948
Froment, Marie-Anne
2530
Fujita, Yujiro
3290
Fukada, Junichi
2231
Fuller, Donald
2387
Fuller, Don
177
Fung, Winky Wing Ki
3311
Furhang, Eli
2782
Fuss, Martin
2331
G
2107
95
2346
3075
2880
2699
2315
3000
3103
232
2889
2318
166
41
3056
2185
2702
3450
1094
Gaffney, David
Galalae, Razvan
Galland, Sigolene
Galland, Sigolene
Galland, Sigolene
Gamez, Mauricio
Gan, Gregory
Gandhi, Saumil
Gandhi, Ajeet
Gao, Wendy
Gao, Wanbao
Garay, Elizabeth
Garcia-Vicente, Feliciano
Gardner, Stephen
Garg, Shivank
Garg, Shalini
Gay, Hiram
Gayar, Omar
Geng, Alexander
71
310
1122
2084
2518
2669
346
2324
77
2620
3007
2882
2424
363
2728
2822
2456
3044
2042
Geng, Hui
Gensheimer, Michael
Gensheimer, Michael
Gentile, Michelle
Gerber, Naamit
Ghadjar, Pirus
Ghaffari, Hamid
Ghaly, Maged
Ghaly, Maged
Ghi, Maria Grazia
Gilbride, Lucas
Gill, Beant
Giordano, Frank
Glanzman, Jonathan
Glanzman, Jonathan
Glanzman, Jonathan
Glide-Hurst, Carri
Godley, Andrew
Goff, Julie
Golchin, Ava
Goldberg, Mira
Golden, Encouse
Golden, Encouse
Golden, Encouse
Golden, Encouse
Goldin, Gregg
Goldsmith, Christy
Goldstein, Nicolas
Gomez, Daniel
Gomez-Iturriaga, Alfonso
Gonzalez, Victor
Gooding, Mark
Gooding, Mark
Gooding, Mark
Goodman, Ben
Goodman, Karyn
Gottschalk, Alex
2982
141
3012
1128
2801
2984
2999
2166
2280
4
277
73
253
2705
2717
2938
167
337
3142
2734
2593
3113
3124
3125
3126
3389
1088
2783
1139
2428
3251
2444
3338
3345
1107
181
258
Goyal, Sharad
Grabowski, Sarah
Grant, Jonathan
Gray, Phillip
Grecula, John
Green, Olga
Greenberger, Benjamin
Greenberger, Joel
Greenwalt, Julie
Greenwalt, Julie
Greer, Peter
Grendarova, Petra
Greskovich, John
Grew, David
Grills, Inga
Grossman, Craig
Grover, Surbhi
Guanhao, Chen
Guckenberger, Matthias
Guix, Benjamin
Gujral, Dorothy
Gulaya, Sachin
Gunn, Brandon G.
Guo, Susan
Guttmann, David
2062
2500
2874
200
1133
32
3024
3109
126
321
2633
295
2101
2780
2753
2878
2146
182
2832
249
2475
1117
2769
285
2625
2559
H
Haas, Jonathan Andrew
Hadley, Scott
Haga, Akihiro
Haider, Syed
Halasz, Lia
Hall, William
Hall, William
Hall, William
Hallman, Mark
Halyard, Michele Yvette
Hamilton, Sarah
Hamker, Jean
Han, Bin
Han, Chun
Han, Guang
Han, Hee Ji
Han, Jae Hong
Han, Kathy
Hanada, Takashi
Hanasoge, Sheela
Handsfield, Lydia
Hanna, Nevine
Harada, Satoshi
Harada, Keiichi
Hardie, John
Harima, Yoko
Haritha, Chiramana
Harkenrider, Matthew
Harris, Timothy
Harris, Jeremy
Harris, Jeremy
Harris, Timothy
Hartsell, William
Hasegawa, Azusa
Hasegawa, Masatoshi
Hashizume, Chisa
Hata, Masaharu
Hattori, Yukiko
Hayashi, Akihiro
Hazariwala, Ronica
Hazell, Irene
He, Zhiyong
Hearn, Jason
Hedayati, Mohammad
Hegarty, Sarah
Helou, Joelle
Hempel, Dominika
Henderson, Randal
Henrich, Dawn
Hentschel, Bettina
Heres, Tomer
Herman, Joseph
Herman, Lauren
Hertan, Lauren
Herman, Michael
Hess, Clayton
Hill-Kayser, Christine
Hiniker, Susan
Hinse, Martin
Hinton, Benjamin
Hirata, Takero
Ho, Alice
2386
3353
2859
2885
97
2270
329
3210
127
324
2636
2591
297
2215
3293
2715
2599
70
2406
1111
2991
2720
3163
162
255
230
2211
3399
2138
24
2808
268
2499
2706
3153
2842
3073
2665
2418
2260
333
3201
1021
3187
2477
2347
2451
1017
3019
2372
2411
66
2712
2838
2594
192
288
3033
92
2083
2819
2278
116
Hodges, Joseph
Hoeller, Ulrike
Hollander, Andrew
Hollen, Tyler
Holliday, Emma
Holtzman, Adam
Hong, Ji-Hong
Hong, Linda
Hong, Robert
Hong, Theodore
Hong, Zhen-Yu
Hoopes, David
Hoover, Andrew
Hoppe, Bradford
Hoppe, Bradford
Hori, Masakazu
Horowitz, David
Horton, Janet
Hosotani, Martha
Houghton, Frank
Housri, Nadine
Howell, David
Hsi, Wen
Hsieh, Cheng-En
Hsu, Che-Yu
Hsu, Howard
Hu, Kenneth Shung
Hu, Yanle
Hu, Yanle
Hua, Chia-Ho
Huang, Kitty
Huang, Long
Huang, Pin-I
Huang, Xin
Huang, Zhibin
Huddleston, Adam
Hughes, Michael
Huguet, Florence
Hui, Zhouguang
Hurst, Newton
Husaini, Hasan
Hutcheson, Katherine
Huynh-Le, Minh-Phuong
Hwang, Ken-Pin
Hymas, Richard
I
Iftimia, Ileana
Igaki, Hiroshi
Iganej, Shahrokh
Ikeda, Itaru
Indelicato, Daniel
Inokuchi, Haruo
Iqbal, Hassan
Irie, Daisuke
Ishii, Kentaro
Ishikawa, Hitoshi
Ishiyama, Hiromichi
Isohashi, Fumiaki
Ito, Yasushi
Iwana, Maho
2773
158
3023
3069
2784
2389
3116
3363
2076
65
3208
291
2722
2374
1038
2221
2104
2065
2141
3119
2755
217
3406
2672
2226
1101
195
30
3351
3021
1143
3370
2635
2223
103
2566
2415
69
2839
2655
2624
352
3049
3041
3334
23
3418
3143
2617
3242
90
2393
2647
2537
2410
2238
2376
2544
3354
3374
Iwata, Hiromitsu
Iwata, Hiromitsu
Izadbakhsh, Mark
J
Jackson, William
Jackson, William
Jacob, Julian
Jacobs, Corbin
Jadon, Rashmi
Jaffray, David
Jaffray, David
Jagsi, Reshma
Jain, Anshu
Jain, Prachi
Jang, HongSeok
Janssen, Rogier
Jaswal, Jasbir
Jawad, Maha
Jegadeesh, Naresh
Jenkins, Neil
Jennelle, Richard
Jensen, Alexandra
Jeong, Ho jin
Jeong, Jeho
Jeong, Kyoungkeun
Jeongshim, Lee
Jeyaseelan, Krishinima
Ji, Jiang
Ji, ShengJun
Ji, Zhe
Jiang, Yuliang
Jimenez, Rachel
Jimenez, Rachel
Jin, Jing
Jin, Feng
Jingu, Keiichi
Johnson, Matthew
Johnson, Skyler
Johnson, Skyler
Johnson, Skyler
Jones, Bernard
Jones, Daniel Adam
Josipovic, Mirjana
Jozsef, Gabor
Juloori, Aditya
Jung, Jinhong
Jung, David
K
Kabarriti, Rafi
Kabolizadeh, Peyman
Kai, Naoki
Kainickal, Cessal
Kainz, Kristofer
Kalakota, Kapila
Kalapurakal, John
Kalash, Ronny
Kalash, Ronny
Kalbasi, Anusha
Kamran, Sophia
3149
3227
3102
1024
2459
2021
3209
2558
29
3322
2046
2171
2496
3312
3088
2732
2162
247
3401
3348
138
3245
231
3331
2122
3220
3112
3110
2861
3094
2187
3222
2354
2641
2210
2199
1062
2501
2502
356
3064
2890
2071
2240
2300
2961
2540
319
2589
2719
1005
1033
2381
2038
275
2468
2167
183
Kamrava, Mitchell
55
Kan, Charlene
2440
Kan, Charlene
2716
Kanakamedala, Madhava 2726
Kanakamedala, Madhava 2727
Kanazawa, Aki
2545
Kandula, Shravan
2126
Kandula, Shravan
3037
Kaneyasu, Yuko
2563
Kang, Julie Jung
2505
Kann, Benjamin
326
Kao, Johnny
2173
Kao, Wei Heng
2197
Kapadia, Nirav
2767
Kapoor, Rishabh
2758
Kapur, Ajay
2763
Karasawa, Katsuyuki
2679
Karasawa, Katsuyuki
2910
Kasuya, Goro
2531
Katayama, Emiko
2925
Kathpal, Madeera
2476
Kathpal, Madeera
3267
Katoh, Norio
2797
Katz, Alan
57
Kaufman, Isaac
3395
Kawaguchi, Gen
2220
Kawanaka, Takashi
320
Kazuhiko, Hayashi
1044
Kelly, Maria
2486
Kerns, Sarah
327
Kersh, C. Ronald
248
Keruakous, Amany
1129
Kesava Ramgopal,
Adavikolanu
2725
Khan, Luluel
218
Khandelwal, Shiv
3459
Kharofa, Jordan
1105
Kharofa, Jordan
2963
Khwaja, Shariq
2006
Khwaja, Shariq
2089
Kierkels, Roel
2707
Kil, Whoon
2385
Kilburn, Jeremy
2908
Kim, Aileen
2673
Kim, Byounghyuck
2818
Kim, Dae Il
3373
Kim, Daniel
2933
Kim, Dong Wook Nathan 2405
Kim, Gwe-Ya
3454
Kim, Haksoo
3286
Kim, Haksoo
3392
Kim, In Ah
3162
Kim, Jin Ho
3179
Kim, Jinkoo
3335
Kim, Julian
2897
Kim, Jun Won
2313
Kim, Jun Won
2654
Kim, Kyung Hwan
2198
Kim, Kyung Hwan
2244
Kim, Kyung Su
2298
Kim, Miranda
1022
Kim, Robert
2529
Kim, Sungjune
3121
Kim, Tae Gyu
3380
184
Kim, Young Il
Kincaid, Russell
King, Martin
Kirkpatrick, John
Kirschner, Austin
Kishan, Amar
Kittel, Jeffrey
Kjaer-Kristoffersen,
Flemming
Klein, Eric
Klein, Jonathan
Kleinberg, Lawrence
Koay, Eugene
Koc, Mehmet
Koch, Siete
Kodaira, Takeshi
Kohutek, Zachary
Kole, Thomas
Kole, Thomas
Kollar, Laura
Kollmeier, Marisa
Komaki, Ritsuko
Kong, Feng-Ming
Konski, Andre
Konski, Andre
Koo, Tae Ryool
Koontz, Bridget
Korah, Mariam
Korideck, Houari
Kotler, Monica
Kovalchuk, Nataliya
Kozak, Margaret
Kozono, David
Krasin, Matthew
Krauss, Daniel
Krauss, Daniel
Kress, Marie-Adele
Krishnan, Monica
Kriz, Jan
Ku, Lichung
Kudrimoti, Mahesh
Kuhn, Elizabeth
Kumar, Aryavarta
Kumar, Rachit
Kumar, Sanath
Kumar, Shaleen
Kumar, Parvesh
Kunhiparambath, Haresh
Kunnambath, Ramadas
Kuo, Hsiang-Chi
Kuo, Jeffrey
Kuo, SUng-Hsin
Kuremsky, Jeffrey
Kusano, Aaron
Kushnirsky, Marina
Kuske, Robert
Kwak, Yoo Kang
Kwon, Jeanny
L
Lachance, Bernard
Ladra, Matthew
Lai, Chiahsuan
Lai, Shihfan
3077
362
235
119
3189
2790
2404
3439
3412
3053
2115
318
2917
3375
2632
27
3367
3428
3078
222
2875
184
2283
3178
2033
2417
2067
1007
3177
2735
2365
50
168
54
2396
176
220
11
3261
3120
2144
2272
1097
1053
2245
2484
2125
353
3234
2039
2934
1079
298
120
2106
2524
2676
3346
3034
2640
2102
Lally, Brian
Lam, Wai Wang
Lamb, James
Lang, Jinyi
Lang, Jinyi
Lanni, Thomas
Lappinen, Erik
Larrea, Luis
Lasley, Foster
Lau, Steven
Lau, Steven
Laufer, Marsha
Lautenschlaeger, Tim
Lazow, Stefanie
Le, Yi
Lee, Andrew
Lee, Dong-Soo
Lee, Eva
Lee, Joo Ho
Lee, Joseph
Lee, Larissa
Lee, Richard
Lee, Suk
Lee, Sung Uk
Lee, Sung-Wei
Lee, Tsz Kin
Lefresne, Shilo
Lei, Rachel
Lei, Xin
LeMieux, Melissa
LeMieux, Melissa
Lemons, Jeffrey
Leonard, Kara
Leong, Aidan
Lester, Scott
Lester-Coll, Nataniel
Letourneau, Daniel
Leung, Eric
Leung, Paikin
Leuthold, Susan
Levin, Daphne
Levy, Antonin
Lewis, Stephen
Lewis, Trevor
Li, Allen
Li, Feng
Li, Guang
Li, Guichao
Li, Hao
Li, Hualei
Li, Jiancheng
Li, Jingdong
Li, Jun
Li, Ling
Li, Ling
Li, Min
Li, Minghuan
Li, Minghuan
Li, Qiwen
Li, Ruijiang
Li, Ruijiang
Li, Rongmao
Li, Xiang
Li, Winnie
188
2985
3001
2534
3206
2775
2303
2891
64
2181
2809
1080
3193
2136
2457
179
2196
2551
2341
198
2579
2397
3310
2336
3214
3055
2959
1123
2355
2140
3043
2652
2370
2750
2892
1076
2983
74
3263
3455
3432
2650
3052
2895
2063
3298
3238
2259
2360
2851
2247
3394
3239
186
2905
2887
2212
2213
2252
3368
109
3233
3236
3386
Lian, Jun
Liang, Jun
Liang, Jian
Liao, Zhongxing
Liapi, Eleni
Lim, Yujin
Lim, Kyoung-Dal
Li-Ming, Xu
Lin, Alexander
Lin, Chi
Lin, Hong-Yiou
Lin, Lilie
Lin, Mu-Han
Lin, Qin
Lin, Shinn-Yn
Lin, Steven
Lin, Steven
Lin, Yuting
Lin, Yuting
Lin, Yu-Wei
Lin, Yu-Wei
Lindsay, Daniel
Ling, Ted
Liss, Adam
Liu, An
Liu, Dan
Liu, Feng
Liu, Gene-Fu
Liu, Han
Liu, Huiming
Liu, Qingfeng
Liu, Qi
Liu, Qi
Liu, Tian
Liu, Wei
Liu, Wenyang
Liu, Wu
Liu, Xiao
Liu, Xiao
Liu, Yilin
Lloyd, Shane
Lloyd, Shane
Lo, Andrea
Lock, Michael
Logan, Jennifer
Logue, Jennifer
Lopater, Zachary
Lopez-Araujo, Javier
Low, Daniel
Low, Daniel
Lozano, Joan
Lu, Bing
Lu, Bing
Lu, Diana
Lu, NingNing
Lu, Shawn Shao-Lun
Lu, Weiguo
Lucas, John
Lukens, John
Lukovic, Jelena
Luo, Guozhen
Luo, Wen Min
Lutkenhaus, Lotte
Ly, David
134
2233
3301
226
3196
2123
3302
2922
2997
68
2184
3413
1010
2643
2721
274
3172
2414
2416
2443
1109
2506
3404
2032
2724
3273
3340
196
3398
2222
2923
2227
2248
2087
2628
2836
2419
1102
1108
2319
2929
2947
2394
2332
2383
2729
3014
2512
357
3229
2425
2803
2804
2805
2253
1099
338
124
2284
2570
3344
3376
2237
2203
M
Ma, Changsheng
2218
Ma, Jinli
2008
Ma, Jin-lu
3122
Ma, Lijun
3384
Ma, Lin
2638
Macklis, Roger
2516
Macrie, Bryan
2407
Maghsoudi, Kaveh
3421
Magnan, Sindy
1023
Magnuson, William
2564
Mahadevan, Anand
2305
Mahantshetty, Umesh
3343
Mahjoubi, Khalil
3381
Mahmoud, Omar
2825
Mahmoud, Omar
332
Mahmoud, Omar
3071
Mahmud, Aamer
2514
Mailhot Vega, Raymond
10
Maity, Amit
1057
Majithia, Lonika
3262
Mak, Kimberley
122
Mak, Raymond
2794
Maldonado, Xavier
257
Maldonado, Javier
3170
Maletz, Kristina
93
Mallick, Indranil
2586
Mallick, Indranil
2723
Mancini, Brandon
2265
Mancini, Brandon
26
Mancosu, Pietro
3244
Mandeville, Henry
169
Mangona, Victor
2812
Mangona, Victor
102
Mannina, Edward
2317
Manning, Matthew
2893
Mantz, Constantine
2493
Manyam, Bindu
2358
Mao, Weihua
3265
Maraldo, Maja
3039
Marchan, Edward
2120
Marciscano, Ariel
1029
Marcrom, Samuel
2056
Maria, Ola
3139
Maria Das, Koilpillai Joseph 3253
Marina, Ovidiu
2342
Mariscal, Luis
2957
Markovic, Alexander
3002
Markovina, Stephanie
2485
Marquardt, Michael
1120
Marques, Tatiana
3192
Marshall, Ingrid
2992
Martin, Neil
3010
Marwaha, Gaurav
2388
Masunaga, Shin-ichiro
3161
Matsuo, Yoshiro
2940
Matsuo, Masayuki
3156
Matsuura, Tomohiro
2639
Mattes, Malcolm
2744
Mattes, Malcolm
3299
Mattonen, Sarah
25
Matulewicz, Lukasz
3422
Matuschek, Christiane
2002
2681
Matysiak, Witold
3402
Mayadev, Jyoti
2020
Maymani, Rebekah
2608
Mayr, Nina
75
Mazloom, Ali
175
McBride, Sean
204
McBride, Sean
3025
McDonald, Mark
2194
McDonald, Andrew
2483
McGee, Lisa
1141
McGuinness, Christopher 3379
McGuire, Sean
2470
Mehmood, Tahir
322
Mehta, Niraj
3442
Mei, Feng
2645
Meier, Robert
58
Mellon, Eric
2003
Mellon, Eric
2261
Men, Yu
2823
Mendenhall, Nancy
1019
Mendez Romero,
Alejandra
2302
Meng, Bowen
359
Menichelli, Claudia
2323
Menzel, Paul
3072
Meral, Rasim
2158
Merchant, Thomas
91
Meredith, Ruby
1001
Merrell, Kenneth
2074
Merrell, Kenneth
2314
Merrell, Kenneth
3409
Meshkov, Dmitriy
276
Meshkov, Dmitriy
2881
Mestre, Francisco
2918
Meyer, Joshua
2952
Meyer, Kurt
2651
Mian, Omar
2163
Michalski, Jeff
265
Michaud, Anthony
2871
Mikell, John
2932
Milano, Michael
2810
Milecki, Piotr
264
Milgrom, Sarah
314
Milgrom, Sarah
3058
Miljkovic, Milos
3045
Miller, Luke
1043
Min, Christine
209
Min, Christine
2772
Ming, Xin
1012
Mirabeau-Beale, Kristina
180
Mirhadi, Amin
61
Mishra, Mark
1078
Misirlioglu, Cem
2255
Mislmani, Mazen
2583
Mitchell, James
3006
Mitsuyoshi, Takamasa
2596
Miwa, Kazuhiro
2113
Mix, Michael
2693
Miyakawa, Akifumi
3148
Miyawaki, Daisuke
2708
Modh, Ankit
78
Mohanty, Partha Pratim
3435
Mohindra, Pranshu
212
Mohindra, Pranshu
3015
Mohr, Angela
Moleron, Rafael
Molitoris, Jason
Monjazeb, Arta
Mooney, Karen
Mooney, Karen
Moore, Joseph
Moore, Joseph
Mori, Yoshimasa
Morris, Ann
Morris, Zachary
Mosaly, Prithima Reddy
Moskvin, Vadim
Moteabbed, Maryam
Motwani, Sabin
Mou, Benjamin
Mourad, Waleed
Mourad, Waleed
Mourad, Waleed
Mourad, Waleed
Mouw, Kent
Movsas, Benjamin
Mrochem-Kwarciak,
Jolanta
Muanza, Thierry
Muanza, Thierry
Mukai, Yuki
Mukumoto, Naritoshi
Müller, Klaus
Munbodh, Reshma
Munbodh, Reshma
Munoz Garcia, Julia Luisa
Murai, Taro
Murai, Taro
Murakami, Yuji
Murphy, Colin
Murphy, Colin
Murphy, Erin
Muraoka, Osamu
Murray, Louise
Mut, Alejandro
Mutyala, Subhakar
Myers, Carey
Myers, Carey
Myers, Carey
Myojin, Miyako
N
3316
2191
2990
272
3224
3268
3096
335
2155
2786
84
290
3259
1096
1092
2127
2765
2206
2694
2935
2943
87
2
2656
2036
3168
2856
3175
88
3264
3283
2399
2412
2179
81
2229
2400
2455
2142
2674
33
3383
3087
1135
2894
2896
2236
Nath, Sameer
Nautiyal, Vipul
Navarria, Piera
Navarria, Piera
Nedelka, Michele
Nedialkova, Lucy
Nedzi, Lucien
Ng, Andrea
Nguyen, Hannah
Nguyen, Nathalie
Nguyen, Nhu Tram
Nguyen, Paul
Nguyen, Phuong
Nguyen, Quynh
Nguyen-Tan, Phuc Felix
Ngwa, Wilfred
Niazi, Tamim
Niazi, Tamim
Nicholas, Zachary
Nichols, R. Charles
Nickols, Nicholas
Nicolaou, Nicos
Niermann, Kenneth
Nishibuchi, Ikuno
Nishioka, Kentaro
Nishioka, Takeshi
Niu, Tianye
Niu, Tianye
Nixon, Lisette
Noh, Jae Myoung
Noto, Kimiya
Nowak, Ryan
Nowotnik, David
Nuver, Tonnis
Nwachukwu, Chika
Nyflot, Matthew
O
2055
3059
2930
3365
2942
3446
139
144
2413
2153
2909
261
2350
190
135
1009
1020
2433
2461
308
3174
3235
325
51
2504
3135
3247
3248
2271
1130
3424
2145
2967
2449
2968
2994
Obasaju, Patience
Obayomi-Davies, Olusola
Obedian, Edward
Ogawa, Yasuhiro
Oguchi, Masahiko
Oguri, Mitsuhiko
Oh, Steven
Oh, Seungjong
Ohashi, Toshio
Ohashi, Toshio
Oike, Takahiro
Okoye, Christian
Okumura, Toshiyuki
Oliai, Caspian
Olivera, Gustavo
Olsen, Jeff
Olson, Robert
Olson, Robert
Onal, Cem
Ong, Leonard
Onimaru, Rikiya
Onishi, Hiroshi
Onozato, Yusuke
Onukwugha,
Eberechukwu
2045
178
2467
2014
2054
2912
2118
300
2371
2377
2527
2204
2311
2503
3326
213
215
2974
2472
2877
22
21
3332
185
Na, Yong Hum
Nabavizadeh, Nima
Nagar, Himanshu
Nagar, Himanshu
Nagata, Yasushi
Naik, Nilan
Nakagawa, Keiichi
Nakamatsu, Kiyoshi
Nakamatsu, Kiyoshi
Nakamura, Naoki
Nam, Jiho
Narang, Amol
Nath, Sameer
3433
3391
2035
2554
3369
2829
3437
2117
2408
2001
2075
254
2023
2384
Orisamolu, Abimbola
Orman, Amber
Orton, Matthew
Osmundson, Evan
O’Sullivan, Brian
Otani, Keisuke
Ou, Dan
Owen, Dawn
Owen, Dawn
Owen, Dawn
P
2688
3035
2815
2330
136
1100
2962
2684
132
3362
Pai, Jonathan
1034
Pai, Jonathan
3219
Pai Panandiker,
Atmaram
3036
Pai Panandiker,
Atmaram
3038
Palma, David
7
Palmer, Joshua
1032
Pan, Elizabeth
156
Pan, Hubert
3066
Pandit-Taskar, Neeta
2547
Pang, Tingtian
2995
Panoff, Joseph
3027
Papachristofilou, Alexandros 82
Pappas, Evangelos
3448
Parashar, Bhupesh
1142
Pardo, Jose
2026
Parekh, Akash
2458
Parekh, Akash
2489
Parikh, Dhwani
2831
Parikh, Rahul
2920
Parikh, Ravi
1138
Parisi, Elisabetta
2846
Park, Catherine
1060
Park, Heon Joo
3180
Park, Jaehyeon
2833
Park, Junsu
2448
Park, Sang-June
2578
Parsai, E. Ishmael
3285
Parvathaneni, Upendra
3085
3086
Paryani, Nitesh
2010
Pasha, Junaid
3325
Patel, Abhilasha
2517
Patel, Abhilasha
2584
Patel, Abhilasha
3372
Patel, Abhilasha
2756
Patel, Abhilasha
2970
Patel, Ajay
2288
Patel, Ajaykumar
2403
Patel, Kirtesh
2951
Patel, Kruti
2843
Patel, Nisha
86
Patel, Pretesh
2733
Patel, Rajal
2258
Patel, Sagar
112
Patel, Sagar
2234
Patel, Shilpen
2914
Patel, Shilpen
2915
Patel, Shilpen
2738
Patel, Suchit
189
186
Patil, Nikhilesh
Pavelic, Martin
Peacock, Justin
Pearce, Andrew
Pearlstein, Kevin
Pearson, David
Pellicciotta, Ilenia
Peng, Cheng
Perez, Bradford
Perez, Carmen
Perez, Carmen
Perez-Andujar, Angelica
Perkins, Gregory
Pernin, Victor
Petersen, Peter
Petoukhova, Anna
Petras, Katarina
Pham, Huong
Picone, James
Ping, Yan
Pinkawa, Michael
Pinnix, Chelsea
Piper, Jonathan
Piper, Jonathan
Piper, Jonathan
Pisansky, Thomas
Pitroda, Sean
Platta, Christopher
Podder, Tarun
Polishchuk, Alexei
Polo, Alfredo
Popovic, Marija
Poulsen, Per
Prabhu, Roshan
Prasad, Shreya
Prasad, Shreya
Press, Robert
Price, Jeremy
Price, Jeremy
Prieto, Isabel
Prior, Phillip
Pukala, Jason
Pyakuryal, Anil
Q
Qi, Huanpeng
Qi, Xiangrong
Qi, Xiangrong
Qian, Xin
Qiao, Xueying
Qiao, Qiao
Qin, An
Qiu, Haoming
Qiu, Haoming
Qiu, Su
Qu, Ang
Quang, Tony
Quanshi, Zhang
Que, jenny
Quek, Ruben
Quek, Ruben
Quon, Harry
Quon, Harvey
2577
1025
2664
2740
1073
2100
344
3427
2064
1052
3127
3449
3359
2092
150
2012
2913
3008
3388
3318
2379
2927
355
3349
3350
1
46
2560
2876
174
1047
2690
107
2592
241
2273
1027
2398
273
2955
239
3336
3106
2807
2703
331
3197
2176
3328
336
2209
2911
2631
3137
2986
3274
2296
2739
2741
348
351
R
Raaijmakers, Cornelis
142
Rabinovitch, Rachel Abrams 13
Rafie, Frank
3453
Rahimian, Javad
1004
Rahn, Douglas
292
Rainey, David
3083
Rajagopalan, Malolan
2965
Rajakesari, Selvan
2189
Rajan, Saju
185
Rajpara, Raj
2845
Raldow, Ann
1077
Ram, Ashwin
3031
Ramos, Clementina
2730
Rana, Shushan
2562
Rancati, Tiziana
2462
Ranck, Mark
2701
Randolph, David
3061
Rao, Nalini
2070
Rao, Malay
2172
Rash, Dominique
2535
Rash, Dominique
1119
Rasheed, Abdullah
2907
Rasmussen, Jacob
2709
Rath, Goura
2533
Raval, Raju
342
Recht, Abram
287
Reddy, Jay
2105
Reddy, Srilakshmi
341
Redmond, Kristin
89
Reese, Adam
2049
Refaat, Tamer
2520
Refaat, Tamer
2602
Register, Steven
2058
Reiff, Jay
2069
Reinartz, Gabriele
1042
Ren, Hua
2254
Ren, Lei
358
Renaud, Marc-Andre
3101
Renaud, Marc-Andre
3416
Riaz, Nadeem
191
Rice, Lynsey
3443
Rich, Shayna
2746
Richard, Patrick
2623
Richard, Patrick
2627
Richter, Daniel
1090
Richter, Andreas
3270
Riegel, Adam
3292
Rimner, Andreas
281
Riou, Olivier
2079
Riou, Olivier
2361
Rishi, Anupam
137
Roach, Mack
260
Roach, Mack
2401
Roach, Michael
2091
Roach, Michael
2093
Robinson, Timothy
2751
Robinson, Timothy
3207
Rochet, Nathalie
1127
Rochet, Nathalie
3426
Rodrigues, George
118
Rodrigues, Anna
296
Roeder, Falk
154
Rolfo, Maureen
Romano, Mario
Romeo, Antonino
Romesser, Paul
Romesser, Paul
Ronny, Kalash
Rooney, Jessica
Rosenberg, Jennifer
Rosenthal, David
Rothenstein, Diana
Rouscoff, Yohann
Roux, Audrey
Ruggieri, Ruggero
Russo, Andrea
Russo, Andrea
Rutenberg, Michael
Rutter, Charles
Rutter, Charles
Rutter, Charles
Rwigema, Jean-Claude
Ryu, Samuel
S
Sabater, Sebastia
Sabolch, Aaron
Sadek, Betro
Sahai, Puja
Sahgal, Arjun
Saigal, Kunal
Saito, Anneyuko
Saito, Makoto
Saito, Tetsuo
Sakthivel, Vasanthan
Salama, Joseph
Salamekh, Samer
Salem, Ahmed
Samuels, Stuart
Sanchez Parcerisa, Daniel
Santanam, Lakshmi
Santivasi, Wil
Santos, Tamara
Sanuki, Naoko
Sarabia-Estrada, Rachel
Saran, Frank
Sarmey, Nehaw
Sasaki, Ryohei
Savir, Guy
Sayre, George
Schadewaldt, Nicole
Schanne, Daniel
Scharf, Lawrence
Schefter, Tracey
Schinkel, Colleen
Schlaff, Cody
Schmitt, Adam
Schulte, Reinhard
Schuster, Jessica
Schutzer, Matthew
Schutzer, Matthew
Schwartz, David Louis
Schwartz, David
Scott, Michael
Scott, Michael
Sekiguchi, Akane
2351
159
2274
1016
323
3108
3081
1035
3004
2348
2515
2588
3252
19
2667
1104
2017
2180
2186
2368
83
250
2557
205
20
2789
2174
2082
2085
2668
2806
2660
306
164
3181
79
3410
294
245
2202
2310
303
37
2161
3146
2207
301
3423
2868
2453
208
3337
3171
45
105
334
2490
2900
1113
286
2658
3068
2390
Semon, Meredith
Sen, Amarjit
Seo, Yuji
Seol, Seung Won
Sethi, Roshan
Sethi, Manish
Sethukavalan, Perakaa
Setton, Jermey
Sevak, Parag
Seyedin, Steven
Seymour, Zachary
Seymour, Zachary
Shabason, Jacob
Shaffer, Jenny
Shah, Anand
Shah, Anand
Shah, Jennifer
Shah, Jennifer
Shah, Mira
Shakir, Shakir
Shang, Qingyang
Shankar, Vangipuram
Sharabi, Andrew
Sharma, Navesh
Sharma, Daya Nand
Shasha, Daniel
Sheets, Nathan
Shen, Yuxin
Shen, Yi-Liang
Shen, Chunying
Sheng, Ke
Shenouda, Mina
Shenouda, George
Sher, David
Sherman, Alexandra
Sherr, David
Sheu, Tommy
Sheybani, Arshin
Shi, Qi
Shi, Pengyue
Shi, Xiutao
Shibamoto, Yuta
Shih, Helen
Shikama, Naoto
Shikama, Naoto
Shim, Su Jung
Shimizuguchi, Takuya
Shin, Samuel
Shin, Jacob
Shin, Samuel
Shin, Naomi
Shin, Hun-Joo
Shinde, Prashantkumar
Shioyama, Yoshiyuki
Shiraishi, Yutaka
Shiraishi, Kenshiro
Shiue, Kevin
Showalter, Timothy
Shridhar, Ravi
Shukla, Monica
Shukla, Monica
Shukla, Gaurav
Shultz, David
Shultz, David
3352
2473
3215
2312
2188
3166
60
347
2657
2250
2745
3050
1084
2316
98
2743
2154
2256
2369
2474
2466
2680
1131
2327
3076
2497
2770
2246
2590
2662
299
2061
1031
1082
2956
2266
3132
2941
2637
2795
163
256
1028
2004
2007
2044
2495
16
315
2928
3280
3327
3378
2837
2409
2460
2195
2768
2214
2053
263
1063
2293
3397
Shumway, Dean
Shvydka, Diana
Siddiqui, Faisal
Siddiqui, Farzan
Siddiqui, Farzan
Siglin, Joshua
Simone, Brittany
Simone, Brittany
Simpson, Daniel
Sindhwani, Ragini
Sinha, Uttam
Sio, Terence
Sio, Terence
Sirak, Igor
Sittig, Mark
Skamene, Sonia
Slater, Jerry
Slater, Jason
Small, William
Smith, Linda
Smith, Tamara
Smith, Adam
Soh, Hendrick
Soike, Michael
Solanki, Abhishek
Solanki, Abhishek
Solanki, Abhishek
Solanki, Abhishek
Sole, Claudio
Son, Christina
Son, Christina
Song, Yongchun
Sonke, Jan-Jakob
Soong, Chen-Pang
Sostin, Oleg
Sottero, Theo
Souranis, Annette
Sours, Chandler
Speers, Corey
Speirs, Christina
Spektor, Alexander
Spencer, Christopher
Sperduto, Paul
Spiotto, Michael
Spratt, Daniel
Spratt, Daniel
Spratt, Daniel
Sreeraman, Radhika
Stanescu, Teo
Stanton, Paul
Stecklein, Shane
Steineck, Gunnar
Stenmark, Matthew
Stephans, Kevin
Stephens, Kevin
Stessin, Alexander
Stessin, Alexander
Stewart, Robert
Stish, Bradley
Stockham, Abigail
Stone, Brandon
Stoyanova, Radka
Strom, Tobin
Strom, Tobin
2870
1002
2241
2609
3305
1030
3167
3240
2978
2481
2629
2973
328
2519
2771
2295
59
2392
3
2059
1018
3190
3176
2903
2108
2110
2687
145
2352
1070
3054
2793
101
47
2491
2802
2989
2131
244
2307
3279
1110
123
1059
42
311
1071
2025
104
1137
2109
131
194
2438
2488
2251
1051
3151
2872
3237
2452
2134
2615
146
Suh, Yelin
130
Sulaiman, Nor Shazrina
2426
Sulman, Erik
3213
Sun, Jason
2661
Sundararaman, Srinath
3017
Suneja, Gita
2759
Sura, Karna
283
Surapaneni, Aparna
2441
Suri, Jaipreet
173
Surucu, Murat
2626
Susheela, Sridhar
2116
Sveistrup, Joen
2380
Swanick, Cameron
2800
Swartz, Harold
3194
Swisher-McClure, Samuel 1074
Symon, Zvi
2430
Szeja, Sean
2556
Szumacher, Ewa
2781
T
Tachibana, Izumi
Tadic, Tony
Tagliagambe, Angiolo
Tai, An
Tait, Lauren
Takagi, Masaru
Takahashi, Ippei
Takahashi, Wataru
Takahashi, Yutaka
Takanaka, Tsuyoshi
Takao, Seishin
Takeda, Atsuya
Takiar, Vinita
Takiar, Vinita
Tam, Moses
Tam, Moses
Tam, Moses
Tam, Moses
Tamari, Keisuke
Tan, Wenyong
Tang, Chad
Tang, Justin
Tang, Justin
Tang, Shikui
Tang, Xiaoli
Tang, Yu
Tanzler, Emily
Tao, Randa
Tarnawski, Rafal
Tatekawa, Kotoha
Tatewaki, Koshi
Taylor, Robert
Teckie, Sewit
Tennyson, Nathan
Terashima, Kotaro
Terezakis, Stephanie
Terhaard, Chris
Tetreault, Audrey
Thaker, Nikhil
Thariat, Juliette
Thariat, Juliette
Thawani, Nitika
Thibault, Isabelle
2835
31
2435
3278
2208
2692
3140
1093
3356
1006
161
2308
2689
2696
38
197
2612
2613
2219
2630
187
3185
3199
3403
3225
3051
2151
2697
1003
2865
2149
2581
147
2478
2290
3046
349
2555
317
2595
2678
2766
2183
Thibault, Isabelle
Thiruganasambandam,
Sivarajan
Thirumoorthy, Krishnan
Thomas, Kimberly
Thomas, Charles
Thompson, Jonathan
Thompson, Marcher
Thompson, Marcher
Thompson, Reid
Thompson, Reid
Thoms, John
Tinkle, Christopher
Tiwana, Manpreet
Todor, Dorin
Tokita, Kenneth
Tol, Jim
Tom, Ashlyn
Tomita, Natsuo
Tong, Xu
Tong, William
Tongtip, Naruemon
Tonlaar, Nathan
Torok, Jordan
Townsend, Natasha
Tozzi, Angelo
Tran, Phuoc
Tree, Alison
Trister, Andrew
Troeller, Almut
Trovo, Marco
Trovo, Marco
Trovo, Marco
Trovo, Marco
Tsai, Chiaojung Jillian
Tsai, Yu-Chen
Tsang, Derek
Tseng, Chia-Lin
Tseng, Yolanda
Tsujii, Mari
Turaka, Aruna
Turaka, Aruna
Turgeon, Guy
Turner, Kathryn
U
Ujaimi, Reem
Umezawa, Rei
Uno, Takashi
Urbanic, James
Usui, Keisuke
V
Vaiduriam, Mayuraa
Vaidya, Jayant
Vaidya, Jayant
Vainshtein, Jeffrey
Vainshtein, Jeffrey
Vainshtein, Jeffrey
Valdes, Gilmer
Vali, Faisal
Valicenti, Richard
2863
1056
3221
2041
214
3445
2666
3136
2282
3032
3165
121
2731
2464
1064
3315
2966
2422
2378
170
3360
1072
2853
2677
2268
1055
2423
3216
3271
2027
2028
279
2813
3204
18
160
2165
219
3382
2798
2827
2511
3254
2931
2232
2541
85
3307
2005
15
2094
2610
2611
2774
237
3089
2981
187
Vallieres, Martin
2695
Van den Bosch, Michiel
3333
Van Den Heuvel, Frank
236
Van der Steen-Banasi, E.M. 2507
Van Sornsen de Koste, John 360
VanderWalde, Noam
1116
Vargo, John
2683
Vargo, John
3065
Varia, Mahesh
3217
Varlotto, John
2864
Vatner, Ralph
271
Vatyam, Sathiya Narayanan 3241
Veldwijk, Marlon
3198
Vergalasova, Irina
3306
Verhoeven, Karolien
2034
Vicini, Frank
2975
Videtic, Gregory
6
Vinogradskiy, Yevgeniy
1136
Viswanathan, Akila
9
Vlacich, Gregory
1054
Volotskova, Olga
3159
Voong, Ranh
1041
Voong, Ranh
2924
Vujovic, Olga
2086
Vuong, Te
2357
W
Wagner, Aaron
Wagner, Henry
Wakai, Nobuhide
Wakatsuki, Masaru
Walker, Amanda
Walker, Gary
Walker, Gary
Wallace, Harold
Waller, Joseph
Wang, Bin
Wang, Chenyang
Wang, Dian
Wang, Edina
Wang, Hao
Wang, He
Wang, Henry
Wang, Jianyang
Wang, Jin
Wang, Jing
Wang, Jingya
Wang, Jun
Wang, Jun
Wang, Lan
Wang, Lilie
Wang, Ping
Wang, Ricardo
Wang, Shulian
Wang, Song
Wang, Suzhen
Wang, Tony
Wang, XiaoShen
Wang, Yuefeng
Wang, Ziwei
Wang, Zheng
Warner, Lindsay
Warrell, Gregory
188
1067
3057
3304
2532
1039
3090
149
2382
2325
3458
2971
151
3191
2281
1040
3358
155
3130
1085
210
2225
2228
2217
3396
3296
2359
17
3457
2796
2329
1114
2437
2691
3321
3084
3456
Warren, Laura
Watkins, John
Watkins, William
Wattson, Daniel
Wattson, Daniel
Waxweiler, Timothy
Wei, Xiong
Weiss, Elisabeth
Weller, Michael
Welliver, Meng
Wenz, Frederik
Werner-Wasik, Maria
Werner-Wasik, Maria
Westerly, David
White, Evan
Whitley, Alexander
Widlak, Piotr
Wijesooriya, Krishni
Wilcox, Shea
Wild, Aaron
Wild, Sommer
Wild, Aaron
Wilkinson, Ben
Willers, Henning
Willett, Addison
Williams, Benjamin
Williams, Eric
Williams, Noelle
Willson, Adam
Willson, Adam
Wilson, David
Wilson, William
Wilson, William
Wilson, Zachary
Wissel, Tobias
Witek, Matthew
Wo, Jennifer
Wo, Jennifer
Wobb, Jessica
Wojcieszynski, Andrzej
Wolfe, Adam
Wong, Raimond
Wong, Rebecca
Wong, Winnifred
Woo, Joong Yeol
Woods, Charles
Woodward, Wendy
Woody, Neil
Wooten, Charles
Wooten, Charles
Wooten, Hasani
Wright, Florence
Wu, Abraham
Wu, Jeffrey
Wu, Huanmei
Wynne, Jacob
113
262
3452
2157
1083
171
2873
36
1013
3186
2096
2799
2884
3048
2337
2523
3138
3357
2395
67
2979
3195
117
339
1045
3266
106
3026
3029
3074
2946
2150
2429
3444
3223
266
207
2285
14
2339
3164
284
2954
2960
2287
2649
246
2852
2585
3434
3152
2939
2235
2670
1091
1134
X
Xanthopoulos, Eric
Xanthopoulos, Eric
Xia, Tingyi
Xiao, Qin
Xiao, Nian
Xing, Lei
Xu, Ting
Xue, Jinyu
Y
Yamada, Shigeru
Yamada, Yoshiya
Yamamoto, Takaya
Yamashita, Hideomi
Yamoah, Kosj
Yan, Susu
Yanagi, Takeshi
Yang, Bin
Yang, Cungeng
Yang, Daniel
Yang, Deshan
Yang, Joanna
Yang, Kai
Yang, Ruijie
Yang, Tzu-I Jonathan
Yang, Wensha
Yang, Xiaofeng
Yang, Xiaofeng
Yang, Xiaofeng
Yang, Xiaofeng
Yang, Yun
Yang, Yun
Yap, Mei Ling
Yaparpalvi, Ravindra
Yashar, Catheryn
Yasuda, Koichi
Ybarra, Norma
Ye, Jason
Ye, Jason
Ye, Jing jing
Yeager, Caitlyn
Yeboa, Debra
Yechieli, Raphael
Yechieli, Raphael
Yeh, Chi-Yuan
Yeung, Daniel
Yi, Junlin
Yipeng, Ling
Yogo, Katsunori
Yondorf, Menachem
Yondorf, Menachem
Yondorf, Menachem
Yoo, Sua
Yoon, Sang Min
Yoon, Hannah
Yordy, John
Yorke, Ellen
Yorozu, Atsunori
Yoshida, Masahiro
Yoshikawa, Nobuhiko
Young, Kristina
316
2902
2262
2340
2888
3430
228
2953
2353
3060
2840
2309
2160
3319
2604
2988
3284
2338
3091
3030
3291
3438
125
2344
3230
115
2439
2587
2671
133
3419
2886
2542
2043
3155
3118
110
2119
3323
3411
2037
2269
2402
3314
3317
2619
2249
2987
1036
2130
2152
2029
2306
2844
3436
128
2391
2048
3145
3129
Youssef, Ashraf
Yovino, Susannah
Yu, James
Yu, Jennifer
Yu, Juan
Yu, Tosol
Yu, Naichang
Yu, Shu-Jung
Yu, Yao
Yuan, Jiankui
Yuan, Lulin
Yuan, Lulin
Yuh, William
Yuan, Ye
Z
Zachman, Derek
Zaki, Bassem
Zaorsky, Nicholas
Zaorsky, Nicholas
Zaorsky, Nicholas
Zapatero, Almudena
Zapatero, Almudena
Zeidan, Youssef
Zeitlin, Ross
Zelefsky, Michael
Zeng, Jing
Zerounian, Sophie
Zhang, Chi
Zhang, Geoffrey
Zhang, Guangyu
Zhang, Hao
Zhang, Hualin
Zhang, Lifei
Zhang, Pengpeng
Zhang, Qian
Zhang, Rui
Zhang, Wencheng
Zhang, Wenjue
Zhang, Ying
Zhao, Bo
Zhao, Lujun
Zhao, Lujun
Zhao, Sherry
Zhao, Tianyu
Zhao, Xiao
Zhen, Heming
Zhen, Weining
Zheng, Dandan
Zheng, Yuanshui
Zheng, Yuanshui
Zhikai, Liu
Zhong, Hualiang
Zhong, Jim
Zhou, Di
Zhou, Jessica
Zhou, Lili
Zhou, Lin
2047
2349
1015
3183
2031
2565
304
3400
2621
3272
3100
3339
3105
3182
49
1103
2200
56
2816
2445
3203
3141
2471
2463
293
2133
242
3282
2522
3104
3281
234
3300
2066
3405
2239
2820
3431
3226
2841
2858
2653
3269
2095
3387
2132
2292
3407
3414
3440
3277
2299
2168
2964
3295
2791
Zhou, Peng
Zhou, Qichao
Zhou, Qichao
Zhou, Qichao
Zhou, Zongmei
Zhu, Guangying
Zhu, Goupei
Zhu, Lihong
Zhu, Shuchai
Zhu, Shuchai
Zhu, Ya
Zhuang, Hong-Qing
Zhung, Joanne
Ziel, Ellis
Zilli, Thomas
Zuliani, Antonio
Zumsteg, Zachary
2097
2642
2644
2646
2821
1144
1115
2736
2216
2242
2009
2857
3355
2830
238
8
53
189
Index by Track (Abstracts only)
BREAST CANCER
Rabinovitch, Rachel Abrams 13
Wobb, Jessica
14
Vaidya, Jayant
15
Shin, Samuel
16
Wang, Shulian
17
Tsai, Yu-Chen
18
Russo, Andrea
19
Sadek, Betro
20
Ye, Jason
110
Chen, Jiayi
111
Patel, Sagar
112
Warren, Laura
113
Dan, Tu
114
Yang, Xiaofeng
115
Ho, Alice
116
Wilkinson, Ben
117
Bredel, Markus
240
Prasad, Shreya
241
Zhang, Chi
242
Biswas, Tithi
243
Speers, Corey
244
Santivasi, Wil
245
Woodward, Wendy
246
Jegadeesh, Naresh
247
Badiyan, Shahed
1121
Galland, Sigolene
1122
Lei, Rachel
1123
Braunstein, Steve
1124
Chadha, Manjeet
1125
Batra, Sonny
1126
Rochet, Nathalie
1127
Gentile, Michelle
1128
Keruakous, Amany
1129
Noh, Jae Myoung
1130
Sharabi, Andrew
1131
Aneja, Sanjay
1132
Nakamura, Naoki
2001
2002
Mellon, Eric
2003
Shikama, Naoto
2004
Vaiduriam, Mayuraa
2005
Khwaja, Shariq
2006
Shikama, Naoto
2007
Ma, Jinli
2008
Zhu, Ya
2009
Paryani, Nitesh
2010
2011
Petoukhova, Anna
2012
Ogawa, Yasuhiro
2014
Bondiau, Pierre-Yves
2015
Ding, Yun
2016
Rutter, Charles
2017
Eaton, Bree
2018
Ferreira, Dominihemberg 2019
Mayadev, Jyoti
2020
Jacob, Julian
2021
Dunst, Juergen
2022
Nath, Sameer
2023
Abo-Madyan, Yasser
2024
190
Sreeraman, Radhika
Pardo, Jose
Trovo, Marco
Trovo, Marco
Yoo, Sua
Chaudhry, Huma
Yu, Juan
Liss, Adam
Koo, Tae Ryool
Verhoeven, Karolien
Nagar, Himanshu
Muanza, Thierry
Yeboa, Debra
Kalash, Ronny
Kuo, Jeffrey
Ferro, Adam
Thomas, Kimberly
Geng, Alexander
Yashar, Catheryn
Shim, Su Jung
Obasaju, Patience
Jagsi, Reshma
Youssef, Ashraf
Yoshida, Masahiro
Reese, Adam
Franco, Pierfrancesco
Chen, Peter
Barrett, Olivia
Shukla, Monica
Oguchi, Masahiko
Nath, Sameer
Marcrom, Samuel
Eshleman, Jeffrey
Register, Steven
Smith, Linda
Chen, Quan
Shenouda, Mina
Goyal, Sharad
Li, Allen
Perez, Bradford
Horton, Janet
Zhang, Qian
Korah, Mariam
Chen, Yu
Reiff, Jay
Rao, Nalini
Jozsef, Gabor
Cohen, Randi
Den Hartogh, Mariska
Merrell, Kenneth
Nam, Jiho
Hong, Robert
Atrchian, Siavash
Chadha, Manjeet
Riou, Olivier
Bradley, Julie
Chow, Tiffany
Saigal, Kunal
Hinse, Martin
Galland, Sigolene
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
2051
2052
2053
2054
2055
2056
2057
2058
2059
2060
2061
2062
2063
2064
2065
2066
2067
2068
2069
2070
2071
2072
2073
2074
2075
2076
2077
2078
2079
2080
2081
2082
2083
2084
Saito, Anneyuko
2085
Vujovic, Olga
2086
Liu, Tian
2087
Bhandare, Niranjan
2088
Khwaja, Shariq
2089
Anderson, Bethany
2090
Roach, Michael
2091
Pernin, Victor
2092
Roach, Michael
2093
Vaidya, Jayant
2094
Zhao, Xiao
2095
Wenz, Frederik
2096
Zhou, Peng
2097
Alfaraj, Fatimah
2098
Bradbury, C. Matthew
2099
Pearson, David
2100
Grendarova, Petra
2101
Lai, Shihfan
2102
Edwards-Bennett, Sophia 2103
Horowitz, David
2104
Reddy, Jay
2105
Kuske, Robert
2106
Fagundes, Marcio
2107
Solanki, Abhishek
2108
Stecklein, Shane
2109
Solanki, Abhishek
2110
Einck, John
2111
Burt, Lindsay
2112
CENTRAL NERVOUS SYSTEM
Saran, Frank
37
Tam, Moses
38
Arvold, Nils
39
Chen, Linda
40
Fang, Penny
41
Spratt, Daniel
42
Anwar, Mekhail
43
Danish, Hasan
44
Rodrigues, George
118
Kirkpatrick, John
119
Kushnirsky, Marina
120
Tinkle, Christopher
121
Mak, Kimberley
122
Sperduto, Paul
123
Lucas, John
124
125
Kersh, C. Ronald
248
Guckenberger, Matthias
249
Ryu, Samuel
250
Combs, Stephanie E.
251
Bernad, Daniel
252
Giordano, Frank
253
Narang, Amol
254
Hardie, John
255
Shibamoto, Yuta
256
Pavelic, Martin
1025
Braunstein, Steve
1026
Press, Robert
1027
Shih, Helen
1028
Marciscano, Ariel
1029
Siglin, Joshua
1030
Shenouda, George
1031
Palmer, Joshua
1032
Kalakota, Kapila
1033
Pai, Jonathan
1034
Rosenberg, Jennifer
1035
Yondorf, Menachem
1036
Miwa, Kazuhiro
2113
Chang-Halpenny, Christine 2114
Kleinberg, Lawrence
2115
Susheela, Sridhar
2116
Nakamatsu, Kiyoshi
2117
Oh, Steven
2118
Ye, Jason
2119
Marchan, Edward
2120
Cordova, James
2121
Jeongshim, Lee
2122
Lim, Yujin
2123
Kunhiparambath, Haresh 2125
Kandula, Shravan
2126
Motwani, Sabin
2127
Amelio, Dante
2128
Corso, Christopher
2129
Yondorf, Menachem
2130
Sours, Chandler
2131
Zhen, Weining
2132
Zerounian, Sophie
2133
Stoyanova, Radka
2134
Aizer, Ayal
2135
Lazow, Stefanie
2136
Harris, Timothy
2138
Corwin, David
2139
LeMieux, Melissa
2140
Hosotani, Martha
2141
Murphy, Erin
2142
Chilukuri, Srinivas
2143
Kuhn, Elizabeth
2144
Nowak, Ryan
2145
Grossman, Craig
2146
Arribas, Leoncio
2148
Tatewaki, Koshi
2149
Wilson, William
2150
Tanzler, Emily
2151
Yondorf, Menachem
2152
Nguyen, Nathalie
2153
Shah, Jennifer
2154
Mori, Yoshimasa
2155
Desai, Prashant
2156
Wattson, Daniel
2157
Meral, Rasim
2158
Al-Omair, Ameen
2159
Yamoah, Kosj
2160
Sarmey, Nehaw
2161
Jawad, Maha
2162
Mian, Omar
2163
Christensen, Eva
2164
Tseng, Chia-Lin
2165
Ghaly, Maged
2166
Kamran, Sophia
2167
Zhou, Di
Currier, Blake
Esthappan, Jacqueline
Jain, Anshu
Rao, Malay
Kao, Johnny
Sahgal, Arjun
Arneson, Kyle
Qiao, Xueying
Clark, Grant
Chen, Allan
Murai, Taro
Rutter, Charles
Lau, Steven
Thibault, Isabelle
Lin, Hong-Yiou
Rutter, Charles
Jimenez, Rachel
Sethi, Roshan
Rajakesari, Selvan
Dosoretz, Arie
Moleron, Rafael
Compton, Julia
Alcorn, Sara
McDonald, Mark
Shiue, Kevin
Lee, Dong-Soo
Kao, Wei Heng
Kim, Kyung Hwan
Johnson, Matthew
Zaorsky, Nicholas
Chera, Bhisham
Santos, Tâmara
Ly, David
Okoye, Christian
Figueiredo, Maria Luisa
Mourad, Waleed
Savir, Guy
Tait, Lauren
Qiu, Haoming
2168
2169
2170
2171
2172
2173
2174
2175
2176
2177
2178
2179
2180
2181
2183
2184
2185
2186
2187
2188
2189
2190
2191
2192
2193
2194
2195
2196
2197
2198
2199
2200
2201
2202
2203
2204
2205
2206
2207
2208
2209
GASTROINTESTINAL CANCER
Cao, Yue
62
Feng, Mary
63
Lasley, Foster
64
Hong, Theodore
65
Herman, Joseph
66
Wild, Aaron
67
Lin, Chi
68
Huguet, Florence
69
Wo, Jennifer
207
Schefter, Tracey
208
Min, Christine
209
Wang, Jingya
210
Dholakia, Avani
211
Mohindra, Pranshu
212
Olsen, Jeff
213
Thomas, Charles
214
Kumar, Rachit
1097
Fisher, Sarah
1098
Lu, Shawn Shao-Lun
1099
Otani, Keisuke
1100
Hsu, Howard
Liu, Xiao
Zaki, Bassem
Rutenberg, Michael
Kharofa, Jordan
Erickson, Kelly
Goodman, Ben
Liu, Xiao
Jingu, Keiichi
Haritha, Chiramana
Li, Minghuan
Li, Minghuan
Shridhar, Ravi
Han, Chun
Zhu, Shuchai
Wang, Lan
Ma, Changsheng
Tamari, Keisuke
Kawaguchi, Gen
Hori, Masakazu
Liu, Huiming
Huang, Xin
Boggs, Hunter
Wang, Jun
Hsu, Che-yu
Liu, Qi
Wang, Jun
Murakami, Yuji
Cheng, Yufeng
Fukada, Junichi
Umezawa, Rei
Liang, Jun
Patel, Sagar
Wu, Abraham
Myojin, Miyako
Lutkenhaus, Lotte
Ishikawa, Hitoshi
Zhang, Wencheng
Juloori, Aditya
Siddiqui, Faisal
Zhu, Shuchai
Anker, Christopher
Kim, Kyung Hwan
Kumar, Shaleen
Shen, Yuxin
Li, Jiancheng
Liu, Qi
Yipeng, Ling
Seyedin, Steven
Stessin, Alexander
Li, Qiwen
Lu, NingNing
Ren, Hua
Misirlioglu, Cem
Shah, Jennifer
Chen, Andre
Patel, Rajal
Li, Guichao
Hazariwala, Ronica
Mellon, Eric
Xia, Tingyi
Baine, Michael
Cai, Sophie
Mancini, Brandon
1101
1102
1103
1104
1105
1106
1107
1108
2210
2211
2212
2213
2214
2215
2216
2217
2218
2219
2220
2221
2222
2223
2224
2225
2226
2227
2228
2229
2230
2231
2232
2233
2234
2235
2236
2237
2238
2239
2240
2241
2242
2243
2244
2245
2246
2247
2248
2249
2250
2251
2252
2253
2254
2255
2256
2257
2258
2259
2260
2261
2262
2263
2264
2265
Sherr, David
2266
Chan, Cato
2267
Tozzi, Angelo
2268
Yechieli, Raphael
2269
Hall, William
2270
Nixon, Lisette
2271
Kumar, Aryavarta
2272
Prasad, Shreya
2273
Romeo, Antonino
2274
Freilich, Jessica
2275
Chaudhry, Huma
2276
Dholakia, Avani
2277
Hirata, Takero
2278
Ausborn, Natalie
2279
Ghaly, Maged
2280
Wang, Hao
2281
Thompson, Reid
2282
Konski, Andre
2283
Lukens, John
2284
Wo, Jennifer
2285
Ahmad, Mediha
2286
Woo, Joong Yeol
2287
Patel, Ajay
2288
Bhirud, Abhijeet
2289
Terashima, Kotaro
2290
2291
Zheng, Dandan
2292
Shultz, David
2293
Cruz, Alex
2294
Skamene, Sonia
2295
Que, Jenny
2296
Barney, Brandon
2297
Kim, Kyung Su
2298
Zhong, Jim
2299
Jung, Jinhong
2300
Camborde, Marie-Laure
2301
Mendez Romero, Alejandra 2302
Lappinen, Erik
2303
Blacksburg, Seth
2304
Mahadevan, Anand
2305
Yoon, Sang Min
2306
Speirs, Christina
2307
Takeda, Atsuya
2308
Yamashita, Hideomi
2309
Sanuki, Naoko
2310
Okumura, Toshiyuki
2311
Seol, Seung Won
2312
Kim, Jun Won
2313
Merrell, Kenneth
2314
Fan, Katherine
2315
Shaffer, Jenny
2316
Mannina, Edward
2317
Fang, Charles
2318
Liu, Yilin
2319
Ernst, Iris
2320
Evans, Joseph
2321
Abdel-Wahab, May
2322
Menichelli, Claudia
2323
Gandhi, Saumil
2324
Waller, Joseph
2325
Dyk, Pawel
2326
Sharma, Navesh
2327
Wang, Tony
2329
Osmundson, Evan
Fuss, Martin
Lock, Michael
Diaz Vazquez,
Maria Fernanda
Cai, Yong
Lee, Sung Uk
White, Evan
Yang, Daniel
Wojcieszynski, Andrzej
Xiao, Qin
Lee, Joo Ho
Marina, Ovidi
Appelt, Ane
DeNittis, Albert
Falk, Alexander
Helou, Joelle
Rothenstein, Diana
Yovino, Susannah
Nguyen, Phuong
Rolfo, Maureen
Sole, Claudio
Yamada, Shigeru
Jin, Jing
Lei, Xin
De La Mata, M. Dolores
Vuong, Te
Manyam, Bindu
Wang, Ricardo
Li, Hao
Riou, Olivier
Batra, Sonny
Kozak, Margaret
Abdel-Wahab, May
Cheung, Min Rex
Shah, Mira
2330
2331
2332
2333
2334
2335
2336
2337
2338
2339
2340
2341
2342
2343
2344
2345
2346
2347
2348
2349
2350
2351
2352
2353
2354
2355
2356
2357
2358
2359
2360
2361
2362
2363
2364
2365
2366
2367
2368
2369
GENITOURINARY CANCER
Pisansky, Thomas
1
Zumsteg, Zachary
53
Krauss, Daniel
54
Kamrava, Mitchell
55
Zaorsky, Nicholas
56
Katz, Alan
57
Meier, Robert
58
Slater, Jerry
59
Sethukavalan, Perakaa
60
Mirhadi, Amin
61
Bekelman, Justin
96
Baumann, Brian
199
Gray, Phillip
200
Aluwini, Shafak
201
Clayman, Rebecca
202
Ferrer, Ferran
203
McBride, Sean
204
Sabolch, Aaron
205
Chung, Peter
206
191
Maldonado, Xavier
Gottschalk, Alex
Cheung, Patrick
Roach, Mack
Nguyen, Paul
257
258
259
260
261
Watkins, John
262
Shukla, Monica
263
Milecki, Piotr
264
Michalski, Jeff
265
Fotouhi Ghiam, Alireza
305
Salama, Joseph
306
Feng, Felix
307
Nichols, R. Charles
308
Blacksburg, Seth
309
Galalae, Razvan
Spratt, Daniel
Ferris, Matthew
Weller, Michael
Di Muzio, Nadia
Yu, James
Romesser, Paul
310
311
312
1013
1014
1015
1016
Henderson, Randal
1017
Smith, Tamara
1018
Mendenhall, Nancy
1019
Niazi, Tamim
1020
Hearn, Jason
1021
Kim, Miranda
1022
Magnan, Sindy
1023
Jackson, William
1024
Thiruganasambandam,
Sivarajan
1056
Bravo, Stephen
1061
Johnson, Skyler
1062
Shukla, Gaurav
1063
Tokita, Kenneth
1064
Chapet, Olivier
1065
Foltz, Warren
1066
Wagner, Aaron
1067
Chennupati, Sravana
1068
Elliott, David
1069
Son, Christina
1070
Spratt, Daniel
1071
Tonlaar, Nathan
1072
Swisher-McClure, Samuel 1074
Leonard, Kara
2370
Ohashi, Toshio
2371
Hentschel, Bettina
2372
Allison, Ron
2373
Hoppe, Bradford
2374
Badiozamani, Kasra
2375
Ishiyama, Hiromichi
2376
Ohashi, Toshio
2377
Tong, Xu
2378
Pinkawa, Michael
2379
Sveistrup, Joen
2380
Kalapurakal, John
2381
Wallace, Harold
2382
Logan, Jennifer
2383
Onukwugha, Eberechukwu 2384
Kil, Whoon
2385
Haas, Jonathan Andrew
2386
Fuller, Donald
2387
Marwaha, Gaurav
2388
192
Holtzman, Adam
Sekiguchi, Akane
Yorozu, Atsunori
Slater, Jason
Inokuchi, Haruo
Lo, Andrea
Wilcox, Shea
Krauss, Daniel
Lee, Richard
Price, Jeremy
2389
2390
2391
2392
2393
2394
2395
2396
2397
2398
2399
Murphy, Colin
Roach, Mack
Yechieli, Raphael
Patel, Ajaykumar
Kittel, Jeffrey
Kim, Dong Wook Nathan
Hanada, Takashi
Macrie, Bryan
Nakamatsu, Kiyoshi
Shiraishi, Yutaka
Ishii, Kentaro
Heres, Tomer
Nguyen, Hannah
Lin, Yuting
Hughes, Michael
Lin, Yuting
Koontz, Bridget
Hayashi, Akihiro
Liu, Wu
Fawaz, Ziad
Boychak, Alex
Tomita, Natsuo
Tree, Alison
Garcia-Vicente, Feliciano
Lozano, Joan
Sulaiman, Nor Shazrina
Carillo, Viviana
Gomez-Iturriaga, Alfonso
Wilson, William
Symon, Zvi
Chang, Lynn
Ciezki, Jay
Niazi, Tamim
Blacksburg, Seth
Tagliagambe, Angiolo
Anwar, Mekhail
Wang, Yuefeng
Stephans, Kevin
Yang, Xiaofeng
Kan, Charlene
Surapaneni, Aparna
Cho, Yeona
Lin, Yu-Wei
Gooding, Mark
Zapatero, Almudena
2400
2401
2402
2403
2404
2405
2406
2407
2408
2409
2410
2411
2412
2413
2414
2415
2416
2417
2418
2419
2420
2421
2422
2423
2424
2425
2426
2427
2428
2429
2430
2431
2432
2433
2434
2435
2436
2437
2438
2439
2440
2441
2442
2443
2444
2445
Ferrer, Ferran
Ayakawa, Shiho
Park, Junsu
Nuver, Tonnis
Crandley, Edwin
Hempel, Dominika
Stone, Brandon
2446
2447
2448
2449
2450
2451
2452
Scharf, Lawrence
Agarwal, Manuj
Murphy, Colin
Gay, Hiram
Le, Yi
Parekh, Akash
Jackson, William
Shiraishi, Kenshiro
Nicholas, Zachary
Rancati, Tiziana
Zelefsky, Michael
Todor, Dorin
Alexander, Jesse
Shang, Qingyang
Obedian, Edward
Kalbasi, Anusha
Ashamalla, Mark
McGuire, Sean
Zeitlin, Ross
Onal, Cem
Sen, Amarjit
Shakir, Shakir
Guix, Benjamin
Kathpal, Madeera
Hegarty, Sarah
Tennyson, Nathan
Choi, Seungtaek
Ferrer, Ferran
Sindhwani, Ragini
Arora, Shruthi
McDonald, Andrew
Kumar, Parvesh
Markovina, Stephanie
Kelly, Maria
D’Souza, David Paul
Stephens, Kevin
Parekh, Akash
Schutzer, Matthew
Sostin, Oleg
Mantz, Constantine
Ciezki, Jay
Shimizuguchi, Takuya
Jain, Prachi
Shasha, Daniel
Cahlon, Oren
Hartsell, William
Grabowski, Sarah
Johnson, Skyler
Johnson, Skyler
Oliai, Caspian
Nishioka, Kentaro
Kang, Julie Jung
Lindsay, Daniel
Van der Steen-Banasi, E.M.
Bryant, Curtis
Caparrotti, Francesca
Diaz Pardo, Dayssy
Turgeon, Guy
Lopez-Araujo, Javier
Baquero, William
Mahmud, Aamer
Rouscoff, Yohann
2453
2454
2455
2456
2457
2458
2459
2460
2461
2462
2463
2464
2465
2466
2467
2468
2469
2470
2471
2472
2473
2474
2475
2476
2477
2478
2479
2480
2481
2482
2483
2484
2485
2486
2487
2488
2489
2490
2491
2493
2494
2495
2496
2497
2498
2499
2500
2501
2502
2503
2504
2505
2506
2507
2508
2509
2510
2511
2512
2513
2514
2515
Macklis, Roger
Patel, Abhilasha
Galland, Sigolene
2516
2517
2518
GYNECOLOGICAL CANCER
Zuliani, Antonio
8
Viswanathan, Akila
9
Han, Kathy
70
Gaffney, David
71
Chino, Junzo
72
Gill, Beant
73
Leung, Eric
74
Mayr, Nina
75
Elicin, Olgun
76
Gandhi, Ajeet
77
Blanchard, Miran
313
Milgrom, Sarah
314
Shin, Jacob
315
Xanthopoulos, Eric
316
Thaker, Nikhil
317
Koay, Eugene
318
Kabolizadeh, Peyman
319
Kawanaka, Takashi
320
Greenwalt, Julie
321
Sirak, Igor
2519
Refaat, Tamer
2520
Chibani, Omar
2521
Zhang, Guangyu
2522
Whitley, Alexander
2523
Kwak, Yoo Kang
2524
Dunn, Emily
2525
Choi, Jehee
2526
Oike, Takahiro
2527
Chin, Matthew
2528
Kim, Robert
2529
Froment, Marie-Anne
2530
Kasuya, Goro
2531
Wakatsuki, Masaru
2532
Rath, Goura
2533
Lang, Jinyi
2534
Rash, Dominique
2535
Bo, Yang
2536
Irie, Daisuke
2537
Bagshaw, Hilary
2538
Dean, Mary
2539
Kabarriti, Rafi
2540
Uno, Takashi
2541
Yaparpalvi, Ravindra
2542
Chen, Wenjuan
2543
Isohashi, Fumiaki
2544
Kanazawa, Aki
2545
Chen, Jenny Ling-Yu
2546
Pandit-Taskar, Neeta
2547
Ding, Lei
2548
Fields, Emma
2549
Baden, Craig
2550
Lee, Eva
2551
El-Bared, Nancy
2552
Cheung, Min Rex
2553
Nagar, Himanshu
2554
Tetreault, Audrey
2555
Szeja, Sean
2556
Sabater, Sebastia
Jadon, Rashmi
Guttmann, David
Platta, Christopher
Elshaikh, Mohamed
Rana, Shushan
Kaneyasu, Yuko
Magnuson, William
Yu, Tosol
Huddleston, Adam
Damast, Shari
Banerjee, Robyn
Dominello, Michael
Lukovic, Jelena
Baker, Mariwan
Deutsch, Israel
Desai, Neil
Patil, Nikhilesh
Park, Sang-June
Lee, Larissa
Baliga, Sujith
Taylor, Robert
Boyle, John
Mislmani, Mazen
Patel, Abhilasha
Wooten, Charles
Mallick, Indranil
Yang, Xiaofeng
Roux, Audrey
2557
2558
2559
2560
2561
2562
2563
2564
2565
2566
2567
2568
2569
2570
2572
2573
2574
2576
2577
2578
2579
2580
2581
2582
2583
2584
2585
2586
2587
2588
HEAD AND NECK CANCER
Ghi, Maria Grazia
4
Berhane, Hebist
52
Nguyen-Tan, Phuc Felix
135
O’Sullivan, Brian
136
Rishi, Anupam
137
Jensen, Alexandra
138
Nedzi, Lucien
139
Ahn, Peter
140
Gensheimer, Michael
141
Raaijmakers, Cornelis
142
Riaz, Nadeem
191
Hess, Clayton
192
Beadle, Beth
193
Stenmark, Matthew
194
Hu, Kenneth Shung
195
Liu, Gene-Fu
196
Tam, Moses
197
Lee, Joseph
198
Setton, Jermey
347
Quon, Harry
348
Terhaard, Chris
349
Chaudhary, Ahmed
350
Quon, Harvey
351
352
Kunnambath, Ramadas
353
Frank, Steven
354
Lin, Yu-Wei
1109
Spencer, Christopher
1110
Hanasoge, Sheela
1111
Berhane, Hebist
1112
Schwartz, David Louis
1113
Wang, XiaoShen
Zhu, Goupei
VanderWalde, Noam
Gujral, Dorothy
Alshehri, Salem
Rash, Dominique
Kai, Naoki
Shen, Yi-Liang
Hamker, Jean
Prabhu, Roshan
Goldberg, Mira
Herman, Michael
Thariat, Juliette
Mitsuyoshi, Takamasa
Dutta, Pinaki
Contreras, Jessika
Han, Jae Hong
Bhandare, Niranjan
Boelke, Edwin
Refaat, Tamer
Chen, Andy
Yanagi, Takeshi
Chin, Re-I
Crandley, Edwin
Durkee, Ben
Maymani, Rebekah
Siddiqui, Farzan
Vainshtein, Jeffrey
Vainshtein, Jeffrey
Tam, Moses
Tam, Moses
Dewan, Abhinav
Strom, Tobin
Carpenter, Todd
Iganej, Shahrokh
Duvvuri, Umamaheswar
Yi, Junlin
Gao, Wendy
Yu, Yao
Bernier, Laurence
Richard, Patrick
Husaini, Hasan
Guo, Susan
Surucu, Murat
Richard, Patrick
Liu, Wei
Sinha, Uttam
Tan, Wenyong
Qiu, Su
Kodaira, Takeshi
Greenwalt, Julie
Barney, Brandon
Huang, Pin-I
Hamilton, Sarah
Shi, Qi
Ma, Lin
Matsuura, Tomohiro
Lai, Chiahsuan
Jin, Feng
Zhou, Qichao
Lin, Qin
Zhou, Qichao
Mei, Feng
Zhou, Qichao
1114
1115
1116
1117
1118
1119
2589
2590
2591
2592
2593
2594
2595
2596
2597
2598
2599
2600
2601
2602
2603
2604
2605
2606
2607
2608
2609
2610
2611
2612
2613
2614
2615
2616
2617
2618
2619
2620
2621
2622
2623
2624
2625
2626
2627
2628
2629
2630
2631
2632
2633
2634
2635
2636
2637
2638
2639
2640
2641
2642
2643
2644
2645
2646
Iqbal, Hassan
Alite, Fiori
Woods, Charles
Levy, Antonin
Meyer, Kurt
Lemons, Jeffrey
Zhao, Sherry
Kim, Jun Won
Hurst, Newton
Mrochem-Kwarciak,
Jolanta
Sevak, Parag
Scott, Michael
Bhandare, Niranjan
Sakthivel, Vasanthan
Sun, Jason
Shen, Chunying
Peacock, Justin
Hattori, Yukiko
Thompson, Marcher
Russo, Andrea
Saito, Makoto
Gamez, Mauricio
Wu, Jeffrey
Yang, Xiaofeng
Hsieh, Cheng-En
Kim, Aileen
Muraoka, Osamu
Elsayyad, Nagy
Kwon, Jeanny
Townsend, Natasha
Thariat, Juliette
Karasawa, Katsuyuki
Shankar, Vangipuram
Chera, Bhishamjit
Vargo, John
Owen, Dawn
Wang, Yingjie
Solanki, Abhishek
Orisamolu, Abimbola
Takiar, Vinita
Popovic, Marija
Wang, Ziwei
Takagi, Masaru
Mix, Michael
Mourad, Waleed
Vallieres, Martin
Takiar, Vinita
Tao, Randa
Aguirre, Maria
Fan, Kang-Hsing
Bayman, Evrim
Ranck, Mark
Qi, Xiangrong
Anderson, Nigel
Glanzman, Jonathan
Hasegawa, Azusa
Kierkels, Roel
Miyawaki, Daisuke
Rasmussen, Jacob
Brouwer, Charlotte
2647
2648
2649
2650
2651
2652
2653
2654
2655
2656
2657
2658
2659
2660
2661
2662
2663
2664
2665
2666
2667
2668
2669
2670
2671
2672
2673
2674
2675
2676
2677
2678
2679
2680
2681
2682
2683
2684
2685
2687
2688
2689
2690
2691
2692
2693
2694
2695
2696
2697
2698
2699
2700
2701
2702
2703
2704
2705
2706
2707
2708
2709
2710
Cardoso, Richard
Herman, Lauren
Emami, Bahman
Han, Hee Ji
Kan, Charlene
Glanzman, Jonathan
Cha, Jihye
Kainickal, Cessal
Hanna, Nevine
Lin, Shinn-yn
Hoover, Andrew
Mallick, Indranil
Liu, An
Kesava Ramgopal,
Adavikolanu
Kanakamedala, Madhava
Kanakamedala, Madhava
Garg, Shivank
Logue, Jennifer
Ramos, Clementina
Tiwana, Manpreet
Jaswal, Jasbir
Patel, Pretesh
Golchin, Ava
Kovalchuk, Nataliya
Zhu, Lihong
Doke, Kaleigh
Patel, Shilpen
2711
2712
2713
2714
2715
2716
2717
2718
2719
2720
2721
2722
2723
2724
2725
2726
2727
2728
2729
2730
2731
2732
2733
2734
2735
2736
2737
2738
HEALTH SERVICES RESEARCH
Maletz, Kristina
93
Fowble, Barbara
94
Falchook, Aaron
95
Halasz, Lia
97
Shah, Anand
98
Dinan, Michaela
99
Carmona, Ruben
100
Pearlstein, Kevin
1073
Byun, John
1075
Lester-Coll, Nataniel
1076
Raldow, Ann
1077
Mishra, Mark
1078
Kuremsky, Jeffrey
1079
Laufer, Marsha
1080
Chen, Ronald
1081
Sher, David
1082
Shabason, Jacob
1084
Parikh, Ravi
1138
Quek, Ruben
2739
Pearce, Andrew
2740
Quek, Ruben
2741
Chang, Daniel
2742
Shah, Anand
2743
Mattes, Malcolm
2744
Seymour, Zachary
2745
Rich, Shayna
2746
Clayman, Rebecca
2747
Berman, Abigail
2748
Fortin, Marie Andree
2749
Leong, Aidan
2750
Robinson, Timothy
2751
Elson, Joshua
2752
193
Grew, David
DiPardo, Benjamin
Housri, Nadine
Patel, Abhilasha
Carlson, Julie
Kapoor, Rishabh
Suneja, Gita
Bekelman, Justin
Bleyer, Archie
Cramer, Christina
Kapur, Ajay
Efstathiou, Jason
Mou, Benjamin
Thawani, Nitika
Kapadia, Nirav
Showalter, Timothy
Gulaya, Sachin
Sheets, Nathan
Sittig, Mark
Min, Christine
Hodges, Joseph
Vainshtein, Jeffrey
Lanni, Thomas
Dorth, Jennifer
Dosoretz, Arie
Curry, Heather
Greskovich, John
Szumacher, Ewa
Furhang, Eli
Goldstein, Nicolas
2753
2754
2755
2756
2757
2758
2759
2760
2761
2762
2763
2764
2765
2766
2767
2768
2769
2770
2771
2772
2773
2774
2775
2776
2777
2778
2779
2780
2781
2782
2783
HISTORY
Holliday, Emma
Dhami, Gurleen
Morris, Ann
Amarnath, Sudha
Chapman, Christina
2784
2785
2786
2787
2788
INFORMATICS
Janssen, R.
Vali, Faisal
Walker, Gary
Yang, Deshan
Blacksburg, Seth
Blacksburg, Seth
Jiang, Yuliang
Fechter, Tobias
Moore, Joseph
Ball, Christine
Yuan, Lulin
Renaud, Marc-Andre
Izadbakhsh, Mark
Fan, Michael
Zhang, Hao
Yuh, William
Pyakuryal, Anil
3088
3089
3090
3091
3092
3093
3094
3095
3096
3097
3098
3099
3100
3101
3102
3103
3104
3105
3106
194
LUNG CANCER
Videtic, Gregory
6
Palma, David
7
Onishi, Hiroshi
21
Onimaru, Rikiya
22
Hymas, Richard
23
Harris, Jeremy
24
Mattonen, Sarah
25
Mancini, Brandon
26
Kohutek, Zachary
27
Modh, Ankit
78
Samuels, Stuart
79
Aneese, Andrew
80
Murai, Taro
81
Papachristofilou, Alexandros 82
83
Morris, Zachary
84
Urbanic, James
85
Ahn, Sung-Ja
183
Kong, Feng-Ming
184
Rajan, Saju
185
Li, Ling
186
Tang, Chad
187
Lally, Brian
188
Patel, Suchit
189
Nguyen, Quynh
190
Lin, Steven
274
Kalash, Ronny
275
Meshkov, Dmitriy
276
Gilbride, Lucas
277
Epperly, Michael
278
Trovo, Marco
279
Feigen, Malcolm
280
Rimner, Andreas
281
Grecula, John
1133
Wynne, Jacob
1134
Myers, Carey
1135
Vinogradskiy, Yevgeniy
1136
Stanton, Paul
1137
Gomez, Daniel
1139
Fidler, Mary
1140
McGee, Lisa
1141
Parashar, Bhupesh
1142
Huang, Kitty
1143
Zhu, Guangying
1144
Sahai, Puja
2789
Kishan, Amar
2790
Zhou, Lin
2791
Asai, Kaori
2792
Song, Yongchun
2793
Mak, Raymond
2794
Shi, Pengyue
2795
Wang, Suzhen
2796
Katoh, Norio
2797
Turaka, Aruna
2798
Werner-Wasik, Maria
2799
Swanick, Cameron
2800
Gerber, Naamit
2801
Sottero, Theo
2802
Lu, Bing
2803
Lu, Bing
2804
Lu, Diana
2805
Saito, Tetsuo
2806
Qi, Huanpeng
2807
Harris, Jeremy
Lau, Steven
Milano, Michael
Chen, Ming
Mangona, Victor
Trovo, Marco
Arsenault, Daniel
Orton, Matthew
Zaorsky, Nicholas
Chang, Joe
Kim, Byounghyuck
Hinton, Benjamin
Zhang, Wenjue
Zhou, Zongmei
Garg, Shalini
Men, Yu
Cole, Aidan
Mahmoud, Omar
Cattaneo, Richard
Turaka, Aruna
Din, Shaun
Naik, Nilan
Ziel, Ellis
Parikh, Dhwani
Guanhao, Chen
Park, Jaehyeon
Feng, Wen
Tachibana, Izumi
Liu, Wenyang
Shioyama, Yoshiyuki
Hertan, Lauren
Hui, Zhouguang
Yamamoto, Takaya
Zhao, Lujun
Hashizume, Chisa
Patel, Kruti
Yoon, Hannah
Rajpara, Raj
Parisi, Elisabetta
Bowen, Stephen
Christian, Nicolas
Bing, Lu
Dalah, Entesar
Li, Hualei
Woody, Neil
Torok, Jordan
Casey, Stephanie
Din, Shaun
Mukai, Yuki
Zhuang, Hong-Qing
Zhao, Lujun
Haga, Akihiro
Amarnath, Sudha
Ji, Zhe
Bing, Lu
Thibault, Isabelle
Varlotto, John
Tatekawa, Kotoha
Baba, Fumiya
Schanne, Daniel
Fischer-Valuck, Ben
Shumway, Dean
Michaud, Anthony
Stish, Bradley
2808
2809
2810
2811
2812
2813
2814
2815
2816
2817
2818
2819
2820
2821
2822
2823
2824
2825
2826
2827
2828
2829
2830
2831
2832
2833
2834
2835
2836
2837
2838
2839
2840
2841
2842
2843
2844
2845
2846
2847
2848
2849
2850
2851
2852
2853
2854
2855
2856
2857
2858
2859
2860
2861
2862
2863
2864
2865
2867
2868
2869
2870
2871
2872
Wei, Xiong
Grant, Jonathan
Komaki, Ritsuko
Podder, Tarun
Ong, Leonard
Grills, Inga
Cannon, Nathan
Fan, ChengCheng
Meshkov, Dmitriy
Garay, Elizabeth
Ashworth, Allison
Werner-Wasik, Maria
Haider, Syed
Yap, Mei Ling
Li, Min
Xiao, Nian
Fan, Yankhua
Josipovic, Mirjana
Larrea, Luis
Lester, Scott
Manning, Matthew
Myers, Carey
Lewis, Trevor
Myers, Carey
Kim, Julian
Binkley, Michael
Aguilera, Todd
Schutzer, Matthew
Chen, Weijun
Xanthopoulos, Eric
Soike, Michael
Daly, Megan
Li, Ling
Alite, Fiori
Rasheed, Abdullah
Kilburn, Jeremy
Nguyen, Nhu Tram
Karasawa, Katsuyuki
Qiu, Haoming
Oguri, Mitsuhiko
Petras, Katarina
Patel, Shilpen
Patel, Shilpen
Arcangeli, Stefano
2873
2874
2875
2876
2877
2878
2879
2880
2881
2882
2883
2884
2885
2886
2887
2888
2889
2890
2891
2892
2893
2894
2895
2896
2897
2898
2899
2900
2901
2902
2903
2904
2905
2906
2907
2908
2909
2910
2911
2912
2913
2914
2915
2916
LYMPHOMA
Kriz, Jan
Fasola, Carolina
Ng, Andrea
Solanki, Abhishek
Strom, Tobin
Teckie, Sewit
Bo, Chen
Walker, Gary
Petersen, Peter
Denniston, Kyle
Hoppe, Bradford
Walker, Amanda
Wang, He
Voong, K.Ranh
Reinartz, Gabriele
Wattson, Daniel
Koc, Mehmet
11
143
144
145
146
147
148
149
150
1037
1038
1039
1040
1041
1042
1083
2917
Mestre, Francisco
Cao, Jianzhong
Parikh, Rahul
Freilich, Jessica
Li-ming, Xu
Liu, Qingfeng
Voong, Ranh
Katayama, Emiko
Adli, Mustafa
Pinnix, Chelsea
Shin, Samuel
Lloyd, Shane
Navarria, Piera
Ujaimi, Reem
Mikell, John
Kim, Daniel
Kuo, SUng-Hsin
2918
2919
2920
2921
2922
2923
2924
2925
2926
2927
2928
2929
2930
2931
2932
2933
2934
NONMALIGNANT DISEASE
Mourad, Waleed
2935
Blanck, Oliver
2936
Dunst, Juergen
2937
Glanzman, Jonathan
2938
Wright, Florence
2939
Matsuo, Yoshiro
2940
Sheybani, Arshin
2941
Nedelka, Michele
2942
Mourad, Waleed
2943
PALLIATIVE CARE
Olson, Robert
Khan, Luluel
Tseng, Yolanda
Krishnan, Monica
Barker, Christopher
Mehmood, Tahir
Alcorn, Sara
Barriger, Bryan
Wilson, David
Lloyd, Shane
Friedman, Jeffrey
Balagamwala, Ehsan
Chang, Jee Suk
Patel, Kirtesh
Meyer, Joshua
Xue, Jinyu
Wong, Rebecca
Prieto, Isabel
Sherman, Alexandra
Mariscal, Luis
Ayala-Peacock, Diandra
Lefresne, Shilo
PATIENT REPORTED
OUTCOMES
Small, William
Obayomi-Davies, Olusola
Lee, Andrew
Mirabeau-Beale, Kristina
215
218
219
220
221
322
2944
2945
2946
2947
2948
2949
2950
2951
2952
2953
2954
2955
2956
2957
2958
2959
3
178
179
180
Goodman, Karyn
Grover, Surbhi
Sura, Karna
Wong, Raimond
Gunn, Brandon G.
Schwartz, David
Recht, Abram
Wong, Winnifred
Jung, David
Ou, Dan
Kharofa, Jordan
Zhou, Jessica
Rajagopalan, Malolan
Tom, Ashlyn
Nowotnik, David
Nwachukwu, Chika
Chawla, Sheema
Patel, Abhilasha
Wang, Chenyang
Bernad, Daniel
Sio, Terence
Olson, Robert
Vicini, Frank
Agarwal, Ankit
Ahuja, Divya
Simpson, Daniel
Wild, Sommer
181
182
283
284
285
286
287
288
2960
2961
2962
2963
2964
2965
2966
2967
2968
2969
2970
2971
2972
2973
2974
2975
2976
2977
2978
2979
PATIENT SAFETY
Cox, Brett
Hoopes, David
Rahn, Douglas
Zeng, Jing
Santanam, Lakshmi
Greer, Peter
Cui, Yunfeng
Valicenti, Richard
Geng, Hui
Letourneau, Daniel
Ghadjar, Pirus
Lam, Wai Wang
Quang, Tony
Yogo, Katsunori
Yang, Bin
Souranis, Annette
Molitoris, Jason
Handsfield, Lydia
Marshall, Ingrid
Admiraal, Marjan
Nyflot, Matthew
Pang, Tingtian
Duplan, Danny
Lin, Alexander
Deraniyagala, Rohan
Ghaffari, Hamid
Fan, Katherine
Lamb, James
Markovic, Alexander
Awan, Musaddiq
Rosenthal, David
Eastham, David
289
290
291
292
293
294
295
2980
2981
2982
2983
2984
2985
2986
2987
2988
2989
2990
2991
2992
2993
2994
2995
2996
2997
2998
2999
3000
3001
3002
3003
3004
3005
Mitchell, James
Gao, Wanbao
Pham, Huong
Martin, Neil
Braunstein, Steve
Gensheimer, Michael
Best, Ryan
Lopater, Zachary
Mohindra, Pranshu
Butler, Brian E.
Sundararaman, Srinath
Elnahal, Shereef
Henrich, Dawn
PEDIATRIC CANCER
Mailhot Vega, Raymond
Patel, Nisha
Mouw, Kent
Müller, Klaus
Redmond, Kristin
Indelicato, Daniel
Merchant, Thomas
Hiniker, Susan
Krasin, Matthew
Mandeville, Henry
Tong, William
Waxweiler, Timothy
Brown, Lindsay
Suri, Jaipreet
Polishchuk, Alexei
Mazloom, Ali
Basu Achari, Rimpa
Hua, Chia-Ho
Hollander, Andrew
McBride, Sean
Williams, Noelle
Panoff, Joseph
Brodin, Patrik
Willson, Adam
Yang, Joanna
Ram, Ashwin
Thompson, Reid
Ladra, Matthew
Orman, Amber
Pai Panandiker, Atmaram
Kandula, Shravan
Pai Panandiker, Atmaram
Maraldo, Maja
Adli, Mustafa
Huynh-Le, Minh-Phuong
Engel, Steven
LeMieux, Melissa
Gayar, Omar
Miljkovic, Milos
Terezakis, Stephanie
Barron, David
Westerly, David
3006
3007
3008
3009
3010
3011
3012
3013
3014
3015
3016
3017
3018
10
86
87
88
89
90
91
92
168
169
170
171
172
173
174
175
3020
3021
3022
3023
3024
3025
3026
3027
3028
3029
3030
3031
3032
3033
3034
3035
3036
3037
3038
3039
3040
3041
3042
3043
3044
3045
3046
3047
3048
QUALITY OF LIFE
Movsas, Benjamin
Chow, Edward
Kress, Marie-Adele
Fuller, Don
Balagamwala, Ehsan
Howell, David
Kollmeier, Marisa
Dunn, Kerry
Romesser, Paul
Halyard, Michele Yvette
Niermann, Kenneth
Kann, Benjamin
Kerns, Sarah
Sio, Terence
Hall, William
Seymour, Zachary
Tang, Yu
Lewis, Stephen
Klein, Jonathan
Son, Christina
Lee, Tsz Kin
Fang, Penny
Wagner, Henry
Milgrom, Sarah
Nautiyal, Vipul
Yamada, Yoshiya
Randolph, David
Chen, Allen
Boothe, Dustin
2
12
176
177
216
217
222
282
323
324
325
326
327
328
329
3049
3050
3051
3052
3053
3054
3055
3056
3057
3058
3059
3060
3061
3062
3063
BIOLOGY
Schmitt, Adam
Pitroda, Sean
Soong, Chen-Pang
Borst, Gerben
Zachman, Derek
Kozono, David
Nishibuchi, Ikuno
Bratman, Scott
Colbert, Lauren
Liao, Zhongxing
Bi, Nan
Xu, Ting
Bazan, Jose
Harima, Yoko
Witek, Matthew
DeWeese, Theodore
Harris, Timothy
Bernstein, Michael
Aiyer, Anita
Vatner, Ralph
Monjazeb, Arta
Price, Jeremy
Willers, Henning
Abazeed, Mohamed
Reddy, Srilakshmi
Raval, Raju
Du, Shisuo
Pellicciotta, Ilenia
45
46
47
48
49
50
51
223
224
225
226
227
228
229
230
266
267
268
269
270
271
272
273
339
340
341
342
343
344
195
Arafat, Waleed
Gan, Gregory
Bi, Nan
Bracey, Daniel
Stessin, Alexander
Perez, Carmen
Kumar, Sanath
Vlacich, Gregory
Tran, Phuoc
Maity, Amit
Dal Pra, Alan
Spiotto, Michael
Park, Catherine
Braunstein, Steve
Ronny, Kalash
Ji, ShengJun
Bornstein, Sophia
Ji, Jiang
Golden, Encouse
Bakst, Richard
Apicelli, Anthony
Hong, Ji-Hong
Boss, Mary-Keara
Ybarra, Norma
Houghton, Frank
Kudrimoti, Mahesh
Kim, Sungjune
Ma, Jin-lu
Bratman, Scott
Golden, Encouse
Golden, Encouse
Golden, Encouse
Perez, Carmen
Braun, Theodore
Young, Kristina
Wang, Jin
Akasaka, Hiroaki
Sheu, Tommy
Fontana, Andrea
Bakhoum, Samuel
Nishioka, Takeshi
Thompson, Marcher
Qu, Ang
Widlak, Piotr
Maria, Ola
Takahashi, Ippei
Zeidan, Youssef
Goff, Julie
Igaki, Hiroshi
Epperly, Michael
Yoshikawa, Nobuhiko
Sasaki, Ryohei
Aiyer, Anita
Miyakawa, Akifumi
Iwata, Hiromitsu
Ando, Ken
Stewart, Robert
Wooten, Hasani
Hasegawa, Masatoshi
Diffenderfer, Eric
Yasuda, Koichi
Matsuo, Masayuki
Evans, Jaden
196
345
346
1049
1050
1051
1052
1053
1054
1055
1057
1058
1059
1060
3107
3108
3109
3110
3111
3112
3113
3114
3115
3116
3117
3118
3119
3120
3121
3122
3123
3124
3125
3126
3127
3128
3129
3130
3131
3132
3133
3134
3135
3136
3137
3138
3139
3140
3141
3142
3143
3144
3145
3146
3147
3148
3149
3150
3151
3152
3153
3154
3155
3156
3157
Arvold, Nils
Volotskova, Olga
Bazalova, Magdalena
Masunaga, Shin-ichiro
Kim, In Ah
Harada, Satoshi
Wolfe, Adam
Thoms, John
Sethi, Manish
Simone, Brittany
Muanza, Thierry
Baschnagel, Andrew
Maldonado, Javier
Schlaff, Cody
Lin, Steven
Chen, Yu-Jen
Nickols, Nicholas
Mukumoto, Naritoshi
Soh, Hendrick
Kotler, Monica
Konski, Andre
Kim, Jin Ho
Park, Heon Joo
Salem, Ahmed
Yuan, Ye
Yu, Jennifer
Allen, Bryan
Tang, Justin
Welliver, Meng
Hedayati, Mohammad
Carrier, France
Kirschner, Austin
Smith, Adam
Wang, Edina
Marques, Tatiana
Lautenschlaeger, Tim
Swartz, Harold
Wild, Aaron
Liapi, Eleni
Qian, Xin
Veldwijk, Marlon
Tang, Justin
Cerne, Jasmina
He, Zhiyong
Biswas, Tithi
Zapatero, Almudena
Tsai, Chiaojung Jillian
Chua, Melvin Lee Kiang
Lang, Jinyi
Robinson, Timothy
Hong, Zhen-Yu
Jacobs, Corbin
Hall, William
Court, Laurence
Baschnagel, Andrew
Sulman, Erik
Lee, Sung-Wei
Seo, Yuji
Trister, Andrew
Varia, Mahesh
Pai, Jonathan
Jeyaseelan, Krishinima
Thirumoorthy, Krishnan
Jimenez, Rachel
3158
3159
3160
3161
3162
3163
3164
3165
3166
3167
3168
3169
3170
3171
3172
3173
3174
3175
3176
3177
3178
3179
3180
3181
3182
3183
3184
3185
3186
3187
3188
3189
3190
3191
3192
3193
3194
3195
3196
3197
3198
3199
3200
3201
3202
3203
3204
3205
3206
3207
3208
3209
3210
3211
3212
3213
3214
3215
3216
3217
3219
3220
3221
3222
PHYSICS
Folkert, Michael
Bahig, Houda
Jaffray, David
Hu, Yanle
Tadic, Tony
Green, Olga
Murray, Louise
Craig, Timothy
Chin, Alexander
Weiss, Elisabeth
Sonke, Jan-Jakob
Mangona, Victor
Huang, Zhibin
Stanescu, Teo
Schulte, Reinhard
Williams, Eric
Poulsen, Per
Li, Ruijiang
Greenberger, Joel
Hallman, Mark
Yorke, Ellen
Aitken, Katharine
Suh, Yelin
Steineck, Gunnar
Owen, Dawn
Yang, Yun
Lian, Jun
Romano, Mario
Tsang, Derek
Takao, Seishin
Harada, Keiichi
Shi, Xiutao
Salamekh, Samer
Atkins, Katelyn
Fang, Li-Ming Christine
Glide-Hurst, Carri
Jeong, Jeho
Fan, Qiyong
Anderson, Carryn
Zhang, Lifei
King, Martin
Van Den Heuvel, Frank
Valdes, Gilmer
Zilli, Thomas
Prior, Phillip
Rodrigues, Anna
Han, Bin
Kusano, Aaron
Sheng, Ke
Oh, Seungjong
Sayre, George
De Souza-Lawrence, Lana
Sarabia-Estrada, Rachel
Yu, Naichang
Ahunbay, Ergun
Qi, Xiangrong
Mahmoud, Omar
Hazell, Irene
Schuster, Jessica
Moore, Joseph
Qin, An
5
28
29
30
31
32
33
34
35
36
101
102
103
104
105
106
107
108
109
126
127
128
129
130
131
132
133
134
159
160
161
162
163
164
165
166
167
231
232
233
234
235
236
237
238
239
296
297
298
299
300
301
302
303
304
330
331
332
333
334
335
336
Godley, Andrew
337
Lu, Weiguo
338
Piper, Jonathan
355
Jones, Bernard
356
Low, Daniel
357
Ren, Lei
358
Meng, Bowen
359
Van Sornsen de Koste, John 360
Azcona, Juan Diego
361
Kincaid, Russell
362
Gardner, Stephen
363
Meredith, Ruby
1001
Shvydka, Diana
1002
Tarnawski, Rafal
1003
Rahimian, Javad
1004
Kainz, Kristofer
1005
Takanaka, Tsuyoshi
1006
Korideck, Houari
1007
Al-Qaisieh, Bashar
1008
Ngwa, Wilfred
1009
Lin, Mu-Han
1010
Akita, Shungo
1011
Ming, Xin
1012
Wang, Jing
1085
Goldsmith, Christy
1088
Dagan, Roi
1089
Richter, Daniel
1090
Wu, Huanmei
1091
Moteabbed, Maryam
1092
Takahashi, Wataru
1093
Farr, Jonathan
1094
Ashman, Jonathan
1095
Moskvin, Vadim
1096
Marquardt, Michael
1120
Wissel, Tobias
3223
Mooney, Karen
3224
Tang, Xiaoli
3225
Zhao, Bo
3226
Iwata, Hiromitsu
3227
Bos, Clemens
3228
Low, Daniel
3229
Yang, Wensha
3230
Bray, Tracy
3231
Choi, Youngmin
3232
Li, Rongmao
3233
Kuo, Hsiang-Chi
3234
Nicolaou, Nicos
3235
Li, Xiang
3236
Stockham, Abigail
3237
Li, Guang
3238
Li, Jun
3239
Simone, Brittany
3240
Vatyam, Sathiya Narayanan 3241
Ikeda, Itaru
3242
Cheung, Michael
3243
Mancosu, Pietro
3244
Jeong, Ho jin
3245
Douglass, Lauren
3246
Niu, Tianye
3247
Niu, Tianye
3248
Baron, Charles
3249
Cooper, Benjamin
3250
Gonzalez, Victor
3251
Ruggieri, Ruggero
3252
Maria Das, Koilpillai Joseph 3253
Turner, Kathryn
3254
Chanyavanich, Vorakarn 3255
Catron, Tom
3256
Abramowitz, Matthew
3257
Bourgouin, Alexandra
3258
3259
Asher, David
3260
Ku, Lichung
3261
Majithia, Lonika
3262
Leung, Paikin
3263
Munbodh, Reshma
3264
Mao, Weihua
3265
Williams, Benjamin
3266
Kathpal, Madeera
3267
Mooney, Karen
3268
Zhao, Tianyu
3269
Richter, Andreas
3270
Troeller, Almut
3271
Yuan, Jiankui
3272
Liu, Dan
3273
Quanshi, Zhang
3274
3275
De Santis, Maria Carmen 3276
Zhong, Hualiang
3277
Tai, An
3278
Spektor, Alexander
3279
Shin, Naomi
3280
Zhang, Hualin
3281
Zhang, Geoffrey
3282
Munbodh, Reshma
3283
Yang, Cungeng
3284
Parsai, E. Ishmael
3285
Kim, Haksoo
3286
Brock, Kristy
3287
Deasy, Joseph
3288
Cheng, ChihYao
3289
Fujita, Yujiro
3290
Yang, Kai
3291
Riegel, Adam
3292
Han, Guang
3293
Doi, Yoshiko
3294
Zhou, Lili
3295
Wang, Ping
3296
Cao, Yuanjie
3297
Li, Feng
3298
Mattes, Malcolm
3299
Zhang, Pengpeng
3300
Liang, Jian
3301
Lim, Kyoung-Dal
3302
Feygelman, Vladimir
3303
Wakai, Nobuhide
3304
Siddiqui, Farzan
3305
Vergalasova, Irina
3306
Usui, Keisuke
3307
Catan, Ilker
3308
An, Sohyun
3309
Lee, Suk
3310
Fung, Winky Wing Ki
3311
Jang, HongSeok
3312
Chang, Kyung-Hwan
3313
Yeh, Chi-Yuan
3314
Tol, Jim
3315
Mohr, Angela
3316
Yeung, Daniel
Ping, Yan
Yan, Susu
Day, Ellen
Wang, Zheng
Jaffray, David
Ye, Jing Jing
Chen, Guang-Pei
Pasha, Junaid
Olivera, Gustavo
Shin, Hun-Joo
Qiao, Qiao
Arai, Kazuhiro
Chan, Siu Keung
Jeong, Kyoungkeun
Onozato, Yusuke
Van den Bosch, Michiel
Hwang, Ken-Pin
Kim, Jinkoo
Pukala, Jason
Schinkel, Colleen
Gooding, Mark
Yuan, Lulin
Liu, Feng
Chaudhari, Lalit
Damato, Antonio
Mahantshetty, Umesh
Luo, Guozhen
Gooding, Mark
Lachance, Bernard
Chen, Xiaoming
Jennelle, Richard
Piper, Jonathan
Piper, Jonathan
Hu, Yanle
Semon, Meredith
Hadley, Scott
Ito, Yasushi
Zhung, Joanne
Takahashi, Yutaka
Wijesooriya, Krishni
Wang, Henry
Perkins, Gregory
Tongtip, Naruemon
Clayton, Ravinder
Owen, Dawn
Hong, Linda
Navarria, Piera
Dandekar, Virag
Kole, Thomas
Li, Ruijiang
Nagata, Yasushi
Huang, Long
Chen, Hairong
Patel, Abhilasha
Kim, Dae Il
Iwana, Maho
Koch, Siete
Luo, Wen Min
Dizman, Aysen
Shinde, Prashantkumar
McGuinness, Christopher
Kim, Tae Gyu
Mahjoubi, Khalil
3317
3318
3319
3320
3321
3322
3323
3324
3325
3326
3327
3328
3329
3330
3331
3332
3333
3334
3335
3336
3337
3338
3339
3340
3341
3342
3343
3344
3345
3346
3347
3348
3349
3350
3351
3352
3353
3354
3355
3356
3357
3358
3359
3360
3361
3362
3363
3365
3366
3367
3368
3369
3370
3371
3372
3373
3374
3375
3376
3377
3378
3379
3380
3381
Tsujii, Mari
Mut, Alejandro
Ma, Lijun
Caussa, Lucas
Li, Winnie
Zhen, Heming
Picone, James
Goldin, Gregg
El Kaissi, Tarek
Nabavizadeh, Nima
Kim, Haksoo
Boothe, Dustin
Li, Jingdong
Kaufman, Isaac
Wang, Lilie
Shultz, David
Liu, Han
Harkenrider, Matthew
Yu, Shu-Jung
Jenkins, Neil
Matysiak, Witold
Tang, Shikui
Ling, Ted
Zhang, Rui
Hsi, Wen
Zheng, Yuanshui
Chen, Chin-Cheng
Merrell, Kenneth
Sanchez Parcerisa, Daniel
Yeager, Caitlyn
Klein, Eric
Lin, Lilie
Zheng, Yuanshui
Dhanesar, Sandeep
Renaud, Marc-Andre
Cahlon, Oren
Iftimia, Ileana
3382
3383
3384
3385
3386
3387
3388
3389
3390
3391
3392
3393
3394
3395
3396
3397
3398
3399
3400
3401
3402
3403
3404
3405
3406
3407
3408
3409
3410
3411
3412
3413
3414
3415
3416
3417
3418
Thompson, Jonathan
Nedialkova, Lucy
Cho, DooKee
Pappas, Evangelos
Perez-Andujar, Angelica
Farol, Hanako
Camarata, Andrew
Watkins, William
Rafie, Frank
Kim, Gwe-Ya
Leuthold, Susan
Warrell, Gregory
Wang, Song
Wang, Bin
Khandelwal, Shiv
Dumane, Vishruta
Yang, Yun
El-Haddad, Mostafa
Maghsoudi, Kaveh
Matulewicz, Lukasz
Schadewaldt, Nicole
Noto, Kimiya
Chaudhry, Huma
Rochet, Nathalie
Peng, Cheng
Kole, Thomas
Ferreira, Maria Clara
Xing, Lei
Zhang, Ying
Levin, Daphne
Na, Yong Hum
Wooten, Charles
Mohanty, P.P.
Yordy, John
Nakagawa, Keiichi
Yang, Ruijie
Kjaer-Kristoffersen,
Flemming
Zhikai, Liu
Cho, Yu Ra
Mehta, Niraj
Rice, Lynsey
Wilson, Zachary
3419
3420
3421
3422
3423
3424
3425
3426
3427
3428
3429
3430
3431
3432
3433
3434
3435
3436
3437
3438
Cassidy, Richard
Scott, Michael
Hollen, Tyler
Mahmoud, Omar
Menzel, Paul
Hata, Masaharu
Willson, Adam
Falk, Alexander
Sharma, Daya Nand
Kim, Young Il
Kollar, Laura
Cengel, Keith
Amendola, Beatriz
Rooney, Jessica
Bedi, Manpreet
Rainey, David
Warner, Lindsay
Mutyala, Subhakar
3445
3446
3447
3448
3449
3450
3451
3452
3453
3454
3455
3456
3457
3458
3459
3460
SARCOMA AND CUTANEOUS
TUMORS
Wang, Dian
151
Alektiar, Kaled
152
Dickie, Colleen
153
Roeder, Falk
154
Wang, Jianyang
155
Pan, Elizabeth
156
Bhatnagar, Ajay
157
Hoeller, Ulrike
158
Miller, Luke
1043
Kazuhiko, Hayashi
1044
Willett, Addison
1045
Bishop, Andrew
1046
Polo, Alfredo
1047
Bhatt, Aashish
1048
Jones, Daniel Adam
3064
Vargo, John
3065
Pan, Hubert
3066
3067
3068
3069
3071
3072
3073
3074
3075
3076
3077
3078
3079
3080
3081
3082
3083
3084
3085
3086
3087
3439
3440
3441
3442
3443
3444
197
NOTES
198
NOTES
199
NOTES
200
INSIDE:
Exhibitor Lists
Exhibitor Lists by Product/Service
Floor Plan
INDUSTRY-EXPERT THEATER*
Rear of 100 Aisle, Exhibit Hall B1
This activity allows companies to present their noteworthy products and services through a live
presentation in the Industry-Expert Theater located in the Exhibit Hall. Seating is available on a first-come,
first-served basis. The Industry-Expert Theater content and views expressed therein are those of the
exhibitor and not of ASTRO.
*Industry-Expert Theaters are not accredited for continuing medical education credits.
Time: 12:45 p.m. – 1:45 p.m.
Accuray: Dynamic Technology in Motion
Supported by Accuray
Contact: Jim Bilich
Phone: 925-348-2082
Box lunch provided
Time: 12:15 p.m. – 1:15 p.m.
An In-depth Look at Xofigo® (radium Ra 223
dichloride)
Supported by Bayer HealthCare and Algeta
Contact: The Lockwood Group
Phone: 203-817-0951
Box lunch provided
11:45 a.m. – 12:45 p.m.
Increasing Quality in Radiation Therapy
Supported by ScandiDos
Contact: Marni Brown
Phone: 608-630-9415
Box lunch provided
Exhibitor
Time: 10:15 a.m. – 10:45 a.m.
Electronic Brachytherapy Utilizing the
Xoft® System for the Treatment of
Non-Melanoma Skin Cancer
Supported by Xoft, A subsidiary of iCAD Inc.
Contact: Donna Breault
Phone: 978-337-2786
Refreshments provided
Exhibitor
Exhibitor List (as of August 27, 2013)
EXHIBITOR NAME
BOOTH#
EXHIBITOR NAME
BOOTH#
EXHIBITOR NAME
BOOTH#
.decimal
121 Central Park Place
Sanford, FL 32771
Phone: 800-255-1613
Email: contact@dotdecimal.com
Website: www.dotdecimal.com
1659
Advanced Shielding Technologies Inc.
823
23355 L & N Turnpike, Building F
West Point, KY 40177
Phone: 502-922-3009
Email: svantilburg@advancedshieldingtech.com
Website: www.advancedshieldingtech.com
American College of Radiology
1891 Preston White Drive
Reston, VA 20191
Phone: 703-648-8900
Email: bmonzon@acr.org
Website: www.acr.org
413
21st Century Oncology
2270 Colonial Boulevard
Fort Myers, FL 33907
Phone: 239-931-7333
Email: jhobaugh@rtsx.com
Website: www.21stCenturyOncology.com
R
757
Aktina Medical Corporation
360 North Route 9W
Congers, NY 10920
Phone: 845-268-0101
R
2233
American Medical Accounting and
Consulting
2864 Johnson Ferry Boulevard, Suite 150
Marietta, GA 30062
Phone: 770-693-6031
Email: info.amac@amac-usa.com
Website: www.amac-usa.com
1022
Algeta
210 Broadway
Cambridge, MA 02139
Phone: 617-225-2301
Email: cambridge@algeta.com
Website: www.algeta.com
554
American Radium Society
11300 West Olympic Boulevard, Suite 600
Los Angeles, CA 90064
Phone: 310-437-0581
Email: info@americanradiumsociety.org
Website: www.americanradiumsociety.org
616
Alliance Oncology
100 Bayview Circle, Suite 400
Newport Beach, CA 92660
Phone: 949-242-5497
Email: dmussleman@allianceoncology.com
Website: www.allianceoncology.com
R
712
515
Alphatron Linac
3870-B Longview Drive
Douglasville, GA 30135
Phone: 678-838-3737
Email: sales@alphatronlinac.com
Website: www.alphatronlinac.com
2526
American Society of Radiologic
Technologists
15000 Central Avenue SE
Albuquerque, NM 87123-3909
Phone: 505-298-4500
Email: mryerson@asrt.org
Website: www.asrt.org
2755
American Association of Medical
Dosimetrists
2201 Cooperative Way, Suite 600
Herndon, VA 20171
Phone: 703-677-8071
Email: aamd@medicaldosimetry.org
Website: www.medicaldosimetry.org
R
432
Anzai Medical Co. Ltd.
3-6-25 Nishi-ShinagawaShinagawa-ku
Tokyo, 141-0033
Japan
Phone: 81-337-791-611
Email: f.sakaguchi@anzai-med.co.jp
Website: www.anzai-med.co.jp
2732
American Chillers and Cooling Tower
Systems Inc.
15 Rest Master Lane
North Augusta, SC 29860
Phone: 803-278-1463
Email: marvw@amchiller.com
Website: www.amchiller.com
522
AQUILAB
Parc Eurasante, 250 rue Salvador Allende
Loos Les Lille, 59120
France
Phone: 00-333-696-1515-1
Email: info@aquilab.com
Website: www.aquilab.com
R
1621
American College of Radiation Oncology
5272 River Bend, Suite 630
Bethesda, MD 20816
Phone: 301-718-6533
Email: info@acro.org
Website: www.acro.org
241
architection
425 W. Market Street
Louisville, KY 40202
Phone: 502-561-1024
Email: ptorp@architection.com
Website: www.architection.com
R
A2J Laser Technology
1535
Parc d’Activité des Vallières, 5 allée des Rousselets
Thorigny sur Marne, 77 77400
France
Phone: +33-(0)1-60-94-22-99
Email: export@a2jlaser.com
Website: www.a2jlaser.com
Acceletronics
602 Gordon Drive
Exton, PA 19341
Phone: 800-543-5144
Email: info@acceletronics.com
Website: www.acceletronics.com
R
1913
AccuBoost
1 Industrial Way
Tyngsboro, MA 01879
Phone: 978-649-0007
Email: ryan.flynn@accuboost.com
Website: www.accuboost.com
R
243
Accuray Inc.
1310 Chesapeake Terrace
Sunnyvale, CA 94089
Phone: 408-716-4600
Email: sales@accuray.com
Website: www.accuray.com
R A
1842
LEGEND
A
P
G
S
Ambassador
Platinum Sponsor
Gold Sponsor
Silver Sponsor
Bronze Sponsor
Copper Sponsor
R Enhanced RO MarketPlace
Listing
B
C
Corporate members in bold.
203
EXHIBITOR NAME
BOOTH#
ASCO
2318 Mill Road, Suite 800
Alexandria, VA 22314
Phone: 888-282-2552
Email: membermail@asco.org
Website: www.asco.org
733
ASTRO Resource Center
543
8280 Willow Oaks Corporate Drive, Suite 500
Fairfax, VA 22031
Phone: 703-502-1550
Email: membership@astro.org
Website: www.astro.org
Augmenix
204 2nd Avenue, Lower Level
Waltham, MA 02451
Phone: 781-895-3235
Email: egardner@augmenix.com
Website: www.augmenix.com
343
Azimuth Therapy
68 B Amal Street
Petach Tikva, 49513
Israel
Phone: 97-2-3-92-781-11
Email: info@azimutherapy.com
Website: www.azimutherapy.com
327
Bayer HealthCare
6 West Belt
Wayne, NJ 07470
Phone: 973-305-5000
Email: jerry.samuels@bayer.com
Website: www.pharma.bayer.com
A
554
Best Medical International Inc.
7643 Fullerton Road
Springfield, VA 22153
Phone: 703-451-2378
Website: www.teambest.com
R
2261, 2715, 2819
LEGEND
A
Ambassador
P
Platinum Sponsor
Gold Sponsor
Silver Sponsor
G
S
Bronze Sponsor
Copper Sponsor
Listing
Corporate
Corporate members
members inin bold.
bold.
B
EXHIBITOR NAME
Biocompatibles Inc.
926
115 Hurley Road, Building 3
Oxford, CT 06478
Phone: 203-262-4198
Email: lindsey.raymond@biocompatibles.com
Website: www.biocompatiblesinc.com
R
EXHIBITOR NAME
BOOTH#
Buck Engineering & Consulting
GMBH
Gartenstrasse 11
Reutlingen, 72764
Germany
Phone: 49-7121-930-721-0
Email: m.gerlich@b-e-c.net
Website: www.b-e-c.net
2853
C&G Technologies
6209 Gheens Mill Road
Jeffersonville, IN 47130
Phone: 812-280-0048
Email: sales@cgtscan.com
Website: www.cgtscan.com
519
C.R. Bard Inc.
8195 Industrial Boulevard
Covington, GA 30014
Phone: 770-784-6223
Email: april.wilson@crbard.com
Website: www.crbard.com
2030
Cancer CarePoint Inc.
17 Executive Park Drive, Suite 520
Atlanta, GA 30329
Phone: 800-998-5859
Email: jlux@cancercarepoint.com
Website: www.cancercarepoint.com
R
1722
Cancer Treatment Centers of America
2610 Sheridan Road
Zion, IL 60099
Phone: 847-746-4441
Email: jeanette.krimmer@ctca-hope.com
Website: www.cancercenter.com
2712
Cangene Corporation
920 Cassatt Road, Suite 100
Berwyn, PA 19312
Phone: 215-778-4743
Email: sclement@cangene.com
Website: www.cangene.com
2112
Bionix Radiation Therapy
5154 Enterprise Boulevard
Toledo, OH 43612
Phone: 419-727-8421, ext. 262
Email: sromano@bionix.com
Website: www.bionixrt.com
1653
BK Medical Systems
8 Centennial Drive
Peabody, MA 01960
Phone: 978-326-1300
Email: info@us.bkmed.com
Website: www.bkmed.com
918
Bogardus Medical Systems Inc.
3555 N. W. 58th Street, Suite 500
Oklahoma City, OK 73112
Phone: 405-917-0500
Email: jcarlin@oncochart.com
Website: www.oncochart.com
R
820
Boiron
6 Campus Boulevard
Newtown Square, PA 19073-3267
Phone: 610-325-7464
Website: www.boironusa.com
2613
Brainlab
3 Westbrook Corporate Center, Suite 400
Westchester, IL 60154
Phone: 708-409-1343
Email: anna.bliss@brainlab.com
Website: www.brainlab.com
A R
1243
Bristol-Myers Squibb
P.O. Box 4500
Princeton, NJ 08543
Phone: 609-897-2000
Email: colleen.peacos@bms.com
Website: www.bms.com
1635
Carbon Medical Technologies
1290 Hammond Road
St. Paul, MN 55110
Phone: 651-653-8512
Email: info@carbonmed.com
Website: www.carbonmed.com
2716
BSD Medical
2188 W. 2200 S.
Salt Lake City, UT 84119
Phone: 801-972-5555
Website: www.bsdmedical.com
2852
Carl Zeiss Meditec Inc.
5160 Hacienda Drive
Dublin, CA 94568
Phone: 925-557-4100
Email: info@meditec.zeiss.com
Website: www.zeiss.com
R
627
C
204
BOOTH#
EXHIBITOR NAME
CDR Systems Inc.
#33, 235105 Wrangler Drive, SE
Calgary, AB T1X 0K3
Canada
Phone: 403-850-7035
Email: carldenis@cdrsys.ca
Website: www.cdrsys.ca
R
Cemar Electro Inc.
1370 55th Avenue
Lachine, QC H8T 3J8
Canada
Phone: 514-631-5807
Email: wilson@cemarelectro.com
Website: www.cemarelectro.com
BOOTH#
613
514
Churchill Consulting Inc.
384 Route 148
Killingworth, CT 06419
Phone: 860-663-5630
Email: Deb@ChurchillConsulting.com
Website: www.ChurchillConsulting.com
R
920
Cianna Medical
6 Journey, Suite 125
Aliso Viejo, CA 92656
Phone: 949-360-0059
Email: customercare@ciannamedical.com
Website: www.ciannamedical.com
542
CIRS
2428 Almeda Avenue, Suite 316
Norfolk, VA 23513
Phone: 757-855-2765
Email: info@cirsinc.com
Website: www.cirsinc.com
R
2219
CivaTech Oncology
104 T W Alexander Drive, #4
Res Triangle Park, NC 27709
Phone: 919-314-5515
Website: www.civatechoncology.com
2929
1401 8th Street SE
Orange City, IA 51041
Phone: 712-737-8688
Email: info@civco.com
Website: www.civco.com
B R
1826
Cold Shot Chillers
14020 Interdrive West
Houston, TX 77032
Phone: 281-227-8400
Email: bcasto@waterchillers.com
Website: www.waterchillers.com
R
417
EXHIBITOR NAME
BOOTH#
CompHealth
6440 South Millrock Drive, Suite 175
Phone: 800-453-3030
Email: jobs@comphealth.com
Website: www.comphealth.com
2515
Computerized Radiation Scanners Inc.
140 Sopwith Drive
Vero Beach, FL 32968
Phone: 772-562-0405
Email: crs7@bellsouth.net
Website: www.beamscanners.com
717
C-RAD Inc.
70 SE 4th Avenue
Delray Beach, FL 33483
Phone: 561-742-9260
Email: martin.clay@c-rad.se
Website: www.c-rad.se
661
Cura Medical Technologies
23 Rancho Circle
Lake Forest, CA 92630
Phone: 949-716-2447
2714
CYRPA America LLC
6725 Mesa Ridge Road, Suite 100
San Diego, CA 92121
455
D3 Oncology Solutions
5750 Centre Avenue, Suite 500
Pittsburgh, PA 15206
Phone: 412-365-0719
Email: briggsla2@d3onc.com
Website: www.d3onc.com
R
1023
Dara BioSciences
8601 Six Forks Road, Suite 160
Raleigh, NC 27615
Phone: 919-861-0236
1020
Demos Medical Publishing
11 West 42nd Street, 15th Floor
New York, NY 10036
Phone: 212-683-0072, ext. 217
Website: www.demosmedpub.com
513
Desert Harvest
20070 Roaming Drive
Colorado Springs, CO 80908
Phone: 719-592-0223
2450
DIACOR
2550 Decker Lake Boulevard
West Valley, UT 84119
Phone: 763-227-2256
Email: tpierson@diacorinc.com
Website: www.diacorinc.com
R
2034
EXHIBITOR NAME
BOOTH#
DOSIsoft
45-47 Avenue Carnot
Cachan, 94230
France
Phone: 33-141-242-626
2612
Dynasource LLC
7362 Futures Drive, Suite 15
Orlando, FL 32819
Phone: 407-792-8490
Email: roseli@dynasource.us
2428
e+CancerCare
104 Woodmont Boulevard, Suite 500
Nashville, TN 37205
Phone: 615-467-7407
Email: jjohnson@epluscancercare.com
Website: www.epluscancercare.com
2113
e2v
520 White Plains Road
Tarrytown, NY 10591
Phone: 914-592-6050
Email: vijay.patel@e2v.com
Website: www.e2v.com
2528
Eckert & Ziegler BEBIG
Robert-Rössle-Strasse 10
Berlin, 13125
Germany
Phone: 49-30-94-10-84-272
Email: dorota.tkaczyk@bebig.eu
Website: www.bebig.eu
R
1758
Elekta
400 Perimeter Center Terrace, Suite 50
Atlanta, GA 30346
Phone: 770-670-2592
Email: doris.aubuchon@elekta.com
Website: www.elekta.com
A R
942
ELSEVIER
1600 JFK Boulevard
Philadelphia, PA 19103
Phone: 702-260-4628
Website: www.us.elsevierhealth.com
1617
Equal-Estro Inc.
Place de l’Alama 3
Brussels, 1200
Belgium
Phone: +32-277-681-59
Email: jxhallet@equal-estro.org
Website: www.equalestro.com
R
245
205
EXHIBITOR NAME
BOOTH#
Equicare Health Inc.
2653
201-2020 Yukon Street
Vancouver, BC V5Y 3N8
Canada
Phone: 604-398-2956
Email: rachel.richardson@equicarehealth.com
Website: www.equicarehealth.com
Everson Tesla Inc.
615 Daniels Road
Nazareth, PA 18064
Phone: 610-216-6279
Email: tstenulis@eversontesla.com
Website: www.eversontesla.com
1120
Focal Therapeutics
4370 Alpine Road, Suite 101
Portola Valley, CA 94028
Phone: 949-521-4949
423
Foss Therapy Services Inc.
8794 Avalon Street
Alta Loma, CA 91701
Phone: 909-980-6229
Email: ftsinc@roadrunner.com
Website: www.fosstherapyservices.net
719
Gammex Inc.
7600 Discovery Drive
Middleton, WI 53562
Phone: 608-828-7000
Email: sales@gammex.com
Website: www.gammex.com
R
1435
GE Healthcare
P.O. Box 414
Milwaukee, WI 53201
Phone: 262-544-3011
Website: www.gehealthcare.com
2242
GeneDx Inc.
207 Perry Parkway
Gaithersburg, MD 20877
Phone: 800-229-5227, ext. 8205
Website: www.genedx.com
416
LEGEND
A
Ambassador
P
Platinum Sponsor
Gold Sponsor
Silver Sponsor
G
S
Bronze Sponsor
C Copper Sponsor
Listing
Corporate
Corporatemembers
membersininbold.
bold.
B
206
EXHIBITOR NAME
BOOTH#
EXHIBITOR NAME
BOOTH#
Genomic Health Inc.
1817
301 Penobscot Drive
Redwood City, CA 94063
Phone: 866-662-6897
Email: CustomerService@genomichealth.com
Website: www.OncotypeDX.com
Hitachi Aloka Medical
10 Fairfield Boulevard
Wallingford, CT 06492
Phone: 800-872-5652
Email: inquiry@hitachi-aloka.com
Website: www.hitachi-aloka.com
2421
GMV Soluciones Globales Internet
S.A.U
Isaac Newton, 11
Tres Cantos, MADRID 28760
Spain
Phone: 34-918-072-100
Email: cillana@gmv.com
Website: www.gmv.com
Hitachi America Ltd.
50 Prospect Avenue
Tarrytown, NY 10591
Phone: 914-524-6654
Email: ken.umei@hal.hitachi.com
Website: www.hitachi-america.us
2520
Hologic Inc.
35 Crosby Drive
Bedford, MA 01730
Phone: 781-999-7300
Website: www.hologic.com
S
734
HyperDrive Medical
1110 Sunset Drive
Salt Spring Island, British Columbia
V8K1E6 Canada
Email: info@hyperdrivemed.com
Website: www.hyperdrivemed.com
563
IBA SA
Chemin du Cyclotron, 3 ES1
Louvain-la-Neuve, 1348
Belgium
Phone: 32-470-048-622
Email: daniel.ernult@iba-group.com
Website: www.iba-worldwide.com
R
1543
921
422
Gold Anchor
622
Vassvagen 21
Huddinge, 14139
Sweden
Phone: 46-706-105-411
Email: samuel.naslund@FineNeedleMarker.com
Website: www.FineNeedleMarker.com
R
Guangzhou Renfu Medical Equipment Co. Ltd. 2514
No. 2 Zhiye RD Dalong Street, Panyu
Guangzhou, Guangdong 511450
China
Phone: 86-203-839-1508
Email: renfu@renfumed.com
Website: www.renfumed.com
Healthcare Administrative Partners
112 Chesley Drive
Media, PA 19063
Phone: 610-892-8889
Email: ccarlson@hapusa.com
Website: www.hapusa.com
R
2353
Healthcare Global Enterprises
#8, P Kalinga Rao Road, Tower IV, HCG,
Sampaniramnagar
Bangalore, Karnataka 560027
India
Phone: 91-804-020-6058
Website: www.hcgoncology.com
426
Imaging Technology News
3030 West Salt Creek Lane, Suite 201
Arlington Heights, IL 60005
Phone: 847-391-1000
Email: sreilly@sgcmail.com
Website: www.ITNonline.com
420
Heritage Capital Group
4811 Beach Boulevard, Suite 300
Jacksonville, FL 32207
Phone: 904-394-3525
Website: www.heritagecapitalgroup.com
334
ImpediMed Inc.
5900 Pasteur Court, Suite 125
Carlsbad, CA 92008
Phone: 877-247-0111
Email: info@impedimed.com
Website: www.impedimed.com
R
INSYS Therapeutics Inc.
10220 S. 51st Street
Chandler, AZ 85224
Phone: 602-910-2617, ext. 9020
1916
Hermes Medical Solutions Inc.
710 Cromwell Drive, Suite A
Greenville, NC 27858
Phone: 866-437-6372
Email: info@hermesmedical.com
Website: www.hermesmedical.com
2420
Integrated Oncology Network
2865 E. Coast Hwy, Suite 210
Corona del Mar, CA 92625
Phone: 949-933-8800
Website: www.ion-llc.com
2843
EXHIBITOR NAME
BOOTH#
IntraOp Medical
570 Del Rey Avenue
Sunnyvale, CA 94085
Phone: 408-636-1020
Website: www.intraopmedical.com
821
IOP Publishing
150 S. Independence Mall West, Suite 929
Phone: 215-627-0880
Email: info@ioppubusa.com
Website: www.ioppublishing.org
418
IOS Consultants LLC
2422
7770 West Chester Road, Suite 150
West Chester, OH 45069
Phone: 888-870-1780
Email: mckinneyf@innovativeofficesolutions.net
Website www.innovativeofficesolutions.net
Iron Medical Systems Inc.
3104 E. Camelback Road, #562
Phoenix, AZ 85016
Phone: 602-343-6440
Email: mary@ironmedicalsystems.com
Website: www.ironmedicalsystems.com
428
IsoAid
7824 Clark Moody Boulevard
Port Richey, FL 34668
Phone: 727-207-5973
Email: jgibson@isoaid.com
Website: www.isoaid.com
R
2427
IsoRay Medical Inc.
350 Hills Street, Suite 106
Richland, WA 99354
Phone: 509-375-1202
Email: dbabcock@isoray.com
Website: www.isoray.com
R
2736
James L. Davis
13521 Walsingham Road
Largo, FL 33774
Phone: 727-596-0408
Email: sales@jld-radcon.com
Website: www.jld-radcon.com
R
1017
Klarity
80 Westgate Drive
Newark, OH 43055
Phone: 740-788-8107
Email: peter@klaritymedical.com
Website: www.klaritymedical.com
2343
Kobold
P.O. Box 1994
Veradale, WA 99037
Phone: 509-703-5090
2352
EXHIBITOR NAME
BOOTH#
EXHIBITOR NAME
Kyoto Kagaku Co. Ltd.
3109 Lomita Boulevard
Torrance, CA 90505
Phone: 310-325-8860
Email: f_kawamoto@kyotokagaku.co.jp
Website: www.kyotokagaku.com
523
Lippincott Williams & Wilkins
Two Commerce Square, 2001 Market Street
Phone: 215-521-8300
Email: customerservice@lww.com
Website: www.lww.com
1716
Landauer Inc.
2 Science Road
Glenwood, IL 60425
Phone: 877-476-8433
Email: info@landauermp.com
Website: www.landauermp.com
R
2333
Locumtenens.com
2655 Northwinds Parkway
Alpharetta, GA 30009-2280
Phone: 770-643-5559
Email: ccruz@locumtenens.com
Website: www.locumtenens.com
729
LAP of America LLC
2142
161 Commerce Road, Suite 3
Boynton Beach, FL 33426
Phone: 561-416-9250
Email: tava@lap-laser.com
Website: www.lap-laser.com/medical-systems
R
MACROMEDICS BV
Kouwe Hoek 18
Waddinxveen, 2741 PX
Netherlands
Phone: 31-018-238-9777
Website: www.macromedics.com
447
Math Resolutions LLC
5975 Gales Lane
Columbia, MD 21045
Website: www.MathResolutions.com
335
Max Medical Co. Ltd.
4-5-1, Nishinakajima, Yodogawa-ku
Osaka, 532-0011
Japan
Phone: +81-6-6886-7351
Email: info@maxmedical.com
Website: www.maxmedical.co.jp
2454
McKesson Specialty Health
10101 Woodloch Forest
The Woodlands, TX 77380
Phone: 832-601-6208
Email: lorry.harju@usoncology.com
2513
Leoni CIA Cable Systems S.A.S.
1663
1, Ave Louis Pasteur, Zone Industrielle de Gellainville
Gellainville, 28630
France
Phone: 0033-237333204
Email: samuel.pinault@leoni.com
Website: www.leoni-healthcare.com
Liberty Medical Inc.
22135 Davis Drive, #112
Sterling, VA 20164
Phone: 888-257-2408
R
2448
LifeLine Software Inc.
2407 Pemberton Place
Austin, TX 78703
Phone: 866-592-1343
Email: sales@lifelinesoftware.com
Website: www.lifelinesoftware.com
R
2743
LinaTech LLC
1294 Kifer Road, Suite 705
Sunnyvale, CA 94086
Phone: 408-733-2051
Email: corynorris@linatech.com
Website: www.linatech.com
R
1762
Linbeck Group LLC
3900 EssexSuite 1200
Houston, TX 77027
Phone: 713-621-2350
2955
BOOTH#
medPhoton GMBH
2853
Muellner Hauptstrasse 48
Salzburg 5020 Austria
Phone: +43-662-4482-3928
Email: Heinz.deutschmann@medphoton.at
Medspira LLC
2718 Summer Street NE
Minneapolis, MN 55413
Phone: 612-789-0013
Website: www.medspira.com
521
Mevion Medical Systems
300 Foster Street
Littleton, MA 01460
Phone: 978-540-1500
Email: info@mevion.com
Website: www.mevion.com
G R
1253
207
EXHIBITOR NAME
Miaderm Radiation Relief at Aiden
Industries LLC
2412 Calle San Miguel
Encinitas, CA 92024
Phone: 617-461-5959
Email: plinson@post.harvard.edu
Website: www.miaderm.com
R
BOOTH#
443
Mick Radio Nuclear-Instruments Inc.
521 Homestead Avenue
Mount Vernon, NY 10550
Phone: 914-667-3999
Email: fran@micknuclear.com
Website: www.micknuclear.com
R
1334
Micropos Medical AB
Stena Center 1
Gothenburg, 41292
Sweden
Phone: +46-31-772-80-99
Email: info@micropos.se
Website: www.micropos.se
R
559
MIM Software
25800 Science Park Drive, Suite 180
Cleveland, OH 44122
Phone: 216-455-0600
Email: info@mimsoftware.com
Website: www.mimsoftware.com
433
Ministry Health Care
2426
900 Illinois Avenue
Stevens Point, WI 54481
Phone: 715-342-7772
Email: mmgrecruitment@ministryhealth.org
Website: www.ministryhealth.org
Mirada Medical
Oxford Centre for Innovation, New Road
Oxford, OX1 1BY
United Kingdom
Phone: 44-(0)-1865-261-410
Email: support@mirada-medical.com
Website: www.mirada-medical.com
R
2733
EXHIBITOR NAME
BOOTH#
EXHIBITOR NAME
BOOTH#
Mission Search
2203 N. Lois Avenue, Suite 1225
Tampa, FL 33607
Phone: 813-870-9500
Email: info@missionsearchusa.com
Website: www.MissionSearchUSA.com
715
NELCO
2 Burlington Woods Drive, Suite 300
Burlington, MA 01803
Phone: 781-933-1940
Website: www.nelcoworldwide.com
R
2026
Network Imaging System
8100-C Arrowridge Boulevard
Charlotte, NC 28273
Phone: 704-619-0290
517
Neurologica
14 Electronics Avenue
Danvers, MA 01923
Phone: 978-564-8533
Website: www.neurologica.com
249
Novocure
1500 Broadway, 29th Floor
New York, NY 10036
Website: www.novocure.com
2615
Mitsubishi Electric
2934
3124 Fox Creek Drive
Danville, CA 94506
Phone: 925-890-8935
Email: dennisfalkenstein@sbcglobal.net
Website: www.mitsubishi-presentations.com
Mobius Medical Systems
906 Hutchins Street
Houston, TX 77003
Phone: 713-234-0123
Email: nathan@doselab.com
Website: www.doselab.com
2519
Modus Medical Devices Inc.
1570 North Routledge Park
London, ON N6H 5L6
Canada
Phone: 519-438-2409
Email: info@modusmed.com
Website: www.modusmed.com
2633
MPM Medical Inc.
2301 Crown Court
Irving, TX 75038
Phone: 972-893-4090
Email: mary.jones@mpmmed.com
Website: www.mpmmed.com
R
819
MuCheck-Oncology Data Systems
1601 SW 89th Street, E-100
Oklahoma City, OK 73159
Phone: 405-680-5222
Email: admin@mucheck.com
Website: www.mucheck.com
633
Multidata Systems International Corp.
10816 Indian Head Industrial Boulevard
St. Louis, MO 63132
Phone: 314-968-6880
Website: www.multidata-systems.com
1235
Myriad Genetic Laboratories
320 Wakara Way
Phone: 801-584-3535
Email: cscomments@myriad.com
Website: www.myriad.com
331
OiService CT & MR
2349
64 Union Way
Vacaville, CA 95687
Phone: 888-673-5151
Email: michaelle.serrano@oxinst.com
Website: www.oxford-instruments.com/ct-mr
LEGEND
A
P
G
S
Ambassador
Platinum Sponsor
Gold Sponsor
Silver Sponsor
Bronze Sponsor
Copper Sponsor
Listing
Corporate
Corporatemembers
membersininbold.
bold.
B
C
208
Oncolink-University of Pennsylvania
1021
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
Radiation Oncology Admin Offices, Suite 2338
Phone: 215-349-8895
Email: hampshire@uphs.upenn.edu
Website: www.oncolink.upenn.edu
Oncology Services International
400 Rella Boulevard, Suite 123
Montebello, NY 10901
Phone: 845-357-6560
Email: trichardson@thinkosi.com
Website: www.thinkosi.com
R
727
Oncology Systems Limited
14 Longbow Professional Centre
Shrewsbury, SY1 3GZ
United Kingdom
Phone: +44-(0)1743-462694
Email: enquiry@osl.uk.com
Website: www.osl.uk.com
763
Orfit Industries America
350 Jericho Turnpike, Suite 101
Jericho, NY 11753
Phone: 516-935-8500
Email: martinj.ratner@orfit.com
Website: www.orfit.com
2543
EXHIBITOR NAME
BOOTH#
P-Cure Ltd.
500 Lake Cook Road
Deerfield, IL 60015
Phone: 847-874-7771
Email: israel.raz@p-cure.com
Website: www.p-cure.com
2554
Perioperative Services LLC
111 Continental Drive, Suite 412
Newark, DE 19713
Phone: 302-709-4502
445
Phantom Laboratory
P.O. Box 511
Salem, NY 12865
Phone: 518-692-1190
Email: levy@phantomab.com
Website: www.phantomlab.com
917
Philips Healthcare
3000 Minuteman Road
Andover, MA 01810
Phone: 800-229-6417
Website: www.philips.com/healthcare
A
1832
Pioneer Bioscience Publishing Company
3/F, 1st Building, Le Su Science Park, 1526,
Chunbo Rd., Binjiang District
Hangzhou, Zhejiang Province 310052
China
Phone: +86-571-28182610
Email: tcr@thepbpc.org
Website: www.thepbpc.org
516
Pitts Little Corp.
2711 Alton Road
Birmingham, AL 35210
Phone: 205-833-5911
Email: sales@pittslittle.com
Website: www.pittslittle.com
1116
Precise Construction Inc.
5026 Trenton Street
Tampa, FL 33619
Phone: 813-241-2403, ext. 20
Website: www.preciseconstruction.com
2318
Precision X-Ray
15 Commerce Drive, Unit 1
North Branford, CT 06471
Phone: 203-484-2011
Email: wmclaughlin@pxinc.com
Website: www.pxinc.com
R
2751
Progenics Pharmaceuticals
777 Old Saw Mill River Road
Tarrytown, NY 10591
Phone: 914-789-2800
332
EXHIBITOR NAME
BOOTH#
EXHIBITOR NAME
ProNova Solutions
1450 Dowell Springs Boulevard, Suite 230
Knoxville, TN 37909
Phone: 865-684-2616
1863
Radiation Business Solutions
1044 Jackson Felts Road
Joelton, TN 37080
Phone: 615-746-4711
Email: dan@radiationbilling.com
Website: www.radiationbusiness.com
923
ProTom International Inc.
1100 Parker Square, Suite 230
Flower Mound, TX 75028
Phone: 972-410-3551
Email: jfrank@protominternational.com
Website: www.protominternational.com
R
1561
Radiation Oncology Resources
P.O. Box 76
Goshen, IN 46527
Phone: 574-364-2474
Email: wtroyer@roresources.com
Website: www.roresources.com
R
721
Prowess Inc.
1844 Clayton Road
Concord, CA 94520
Phone: 925-356-0360
Email: sharon.springorum@prowess.com
Website: www.prowess.com
2135
816
PTW
205 Park Avenue
Hicksville, NY 11801
Phone: 516-827-3181
Email: john@ptwny.com
Website: www.ptwny.com
2435
Radiation Products Design Inc.
5218 Barthel Industrial Drive
Albertville, MN 55301
Phone: 763-497-2071
Email: sales@rpdinc.com
Website: www.rpdinc.com
R
618
Qfix
440 Church Road
Avondale, PA 19311
Phone: 800-526-5247, ext. 713
Website: www.q-fix.com
R
1627
1818 Market Street, Suite 1600
Phone: 215-717-0843
Email: shartson@acr.org
Website: www.rtog.org
2443
QLRAD Inc.
80 S.W. 8th Street, Suite 2000
Miami, FL 33130
Phone: 770-335-5601
Email: awinkel@qlrad.com
Website: www.QLRAD.com
412
Radiological Imaging Technology - RIT
5065 List Drive
Colorado Springs, CO 80919-3321
Phone: 719-590-1077
Email: mac@radimage.com
Website: www.radimage.com
751
RAD Technology Medical Systems
20801 Biscayne Boulevard, Suite 403
Aventura, FL 33180
Phone: 305-898-2544
Email: info@radtechnology.com
Website: www.radtechnology.com
743
Radiology Oncology Systems Inc.
6725 Mesa Ridge Road, Suite 100
San Diego, CA 92121
Phone: 858-454-8100
Email: info@oncologysystems.com
Website: www.oncologysystems.com
827
RadiaDyne
3801 Kirby Drive, Suite 710
Houston, TX 77098
Phone: 713-807-9100
Website: www.radiadyne.com
2213
RADMAX Ltd.
3304 S. Broadway Avenue, Suite 200
Tyler, TX 75701
Phone: 903-531-2371
Email: kevin.ewalt@radmaxonline.com
Website: www.radmaxonline.com
R
RaySearch Laboratories AB
150 N. Michigan Avenue, Suite 1950
Chicago, IL 60601
Phone: 877-778-3849
Email: sales@raysearchlabs.com
Website: www.raysearchlabs.com
1453
Radia-Guard
419 Erin Drive, Suite 5
Knoxville, TN 37919
Phone: 866-400-8080
R
512
BOOTH#
209
EXHIBITOR NAME
BOOTH#
Remetronix
2190 N.W. Reserve Park Trace
Port Saint Lucie, FL 34986
Phone: 800-875-0856
Website: www.remetronix.com
453
Revenue Cycle Inc.
1817 West Braker Lane, Building F,
Suite 200
Austin, TX 78758
Phone: 512-583-2000
Email: info@revenuecycleinc.com
Website: www.revenuecycleinc.com
R
612
RS&A Inc.
465 Forum Parkway
Rural Hall, NC 27045
Phone: 336-969-0583
Email: bginas@rsainc.net
Website: www.rsa-inc.com
442
S+S Par Scientific
10625 Telge Road
Houston, TX 77095
Phone: 281-815-1300
Email: tj@parscientific.com
Website: www.ParScientific.com
1118
ScandiDos
Uppsala Science Park
Uppsala, SE-751 83
Sweden
Phone: 46-018-472-3030
Email: matt.douglass@scandidos.com
Website: www.scandidos.com
653
Sensus Healthcare
851 Broken Sound Parkway, #215
Boca Raton, FL 33487
Phone: 800-324-9890
Email: info@sensushealthcare.com
Website: www.sensushealthcare.com
R
427
Shandong Xinhua Medical Instruments Co. Ltd. 2627
No.7 Taimei Road, Zibo New & Hi - Tech Zone
Shandong, 255086
China
Phone: 86-533-358-7719
Email: xhliping@hotmail.com
Website: www.shinva.com
Shielding Construction Solutions Inc.
4620 S. Coach Drive
Tucson, AZ 85714
Phone: 520-917-0661
Email: info@nuclearshielding.com
Website: www.shieldingconstruction.com
R
210
1135
EXHIBITOR NAME
BOOTH#
Siemens Medical Solutions USA Inc.
51 Valley Stream Parkway
Malvern, PA 19355
Phone: 610-448-4252
Website: www.medical.siemens.com
A R
929
Sky Factory
801 N. 18th Street, P.O. 1177
Fairfield, IA 52556
Phone: 641-472-1747
Email: Info@SkyFactory.com
Website: www.SkyFactory.com
732
SonaCare Medical LLC
801 E. Morehead Street, Suite 201
Charlotte, NC 28202
Phone: 704-817-1170
Website: www.sonacaremedical.com
2850
Sordina IORT Technologies S.p.A
14530 Falling Waters Drive
Jacksonville, FL 32258
353
SPEC MED
113 Teal Street
St. Rose, LA 70087
Phone: 504-464-9471
Website: www.spec-med.com
2452
Spectrum Pharmaceuticals Inc.
11500 S. Eastern Avenue, #240
Henderson, NV 89052
Phone: 702-835-6300
Email: info@sppirx.com
Website: www.sppirx.com
R
546
Springer
233 Spring Street
New York, NY 10013
Phone: 212-460-1500
Email: exhibits-ny@springer.com
Website: www.springer.com
1016
Standard Imaging
833
3120 Deming Way
Middleton, WI 53562
Phone: 800-261-4446
Email: standardimaging@standardimaging.com
Website: www.standardimaging.com
R
Sumitomo Heavy Industries Ltd.
2553
Think Park Tower 1-1, Osaki 2-chome, Shinagawa
Tokyo, 141-6025
Japan
Phone: 61-079-167-16
Email: shn_masui@shi.co.jp
Website: www.shi.co.jp/english/index.html
EXHIBITOR NAME
BOOTH#
Sun Nuclear Corporation
3275 Suntree Boulevard
Melbourne, FL 32940
Phone: 321-259-6862, ext. 275
Email: luisrivera@sunnuclear.com
Website: www.sunnuclear.com
C R
2116
superDimension Inc.
161 Cheshire Lane, Suite 100
Plymouth, MN 55441
Phone: 763-210-4013
Email: kobrien@superdimension.com
Website: www.superdimension.com
434
Suremark Company
4645 Industrial Street, 2C
Simi Valley, CA 93063
Phone: 800-406-3399
Email: customerservice@suremark.com
Website: www.suremark.com
430
Teva CNS
41 Moores Road
Frazer, PA 19355
Phone: 610-786-7213
Email: tish.mccarter@tevapharm.com
Website: www.tevapharm.com
2827
The Red Journal/Practical Radiation Oncology 1619
1600 JFK Boulevard
Phone: 702-260-4628
Website: www.us.elsevierhealth.com
Theragenics Corporation
5203 Bristol Industrial Way
Buford, GA 30518
Phone: 770-271-0233
Email: roeslerj@theragenics.com
Website: www.theragenics.com
R
2527
Top Grade Medical Equipment Co. Ltd.
No. 11 Yongchang North Road, BDA
Beijing, P.R.C. 10076
China
Phone: 86-106-788-5599, ext. 398
Email: pengcheng.zhang@topgradehc.com
Website: www.topgradehc.com
2160
Toshiba Medical Systems
2441 Michelle Drive
Tustin, CA 92780-7043
Phone: 714-669-4190
Email: dkemp@tams.com
Website: www.medical.toshiba.com
227
EXHIBITOR NAME
BOOTH#
EXHIBITOR NAME
BOOTH#
EXHIBITOR NAME
BOOTH#
TRG Oncology Equipment
5318 E. 2nd Street, #682
Long Beach, CA 90803
Phone: 949-622-0022
Website: www.oncologyequipment.com
R
1122
Vision RT Ltd.
Dove House, Arcadia Avenue
London, UK N3 2JU
United Kingdom
Phone: 00-44-771-432-7781
Email: jturner@visionrt.com
Website: www.visionrt.com
2227
Xoft
101 Nicholson Lane
San Jose, CA 95134
Phone: 408-493-1500
Email: dbreault@icadmed.com
Website: www.xoftinc.com
B R
2449
Universal Health Network
32 Broadway
Hornell, NY 14843
Website: www.uhnllc.com
735
VisionTree Software Inc.
8885 Rio San Diego Drive, #220
San Diego, CA 92108
Phone: 619-295-2800
Website: www.visiontree.com
446
619
Vantage Oncology
1500 Rosecrans Avenue, Suite 400
Manhattan Beach, CA 90266
Phone: 310-335-4074
Website: www.vantageoncology.com
2313
Xstrahl Ltd.
480 Brogdon Road, Suite 100
Suwanee, GA 30024
Phone: 678-482-6800
Email: support@xstrahl.com
Website: www.xstrahl.com
S
VOA Associates
722 12th Street N.W., Suite 100
Washington, DC 20005
Phone: 202-822-8227
Email: jjessen@voa.com
Website: www.voa.com
620
Water-Jel Technologies
50 Broad Street
Carlstadt, NJ 07072
Phone: 201-507-8300
Email: Jdomanski@WaterJel.com
Website: www.Radiaderm.com
R
336
Varian Medical Systems
3100 Hansen Way
Palo Alto, CA 94304
Phone: 650-424-5927
Email: robert.capuzelo@varian.com
Website: www.varian.com
A R
Velocity Medical Solutions
1350 Spring Street, Suite 275
Atlanta, GA 30309
Phone: 404-907-1705
Email: chris.hanna@velocitymedical.com
Website: www.velocitymedical.com
1115, 1335
1461
Wells Fargo Equipment Finance Inc.
2455
733 Marquette Avenue, N9306-070, 7th Floor
Minneapolis, MN 55402
Phone: 612-667-1674
Email: julie.k.dey@wellsfargo.com
Website: www.wellsfargo.com/healthcarefinancing
Veritas Medical Solutions
2150
5 Great Valley Parkway, Suite 210
Malvern, PA 19355
Phone: 888-242-6760
Email: info@veritas-medicalsolutions.com
Website: www.veritas-medicalsolutions.com
R
Vertual Ltd.
Logistics Institute
Hull, UK HU6 7RX
United Kingdom
Phone: 44-148-234-7572
Email: sales@vertual.co.uk
Website: www.vertual.co.uk
C
1263
ViewRay Inc.
2 Thermo Fisher Way
Oakwood Village, OH 44146
Phone: 408-368-2244
Email: mbrandt@viewray.com
Website: www.viewray.com
S R
2126
Wiley
350 Main Street
Malden, MA 02148
Phone: 781-388-8313
Email: dguerrero@wiley.com
Website: www.wiley.com/WileyCDA
415
Willmed Corporation
51 Valley Stream Parkway
Malvern, PA 19355
Phone: 821-051-9084, ext. 41
658
Xecan
275 Grove Street, Building 2, Suite 400
Newton, MA 02466
Phone: 617-686-9953
731
211
Exhibitor Listing by Product/Service
ACCELERATOR
Acceletronics
1913
Dynasource LLC
2428
2520
IBA SA
1543
LAP of America LLC
2142
1253
Mitsubishi Electric
2934
727
1561
751
RS&A Inc.
442
1135
929
2553
2160
1122
1115, 1335
BRACHYTHERAPY
757
AccuBoost
243
2261, 2715, 2819
Biocompatibles Inc.
926
BK Medical Systems
918
BSD Medical
2852
C.R. Bard Inc.
2030
Cianna Medical
542
CIRS
2219
1826
DIACOR
2034
Dynasource LLC
2428
1758
Hologic Inc.
734
IsoAid
2427
IsoRay Medical Inc.
2736
2743
1334
MIM Software
433
633
Prowess Inc.
2135
PTW
2435
QLRAD Inc.
412
929
SPEC MED
2452
Standard Imaging
833
2527
1115, 1335
Xoft
2449
DOSIMETRY/DETECTORS
2261, 2715, 2819
Equal-Estro Inc.
245
Gammex Inc
1435
IBA SA
1543
Micropos Medical AB
559
1235
Phantom Laboratory
917
PTW
2435
QLRAD Inc.
412
2443
Standard Imaging
833
212
2116
1115, 1335
ELECTRONIC MEDICAL RECORDS
Elekta
Equal-Estro Inc.
820
920
942
245
2653
2353
929
1115, 1335
446
FACILITY CONSTRUCTION AND DESIGN
architection
IBA SA
James L. Davis
NELCO
Precise Construction Inc.
Sky Factory
823
1621
1543
1017
2026
2318
743
1135
732
2150
FINANCIAL SERVICES
Alliance Oncology
Wells Fargo Equipment Finance Inc.
712
920
923
929
2455
IMAGING PRODUCTS
Acceletronics
1913
AQUILAB
2732
2261, 2715, 2819
BK Medical Systems
918
Buck Engineering & Consulting GMBH
2853
C&G Technologies
519
C-RAD Inc.
661
Gammex Inc
1435
GE Healthcare
2242
2420
2421
Kyoto Kagaku Co. Ltd
523
MIM Software
433
OiService CT & MR
2349
763
P-Cure Ltd.
2554
Phantom Laboratory
917
Philips Healthcare
1832
PTW
2435
751
929
2160
227
1461
Vision RT Ltd.
2227
Xoft
2449
Xstrahl Ltd.
619
INFORMATION/TECHNOLOGY
MIM Software
Philips Healthcare
820
2420
433
633
1832
929
1115, 1335
1461
446
MEDICAL DEVICE
.decimal
1659
1535
AccuBoost
243
Accuray Inc.
1842
Augmenix
343
2261, 2715, 2819
Biocompatibles Inc.
926
BK Medical Systems
918
C&G Technologies
519
2716
Carl Zeiss Meditec Inc.
627
DIACOR
2034
e2v
2528
1758
Elekta
942
719
Gammex Inc
1435
GE Healthcare
2242
Gold Anchor
622
2421
2520
Hologic Inc.
734
ImpediMed Inc.
420
IsoRay Medical Inc.
2736
Klarity
2343
LinaTech LLC
1762
Medspira LLC
521
1253
1334
Micropos Medical AB
559
MIM Software
433
OiService CT & MR
2349
727
P-Cure Ltd.
2554
Philips Healthcare
1832
1561
Qfix
1627
QLRAD Inc.
412
RS&A Inc.
442
S+S Par Scientific
1118
Sensus Healthcare
427
SPEC MED
2452
Standard Imaging
833
2116
superDimension Inc.
434
2527
227
1115, 1335
ViewRay Inc.
2126
Vision RT Ltd.
2227
Xstrahl Ltd.
619
OTHER
Alphatron Linac
BSD Medical
CDR Systems Inc.
Cold Shot Chillers
Gammex Inc
ImpediMed Inc.
Iron Medical Systems Inc.
Landauer Inc.
MIM Software
Myriad Genetic Laboratories
RADMAX Ltd.
Revenue Cycle Inc.
RS&A Inc.
Sky Factory
Vertual Ltd.
VOA Associates
Water-Jel Technologies
823
2526
241
616
2852
613
1826
417
719
1435
2353
420
428
2333
433
331
727
618
827
612
442
732
1263
620
336
PATIENT HANDLING/POSITIONING
1535
2261, 2715, 2819
1653
Brainlab
1243
2853
CDR Systems Inc.
613
Cemar Electro Inc.
514
1826
C-RAD Inc.
661
DIACOR
2034
Elekta
942
2653
Gold Anchor
622
Klarity
2343
LAP of America LLC
2142
Leoni CIA Cable Systems S.A.S.
1663
Micropos Medical AB
559
Philips Healthcare
1832
Qfix
1627
QLRAD Inc.
412
S+S Par Scientific
1118
Vision RT Ltd.
2227
PHARMACEUTICAL
Bayer HealthCare
554
1635
Cangene Corporation
2112
Miaderm Radiation Relief at Aiden Industries LLC 443
Spectrum Pharmaceuticals Inc.
546
Teva CNS
2827
PRACTICE MANAGEMENT
Alliance Oncology
e+CancerCare
Mission Search
757
712
2113
2353
715
923
446
PROFESSIONAL SOCIETY
American Association of Medical Dosimetrists
American Society of Radiologic Technologists
ASTRO Resource Center
432
413
241
616
515
543
PUBLISHER
Demos Medical Publishing
ELSEVIER
Imaging Technology News
IOP Publishing
Lippincott Williams & Wilkins
Pioneer Bioscience Publishing Company
Springer
The Red Journal/Practical Radiation Oncology
Wiley
513
1617
921
418
1716
516
1016
1619
315
QUALITY ASSURANCE
AQUILAB
CIRS
Dynasource LLC
Equal-Estro Inc.
Gammex Inc
IBA SA
Micropos Medical AB
Phantom Laboratory
PTW
ScandiDos
241
413
2732
920
2219
1826
717
1023
2428
245
719
1435
2420
1543
2743
1334
559
2633
633
1235
917
2435
721
618
2443
653
2116
RADIATION PROTECTION/SHIELDING
architection
Augmenix
James L. Davis
NELCO
Pitts Little Corp.
PTW
823
1621
343
1017
2026
1116
2435
816
1135
929
2150
RADIATION THERAPY
Acceletronics
AccuBoost
Accuray Inc.
Alliance Oncology
757
1535
1913
243
1842
712
413
Anzai Medical Co. Ltd.
2755
Augmenix
343
2261, 2715, 2819
Biocompatibles Inc.
926
1653
Brainlab
1243
2853
2716
CDR Systems Inc.
613
Cianna Medical
542
CIRS
2219
1826
717
C-RAD Inc.
661
e2v
2528
1758
Elekta
942
Equal-Estro Inc.
245
719
GMV Soluciones Globales Internet S.A.U
422
Gold Anchor
622
Hologic Inc.
734
HyperDrive Medical
563
IBA SA
1543
IsoAid
2427
IsoRay Medical Inc.
2736
Klarity
2343
Landauer Inc.
2333
LAP of America LLC
2142
2743
MASEP Infini Medical Science Technology
Development Co. Ltd.
135
2454
Medspira LLC
521
1253
Micropos Medical AB
559
MIM Software
433
Mirada Medical
2733
Mitsubishi Electric
2934
2633
MPM Medical Inc.
819
633
OiService CT & MR
2349
1021
727
763
Oncure Medical Corp.
421
Orfit Industries America
2543
P-Cure Ltd.
2554
Phantom Laboratory
917
Philips Healthcare
1832
Precision X-Ray
2751
PTW
2435
Qfix
1627
QLRAD Inc.
412
RadiaDyne
2213
816
618
2443
751
1453
RS&A Inc.
442
S+S Par Scientific
1118
929
Standard Imaging
833
2553
2116
213
Vertual Ltd.
ViewRay Inc.
Xoft
Xstrahl Ltd.
2160
1122
1115, 1335
1263
2126
2449
619
RADIOISOTOPE SOURCE MANUFACTURER
IBA SA
IsoAid
1543
2427
2527
SEARCH FIRM/STAFFING/RECRUITMENT
Cancer Treatment Centers of America
CompHealth
Landauer Inc.
Locumtenens.com
Ministry Health Care
Mission Search
1722
2712
2515
2333
729
2426
715
TREATMENT ACCESSORIES
Alphatron Linac
2526
2261, 2715, 2819
BSD Medical
2852
CDR Systems Inc.
613
Dynasource LLC
2428
1758
2520
2454
Medspira LLC
521
MIM Software
433
QLRAD Inc.
412
816
RS&A Inc.
442
S+S Par Scientific
1118
929
Sky Factory
732
Suremark Company
430
TREATMENT PLANNING
Accuray Inc.
AQUILAB
Brainlab
Cangene Corporation
CIRS
Elekta
214
GE Healthcare
2242
GMV Soluciones Globales Internet S.A.U
422
HyperDrive Medical
563
LinaTech LLC
1762
2454
Medspira LLC
521
MIM Software
433
Mirada Medical
2733
Mission Search
715
Mitsubishi Electric
2934
OiService CT & MR
2349
1021
763
Phantom Laboratory
917
Philips Healthcare
1832
Precision X-Ray
2751
Prowess Inc.
2135
721
751
1453
929
227
1115, 1335
1461
ViewRay Inc.
2126
1842
2732
2261, 2715, 2819
1243
2112
2716
2219
1826
1023
1758
942
2653
Stop by the ASTRO Resource Center
Booth #543
LEARN ABOUT ASTRO’S NEWEST PRODUCTS AND SERVICES.
2013 S
UR
CIRCLVIVOR
E
VISIT THE RESOURCE CENTER TO:
Stop b
y the S
urvivo
Resou
r Circle
rce Cen
in the
ter. Me
Surviv
et this
or Circ
y
ear’s
le
A
ward w
the 20
inner a
13 Sur
nd
vivor C
recipie
ircle G
nts. Plu
rant
s, don’t
off you
forget
r stam
to drop
ped Pa
chance
ssport
to win
for a
great p
rizes.
•
Receive training on the ROhub, ASTRO’s exclusive
online community.
•
Have your photo taken for the ASTRO member directory.
•
Learn about APEx, ASTRO’s new practice accreditation program.
•
Pick up information on the latest changes to the MOC process.
•
Ask about RO-ILS: Radiation Oncology Incident Learning System,
ASTRO’s new patient safety organization.
•
Get information on the 2013 ASTRO PQRIwizard, the online tool that
reduces the burden of PQRS reporting.
•
Pick up free patient brochures and browse our patient website RTAnswers.org.
•
Purchase the ASTRO/ACR Guide to Radiation Oncology Coding supplement
and multi-year Web subscription.
•
Apply online for ASTRO membership.
•
Search for job openings and job seekers on the ASTRO Career Center site.
•
Get your questions answered by ASTRO’s knowledgeable staff.
ANNUAL MEE TING
NOTES
Mark Your Calendars!
A S T R O 56 T H A N N UA L M E E T I N G
TARGETING
CANCER:
Technology
Biology
Meeting Dates: September 14 -17, 2014 • Exhibit Dates: September 14 -16, 2014 • Moscone Center • San Francisco
Call for abstracts site opens: December 17, 2013
Closes: February 17, 2014
TA R G E T I N G C A N C E R CAR E
2013 ASTRO Annual Meeting | Georgia World
Meeting Dates: September 22-25, 2013
Exhibition Dates: September 22-24, 2013
218
Congress Center | Halls B1 - B4
EXHIBIT H
ALL HOUR
S
:00 p.m.
:00 a.m. – 5
Sunday: 10
5:00 p.m.
0:00 a.m. –
Monday: 1
5:00 p.m.
0:00 a.m. –
Tuesday: 1
219
Thank you
Recognizing ASTRO’s 2013 Corporate Members
.decimal
Acceletronics/Rad Parts
Accuray Incorporated
Advanced Particle Therapy
a-fabco Inc.
Aktina Medical Corporation
Alliance Oncology
AMAC
Amgen Inc.
architection PLLC
Bayer HealthCare
Pharmaceuticals
The Bergendahl Institute LLC
Biocompatibles Inc.
Boehringer Ingelheim
Pharmaceuticals
Brainlab AG
C. R. Bard Inc.
Cangene Corporation
Cianna Medical
CivaTech Oncology Inc.
CompHealth Locum Tenens
D3 Radiation Planning
Diacor Inc.
ELEKTA
Gammex Inc.
Genomic Health Inc.
Gold Anchor (Naslund Medical)
Healthcare Administrative
Partners
Hologic Inc.
IBA
InSightec
IntraOp Medical Corporation
IsoRay Medical Inc.
James L. Davis Inc.
Klarity Medical Products, LLC
Landauer Inc.
LAP of America LLC
Mick Radio-Nuclear
Instruments, Inc.
MIM Software Inc.
Mirada Medical
Mobius Medical Systems LP
MRP Inc.
NELCO
New Bedford Corporation
Oncure Medical Corporation
Philips Healthcare
Pitts Little Corp.
ProNova Solutions
Prowess Inc.
PTW
Qfix
Radiological Imaging
Technology (RIT)
RADMAX Ltd.
RaySearch Laboratories, AB
RC Billing
Revenue Cycle Inc.
ScandiDos AB
Sensus Healthcare
Shielding Construction
Solutions Inc.
Siemens Healthcare
Spectrum Pharmaceuticals
Standard Imaging
Vantage Oncology
Vertual Ltd.
ViewRay Inc.
Vision RT
VisionTree
Weatherby Healthcare
Xoft Inc.
Xstrahl Ltd.
CO R P O R AT E
M E M B E R

patients

Transcription

Similar documents

Program

Final Program - American Society for Radiation Oncology

merrell moc speed streak